1	DOI	NNP	O	DOI	_	0	SENT_1	[p1l81t84r142b109],
2	:	:	O	:	_	0	SENT_1	[p1l81t84r142b109],
3	10.1111	CD	NUMBER	10.1111	dep	1	SENT_1	[p1l160t84r672b115],
4	/	:	O	/	punct	5	SENT_1	[p1l160t84r672b115],
5	j.1468-3083	NN	DURATION	j.1468-3083	dep	3	SENT_1	[p1l160t84r672b115],
6	.2011.04313	CD	NUMBER	.2011.04313	num	5	SENT_1	[p1l160t84r672b115],
7	.	.	O	.	_	0	SENT_1	[p1l160t84r672b115],

1	X	NN	O	x	nn	2	SENT_2	[p1l160t84r672b115],
2	IEADV	NN	O	ieadv	_	0	SENT_2	[p1l1954t81r2082b114],

1	ORIGINAL	JJ	O	original	amod	2	SENT_3	[p1l80t209r271b240],
2	ARTICLE	NN	O	article	_	0	SENT_3	[p1l285t209r452b240],

1	Cutaneous	JJ	MISC	cutaneous	amod	4	SENT_4	[p1l80t292r399b339],
2	adverse	JJ	O	adverse	amod	4	SENT_4	[p1l423t293r656b339],
3	drug	NN	O	drug	nn	4	SENT_4	[p1l680t293r812b350],
4	reactions	NNS	O	reaction	dep	19	SENT_4	[p1l840t293r1113b339],
5	to	TO	O	to	_	0	SENT_4	[p1l1136t296r1194b339],
6	allopurinol	NN	O	allopurinol	prep_to	4	SENT_4	[p1l1219t293r1544b349],
7	:	:	O	:	_	0	SENT_4	[p1l1219t293r1544b349],
8	10	CD	DURATION	10	num	9	SENT_4	[p1l1573t293r1637b339],
9	year	NN	NUMBER	year	dep	4	SENT_4	[p1l1658t304r1787b349],
10	observational	JJ	O	observational	amod	11	SENT_4	[p1l80t367r478b413],
11	survey	NN	O	survey	dep	9	SENT_4	[p1l504t379r698b423],
12	of	IN	O	of	_	0	SENT_4	[p1l721t367r778b413],
13	the	DT	O	the	det	14	SENT_4	[p1l799t367r892b413],
14	dermatology	NN	O	dermatology	prep_of	4	SENT_4	[p1l916t367r1291b424],
15	department	NN	O	department	dep	19	SENT_4	[p1l1313t367r1656b423],
16	—	CD	NUMBER	—	num	15	SENT_4	[p1l1677t391r1709b399],
17	Cagliari	NNP	ORGANIZATION	Cagliari	nn	19	SENT_4	[p1l80t453r303b511],
18	University	NNP	ORGANIZATION	University	nn	19	SENT_4	[p1l331t454r623b510],
19	(	NNP	O	(	dep	29	SENT_4	[p1l647t453r802b510],
20	Italy	NNP	LOCATION	Italy	nn	23	SENT_4	[p1l647t453r802b510],
21	)	NNP	O	)	nn	23	SENT_4	[p1l647t453r802b510],
22	L.	NNP	PERSON	L.	nn	23	SENT_4	[p1l81t558r106b586],
23	Atzori	NNP	PERSON	Atzori	dep	19	SENT_4	[p1l121t551r264b591],
24	,	,	O	,	_	0	SENT_4	[p1l121t551r264b591],
25	t	NN	O	t	appos	23	SENT_4	[p1l121t551r264b591],
26	'	''	O	'	_	0	SENT_4	[p1l121t551r264b591],
27	*	CD	NUMBER	*	num	29	SENT_4	[p1l121t551r264b591],
28	A.L.	NNP	ORGANIZATION	A.L.	nn	29	SENT_4	[p1l277t559r340b586],
29	Pinna	NNP	ORGANIZATION	Pinna	dep	52	SENT_4	[p1l358t551r474b591],
30	,	,	O	,	_	0	SENT_4	[p1l358t551r474b591],
31	t	NN	O	t	nn	33	SENT_4	[p1l358t551r474b591],
32	L.	NNP	PERSON	L.	nn	33	SENT_4	[p1l490t559r516b586],
33	Mantovani	NNP	PERSON	Mantovani	appos	29	SENT_4	[p1l534t551r731b591],
34	,	,	O	,	_	0	SENT_4	[p1l534t551r731b591],
35	t	NN	O	t	nn	37	SENT_4	[p1l534t551r731b591],
36	C.	NNP	PERSON	C.	nn	37	SENT_4	[p1l745t558r778b587],
37	Ferreli	NNP	PERSON	Ferreli	appos	29	SENT_4	[p1l796t551r922b591],
38	,	,	O	,	_	0	SENT_4	[p1l796t551r922b591],
39	t	NN	O	t	nn	41	SENT_4	[p1l796t551r922b591],
40	M.	NN	PERSON	m.	nn	41	SENT_4	[p1l938t559r976b586],
41	Pau	NNP	PERSON	Pau	appos	29	SENT_4	[p1l994t551r1081b591],
42	,	,	O	,	_	0	SENT_4	[p1l994t551r1081b591],
43	t	NN	O	t	nn	44	SENT_4	[p1l994t551r1081b591],
44	M.	NN	PERSON	m.	appos	29	SENT_4	[p1l1097t559r1135b586],
45	Mulargia	NNP	PERSON	Mulargia	dep	44	SENT_4	[p1l1153t551r1319b594],
46	,	,	O	,	_	0	SENT_4	[p1l1153t551r1319b594],
47	*	CD	NUMBER	*	appos	29	SENT_4	[p1l1153t551r1319b594],
48	N.	NNP	PERSON	N.	nn	49	SENT_4	[p1l1335t559r1367b586],
49	Astet	NNP	PERSON	Astet	poss	52	SENT_4	[p1l1382t551r1472b586],
50	'	POS	O	'	_	0	SENT_4	[p1l79t605r249b640],
51	‘	NNP	O	‘	nn	52	SENT_4	[p1l79t605r249b640],
52	Department	NNP	ORGANIZATION	Department	dep	80	SENT_4	[p1l79t605r249b640],
53	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l261t611r286b635],
54	Dermatology	NNP	ORGANIZATION	Dermatology	nn	56	SENT_4	[p1l298t611r472b641],
55	,	,	O	,	_	0	SENT_4	[p1l298t611r472b641],
56	University	NNP	ORGANIZATION	University	prep_of	52	SENT_4	[p1l487t611r614b640],
57	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l625t611r650b635],
58	Cagliari	NNP	ORGANIZATION	Cagliari	nn	67	SENT_4	[p1l661t611r765b641],
59	,	,	O	,	_	0	SENT_4	[p1l661t611r765b641],
60	Cagliari	NNP	ORGANIZATION	Cagliari	appos	67	SENT_4	[p1l779t611r883b641],
61	,	,	O	,	_	0	SENT_4	[p1l779t611r883b641],
62	Italy	NNP	LOCATION	Italy	appos	67	SENT_4	[p1l899t611r949b640],
63	*	NNP	O	*	nn	67	SENT_4	[p1l79t650r207b680],
64	Cattedra	NNP	O	Cattedra	nn	67	SENT_4	[p1l79t650r207b680],
65	di	NNP	O	di	nn	67	SENT_4	[p1l219t656r240b680],
66	Genetica	NNP	ORGANIZATION	Genetica	nn	67	SENT_4	[p1l253t656r372b680],
67	Medica	NNP	ORGANIZATION	Medica	prep_of	56	SENT_4	[p1l384t656r486b684],
68	,	,	O	,	_	0	SENT_4	[p1l384t656r486b684],
69	University	NNP	ORGANIZATION	University	appos	67	SENT_4	[p1l501t656r628b686],
70	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l640t657r665b680],
71	Cagliari	NNP	ORGANIZATION	Cagliari	nn	77	SENT_4	[p1l675t656r779b686],
72	,	,	O	,	_	0	SENT_4	[p1l675t656r779b686],
73	Cagliari	NNP	ORGANIZATION	Cagliari	appos	77	SENT_4	[p1l794t656r897b686],
74	,	,	O	,	_	0	SENT_4	[p1l794t656r897b686],
75	Italy	NNP	LOCATION	Italy	appos	77	SENT_4	[p1l913t656r963b686],
76	*	NNP	O	*	nn	77	SENT_4	[p1l79t702r329b731],
77	Correspondence	NNP	O	Correspondence	prep_of	69	SENT_4	[p1l79t702r329b731],
78	:	:	O	:	_	0	SENT_4	[p1l79t702r329b731],
79	L.	NNP	PERSON	L.	nn	80	SENT_4	[p1l344t702r365b725],
80	Azori	NNP	PERSON	Azori	_	0	SENT_4	[p1l377t702r450b725],
81	.	.	O	.	_	0	SENT_4	[p1l377t702r450b725],

1	E-mails	NNS	O	e-mail	_	0	SENT_5	[p1l466t702r574b725],
2	:	:	O	:	_	0	SENT_5	[p1l466t702r574b725],
3	|	CD	NUMBER	|	num	5	SENT_5	[p1l588t702r860b729],
4	aura.atzori@libero.it;	NN	O	aura.atzori@libero.it;	nn	5	SENT_5	[p1l588t702r860b729],
5	atzoril@unica.it	NN	O	atzoril@unica.it	dep	1	SENT_5	[p1l874t702r1072b725],

1	Abstract	JJ	O	abstract	amod	3	SENT_6	[p1l78t806r246b835],
2	Background	NN	O	background	nn	3	SENT_6	[p1l80t856r276b886],
3	Allopurinol	NN	O	allopurinol	nsubjpass	6	SENT_6	[p1l306t856r459b887],
4	is	VBZ	O	be	auxpass	6	SENT_6	[p1l484t856r505b881],
5	extensively	RB	O	extensively	advmod	6	SENT_6	[p1l528t856r691b887],
6	prescribed	VBN	O	prescribe	_	0	SENT_6	[p1l713t856r868b887],
7	for	IN	O	for	_	0	SENT_6	[p1l891t856r931b881],
8	conditions	NNS	O	condition	prep_for	6	SENT_6	[p1l952t856r1104b881],
9	associated	VBN	O	associate	partmod	8	SENT_6	[p1l1127t856r1285b881],
10	with	IN	O	with	_	0	SENT_6	[p1l1308t856r1367b880],
11	urate	NN	O	urate	nn	12	SENT_6	[p1l1391t858r1465b881],
12	excess	NN	O	excess	prep_with	9	SENT_6	[p1l1487t862r1597b885],
13	,	,	O	,	_	0	SENT_6	[p1l1487t862r1597b885],
14	despite	IN	O	despite	_	0	SENT_6	[p1l1621t856r1729b887],
15	being	VBG	O	be	cop	16	SENT_6	[p1l1752t856r1831b887],
16	responsible	JJ	O	responsible	prepc_despite	9	SENT_6	[p1l80t901r248b933],
17	for	IN	O	for	mark	23	SENT_6	[p1l260t901r300b926],
18	severe	JJ	O	severe	amod	22	SENT_6	[p1l312t908r409b926],
19	cutaneous	JJ	O	cutaneous	amod	22	SENT_6	[p1l421t903r574b926],
20	adverse	JJ	O	adverse	amod	22	SENT_6	[p1l587t901r703b926],
21	drug	NN	O	drug	nn	22	SENT_6	[p1l715t901r781b933],
22	reactions	NNS	O	reaction	nsubj	23	SENT_6	[p1l795t901r929b926],
23	(	VBP	O	(	ccomp	16	SENT_6	[p1l942t901r1032b933],
24	ADR	NN	O	adr	nn	25	SENT_6	[p1l942t901r1032b933],
25	)	NN	O	)	dobj	23	SENT_6	[p1l942t901r1032b933],
26	.	.	O	.	_	0	SENT_6	[p1l942t901r1032b933],

1	Objective	NN	O	objective	nn	2	SENT_7	[p1l79t947r235b978],
2	A	NN	O	a	nn	4	SENT_7	[p1l263t947r285b972],
3	cross-sectional	JJ	O	cross-sectional	amod	4	SENT_7	[p1l306t947r529b972],
4	survey	NN	O	survey	nsubj	8	SENT_7	[p1l553t954r649b979],
5	of	IN	O	of	_	0	SENT_7	[p1l670t947r698b972],
6	allopurinol	NN	O	allopurinol	nn	7	SENT_7	[p1l719t947r869b979],
7	cases	NNS	O	case	prep_of	4	SENT_7	[p1l892t954r977b972],
8	observed	VBN	O	observe	_	0	SENT_7	[p1l999t947r1135b972],
9	at	IN	O	at	_	0	SENT_7	[p1l1158t949r1185b972],
10	the	DT	O	the	det	13	SENT_7	[p1l1206t947r1252b972],
11	main	JJ	O	main	amod	13	SENT_7	[p1l1275t947r1343b972],
12	Dermatology	NNP	O	Dermatology	nn	13	SENT_7	[p1l1368t947r1555b979],
13	Department	NNP	O	Department	prep_at	8	SENT_7	[p1l1578t947r1750b979],
14	with	IN	O	with	_	0	SENT_7	[p1l1772t947r1831b972],
15	inpatients	NNS	O	inpatient	nn	16	SENT_7	[p1l80t994r221b1025],
16	facilities	NNS	O	facility	prep_with	8	SENT_7	[p1l233t993r352b1019],
17	in	IN	O	in	_	0	SENT_7	[p1l366t994r387b1018],
18	southern	JJ	O	southern	amod	19	SENT_7	[p1l401t994r528b1019],
19	Sardinia	NNP	LOCATION	Sardinia	prep_in	8	SENT_7	[p1l542t993r669b1019],
20	.	.	O	.	_	0	SENT_7	[p1l542t993r669b1019],

1	(	NN	O	(	_	0	SENT_8	[p1l683t993r795b1025],
2	approx	RB	O	approx	advmod	1	SENT_8	[p1l683t993r795b1025],
3	560	CD	NUMBER	560	number	4	SENT_8	[p1l807t994r860b1019],
4	836	CD	NUMBER	836	num	5	SENT_8	[p1l873t994r926b1019],
5	inhabitants	NNS	O	inhabitant	dep	1	SENT_8	[p1l940t993r1116b1025],
6	)	CD	NUMBER	)	dep	5	SENT_8	[p1l940t993r1116b1025],
7	.	.	O	.	_	0	SENT_8	[p1l940t993r1116b1025],

1	Material	NN	O	material	nn	4	SENT_9	[p1l80t1039r213b1064],
2	and	CC	O	and	_	0	SENT_9	[p1l234t1039r293b1064],
3	methods	NNS	O	method	nn	4	SENT_9	[p1l314t1039r455b1064],
4	Data	NNS	O	datum	nn	5	SENT_9	[p1l486t1039r553b1064],
5	collection	NN	O	collection	nsubj	10	SENT_9	[p1l573t1039r712b1064],
6	of	IN	O	of	_	0	SENT_9	[p1l733t1039r761b1064],
7	all	DT	O	all	det	9	SENT_9	[p1l779t1039r809b1064],
8	consecutive	JJ	O	consecutive	amod	9	SENT_9	[p1l830t1039r1007b1064],
9	patients	NNS	O	patient	prep_of	5	SENT_9	[p1l1027t1039r1143b1070],
10	referred	VBN	O	refer	_	0	SENT_9	[p1l1163t1039r1276b1064],
11	for	IN	O	for	_	0	SENT_9	[p1l1296t1039r1336b1064],
12	ADR	NN	O	adr	prep_for	10	SENT_9	[p1l1353t1039r1420b1063],
13	between	IN	O	between	_	0	SENT_9	[p1l1441t1039r1565b1064],
14	2001	CD	DATE	2001	prep_between	12	SENT_9	[p1l1585t1039r1652b1064],
15	and	CC	DATE	and	_	0	SENT_9	[p1l1677t1039r1730b1064],
16	2010	CD	DATE	2010	conj_and	14	SENT_9	[p1l1751t1039r1830b1064],
17	.	.	O	.	_	0	SENT_9	[p1l1751t1039r1830b1064],

1	Causality	NNP	MISC	Causality	nn	2	SENT_10	[p1l79t1085r214b1117],
2	assessment	NN	O	assessment	nsubj	3	SENT_10	[p1l227t1087r403b1111],
3	followed	VBD	O	follow	_	0	SENT_10	[p1l415t1085r538b1111],
4	the	DT	O	the	dobj	3	SENT_10	[p1l551t1086r597b1111],
5	WHO	WP	O	who	nsubj	6	SENT_10	[p1l610t1085r689b1111],
6	Collaborating	VBG	O	collaborate	rcmod	4	SENT_10	[p1l703t1085r898b1117],
7	Centre	NNP	O	Centre	dobj	6	SENT_10	[p1l912t1085r1010b1111],
8	for	IN	O	for	_	0	SENT_10	[p1l1022t1085r1062b1111],
9	Drug	NNP	O	Drug	nn	11	SENT_10	[p1l1076t1086r1144b1117],
10	Monitoring	VBG	O	monitor	amod	11	SENT_10	[p1l1160t1086r1314b1117],
11	criteria	NNS	O	criterion	prep_for	7	SENT_10	[p1l1329t1086r1435b1115],
12	;	:	O	;	_	0	SENT_10	[p1l1329t1086r1435b1115],
13	illness	NN	O	illness	nn	15	SENT_10	[p1l1451t1086r1540b1111],
14	severity	NN	O	severity	nn	15	SENT_10	[p1l1553t1086r1667b1117],
15	score	NN	NUMBER	score	nsubjpass	17	SENT_10	[p1l1679t1092r1760b1111],
16	was	VBD	O	be	auxpass	17	SENT_10	[p1l1773t1092r1832b1111],
17	adopted	VBN	O	adopt	parataxis	3	SENT_10	[p1l79t1131r201b1163],
18	for	IN	O	for	_	0	SENT_10	[p1l214t1131r253b1156],
19	toxic	JJ	O	toxic	amod	21	SENT_10	[p1l264t1131r335b1156],
20	epidermal	JJ	O	epidermal	amod	21	SENT_10	[p1l348t1131r492b1163],
21	necrolysis	NN	O	necrolysis	prep_for	17	SENT_10	[p1l507t1131r653b1163],
22	(	CD	NUMBER	(	num	24	SENT_10	[p1l666t1131r845b1163],
23	SCORTEN	NN	O	scorten	nn	24	SENT_10	[p1l666t1131r845b1163],
24	)	NN	O	)	dep	21	SENT_10	[p1l666t1131r845b1163],
25	.	.	O	.	_	0	SENT_10	[p1l666t1131r845b1163],

1	Results	NNS	O	result	nsubj	14	SENT_11	[p1l80t1177r202b1202],
2	Allopurinol	NNP	O	Allopurinol	nsubj	6	SENT_11	[p1l230t1177r384b1208],
3	was	VBD	O	be	cop	6	SENT_11	[p1l401t1183r460b1202],
4	the	DT	O	the	det	6	SENT_11	[p1l476t1177r522b1202],
5	culprit	NN	O	culprit	nn	6	SENT_11	[p1l539t1177r629b1208],
6	drug	NN	O	drug	rcmod	1	SENT_11	[p1l646t1177r711b1208],
7	in	IN	O	in	_	0	SENT_11	[p1l730t1177r752b1201],
8	84	CD	NUMBER	84	prep_in	6	SENT_11	[p1l770t1177r805b1202],
9	of	IN	O	of	_	0	SENT_11	[p1l822t1177r850b1202],
10	780	CD	NUMBER	780	num	13	SENT_11	[p1l867t1177r919b1202],
11	cutaneous	JJ	O	cutaneous	amod	13	SENT_11	[p1l936t1179r1089b1202],
12	ADR	NN	O	adr	nn	13	SENT_11	[p1l1105t1177r1172b1201],
13	cases	NNS	O	case	prep_of	6	SENT_11	[p1l1189t1183r1274b1202],
14	(	VBP	O	(	_	0	SENT_11	[p1l1292t1177r1403b1208],
15	10.7	CD	PERCENT	10.7	num	16	SENT_11	[p1l1292t1177r1403b1208],
16	%	NN	PERCENT	%	dobj	14	SENT_11	[p1l1292t1177r1403b1208],
17	;	:	O	;	_	0	SENT_11	[p1l1292t1177r1403b1208],
18	8.4	CD	NUMBER	8.4	num	20	SENT_11	[p1l1422t1177r1466b1202],
19	cases/year	JJ	O	cases/year	amod	20	SENT_11	[p1l1479t1177r1661b1208],
20	)	NN	O	)	dep	16	SENT_11	[p1l1479t1177r1661b1208],
21	.	.	O	.	_	0	SENT_11	[p1l1479t1177r1661b1208],

1	Mean	NN	O	mean	nn	2	SENT_12	[p1l1681t1177r1761b1202],
2	age	NN	O	age	nsubj	5	SENT_12	[p1l1778t1183r1832b1208],
3	was	VBD	O	be	cop	5	SENT_12	[p1l79t1230r137b1249],
4	74	CD	DURATION	74	num	5	SENT_12	[p1l158t1224r193b1248],
5	years	NNS	NUMBER	year	ccomp	13	SENT_12	[p1l205t1230r291b1255],
6	,	,	O	,	_	0	SENT_12	[p1l205t1230r291b1255],
7	58	CD	PERCENT	58	num	8	SENT_12	[p1l314t1223r380b1249],
8	%	NN	PERCENT	%	nsubj	13	SENT_12	[p1l314t1223r380b1249],
9	of	IN	O	of	_	0	SENT_12	[p1l403t1223r431b1249],
10	the	DT	O	the	det	11	SENT_12	[p1l450t1224r496b1249],
11	patients	NNS	O	patient	prep_of	8	SENT_12	[p1l518t1224r634b1255],
12	were	VBD	O	be	cop	13	SENT_12	[p1l654t1230r725b1249],
13	female	JJ	O	female	_	0	SENT_12	[p1l745t1223r851b1253],
14	,	,	O	,	_	0	SENT_12	[p1l745t1223r851b1253],
15	95	CD	PERCENT	95	num	16	SENT_12	[p1l874t1223r940b1249],
16	%	NN	PERCENT	%	dep	13	SENT_12	[p1l874t1223r940b1249],
17	of	IN	O	of	_	0	SENT_12	[p1l963t1223r991b1249],
18	patients	NNS	O	patient	prep_of	16	SENT_12	[p1l1012t1224r1127b1255],
19	required	VBN	O	require	partmod	18	SENT_12	[p1l1149t1224r1268b1255],
20	hospitalization	NN	O	hospitalization	dobj	19	SENT_12	[p1l1291t1224r1508b1255],
21	.	.	O	.	_	0	SENT_12	[p1l1291t1224r1508b1255],

1	Clinical	JJ	O	clinical	amod	2	SENT_13	[p1l1531t1223r1636b1249],
2	forms	NNS	O	form	nsubj	5	SENT_13	[p1l1657t1223r1740b1249],
3	were	VBD	O	be	cop	5	SENT_13	[p1l1761t1230r1832b1249],
4	maculo-papular	JJ	O	maculo-papular	amod	5	SENT_13	[p1l80t1269r312b1301],
5	eruptions	NNS	O	eruption	dep	6	SENT_13	[p1l326t1269r463b1301],
6	(	VBP	O	(	_	0	SENT_13	[p1l478t1269r521b1301],
7	34	CD	NUMBER	34	num	8	SENT_13	[p1l478t1269r521b1301],
8	cases	NNS	O	case	dobj	6	SENT_13	[p1l536t1269r638b1301],
9	)	RB	O	)	advmod	8	SENT_13	[p1l536t1269r638b1301],
10	,	,	O	,	_	0	SENT_13	[p1l536t1269r638b1301],
11	Stevens-Johnson	NNP	MISC	Stevens-Johnson	nn	14	SENT_13	[p1l655t1269r911b1295],
12	Syndrome/Toxic	NNP	MISC	Syndrome/Toxic	nn	14	SENT_13	[p1l927t1269r1175b1301],
13	Epidermal	NNP	MISC	Epidermal	nn	14	SENT_13	[p1l1191t1269r1337b1301],
14	Necrolysis	NNP	MISC	Necrolysis	appos	8	SENT_13	[p1l1354t1269r1505b1301],
15	(	CD	NUMBER	(	num	17	SENT_13	[p1l1521t1269r1558b1301],
16	31	CD	NUMBER	31	num	17	SENT_13	[p1l1521t1269r1558b1301],
17	cases	NNS	O	case	dep	14	SENT_13	[p1l1579t1269r1681b1301],
18	)	RB	O	)	advmod	14	SENT_13	[p1l1579t1269r1681b1301],
19	,	,	O	,	_	0	SENT_13	[p1l1579t1269r1681b1301],
20	vasculitis	NN	O	vasculitis	appos	8	SENT_13	[p1l1697t1269r1832b1294],
21	(	CD	NUMBER	(	num	20	SENT_13	[p1l79t1315r127b1347],
22	six	CD	NUMBER	six	num	23	SENT_13	[p1l79t1315r127b1347],
23	cases	NNS	O	case	tmod	20	SENT_13	[p1l158t1315r259b1347],
24	)	RB	O	)	advmod	23	SENT_13	[p1l158t1315r259b1347],
25	,	,	O	,	_	0	SENT_13	[p1l158t1315r259b1347],
26	Drug	NN	O	drug	appos	8	SENT_13	[p1l292t1315r360b1347],
27	Rash	NNP	O	Rash	nn	28	SENT_13	[p1l393t1315r464b1340],
28	Eosinophilia	NNP	O	Eosinophilia	nsubj	32	SENT_13	[p1l497t1315r673b1347],
29	and	CC	O	and	_	0	SENT_13	[p1l702t1315r755b1340],
30	Systemic	JJ	O	systemic	amod	31	SENT_13	[p1l787t1315r921b1347],
31	Symptoms	NNS	O	symptom	conj_and	28	SENT_13	[p1l952t1315r1111b1347],
32	(	VBP	O	(	rcmod	26	SENT_13	[p1l1141t1315r1265b1347],
33	DRESS	NN	O	dress	dobj	32	SENT_13	[p1l1141t1315r1265b1347],
34	)	CD	NUMBER	)	number	35	SENT_13	[p1l1141t1315r1265b1347],
35	(	CD	NUMBER	(	dep	33	SENT_13	[p1l1297t1315r1379b1347],
36	three	CD	NUMBER	three	num	37	SENT_13	[p1l1297t1315r1379b1347],
37	cases	NNS	O	case	dep	35	SENT_13	[p1l1409t1315r1510b1347],
38	)	RB	O	)	advmod	32	SENT_13	[p1l1409t1315r1510b1347],
39	,	,	O	,	_	0	SENT_13	[p1l1409t1315r1510b1347],
40	Acute	JJ	O	acute	amod	43	SENT_13	[p1l1541t1315r1627b1340],
41	Generalized	NNP	O	Generalized	nn	43	SENT_13	[p1l1657t1315r1831b1340],
42	Exanthematous	NNP	O	Exanthematous	nn	43	SENT_13	[p1l80t1362r308b1387],
43	Pustolosis	NNP	O	Pustolosis	appos	8	SENT_13	[p1l323t1362r473b1387],
44	(	CD	NUMBER	(	num	45	SENT_13	[p1l487t1361r590b1393],
45	AGEP	NN	O	agep	dep	43	SENT_13	[p1l487t1361r590b1393],
46	)	CD	NUMBER	)	num	49	SENT_13	[p1l487t1361r590b1393],
47	(	CD	NUMBER	(	num	49	SENT_13	[p1l604t1361r687b1393],
48	three	CD	NUMBER	three	num	49	SENT_13	[p1l604t1361r687b1393],
49	cases	NNS	O	case	dep	45	SENT_13	[p1l701t1361r802b1393],
50	)	RB	O	)	advmod	45	SENT_13	[p1l701t1361r802b1393],
51	,	,	O	,	_	0	SENT_13	[p1l701t1361r802b1393],
52	Pityriasis	NNP	O	Pityriasis	nn	54	SENT_13	[p1l819t1362r948b1393],
53	rosea-like	JJ	O	rosea-like	amod	54	SENT_13	[p1l963t1362r1105b1387],
54	eruption	NN	O	eruption	appos	8	SENT_13	[p1l1119t1362r1238b1393],
55	(	CD	NUMBER	(	number	56	SENT_13	[p1l1253t1361r1336b1393],
56	three	CD	NUMBER	three	num	57	SENT_13	[p1l1253t1361r1336b1393],
57	cases	NNS	O	case	dep	54	SENT_13	[p1l1349t1361r1451b1393],
58	)	RB	O	)	advmod	57	SENT_13	[p1l1349t1361r1451b1393],
59	,	,	O	,	_	0	SENT_13	[p1l1349t1361r1451b1393],
60	lichenoid	JJ	O	lichenoid	amod	61	SENT_13	[p1l1468t1362r1597b1387],
61	dermatitis	NN	O	dermatitis	appos	8	SENT_13	[p1l1612t1362r1756b1387],
62	(	CD	NUMBER	(	num	64	SENT_13	[p1l1771t1361r1832b1393],
63	two	CD	NUMBER	two	num	64	SENT_13	[p1l1771t1361r1832b1393],
64	cases	NNS	O	case	tmod	61	SENT_13	[p1l79t1407r181b1438],
65	)	RB	O	)	advmod	64	SENT_13	[p1l79t1407r181b1438],
66	,	,	O	,	_	0	SENT_13	[p1l79t1407r181b1438],
67	fixed	VBN	O	fix	amod	69	SENT_13	[p1l202t1407r272b1432],
68	drug	NN	O	drug	nn	69	SENT_13	[p1l293t1407r358b1438],
69	eruption	NN	O	eruption	appos	8	SENT_13	[p1l379t1407r499b1438],
70	(	CD	NUMBER	(	number	71	SENT_13	[p1l520t1407r582b1438],
71	one	CD	NUMBER	one	nsubj	6	SENT_13	[p1l520t1407r582b1438],
72	case	NN	O	case	dep	71	SENT_13	[p1l602t1407r687b1438],
73	)	CD	NUMBER	)	num	72	SENT_13	[p1l602t1407r687b1438],
74	,	,	O	,	_	0	SENT_13	[p1l602t1407r687b1438],
75	erythroderma	FW	O	erythroderma	nn	76	SENT_13	[p1l709t1407r906b1438],
76	(	FW	O	(	amod	78	SENT_13	[p1l927t1407r988b1438],
77	one	CD	NUMBER	one	num	78	SENT_13	[p1l927t1407r988b1438],
78	case	NN	O	case	appos	71	SENT_13	[p1l1008t1407r1093b1438],
79	)	CD	NUMBER	)	dep	78	SENT_13	[p1l1008t1407r1093b1438],
80	.	.	O	.	_	0	SENT_13	[p1l1008t1407r1093b1438],

1	The	DT	O	the	det	2	SENT_14	[p1l1114t1407r1169b1432],
2	indication	NN	O	indication	nsubj	8	SENT_14	[p1l1190t1407r1330b1432],
3	for	IN	O	for	_	0	SENT_14	[p1l1350t1407r1390b1432],
4	allopurinol	NN	O	allopurinol	nn	5	SENT_14	[p1l1409t1407r1558b1438],
5	prescription	NN	O	prescription	prep_for	2	SENT_14	[p1l1580t1407r1752b1438],
6	was	VBD	O	be	cop	8	SENT_14	[p1l1773t1413r1832b1432],
7	asymptomatic	JJ	O	asymptomatic	amod	8	SENT_14	[p1l79t1453r287b1484],
8	hyper-uricemia	NN	O	hyper-uricemia	_	0	SENT_14	[p1l307t1453r527b1484],
9	in	IN	O	in	_	0	SENT_14	[p1l546t1453r568b1477],
10	95	CD	PERCENT	95	num	11	SENT_14	[p1l587t1453r653b1478],
11	%	NN	PERCENT	%	prep_in	8	SENT_14	[p1l587t1453r653b1478],
12	of	IN	O	of	_	0	SENT_14	[p1l674t1453r702b1478],
13	the	DT	O	the	det	14	SENT_14	[p1l718t1453r764b1478],
14	patients	NNS	O	patient	prep_of	11	SENT_14	[p1l783t1453r906b1484],
15	.	.	O	.	_	0	SENT_14	[p1l783t1453r906b1484],

1	Twelve	CD	NUMBER	twelve	num	2	SENT_15	[p1l925t1453r1029b1478],
2	patients	NNS	O	patient	nsubj	3	SENT_15	[p1l1048t1453r1164b1484],
3	were	VBD	O	be	_	0	SENT_15	[p1l1182t1459r1253b1478],
4	under	IN	O	under	_	0	SENT_15	[p1l1272t1453r1356b1478],
5	allopurinol	NN	O	allopurinol	nn	7	SENT_15	[p1l1373t1453r1522b1484],
6	dosage	NN	O	dosage	nn	7	SENT_15	[p1l1542t1453r1650b1484],
7	adjustment	NN	O	adjustment	prep_under	3	SENT_15	[p1l1669t1453r1832b1484],
8	according	VBG	O	accord	_	0	SENT_15	[p1l79t1499r224b1530],
9	to	TO	O	to	prepc_according_to	3	SENT_15	[p1l237t1500r266b1523],
10	creatinine	NN	O	creatinine	nn	11	SENT_15	[p1l279t1499r421b1523],
11	clearance	NN	O	clearance	pobj	3	SENT_15	[p1l434t1499r584b1523],
12	.	.	O	.	_	0	SENT_15	[p1l434t1499r584b1523],

1	Final	JJ	O	final	amod	3	SENT_16	[p1l600t1499r665b1523],
2	causality	NN	O	causality	nn	3	SENT_16	[p1l679t1499r808b1530],
3	assessment	NN	O	assessment	nsubj	13	SENT_16	[p1l820t1500r996b1523],
4	was	VBD	O	be	cop	5	SENT_16	[p1l1008t1505r1066b1523],
5	definite	JJ	O	definite	_	0	SENT_16	[p1l1079t1499r1186b1523],
6	for	IN	O	for	_	0	SENT_16	[p1l1198t1499r1238b1523],
7	12	CD	PERCENT	12	num	8	SENT_16	[p1l1252t1499r1316b1524],
8	%	NN	PERCENT	%	prep_for	5	SENT_16	[p1l1252t1499r1316b1524],
9	of	IN	O	of	_	0	SENT_16	[p1l1330t1499r1359b1523],
10	the	DT	O	the	det	11	SENT_16	[p1l1369t1499r1415b1523],
11	cases	NNS	O	case	prep_of	8	SENT_16	[p1l1428t1505r1513b1523],
12	and	CC	O	and	_	0	SENT_16	[p1l1526t1499r1579b1523],
13	probable	JJ	O	probable	conj_and	5	SENT_16	[p1l1594t1499r1724b1530],
14	for	IN	O	for	_	0	SENT_16	[p1l1735t1499r1775b1523],
15	the	DT	O	the	det	18	SENT_16	[p1l1786t1499r1832b1523],
16	remaining	VBG	O	remain	amod	18	SENT_16	[p1l80t1544r222b1576],
17	88	CD	PERCENT	88	num	18	SENT_16	[p1l238t1544r313b1570],
18	%	NN	PERCENT	%	prep_for	13	SENT_16	[p1l238t1544r313b1570],
19	.	.	O	.	_	0	SENT_16	[p1l238t1544r313b1570],

1	Full	JJ	O	full	amod	2	SENT_17	[p1l332t1544r379b1569],
2	recovery	NN	O	recovery	nsubjpass	4	SENT_17	[p1l396t1551r523b1576],
3	was	VBD	O	be	auxpass	4	SENT_17	[p1l537t1551r595b1569],
4	achieved	VBN	O	achieve	_	0	SENT_17	[p1l611t1544r741b1569],
5	in	IN	O	in	_	0	SENT_17	[p1l759t1544r781b1569],
6	88	CD	PERCENT	88	num	7	SENT_17	[p1l797t1544r863b1570],
7	%	NN	PERCENT	%	prep_in	4	SENT_17	[p1l797t1544r863b1570],
8	of	IN	O	of	_	0	SENT_17	[p1l880t1544r908b1569],
9	subjects	NNS	O	subject	prep_of	7	SENT_17	[p1l922t1544r1053b1576],
10	;	:	O	;	_	0	SENT_17	[p1l922t1544r1053b1576],
11	ten	CD	NUMBER	ten	num	14	SENT_17	[p1l1069t1546r1114b1569],
12	SJS/T	NNP	O	SJS/T	nn	14	SENT_17	[p1l1130t1544r1225b1569],
13	EN	NN	O	en	nn	14	SENT_17	[p1l1227t1544r1267b1569],
14	patients	NNS	O	patient	nsubj	15	SENT_17	[p1l1285t1544r1400b1576],
15	died	VBD	O	die	parataxis	4	SENT_17	[p1l1416t1544r1477b1569],
16	(	CD	PERCENT	(	num	20	SENT_17	[p1l1494t1544r1568b1576],
17	12	CD	PERCENT	12	number	18	SENT_17	[p1l1494t1544r1568b1576],
18	%	NN	PERCENT	%	amod	20	SENT_17	[p1l1494t1544r1568b1576],
19	overall	JJ	O	overall	amod	20	SENT_17	[p1l1586t1544r1680b1569],
20	mortality	NN	O	mortality	dobj	15	SENT_17	[p1l1697t1544r1830b1576],
21	;	:	O	;	_	0	SENT_17	[p1l1697t1544r1830b1576],
22	32	CD	PERCENT	32	number	23	SENT_17	[p1l79t1590r145b1616],
23	%	NN	PERCENT	%	amod	24	SENT_17	[p1l79t1590r145b1616],
24	mortality	NN	O	mortality	dep	20	SENT_17	[p1l161t1591r286b1622],
25	of	IN	O	of	_	0	SENT_17	[p1l299t1590r327b1616],
26	the	DT	O	the	det	29	SENT_17	[p1l338t1591r384b1616],
27	SJS/T	NNP	O	SJS/T	nn	29	SENT_17	[p1l396t1590r492b1616],
28	EN	NN	O	en	nn	29	SENT_17	[p1l494t1591r534b1615],
29	cases	NNS	O	case	prep_of	24	SENT_17	[p1l548t1590r649b1622],
30	)	CD	NUMBER	)	tmod	15	SENT_17	[p1l548t1590r649b1622],
31	.	.	O	.	_	0	SENT_17	[p1l548t1590r649b1622],

1	Conclusion	NN	O	conclusion	nsubj	11	SENT_18	[p1l79t1636r262b1661],
2	Considering	VBG	O	consider	_	0	SENT_18	[p1l293t1636r468b1668],
3	the	DT	O	the	det	5	SENT_18	[p1l483t1636r529b1661],
4	populations	NNS	O	population	nn	5	SENT_18	[p1l544t1636r715b1668],
5	size	NN	O	size	prep_considering	1	SENT_18	[p1l730t1636r786b1661],
6	of	IN	O	of	_	0	SENT_18	[p1l801t1636r829b1661],
7	Southern	NNP	LOCATION	Southern	nn	8	SENT_18	[p1l843t1636r975b1662],
8	Sardinia	NNP	LOCATION	Sardinia	prep_of	5	SENT_18	[p1l990t1636r1117b1666],
9	,	,	O	,	_	0	SENT_18	[p1l990t1636r1117b1666],
10	is	VBZ	O	be	cop	11	SENT_18	[p1l1135t1636r1156b1661],
11	plausible	JJ	O	plausible	_	0	SENT_18	[p1l1172t1636r1301b1668],
12	that	IN	O	that	complm	13	SENT_18	[p1l1315t1636r1371b1661],
13	1.5	CD	NUMBER	1.5	dep	11	SENT_18	[p1l1388t1637r1460b1661],
14	/	:	O	/	punct	13	SENT_18	[p1l1388t1637r1460b1661],
15	1	CD	NUMBER	1	num	17	SENT_18	[p1l1388t1637r1460b1661],
16	oo	NN	O	oo	nn	17	SENT_18	[p1l1468t1637r1502b1661],
17	ooo	NN	O	ooo	nsubjpass	21	SENT_18	[p1l1515t1637r1568b1661],
18	Sardinian	NNP	MISC	Sardinian	dep	17	SENT_18	[p1l1583t1636r1720b1662],
19	will	MD	O	will	aux	21	SENT_18	[p1l1735t1636r1780b1661],
20	be	VB	O	be	auxpass	21	SENT_18	[p1l1797t1636r1832b1661],
21	affected	VBN	O	affect	dep	13	SENT_18	[p1l79t1682r197b1707],
22	by	IN	O	by	_	0	SENT_18	[p1l212t1682r247b1714],
23	allopurinol	NN	O	allopurinol	nn	25	SENT_18	[p1l259t1682r408b1714],
24	related	JJ	O	related	amod	25	SENT_18	[p1l423t1682r522b1707],
25	ADR	NN	O	adr	agent	21	SENT_18	[p1l534t1682r601b1707],
26	per	IN	O	per	_	0	SENT_18	[p1l615t1689r662b1714],
27	year	NN	DURATION	year	prep_per	25	SENT_18	[p1l674t1689r744b1714],
28	.	.	O	.	_	0	SENT_18	[p1l674t1689r744b1714],

1	Advanced	NNP	O	Advanced	nn	2	SENT_19	[p1l757t1682r905b1707],
2	age	NN	O	age	nsubj	11	SENT_19	[p1l919t1689r980b1714],
3	,	,	O	,	_	0	SENT_19	[p1l919t1689r980b1714],
4	and	CC	O	and	_	0	SENT_19	[p1l994t1682r1047b1707],
5	inappropriate	JJ	O	inappropriate	amod	7	SENT_19	[p1l1063t1682r1257b1714],
6	allopurinol	NN	O	allopurinol	nn	7	SENT_19	[p1l1270t1682r1419b1714],
7	prescription	NN	O	prescription	conj_and	2	SENT_19	[p1l1434t1682r1607b1714],
8	were	VBD	O	be	cop	11	SENT_19	[p1l1620t1689r1691b1707],
9	the	DT	O	the	det	11	SENT_19	[p1l1703t1682r1749b1707],
10	main	JJ	O	main	amod	11	SENT_19	[p1l1763t1682r1831b1707],
11	conditions	NNS	O	condition	_	0	SENT_19	[p1l79t1729r231b1754],
12	affecting	VBG	O	affect	partmod	11	SENT_19	[p1l244t1729r369b1760],
13	morbidity	NN	O	morbidity	dobj	12	SENT_19	[p1l384t1729r521b1760],
14	and	CC	O	and	_	0	SENT_19	[p1l533t1729r586b1754],
15	mortality	NN	O	mortality	conj_and	13	SENT_19	[p1l601t1729r734b1760],
16	.	.	O	.	_	0	SENT_19	[p1l601t1729r734b1760],

1	Received	VBN	O	receive	_	0	SENT_20	[p1l80t1774r223b1799],
2	:	:	O	:	_	0	SENT_20	[p1l80t1774r223b1799],
3	4	CD	DATE	4	num	4	SENT_20	[p1l237t1774r254b1798],
4	February	NNP	DATE	February	dobj	1	SENT_20	[p1l268t1774r397b1805],
5	2011	CD	DATE	2011	num	4	SENT_20	[p1l409t1774r489b1803],
6	;	:	O	;	_	0	SENT_20	[p1l409t1774r489b1803],
7	Accepted	JJ	O	accepted	dep	4	SENT_20	[p1l502t1774r651b1805],
8	:	:	O	:	_	0	SENT_20	[p1l502t1774r651b1805],
9	29	CD	DATE	29	num	10	SENT_20	[p1l666t1774r700b1799],
10	September	NNP	DATE	September	dep	4	SENT_20	[p1l714t1774r877b1805],
11	2011	CD	DATE	2011	num	10	SENT_20	[p1l889t1774r955b1799],

1	Conflicts	NNS	O	conflict	_	0	SENT_21	[p1l80t1880r253b1909],
2	of	IN	O	of	_	0	SENT_21	[p1l269t1880r306b1909],
3	interest	NN	O	interest	nn	4	SENT_21	[p1l322t1880r473b1909],
4	None	NN	O	none	prep_of	1	SENT_21	[p1l80t1930r164b1955],
5	.	.	O	.	_	0	SENT_21	[p1l80t1930r164b1955],

1	Funding	NNP	O	Funding	nn	2	SENT_22	[p1l80t2030r235b2066],
2	sources	NNS	O	source	_	0	SENT_22	[p1l251t2037r406b2059],
3	None	NN	O	none	dep	2	SENT_22	[p1l80t2080r164b2105],
4	.	.	O	.	_	0	SENT_22	[p1l80t2080r164b2105],

1	Introduction	NN	O	introduction	nn	2	SENT_23	[p1l81t2213r318b2242],
2	itor	NN	O	itor	dep	17	SENT_23	[p1l1105t2216r1156b2242],
3	and	CC	O	and	_	0	SENT_23	[p1l1171t2215r1224b2242],
4	considered	VBN	O	consider	conj_and	2	SENT_23	[p1l1239t2215r1395b2242],
5	as	IN	O	as	_	0	SENT_23	[p1l1409t2225r1436b2242],
6	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_23	[p1l1451t2215r1507b2242],
7	choice	NN	O	choice	nn	8	SENT_23	[p1l1522t2215r1613b2242],
8	therapy	NN	O	therapy	prep_as	4	SENT_23	[p1l1627t2215r1738b2251],
9	worldwide	RB	O	worldwide	advmod	4	SENT_23	[p1l1749t2215r1902b2242],
10	in	IN	O	in	_	0	SENT_23	[p1l1917t2216r1945b2242],
11	the	DT	O	the	det	13	SENT_23	[p1l1959t2215r2004b2242],
12	preSevere	JJ	O	presevere	amod	13	SENT_23	[p1l2018t2224r2076b2251, p1l79t2263r170b2288],
13	skin	NN	O	skin	prep_in	4	SENT_23	[p1l184t2261r242b2288],
14	adverse	JJ	O	adverse	amod	16	SENT_23	[p1l256t2261r362b2288],
15	drug	NN	O	drug	nn	16	SENT_23	[p1l376t2261r444b2297],
16	reactions	NNS	O	reaction	nsubj	17	SENT_23	[p1l457t2262r586b2288],
17	(	VBP	O	(	_	0	SENT_23	[p1l602t2261r696b2294],
18	ADR	NN	O	adr	nn	19	SENT_23	[p1l602t2261r696b2294],
19	)	NN	O	)	nsubj	23	SENT_23	[p1l602t2261r696b2294],
20	are	VBP	O	be	cop	23	SENT_23	[p1l713t2271r756b2288],
21	a	DT	O	a	det	23	SENT_23	[p1l770t2271r785b2288],
22	frequent	JJ	O	frequent	amod	23	SENT_23	[p1l798t2261r920b2297],
23	cause	NN	O	cause	ccomp	17	SENT_23	[p1l934t2271r1010b2288],
24	of	IN	O	of	_	0	SENT_23	[p1l1024t2261r1057b2288],
25	vention	NN	O	vention	prep_of	23	SENT_23	[p1l1104t2262r1214b2288],
26	and	CC	O	and	_	0	SENT_23	[p1l1228t2261r1281b2288],
27	treatment	NN	O	treatment	prep_of	23	SENT_23	[p1l1294t2267r1435b2288],
28	of	IN	O	of	_	0	SENT_23	[p1l1449t2261r1481b2288],
29	conditions	NNS	O	condition	prep_of	23	SENT_23	[p1l1491t2261r1643b2288],
30	with	IN	O	with	_	0	SENT_23	[p1l1656t2261r1721b2288],
31	uric	JJ	O	uric	amod	33	SENT_23	[p1l1734t2262r1791b2288],
32	acid	NN	O	acid	nn	33	SENT_23	[p1l1804t2261r1863b2288],
33	excess	NN	O	excess	prep_with	29	SENT_23	[p1l1877t2271r1969b2288],
34	.	.	O	.	_	0	SENT_23	[p1l1877t2271r1969b2288],

1	Minor	JJ	O	minor	amod	2	SENT_24	[p1l1984t2262r2078b2288],
2	morbidity	NN	O	morbidity	nsubjpass	9	SENT_24	[p1l79t2307r225b2343],
3	and	CC	O	and	_	0	SENT_24	[p1l236t2307r290b2335],
4	mortality	NN	O	mortality	conj_and	2	SENT_24	[p1l302t2307r437b2343],
5	and	CC	O	and	_	0	SENT_24	[p1l448t2307r502b2335],
6	allopurinol	NN	O	allopurinol	conj_and	2	SENT_24	[p1l514t2307r674b2343],
7	has	VBZ	O	have	aux	9	SENT_24	[p1l685t2307r732b2335],
8	been	VBN	O	be	auxpass	9	SENT_24	[p1l744t2307r812b2335],
9	reported	VBN	O	report	_	0	SENT_24	[p1l824t2307r948b2343],
10	as	IN	O	as	_	0	SENT_24	[p1l960t2317r987b2335],
11	one	CD	NUMBER	one	num	12	SENT_24	[p1l1000t2317r1052b2335],
12	reactions	NNS	O	reaction	prep_as	9	SENT_24	[p1l1105t2308r1233b2335],
13	presenting	VBG	O	present	partmod	12	SENT_24	[p1l1253t2308r1404b2343],
14	as	IN	O	as	mark	18	SENT_24	[p1l1423t2317r1450b2335],
15	skin	NN	O	skin	nn	16	SENT_24	[p1l1470t2307r1528b2335],
16	rash	NN	O	rash	nsubjpass	18	SENT_24	[p1l1548t2307r1608b2335],
17	are	VBP	O	be	auxpass	18	SENT_24	[p1l1627t2317r1670b2335],
18	reported	VBN	O	report	advcl	13	SENT_24	[p1l1689t2307r1814b2343],
19	in	IN	O	in	dep	18	SENT_24	[p1l1832t2308r1861b2334],
20	about	IN	O	about	_	0	SENT_24	[p1l1880t2307r1963b2335],
21	20/0	CD	NUMBER	20/0	prep_about	18	SENT_24	[p1l1983t2309r2029b2335],
22	of	IN	O	of	prep	21	SENT_24	[p1l2050t2307r2082b2335],
23	of	IN	O	of	pcomp	22	SENT_24	[p1l79t2353r112b2381],
24	the	DT	O	the	det	27	SENT_24	[p1l118t2353r163b2380],
25	major	JJ	O	major	amod	27	SENT_24	[p1l174t2354r260b2389],
26	responsable	JJ	O	responsable	amod	27	SENT_24	[p1l271t2347r486b2389],
27	.1	NN	NUMBER	.1	pobj	23	SENT_24	[p1l271t2347r486b2389],
28	'	''	O	'	_	0	SENT_24	[p1l271t2347r486b2389],
29	5	CD	NUMBER	5	tmod	18	SENT_24	[p1l271t2347r486b2389],
30	This	DT	O	this	det	31	SENT_24	[p1l497t2353r560b2381],
31	drug	NN	O	drug	nsubj	36	SENT_24	[p1l572t2353r639b2389],
32	is	VBZ	O	be	cop	36	SENT_24	[p1l650t2354r671b2381],
33	a	DT	O	a	det	36	SENT_24	[p1l683t2363r698b2380],
34	Xanthine	NN	O	xanthine	nn	36	SENT_24	[p1l708t2353r834b2380],
35	oxidase	NN	O	oxidase	nn	36	SENT_24	[p1l846t2353r952b2381],
36	inhib	NN	O	inhib	rcmod	29	SENT_24	[p1l964t2353r1051b2380],
37	-	:	O	-	_	0	SENT_24	[p1l964t2353r1051b2380],
38	patients	NNS	O	patient	dep	36	SENT_24	[p1l1104t2354r1225b2389],
39	,	,	O	,	_	0	SENT_24	[p1l1104t2354r1225b2389],
40	while	IN	O	while	mark	49	SENT_24	[p1l1239t2353r1316b2380],
41	more	RBR	O	more	advmod	42	SENT_24	[p1l1331t2363r1407b2381],
42	severe	JJ	O	severe	amod	43	SENT_24	[p1l1421t2363r1507b2381],
43	reactions	NNS	O	reaction	nsubj	49	SENT_24	[p1l1522t2354r1651b2381],
44	requiring	VBG	O	require	partmod	43	SENT_24	[p1l1665t2354r1799b2389],
45	drug	NN	O	drug	nn	46	SENT_24	[p1l1813t2353r1881b2389],
46	discontinuation	NN	O	discontinuation	dobj	44	SENT_24	[p1l1895t2353r2076b2381, p1l1104t2400r1163b2426],
47	are	VBP	O	be	cop	49	SENT_24	[p1l1174t2409r1216b2426],
48	rare	JJ	O	rare	amod	49	SENT_24	[p1l1227t2409r1282b2426],
49	(	NN	O	(	dep	38	SENT_24	[p1l1295t2399r1400b2432],
50	0.4	CD	PERCENT	0.4	number	51	SENT_24	[p1l1295t2399r1400b2432],
51	%	NN	PERCENT	%	amod	49	SENT_24	[p1l1295t2399r1400b2432],
52	)	CD	NUMBER	)	dep	29	SENT_24	[p1l1295t2399r1400b2432],
53	,	,	O	,	_	0	SENT_24	[p1l1295t2399r1400b2432],
54	but	CC	O	but	_	0	SENT_24	[p1l1411t2399r1460b2426],
55	life	NN	O	life	nn	56	SENT_24	[p1l1470t2393r1738b2435],
56	—	NN	O	—	nsubjpass	68	SENT_24	[p1l1470t2393r1738b2435],
57	threatening	VBG	O	threaten	partmod	56	SENT_24	[p1l1470t2393r1738b2435],
58	.6	CD	NUMBER	.6	number	59	SENT_24	[p1l1470t2393r1738b2435],
59	‘	CD	NUMBER	‘	num	60	SENT_24	[p1l1470t2393r1738b2435],
60	8	CD	NUMBER	8	dobj	57	SENT_24	[p1l1470t2393r1738b2435],
61	A	DT	O	a	det	62	SENT_24	[p1l1748t2401r1772b2426],
62	reduction	NN	O	reduction	dep	57	SENT_24	[p1l1782t2399r1922b2426],
63	of	IN	O	of	_	0	SENT_24	[p1l1933t2399r1965b2426],
64	adverse	JJ	O	adverse	amod	66	SENT_24	[p1l1972t2399r2078b2426],
65	reactions	NNS	O	reaction	nn	66	SENT_24	[p1l1105t2450r1234b2476],
66	incidence	NN	O	incidence	prep_of	62	SENT_24	[p1l1255t2449r1391b2476],
67	was	VBD	O	be	auxpass	68	SENT_24	[p1l1412t2459r1464b2476],
68	suggested	VBN	O	suggest	conj_but	9	SENT_24	[p1l1486t2449r1623b2485],
69	by	IN	O	by	_	0	SENT_24	[p1l1643t2449r1680b2485],
70	adjusting	VBG	O	adjust	agent	68	SENT_24	[p1l1700t2449r1831b2485],
71	the	DT	O	the	det	72	SENT_24	[p1l1852t2449r1896b2476],
72	allopurinol	NN	O	allopurinol	dobj	70	SENT_24	[p1l1918t2449r2078b2484],
73	The	DT	O	the	det	74	SENT_24	[p1l79t2471r129b2495],
74	authors	NNS	O	author	nsubj	75	SENT_24	[p1l147t2471r247b2495],
75	state	VBP	O	state	rcmod	72	SENT_24	[p1l265t2476r324b2495],
76	that	IN	O	that	complm	79	SENT_24	[p1l342t2471r394b2495],
77	the	DT	O	the	det	78	SENT_24	[p1l411t2471r452b2495],
78	manuscript	NN	O	manuscript	nsubj	79	SENT_24	[p1l470t2472r621b2502],
79	contains	VBZ	O	contain	ccomp	75	SENT_24	[p1l639t2471r750b2495],
80	original	JJ	O	original	amod	85	SENT_24	[p1l768t2471r870b2502],
81	unpublished	JJ	O	unpublished	amod	85	SENT_24	[p1l887t2471r1052b2502],
82	_	NN	O	_	nn	85	SENT_24	[p1l1200t2500r1204b2504],
83	_	CD	NUMBER	_	number	84	SENT_24	[p1l1290t2500r1294b2504],
84	_	CD	NUMBER	_	num	85	SENT_24	[p1l1397t2500r1401b2504],
85	_	NN	O	_	dobj	79	SENT_24	[p1l1451t2500r1455b2504],
86	_	CD	NUMBER	_	number	87	SENT_24	[p1l1526t2500r1530b2504],
87	_	CD	NUMBER	_	num	88	SENT_24	[p1l1760t2500r1764b2504],
88	9	CD	NUMBER	9	dobj	79	SENT_24	[p1l1814t2493r1825b2509],
89	.	.	O	.	_	0	SENT_24	[p1l2012t2500r2017b2504],

1	_	NN	O	_	nn	2	SENT_25	[p1l2033t2500r2037b2504],
2	doses	NNS	O	dose	_	0	SENT_25	[p1l1105t2499r1182b2526],
3	in	IN	O	in	_	0	SENT_25	[p1l1198t2508r1226b2525],
4	patients	NNS	O	patient	prep_in	2	SENT_25	[p1l1241t2504r1354b2534],
5	with	IN	O	with	_	0	SENT_25	[p1l1369t2499r1434b2526],
6	impaired	JJ	O	impaired	amod	8	SENT_25	[p1l1449t2499r1579b2534],
7	renal	JJ	O	renal	amod	8	SENT_25	[p1l1595t2499r1666b2526],
8	function	NN	O	function	prep_with	2	SENT_25	[p1l1682t2499r1811b2526],
9	.	.	O	.	_	0	SENT_25	[p1l1682t2499r1811b2526],

1	The	DT	O	the	det	3	SENT_26	[p1l1841t2499r1896b2526],
2	recognition	NN	O	recognition	nn	3	SENT_26	[p1l1912t2504r2078b2534],
3	work	NN	O	work	nsubj	6	SENT_26	[p1l78t2514r147b2539],
4	and	CC	O	and	_	0	SENT_26	[p1l161t2514r210b2539],
5	it	PRP	O	it	nsubj	6	SENT_26	[p1l225t2515r244b2539],
6	has	VBZ	O	have	_	0	SENT_26	[p1l258t2514r301b2539],
7	not	RB	O	not	dep	6	SENT_26	[p1l316t2519r361b2539],
8	being	VBG	O	be	auxpass	9	SENT_26	[p1l375t2514r448b2546],
9	submitted	VBN	O	submit	dep	7	SENT_26	[p1l463t2514r597b2539],
10	for	IN	O	for	_	0	SENT_26	[p1l612t2514r650b2539],
11	publication	NN	O	publication	prep_for	9	SENT_26	[p1l664t2514r817b2546],
12	elsewhere	RB	O	elsewhere	advmod	9	SENT_26	[p1l832t2514r958b2539],
13	at	IN	O	at	_	0	SENT_26	[p1l973t2519r997b2539],
14	the	DT	O	the	det	16	SENT_26	[p1l1011t2514r1052b2539],
15	same	JJ	O	same	amod	16	SENT_26	[p1l79t2566r145b2581],
16	time	NN	O	time	prep_at	9	SENT_26	[p1l166t2558r233b2585],
17	,	,	O	,	_	0	SENT_26	[p1l166t2558r233b2585],
18	neither	CC	O	neither	dep	7	SENT_26	[p1l255t2557r349b2581],
19	as	IN	O	as	mark	46	SENT_26	[p1l370t2566r395b2581],
20	previous	JJ	O	previous	amod	21	SENT_26	[p1l416t2558r530b2589],
21	reports	NNS	O	report	nsubj	46	SENT_26	[p1l552t2562r645b2589],
22	that	WDT	O	that	nsubjpass	25	SENT_26	[p1l666t2557r718b2581],
23	might	MD	O	might	aux	25	SENT_26	[p1l740t2557r818b2589],
24	be	VB	O	be	auxpass	25	SENT_26	[p1l838t2557r869b2581],
25	regarded	VBN	O	regard	rcmod	21	SENT_26	[p1l890t2557r1006b2589],
26	as	IN	O	as	_	0	SENT_26	[p1l1028t2566r1052b2581],
27	that	DT	O	that	det	28	SENT_26	[p1l1104t2548r1161b2575],
28	0XYPut11101s	NNS	O	0xyput11101	prep_as	25	SENT_26	[p1l1184t2548r1351b2584],
29	the	DT	O	the	det	33	SENT_26	[p1l1375t2548r1420b2575],
30	mam	NN	O	mam	nn	33	SENT_26	[p1l1444t2558r1518b2575],
31	m	NN	O	m	nn	33	SENT_26	[p1l1541t2548r1694b2575],
32	€	CD	NUMBER	€	num	33	SENT_26	[p1l1541t2548r1694b2575],
33	tab0l1te	NN	O	tab0l1te	dep	38	SENT_26	[p1l1541t2548r1694b2575],
34	of	IN	O	of	_	0	SENT_26	[p1l1717t2548r1750b2575],
35	3	CD	NUMBER	3	prep_of	33	SENT_26	[p1l1769t2548r1936b2583],
36	]	NN	O	]	dep	38	SENT_26	[p1l1769t2548r1936b2583],
37	-10	CD	NUMBER	-10	num	36	SENT_26	[p1l1769t2548r1936b2583],
38	Pu1	NN	O	pu1	dep	28	SENT_26	[p1l1769t2548r1936b2583],
39	'	''	O	'	_	0	SENT_26	[p1l1769t2548r1936b2583],
40	1n01	NN	O	1n01	dep	38	SENT_26	[p1l1769t2548r1936b2583],
41	;	:	O	;	_	0	SENT_26	[p1l1769t2548r1936b2583],
42	ma	FW	O	ma	nn	44	SENT_26	[p1l1961t2558r2023b2584],
43	)	FW	O	)	nn	44	SENT_26	[p1l1961t2558r2023b2584],
44	’	FW	O	’	dobj	25	SENT_26	[p1l1961t2558r2023b2584],
45	be	VB	O	be	cop	46	SENT_26	[p1l2044t2548r2078b2575],
46	redundant	JJ	O	redundant	conj	7	SENT_26	[p1l79t2601r218b2626],
47	or	CC	O	or	_	0	SENT_26	[p1l230t2610r258b2626],
48	duplicate	VB	O	duplicate	conj	7	SENT_26	[p1l270t2601r392b2633],
49	publication	NN	O	publication	dobj	48	SENT_26	[p1l404t2601r555b2633],
50	of	IN	O	of	_	0	SENT_26	[p1l568t2601r597b2626],
51	the	DT	O	the	det	56	SENT_26	[p1l605t2601r646b2626],
52	same	JJ	O	same	amod	56	SENT_26	[p1l658t2610r724b2626],
53	or	CC	O	or	_	0	SENT_26	[p1l737t2610r765b2626],
54	very	RB	O	very	advmod	55	SENT_26	[p1l776t2610r833b2633],
55	similar	JJ	O	similar	amod	56	SENT_26	[p1l844t2601r935b2626],
56	work	NN	O	work	prep_of	49	SENT_26	[p1l946t2601r1020b2626],
57	.	.	O	.	_	0	SENT_26	[p1l946t2601r1020b2626],

1	the	DT	O	the	det	3	SENT_27	[p1l1104t2598r1149b2625],
2	principal	JJ	O	principal	amod	3	SENT_27	[p1l1170t2598r1300b2634],
3	cause	NN	O	cause	_	0	SENT_27	[p1l1321t2608r1398b2625],
4	of	IN	O	of	_	0	SENT_27	[p1l1420t2598r1452b2625],
5	delayed-type	JJ	O	delayed-type	amod	8	SENT_27	[p1l1470t2598r1652b2634],
6	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_27	[p1l1673t2592r1924b2634],
7	“	CD	NUMBER	“	num	8	SENT_27	[p1l1673t2592r1924b2634],
8	)	NN	O	)	prep_of	3	SENT_27	[p1l1673t2592r1924b2634],
9	and	CC	O	and	_	0	SENT_27	[p1l1946t2598r2000b2625],
10	that	IN	O	that	conj_and	3	SENT_27	[p1l2021t2598r2078b2625],

1	©	RB	O	©	dep	2	SENT_28	[p1l1838t2710r1857b2729],
2	2011	CD	DATE	2011	dep	4	SENT_28	[p1l1868t2709r1922b2729],
3	The	DT	O	the	det	4	SENT_28	[p1l1935t2709r1979b2729],
4	Authors	NNPS	O	Authors	dep	5	SENT_28	[p1l1988t2709r2078b2729],
5	IEADV	NNP	O	IEADV	dep	20	SENT_28	[p1l77t2743r176b2770],
6	2012	CD	DATE	2012	num	5	SENT_28	[p1l183t2746r247b2769],
7	,	,	O	,	_	0	SENT_28	[p1l183t2746r247b2769],
8	26	CD	NUMBER	26	num	5	SENT_28	[p1l258t2746r293b2769],
9	,	,	O	,	_	0	SENT_28	[p1l258t2746r293b2769],
10	1424-1430	CD	DATE	1424-1430	num	11	SENT_28	[p1l307t2746r436b2766],
11	Journal	NNP	O	Journal	appos	5	SENT_28	[p1l556t2746r639b2766],
12	of	IN	O	of	_	0	SENT_28	[p1l650t2746r672b2766],
13	the	DT	O	the	det	15	SENT_28	[p1l680t2746r716b2766],
14	European	JJ	ORGANIZATION	european	amod	15	SENT_28	[p1l727t2746r836b2771],
15	Academy	NN	ORGANIZATION	academy	prep_of	5	SENT_28	[p1l847t2746r956b2771],
16	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l966t2746r987b2766],
17	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	15	SENT_28	[p1l997t2746r1143b2771],
18	and	CC	O	and	_	0	SENT_28	[p1l1153t2746r1195b2766],
19	Venereology	NNP	O	Venereology	conj_and	17	SENT_28	[p1l1205t2746r1348b2771],
20	©	CD	NUMBER	©	dep	23	SENT_28	[p1l1358t2747r1377b2766],
21	2011	CD	DATE	2011	num	23	SENT_28	[p1l1388t2746r1442b2766],
22	European	JJ	ORGANIZATION	european	amod	23	SENT_28	[p1l1458t2746r1566b2771],
23	Academy	NN	ORGANIZATION	academy	_	0	SENT_28	[p1l1577t2746r1686b2771],
24	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1696t2746r1718b2766],
25	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	23	SENT_28	[p1l1728t2746r1874b2771],
26	and	CC	O	and	_	0	SENT_28	[p1l1883t2746r1925b2766],
27	Venereology	NNP	O	Venereology	prep_of	23	SENT_28	[p1l1935t2746r2078b2771],

1	Cutaneous	JJ	O	cutaneous	amod	3	SENT_29	[p1l81t2846r260b2874],
2	adverse	JJ	O	adverse	amod	3	SENT_29	[p1l275t2846r405b2874],
3	reactions	NNS	O	reaction	_	0	SENT_29	[p1l421t2846r571b2874],
4	to	TO	O	to	_	0	SENT_29	[p1l585t2848r617b2874],
5	allopurinol	NN	O	allopurinol	prep_to	3	SENT_29	[p1l631t2846r800b2881],
6	1425	CD	DATE	1425	num	5	SENT_29	[p1l2018t2852r2079b2874],

1	oxypurinol	NN	O	oxypurinol	nn	2	SENT_30	[p1l12t3073r362b3151],
2	concentrations	NNS	O	concentration	nsubj	5	SENT_30	[p1l390t3075r857b3133],
3	are	VBP	O	be	cop	5	SENT_30	[p1l888t3095r981b3133],
4	frequently	RB	O	frequently	advmod	5	SENT_30	[p1l1010t3073r1334b3151],
5	elevated	JJ	O	elevated	_	0	SENT_30	[p1l1360t3073r1612b3133],
6	in	IN	O	in	_	0	SENT_30	[p1l1641t3075r1704b3132],
7	patients	NNS	O	patient	prep_in	5	SENT_30	[p1l1730t3075r1979b3151],
8	with	IN	O	with	_	0	SENT_30	[p1l2006t3073r2148b3133],
9	renal	JJ	O	renal	amod	10	SENT_30	[p1l11t3174r168b3233],
10	impairment	NN	O	impairment	prep_with	7	SENT_30	[p1l204t3176r583b3251],
11	has	VBZ	O	have	aux	12	SENT_30	[p1l618t3174r720b3233],
12	led	VBN	O	lead	rcmod	10	SENT_30	[p1l757t3174r851b3233],
13	to	TO	O	to	_	0	SENT_30	[p1l886t3186r949b3233],
14	the	DT	O	the	det	16	SENT_30	[p1l987t3174r1085b3233],
15	widespread	JJ	O	widespread	amod	16	SENT_30	[p1l1120t3174r1479b3251],
16	adoption	NN	O	adoption	prep_to	12	SENT_30	[p1l1516t3174r1803b3251],
17	of	IN	O	of	_	0	SENT_30	[p1l1841t3174r1911b3233],
18	dosing	NN	O	dosing	nn	19	SENT_30	[p1l1940t3174r2150b3252],
19	guidelines	NNS	O	guideline	prep_of	16	SENT_30	[p1l12t3274r344b3353],
20	,	,	O	,	_	0	SENT_30	[p1l12t3274r344b3353],
21	which	WDT	O	which	nsubj	22	SENT_30	[p1l382t3274r575b3334],
22	advocate	VBP	O	advocate	rcmod	19	SENT_30	[p1l613t3275r889b3334],
23	allopurinol	NN	O	allopurinol	nn	25	SENT_30	[p1l927t3274r1278b3352],
24	dose	NN	O	dose	nn	25	SENT_30	[p1l1315t3275r1457b3334],
25	reduction	NN	O	reduction	dobj	22	SENT_30	[p1l1494t3275r1801b3334],
26	according	VBG	O	accord	_	0	SENT_30	[p1l1839t3274r2150b3353],
27	to	TO	O	to	prepc_according_to	22	SENT_30	[p1l10t3388r73b3436],
28	creatinine	NN	O	creatinine	nn	29	SENT_30	[p1l118t3378r429b3436],
29	clearance	NN	O	clearance	pobj	22	SENT_30	[p1l472t3376r776b3436],
30	.	.	O	.	_	0	SENT_30	[p1l472t3376r776b3436],

1	However	RB	O	however	advmod	6	SENT_31	[p1l822t3381r1123b3445],
2	,	,	O	,	_	0	SENT_31	[p1l822t3381r1123b3445],
3	recent	JJ	O	recent	amod	4	SENT_31	[p1l1168t3388r1360b3436],
4	studies	NNS	O	study	nsubj	6	SENT_31	[p1l1403t3376r1617b3436],
5	have	VBP	O	have	aux	6	SENT_31	[p1l1660t3376r1805b3436],
6	suggested	VBN	O	suggest	_	0	SENT_31	[p1l1848t3376r2150b3454],
7	that	IN	O	that	complm	15	SENT_31	[p1l10t3477r136b3536],
8	adverse	JJ	O	adverse	amod	9	SENT_31	[p1l184t3477r416b3536],
9	reactions	NNS	O	reaction	nsubj	15	SENT_31	[p1l464t3479r764b3545],
10	,	,	O	,	_	0	SENT_31	[p1l464t3479r764b3545],
11	especially	RB	O	especially	advmod	12	SENT_31	[p1l815t3477r1113b3555],
12	hypersensitive	JJ	O	hypersensitive	amod	13	SENT_31	[p1l1157t3477r1603b3555],
13	syndrome	NN	O	syndrome	appos	9	SENT_31	[p1l1652t3477r1966b3555],
14	may	MD	O	may	aux	15	SENT_31	[p1l2014t3498r2152b3555],
15	occur	VB	O	occur	ccomp	6	SENT_31	[p1l12t3599r189b3638],
16	even	RB	O	even	advmod	15	SENT_31	[p1l217t3599r360b3638],
17	at	IN	O	at	_	0	SENT_31	[p1l388t3590r444b3638],
18	low	JJ	O	low	amod	19	SENT_31	[p1l470t3578r587b3638],
19	doses	NNS	O	dose	prep_at	15	SENT_31	[p1l613t3578r781b3638],
20	of	IN	O	of	_	0	SENT_31	[p1l811t3578r881b3638],
21	allopurinol	NN	O	allopurinol	prep_of	19	SENT_31	[p1l901t3578r1267b3655],
22	,	,	O	,	_	0	SENT_31	[p1l901t3578r1267b3655],
23	which	WDT	O	which	nsubj	26	SENT_31	[p1l1294t3578r1487b3638],
24	in	IN	O	in	_	0	SENT_31	[p1l1515t3580r1577b3637],
25	turn	NN	O	turn	prep_in	26	SENT_31	[p1l1604t3590r1742b3638],
26	fails	VBZ	O	fail	rcmod	21	SENT_31	[p1l1770t3578r1892b3638],
27	to	TO	O	to	aux	29	SENT_31	[p1l1919t3590r1982b3638],
28	adequately	RB	O	adequately	advmod	29	SENT_31	[p1l2013t3578r2145b3638, p1l12t3679r243b3757],
29	treat	VB	O	treat	xcomp	26	SENT_31	[p1l262t3691r406b3738],
30	hyperuricemia	NN	O	hyperuricemia	dobj	29	SENT_31	[p1l429t3679r890b3757],
31	in	IN	O	in	_	0	SENT_31	[p1l913t3681r977b3737],
32	gout	NN	O	gout	prep_in	30	SENT_31	[p1l1000t3666r1301b3757],
33	.	.	O	.	_	0	SENT_31	[p1l1000t3666r1301b3757],

1	”	RB	O	”	_	0	SENT_32	[p1l1000t3666r1301b3757],
2	"	``	O	"	punct	3	SENT_32	[p1l1000t3666r1301b3757],
3	13	CD	NUMBER	13	dep	1	SENT_32	[p1l1000t3666r1301b3757],

1	As	IN	O	as	_	0	SENT_33	[p2l91t22r170b78],
2	part	NN	O	part	prep_as	19	SENT_33	[p2l209t30r339b96],
3	of	IN	O	of	_	0	SENT_33	[p2l379t18r449b78],
4	the	DT	O	the	det	5	SENT_33	[p2l479t18r577b78],
5	activity	NN	O	activity	prep_of	2	SENT_33	[p2l618t20r848b96],
6	of	IN	O	of	_	0	SENT_33	[p2l885t18r956b78],
7	an	DT	O	a	det	10	SENT_33	[p2l987t40r1063b78],
8	intensive	JJ	O	intensive	amod	10	SENT_33	[p2l1102t20r1382b78],
9	drug-surveillance	NN	O	drug-surveillance	nn	10	SENT_33	[p2l1423t18r1971b97],
10	programme	NN	O	programme	prep_of	5	SENT_33	[p2l2009t39r2145b96, p2l12t142r291b198],
11	,	,	O	,	_	0	SENT_33	[p2l2009t39r2145b96, p2l12t142r291b198],
12	assessment	NN	O	assessment	nsubjpass	19	SENT_33	[p2l321t132r664b180],
13	of	IN	O	of	_	0	SENT_33	[p2l692t120r763b180],
14	allopurinol	NN	O	allopurinol	nn	17	SENT_33	[p2l782t120r1133b198],
15	cutaneous	JJ	O	cutaneous	amod	17	SENT_33	[p2l1161t132r1480b180],
16	ADR	NN	O	adr	nn	17	SENT_33	[p2l1507t124r1669b179],
17	frequency	NN	O	frequency	prep_of	12	SENT_33	[p2l1696t120r2009b198],
18	was	VBD	O	be	auxpass	19	SENT_33	[p2l2031t142r2148b180],
19	judged	VBN	O	judge	_	0	SENT_33	[p2l8t221r226b299],
20	a	DT	O	a	det	21	SENT_33	[p2l248t242r281b280],
21	priority	NN	O	priority	dobj	19	SENT_33	[p2l302t223r546b299],
22	and	CC	O	and	_	0	SENT_33	[p2l566t221r683b280],
23	a	DT	O	a	det	27	SENT_33	[p2l706t242r739b280],
24	10-year	JJ	DURATION	10-year	amod	27	SENT_33	[p2l768t226r995b299],
25	observational	JJ	O	observational	amod	27	SENT_33	[p2l1018t221r1441b280],
26	cross	NN	O	cross	nn	27	SENT_33	[p2l1463t221r1924b280],
27	—	NN	O	—	dobj	19	SENT_33	[p2l1463t221r1924b280],
28	sectional	JJ	O	sectional	amod	29	SENT_33	[p2l1463t221r1924b280],
29	survey	NN	O	survey	nsubjpass	31	SENT_33	[p2l1947t242r2151b299],
30	was	VBD	O	be	auxpass	31	SENT_33	[p2l9t343r125b381],
31	conducted	VBN	O	conduct	rcmod	27	SENT_33	[p2l150t321r482b381],
32	at	IN	O	at	_	0	SENT_33	[p2l506t333r562b381],
33	the	DT	O	the	det	35	SENT_33	[p2l584t321r682b381],
34	Dermatology	NNP	O	Dermatology	nn	35	SENT_33	[p2l706t321r1125b400],
35	Clinic	NNP	O	Clinic	prep_at	31	SENT_33	[p2l1147t322r1333b381],
36	of	IN	O	of	_	0	SENT_33	[p2l1357t321r1427b381],
37	Cagliari	NNP	ORGANIZATION	Cagliari	nn	38	SENT_33	[p2l1443t322r1687b400],
38	University	NNP	ORGANIZATION	University	prep_of	35	SENT_33	[p2l1710t324r2051b400],
39	.	.	O	.	_	0	SENT_33	[p2l1710t324r2051b400],

1	Materials	NNPS	O	Materials	_	0	SENT_34	[p2l15t536r412b600],
2	and	CC	O	and	_	0	SENT_34	[p2l445t536r598b600],
3	methods	NNS	O	method	conj_and	1	SENT_34	[p2l636t536r1006b600],

1	From	IN	O	from	_	0	SENT_35	[p2l12t646r186b701],
2	January	NNP	DATE	January	prep_from	16	SENT_35	[p2l224t646r471b720],
3	2001	CD	DATE	2001	num	2	SENT_35	[p2l507t648r650b701],
4	until	IN	O	until	_	0	SENT_35	[p2l697t642r846b701],
5	December	NNP	DATE	December	prep_until	16	SENT_35	[p2l884t642r1208b701],
6	2010	CD	DATE	2010	num	5	SENT_35	[p2l1247t648r1414b711],
7	,	,	O	,	_	0	SENT_35	[p2l1247t648r1414b711],
8	all	DT	O	all	det	9	SENT_35	[p2l1455t642r1526b701],
9	patients	NNS	O	patient	nsubjpass	16	SENT_35	[p2l1564t644r1812b719],
10	reporting	VBG	O	report	partmod	9	SENT_35	[p2l1852t644r2148b720],
11	allopurinol	NN	O	allopurinol	dobj	10	SENT_35	[p2l12t743r362b820],
12	cutaneous	JJ	O	cutaneous	amod	14	SENT_35	[p2l401t754r720b802],
13	adverse	JJ	O	adverse	amod	14	SENT_35	[p2l761t743r993b802],
14	reactions	NNS	O	reaction	dep	11	SENT_35	[p2l1033t745r1315b802],
15	were	VBD	O	be	auxpass	16	SENT_35	[p2l1353t764r1502b802],
16	investigated	VBN	O	investigate	_	0	SENT_35	[p2l1541t743r1917b821],
17	at	IN	O	at	_	0	SENT_35	[p2l1955t755r2012b802],
18	the	DT	O	the	det	20	SENT_35	[p2l2050t743r2148b802],
19	Dermatology	NNP	O	Dermatology	nn	20	SENT_35	[p2l11t843r431b922],
20	Department	NNP	O	Department	prep_at	16	SENT_35	[p2l457t848r843b921],
21	at	IN	O	at	_	0	SENT_35	[p2l872t855r928b903],
22	Cagliari	NNP	ORGANIZATION	Cagliari	nn	26	SENT_35	[p2l958t843r1202b922],
23	University	NNP	ORGANIZATION	University	nn	26	SENT_35	[p2l1231t845r1561b921],
24	(	NNP	O	(	nn	26	SENT_35	[p2l1591t843r1797b921],
25	Italy	NNP	LOCATION	Italy	nn	26	SENT_35	[p2l1591t843r1797b921],
26	)	NN	O	)	prep_at	16	SENT_35	[p2l1591t843r1797b921],
27	.	.	O	.	_	0	SENT_35	[p2l1591t843r1797b921],

1	The	DT	O	the	det	4	SENT_36	[p2l1829t843r1951b903],
2	Local	JJ	O	local	amod	4	SENT_36	[p2l1980t843r2149b903],
3	Ethic	NNP	O	Ethic	nn	4	SENT_36	[p2l11t945r173b1005],
4	Committee	NNP	O	Committee	nsubj	5	SENT_36	[p2l216t947r575b1005],
5	authorized	VBD	O	authorize	_	0	SENT_36	[p2l616t945r956b1005],
6	the	DT	O	the	det	7	SENT_36	[p2l996t945r1094b1005],
7	study	NN	O	study	dobj	5	SENT_36	[p2l1137t945r1324b1023],
8	,	,	O	,	_	0	SENT_36	[p2l1137t945r1324b1023],
9	part	NN	O	part	dep	20	SENT_36	[p2l1366t957r1495b1023],
10	of	IN	O	of	_	0	SENT_36	[p2l1538t945r1608b1005],
11	a	DT	O	a	det	14	SENT_36	[p2l1641t967r1673b1005],
12	more	RBR	O	more	advmod	13	SENT_36	[p2l1714t967r1881b1005],
13	general	JJ	O	general	amod	14	SENT_36	[p2l1923t945r2149b1023],
14	investigation	NN	O	investigation	prep_of	9	SENT_36	[p2l11t1048r416b1124],
15	on	IN	O	on	_	0	SENT_36	[p2l448t1067r530b1105],
16	Cutaneous	JJ	O	cutaneous	amod	17	SENT_36	[p2l563t1049r901b1105],
17	ADR	NN	O	adr	prep_on	14	SENT_36	[p2l932t1049r1095b1105],
18	(	CD	NUMBER	(	num	19	SENT_36	[p2l1129t1046r1271b1118],
19	N	NN	O	n	dep	20	SENT_36	[p2l1129t1046r1271b1118],
20	°	CD	NUMBER	°	dep	23	SENT_36	[p2l1129t1046r1271b1118],
21	1	CD	NUMBER	1	num	22	SENT_36	[p2l1129t1046r1271b1118],
22	880	CD	NUMBER	880	dep	20	SENT_36	[p2l1281t1048r1533b1105],
23	—	NN	O	—	dep	27	SENT_36	[p2l1281t1048r1533b1105],
24	25	CD	NUMBER	25	num	23	SENT_36	[p2l1281t1048r1533b1105],
25	/	:	O	/	punct	27	SENT_36	[p2l1281t1048r1533b1105],
26	04/01	CD	NUMBER	04/01	num	27	SENT_36	[p2l1534t1046r1761b1118],
27	)	NN	O	)	dep	5	SENT_36	[p2l1534t1046r1761b1118],
28	.	.	O	.	_	0	SENT_36	[p2l1534t1046r1761b1118],

1	Cases	NNS	O	case	nsubjpass	3	SENT_37	[p2l1798t1049r1969b1105],
2	were	VBD	O	be	auxpass	3	SENT_37	[p2l2000t1067r2148b1105],
3	selected	VBN	O	select	_	0	SENT_37	[p2l12t1146r254b1206],
4	among	IN	O	among	_	0	SENT_37	[p2l279t1168r498b1225],
5	all	DT	O	all	det	6	SENT_37	[p2l522t1146r594b1206],
6	patients	NNS	O	patient	prep_among	3	SENT_37	[p2l616t1149r864b1224],
7	affected	VBN	O	affect	partmod	6	SENT_37	[p2l890t1146r1132b1206],
8	by	IN	O	by	_	0	SENT_37	[p2l1154t1147r1233b1225],
9	cutaneous	JJ	O	cutaneous	amod	10	SENT_37	[p2l1255t1158r1574b1206],
10	ADR	NN	O	adr	agent	7	SENT_37	[p2l1597t1150r1759b1206],
11	observed	VBN	O	observe	partmod	10	SENT_37	[p2l1782t1147r2063b1206],
12	in	IN	O	in	_	0	SENT_37	[p2l2086t1149r2148b1205],
13	the	DT	O	the	det	15	SENT_37	[p2l10t1248r108b1308],
14	same	JJ	O	same	amod	15	SENT_37	[p2l141t1270r300b1308],
15	period	NN	O	period	prep_in	11	SENT_37	[p2l331t1248r538b1326],
16	of	IN	O	of	_	0	SENT_37	[p2l571t1248r641b1308],
17	time	NN	O	time	prep_of	15	SENT_37	[p2l663t1250r821b1308],
18	.	.	O	.	_	0	SENT_37	[p2l663t1250r821b1308],

1	All	DT	O	all	det	2	SENT_38	[p2l854t1248r945b1307],
2	patients	NNS	O	patient	nsubj	3	SENT_38	[p2l976t1250r1224b1326],
3	agreed	VBD	O	agree	_	0	SENT_38	[p2l1257t1248r1462b1326],
4	to	TO	O	to	aux	5	SENT_38	[p2l1493t1260r1555b1308],
5	participate	VB	O	participate	xcomp	3	SENT_38	[p2l1588t1250r1925b1326],
6	in	IN	O	in	_	0	SENT_38	[p2l1957t1250r2019b1307],
7	the	DT	O	the	det	8	SENT_38	[p2l2050t1248r2148b1308],
8	study	NN	O	study	prep_in	5	SENT_38	[p2l12t1349r185b1427],
9	and	CC	O	and	_	0	SENT_38	[p2l207t1349r324b1408],
10	allopurinol	NN	O	allopurinol	prep_in	5	SENT_38	[p2l349t1349r700b1426],
11	cutaneous	JJ	O	cutaneous	amod	12	SENT_38	[p2l724t1361r1043b1408],
12	ADRS	NNS	O	adr	nsubjpass	14	SENT_38	[p2l1065t1352r1253b1408],
13	were	VBD	O	be	auxpass	14	SENT_38	[p2l1276t1370r1426b1408],
14	recorded	VBN	O	record	rcmod	8	SENT_38	[p2l1450t1349r1730b1408],
15	on	IN	O	on	_	0	SENT_38	[p2l1754t1370r1836b1408],
16	magnetic	JJ	O	magnetic	amod	17	SENT_38	[p2l1860t1351r2149b1427],
17	support	NN	O	support	prep_on	14	SENT_38	[p2l12t1462r275b1527],
18	,	,	O	,	_	0	SENT_38	[p2l12t1462r275b1527],
19	including	VBG	O	include	_	0	SENT_38	[p2l320t1450r620b1528],
20	hospitalized	VBN	O	hospitalize	prep_including	3	SENT_38	[p2l660t1450r1041b1527],
21	and	CC	O	and	_	0	SENT_38	[p2l1083t1450r1201b1510],
22	out-patients	NNS	O	out-patient	prep_including	3	SENT_38	[p2l1243t1452r1643b1527],
23	.	.	O	.	_	0	SENT_38	[p2l1243t1452r1643b1527],

1	Attention	NN	O	attention	nsubjpass	3	SENT_39	[p2l1686t1452r1992b1509],
2	was	VBD	O	be	auxpass	3	SENT_39	[p2l2032t1471r2148b1509],
3	paid	VBN	O	pay	_	0	SENT_39	[p2l10t1551r150b1628],
4	not	RB	O	not	neg	6	SENT_39	[p2l186t1563r294b1610],
5	to	TO	O	to	aux	6	SENT_39	[p2l329t1562r392b1610],
6	duplicate	VB	O	duplicate	xcomp	3	SENT_39	[p2l432t1551r720b1628],
7	cases	NNS	O	case	dobj	6	SENT_39	[p2l758t1572r926b1610],
8	.	.	O	.	_	0	SENT_39	[p2l758t1572r926b1610],

1	The	DT	O	the	det	3	SENT_40	[p2l966t1551r1088b1610],
2	diagnostic	JJ	O	diagnostic	amod	3	SENT_40	[p2l1126t1551r1447b1629],
3	criteria	NNS	O	criterion	nsubj	19	SENT_40	[p2l1485t1553r1706b1610],
4	followed	VBD	O	follow	_	0	SENT_40	[p2l1742t1551r2015b1610],
5	the	DT	O	the	det	9	SENT_40	[p2l2050t1551r2148b1610],
6	World	NNP	ORGANIZATION	World	nn	9	SENT_40	[p2l9t1651r218b1711],
7	Health	NNP	ORGANIZATION	Health	nn	9	SENT_40	[p2l269t1651r482b1711],
8	Organization	NNP	ORGANIZATION	Organization	nn	9	SENT_40	[p2l534t1653r951b1730],
9	(	NNP	O	(	dobj	4	SENT_40	[p2l1006t1651r1251b1724],
10	WHO	WP	O	who	dep	13	SENT_40	[p2l1006t1651r1251b1724],
11	)	CD	NUMBER	)	num	13	SENT_40	[p2l1006t1651r1251b1724],
12	Collaborating	NNP	O	Collaborating	nn	13	SENT_40	[p2l1309t1651r1744b1730],
13	Centre	NNP	O	Centre	rcmod	9	SENT_40	[p2l1795t1655r2006b1711],
14	for	IN	O	for	_	0	SENT_40	[p2l2058t1651r2149b1711],
15	Drug	NNP	O	Drug	prep_for	13	SENT_40	[p2l11t1758r177b1831],
16	Monitoring	VBG	O	monitor	xcomp	4	SENT_40	[p2l200t1755r571b1831],
17	recommendations	NNS	O	recommendation	dobj	16	SENT_40	[p2l595t1753r1170b1813],
18	and	CC	O	and	_	0	SENT_40	[p2l1197t1753r1314b1813],
19	included	VBD	O	include	conj_and	4	SENT_40	[p2l1339t1753r1614b1813],
20	clinical	JJ	O	clinical	amod	21	SENT_40	[p2l1639t1753r1861b1813],
21	features	NNS	O	feature	dobj	19	SENT_40	[p2l1885t1753r2146b1822],
22	,	,	O	,	_	0	SENT_40	[p2l1885t1753r2146b1822],
23	circumstantial	JJ	O	circumstantial	amod	24	SENT_40	[p2l12t1854r462b1913],
24	evidence	NN	O	evidence	appos	21	SENT_40	[p2l512t1854r799b1922],
25	,	,	O	,	_	0	SENT_40	[p2l512t1854r799b1922],
26	time	NN	O	time	nn	27	SENT_40	[p2l850t1856r993b1913],
27	relationships	NNS	O	relationship	appos	21	SENT_40	[p2l1044t1854r1446b1931],
28	between	IN	O	between	_	0	SENT_40	[p2l1495t1854r1755b1913],
29	taking	VBG	O	take	prepc_between	27	SENT_40	[p2l1804t1854r2002b1932],
30	the	DT	O	the	det	34	SENT_40	[p2l2049t1854r2147b1913],
31	drug	NN	O	drug	nn	34	SENT_40	[p2l12t1955r161b2033],
32	and	CC	O	and	_	0	SENT_40	[p2l196t1954r314b2014],
33	rash	NN	O	rash	nn	34	SENT_40	[p2l349t1955r480b2014],
34	onset	NN	O	onset	dobj	29	SENT_40	[p2l516t1966r698b2023],
35	,	,	O	,	_	0	SENT_40	[p2l516t1966r698b2023],
36	and	CC	O	and	_	0	SENT_40	[p2l736t1954r854b2014],
37	exclusion	NN	O	exclusion	dobj	19	SENT_40	[p2l890t1954r1185b2014],
38	of	IN	O	of	_	0	SENT_40	[p2l1221t1954r1292b2014],
39	alternative	JJ	O	alternative	amod	40	SENT_40	[p2l1318t1955r1647b2014],
40	diagnoses	NNS	O	diagnosis	prep_of	37	SENT_40	[p2l1683t1954r2001b2033],
41	.	.	O	.	_	0	SENT_40	[p2l1683t1954r2001b2033],

1	For	IN	O	for	_	0	SENT_41	[p2l2040t1959r2149b2014],
2	this	DT	O	this	det	3	SENT_41	[p2l10t2064r124b2124],
3	purpose	NN	O	purpose	prep_for	22	SENT_41	[p2l162t2085r435b2142],
4	,	,	O	,	_	0	SENT_41	[p2l162t2085r435b2142],
5	accurate	JJ	O	accurate	nsubjpass	22	SENT_41	[p2l477t2076r737b2124],
6	allergic	JJ	O	allergic	amod	5	SENT_41	[p2l777t2064r999b2142],
7	and	CC	O	and	_	0	SENT_41	[p2l1037t2064r1155b2124],
8	pharmacologic	JJ	O	pharmacologic	amod	9	SENT_41	[p2l1192t2064r1666b2142],
9	anamnesis	NN	O	anamnesis	nsubjpass	22	SENT_41	[p2l1704t2066r2047b2133],
10	,	,	O	,	_	0	SENT_41	[p2l1704t2066r2047b2133],
11	as	RB	O	as	_	0	SENT_41	[p2l2089t2086r2148b2124],
12	well	RB	O	well	_	0	SENT_41	[p2l9t2165r136b2224],
13	as	IN	O	as	_	0	SENT_41	[p2l160t2186r218b2224],
14	a	DT	O	a	det	15	SENT_41	[p2l244t2186r276b2224],
15	history	NN	O	history	conj_and	5	SENT_41	[p2l299t2165r521b2243],
16	of	IN	O	of	_	0	SENT_41	[p2l543t2165r614b2224],
17	previous	JJ	O	previous	amod	18	SENT_41	[p2l627t2167r898b2242],
18	reactions	NNS	O	reaction	prep_of	15	SENT_41	[p2l923t2167r1208b2224],
19	to	TO	O	to	_	0	SENT_41	[p2l1231t2177r1293b2224],
20	drugs	NNS	O	drug	prep_to	5	SENT_41	[p2l1320t2165r1494b2243],
21	were	VBD	O	be	auxpass	22	SENT_41	[p2l1517t2186r1666b2224],
22	obtained	VBN	O	obtain	_	0	SENT_41	[p2l1691t2165r1968b2224],
23	from	IN	O	from	_	0	SENT_41	[p2l1991t2165r2148b2224],
24	the	DT	O	the	det	25	SENT_41	[p2l10t2266r108b2325],
25	patients	NNS	O	patient	prep_from	22	SENT_41	[p2l161t2268r409b2343],
26	and	CC	O	and	_	0	SENT_41	[p2l464t2266r582b2325],
27	general	JJ	O	general	amod	28	SENT_41	[p2l635t2266r861b2344],
28	practitioners	NNS	O	practitioner	conj_and	25	SENT_41	[p2l912t2268r1328b2343],
29	.	.	O	.	_	0	SENT_41	[p2l912t2268r1328b2343],

1	When	WRB	O	when	advmod	7	SENT_42	[p2l1382t2266r1578b2325],
2	allopurinol	NN	O	allopurinol	nsubj	7	SENT_42	[p2l1631t2266r1982b2343],
3	was	VBD	O	be	cop	7	SENT_42	[p2l2032t2287r2148b2325],
4	not	RB	O	not	neg	7	SENT_42	[p2l11t2379r119b2426],
5	the	DT	O	the	det	7	SENT_42	[p2l157t2367r255b2426],
6	principle	NN	O	principle	nn	7	SENT_42	[p2l295t2367r576b2444],
7	drug	NN	O	drug	advcl	13	SENT_42	[p2l617t2367r765b2445],
8	suspected	VBN	O	suspect	partmod	7	SENT_42	[p2l805t2367r1124b2444],
9	,	,	O	,	_	0	SENT_42	[p2l805t2367r1124b2444],
10	the	DT	O	the	det	11	SENT_42	[p2l1166t2367r1264b2426],
11	observation	NN	O	observation	nsubjpass	13	SENT_42	[p2l1305t2367r1673b2426],
12	was	VBD	O	be	auxpass	13	SENT_42	[p2l1710t2388r1827b2426],
13	excluded	VBN	O	exclude	_	0	SENT_42	[p2l1868t2367r2148b2426],
14	from	IN	O	from	_	0	SENT_42	[p2l11t2467r168b2527],
15	the	DT	O	the	det	16	SENT_42	[p2l211t2467r309b2527],
16	study	NN	O	study	prep_from	13	SENT_42	[p2l355t2467r540b2545],
17	.	.	O	.	_	0	SENT_42	[p2l355t2467r540b2545],

1	Routine	JJ	O	routine	amod	5	SENT_43	[p2l588t2469r841b2527],
2	blood	NN	O	blood	nn	5	SENT_43	[p2l883t2467r1068b2527],
3	and	CC	O	and	_	0	SENT_43	[p2l1113t2467r1231b2527],
4	instrumental	JJ	O	instrumental	nn	5	SENT_43	[p2l1274t2467r1681b2527],
5	examinations	NNS	O	examination	nsubjpass	7	SENT_43	[p2l1725t2469r2148b2527],
6	were	VBD	O	be	auxpass	7	SENT_43	[p2l9t2591r158b2629],
7	performed	VBN	O	perform	_	0	SENT_43	[p2l202t2569r539b2647],
8	in	IN	O	in	_	0	SENT_43	[p2l584t2571r646b2628],
9	all	DT	O	all	det	10	SENT_43	[p2l692t2569r763b2629],
10	cases	NNS	O	case	prep_in	7	SENT_43	[p2l808t2591r976b2629],
11	.	.	O	.	_	0	SENT_43	[p2l808t2591r976b2629],

1	A	DT	O	a	det	3	SENT_44	[p2l1023t2573r1076b2628],
2	skin	NN	O	skin	nn	3	SENT_44	[p2l1121t2569r1248b2629],
3	biopsy	NN	O	biopsy	nsubjpass	5	SENT_44	[p2l1292t2569r1503b2647],
4	was	VBD	O	be	auxpass	5	SENT_44	[p2l1543t2591r1659b2629],
5	performed	VBN	O	perform	_	0	SENT_44	[p2l1705t2569r2041b2647],
6	in	IN	O	in	_	0	SENT_44	[p2l2086t2571r2148b2628],
7	doubtful	JJ	O	doubtful	amod	8	SENT_44	[p2l12t2670r286b2729],
8	cases	NNS	O	case	prep_in	5	SENT_44	[p2l317t2691r486b2738],
9	,	,	O	,	_	0	SENT_44	[p2l317t2691r486b2738],
10	when	WRB	O	when	advmod	15	SENT_44	[p2l516t2670r689b2729],
11	the	DT	O	the	det	13	SENT_44	[p2l718t2670r816b2729],
12	histological	JJ	O	histological	amod	13	SENT_44	[p2l845t2670r1205b2748],
13	examination	NN	O	examination	nsubjpass	15	SENT_44	[p2l1235t2672r1631b2729],
14	was	VBD	O	be	auxpass	15	SENT_44	[p2l1659t2691r1775b2729],
15	considered	VBN	O	consider	dep	8	SENT_44	[p2l1806t2670r2149b2729],
16	necessary	JJ	O	necessary	acomp	15	SENT_44	[p2l11t2792r308b2848],
17	for	IN	O	for	_	0	SENT_44	[p2l344t2770r435b2830],
18	the	DT	O	the	det	20	SENT_44	[p2l472t2770r570b2830],
19	differential	JJ	O	differential	amod	20	SENT_44	[p2l611t2770r953b2830],
20	diagnosis	NN	O	diagnosis	prep_for	15	SENT_44	[p2l992t2770r1300b2849],
21	,	,	O	,	_	0	SENT_44	[p2l992t2770r1300b2849],
22	and	CC	O	and	_	0	SENT_44	[p2l1341t2770r1459b2830],
23	in	IN	O	in	_	0	SENT_44	[p2l1497t2772r1559b2829],
24	all	PDT	O	all	predet	25	SENT_44	[p2l1599t2770r1670b2830],
25	the	DT	O	the	conj_and	8	SENT_44	[p2l1707t2770r1806b2830],
26	suspected	VBN	O	suspect	partmod	25	SENT_44	[p2l1845t2770r2150b2848],
27	DRESS	NN	O	dress	nn	28	SENT_44	[p2l11t2875r236b2931],
28	cases	NNS	O	case	dobj	26	SENT_44	[p2l266t2894r433b2931],
29	.	.	O	.	_	0	SENT_44	[p2l266t2894r433b2931],

1	Determination	NN	O	determination	_	0	SENT_45	[p2l465t2874r934b2931],
2	of	IN	O	of	_	0	SENT_45	[p2l962t2872r1033b2931],
3	HLA	NN	O	hlum	prep_of	1	SENT_45	[p2l1051t2875r1460b2931],
4	.	.	O	.	_	0	SENT_45	[p2l1051t2875r1460b2931],

1	—	NN	O	—	_	0	SENT_46	[p2l1051t2875r1460b2931],
2	.	.	O	.	_	0	SENT_46	[p2l1051t2875r1460b2931],

1	B	NN	O	b	_	0	SENT_47	[p2l1051t2875r1460b2931],
2	*	CD	NUMBER	*	number	3	SENT_47	[p2l1051t2875r1460b2931],
3	5801	CD	NUMBER	5801	num	4	SENT_47	[p2l1051t2875r1460b2931],
4	carriers	NNS	O	carrier	nsubj	7	SENT_47	[p2l1494t2874r1724b2931],
5	is	VBZ	O	be	cop	7	SENT_47	[p2l1753t2874r1798b2931],
6	an	DT	O	a	det	7	SENT_47	[p2l1828t2894r1903b2931],
7	examination	NN	O	examination	rcmod	1	SENT_47	[p2l1931t2874r2145b2931, p2l11t2975r217b3032],

1	only	RB	O	only	advmod	3	SENT_48	[p2l250t2973r389b3051],
2	recently	RB	DATE	recently	advmod	3	SENT_48	[p2l419t2973r668b3051],
3	accessible	JJ	O	accessible	_	0	SENT_48	[p2l698t2973r997b3032],
4	in	IN	O	in	_	0	SENT_48	[p2l1030t2975r1092b3031],
5	our	PRP$	O	we	poss	8	SENT_48	[p2l1126t2994r1236b3032],
6	University	NNP	ORGANIZATION	University	nn	8	SENT_48	[p2l1268t2975r1598b3051],
7	Genetic	NNP	ORGANIZATION	Genetic	nn	8	SENT_48	[p2l1628t2975r1868b3032],
8	Laboratory	NNP	ORGANIZATION	Laboratory	prep_in	3	SENT_48	[p2l1900t2973r2145b3032, p2l10t3086r142b3152],
9	and	CC	O	and	_	0	SENT_48	[p2l184t3074r301b3133],
10	was	VBD	O	be	auxpass	11	SENT_48	[p2l343t3095r459b3133],
11	performed	VBN	O	perform	conj_and	3	SENT_48	[p2l502t3074r839b3151],
12	in	IN	O	in	_	0	SENT_48	[p2l883t3076r945b3132],
13	a	DT	O	a	det	14	SENT_48	[p2l989t3096r1022b3133],
14	minority	NN	O	minority	prep_in	11	SENT_48	[p2l1065t3076r1347b3152],
15	of	IN	O	of	_	0	SENT_48	[p2l1389t3074r1460b3133],
16	patients	NNS	O	patient	prep_of	14	SENT_48	[p2l1494t3076r1741b3151],
17	affected	VBN	O	affect	partmod	16	SENT_48	[p2l1787t3074r2030b3133],
18	by	IN	O	by	_	0	SENT_48	[p2l2072t3074r2151b3152],
19	SIS	NN	O	si	agent	17	SENT_48	[p2l12t3177r291b3244],
20	.	.	O	.	_	0	SENT_48	[p2l12t3177r291b3244],

1	—	NN	O	—	_	0	SENT_49	[p2l12t3177r291b3244],
2	.	.	O	.	_	0	SENT_49	[p2l12t3177r291b3244],

1	TEN	CD	NUMBER	ten	num	2	SENT_50	[p2l12t3177r291b3244],
2	syndrome	NN	O	syndrome	_	0	SENT_50	[p2l318t3175r650b3253],
3	,	,	O	,	_	0	SENT_50	[p2l318t3175r650b3253],
4	recruited	VBN	O	recruit	partmod	2	SENT_50	[p2l677t3175r962b3234],
5	between	IN	O	between	_	0	SENT_50	[p2l984t3175r1245b3234],
6	2005	CD	DATE	2005	prep_between	4	SENT_50	[p2l1270t3180r1417b3234],
7	and	CC	DATE	and	_	0	SENT_50	[p2l1447t3175r1565b3234],
8	2010	CD	DATE	2010	prep_between	4	SENT_50	[p2l1590t3180r1755b3234],
9	.	.	O	.	_	0	SENT_50	[p2l1590t3180r1755b3234],

1	HLA	NN	O	hlum	nsubj	23	SENT_51	[p2l1784t3178r2145b3253],
2	—	CD	NUMBER	—	num	5	SENT_51	[p2l1784t3178r2145b3253],
3	geno	NN	O	geno	nn	5	SENT_51	[p2l1784t3178r2145b3253],
4	—	NN	O	—	nn	5	SENT_51	[p2l1784t3178r2145b3253],
5	typing	NN	O	typing	nsubjpass	7	SENT_51	[p2l10t3277r213b3354],
6	was	VBD	O	be	auxpass	7	SENT_51	[p2l239t3297r354b3335],
7	performed	VBN	O	perform	rcmod	1	SENT_51	[p2l384t3275r721b3353],
8	by	IN	O	by	_	0	SENT_51	[p2l747t3275r826b3353],
9	polymerase	NN	O	polymerase	nn	12	SENT_51	[p2l851t3275r1211b3353],
10	chain	NN	O	chain	nn	12	SENT_51	[p2l1241t3275r1413b3335],
11	reaction	NN	O	reaction	nn	12	SENT_51	[p2l1441t3277r1697b3335],
12	ampliﬁcation	NN	O	ampliﬁcation	agent	7	SENT_51	[p2l1727t3275r2148b3353],
13	and	CC	O	and	_	0	SENT_51	[p2l12t3377r130b3437],
14	reverse	NN	O	reverse	nn	15	SENT_51	[p2l164t3399r381b3437],
15	hybridization	NN	O	hybridization	conj_and	12	SENT_51	[p2l415t3377r840b3455],
16	using	VBG	O	use	partmod	12	SENT_51	[p2l875t3379r1045b3455],
17	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	19	SENT_51	[p2l1079t3377r1625b3455],
18	oligonucleotide	NN	O	oligonucleotide	nn	19	SENT_51	[p2l1660t3377r2148b3455],
19	probes	NNS	O	probe	dobj	16	SENT_51	[p2l10t3478r221b3555],
20	and	CC	O	and	_	0	SENT_51	[p2l297t3478r415b3537],
21	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	22	SENT_51	[p2l489t3478r1034b3555],
22	primers	NNS	O	primer	conj_and	19	SENT_51	[p2l1106t3480r1352b3555],
23	(	VBP	O	(	_	0	SENT_51	[p2l1431t3478r2145b3550],
24	PCR	NN	O	pcr	dobj	23	SENT_51	[p2l1431t3478r2145b3550],
25	.	.	O	.	_	0	SENT_51	[p2l1431t3478r2145b3550],

1	—	NN	O	—	_	0	SENT_52	[p2l1431t3478r2145b3550],
2	.	.	O	.	_	0	SENT_52	[p2l1431t3478r2145b3550],

1	SSO/PCR	NN	O	sso/pcr	_	0	SENT_53	[p2l1431t3478r2145b3550],
2	.	.	O	.	_	0	SENT_53	[p2l1431t3478r2145b3550],

1	—	NN	O	—	_	0	SENT_54	[p2l1431t3478r2145b3550],
2	.	.	O	.	_	0	SENT_54	[p2l1431t3478r2145b3550],

1	SSP	NN	O	ssp	_	0	SENT_55	[p2l1431t3478r2145b3550],
2	)	NN	O	)	dep	1	SENT_55	[p2l1431t3478r2145b3550],
3	.	.	O	.	_	0	SENT_55	[p2l1431t3478r2145b3550],

1	Information	NN	O	information	nsubj	23	SENT_56	[p2l12t3578r401b3638],
2	on	IN	O	on	_	0	SENT_56	[p2l427t3600r509b3638],
3	co-morbidity	NN	O	co-morbidity	prep_on	1	SENT_56	[p2l535t3578r972b3656],
4	,	,	O	,	_	0	SENT_56	[p2l535t3578r972b3656],
5	indications	NNS	O	indication	nsubj	23	SENT_56	[p2l1000t3578r1348b3638],
6	for	IN	O	for	_	0	SENT_56	[p2l1374t3578r1466b3638],
7	allopurinol	NN	O	allopurinol	nn	8	SENT_56	[p2l1491t3578r1841b3656],
8	administration	NN	O	administration	prep_for	5	SENT_56	[p2l1866t3578r2145b3638, p2l10t3682r243b3749],
9	,	,	O	,	_	0	SENT_56	[p2l1866t3578r2145b3638, p2l10t3682r243b3749],
10	and	CC	O	and	_	0	SENT_56	[p2l273t3680r391b3740],
11	eventual	JJ	O	eventual	amod	13	SENT_56	[p2l419t3680r683b3740],
12	dosage	NN	O	dosage	nn	13	SENT_56	[p2l711t3680r923b3758],
13	adjustment	NN	O	adjustment	conj_and	1	SENT_56	[p2l952t3680r1306b3758],
14	on	IN	O	on	_	0	SENT_56	[p2l1335t3702r1416b3740],
15	the	DT	O	the	det	16	SENT_56	[p2l1444t3680r1541b3740],
16	basis	NN	O	basis	prep_on	13	SENT_56	[p2l1567t3680r1718b3740],
17	of	IN	O	of	_	0	SENT_56	[p2l1747t3680r1818b3740],
18	creatinine	NN	O	creatinine	nn	19	SENT_56	[p2l1838t3682r2149b3740],
19	clearance	NN	O	clearance	prep_of	16	SENT_56	[p3l12t18r300b77],
20	were	VBD	O	be	cop	23	SENT_56	[p3l341t39r489b77],
21	the	DT	O	the	det	23	SENT_56	[p3l531t18r629b77],
22	main	JJ	O	main	amod	23	SENT_56	[p3l672t20r836b77],
23	variables	NNS	O	variable	_	0	SENT_56	[p3l875t18r1151b77],
24	of	IN	O	of	_	0	SENT_56	[p3l1194t18r1265b77],
25	interest	NN	O	interest	prep_of	23	SENT_56	[p3l1299t20r1546b77],
26	.	.	O	.	_	0	SENT_56	[p3l1299t20r1546b77],

1	Evolution	NN	O	evolution	nsubjpass	10	SENT_57	[p3l1592t18r1903b77],
2	of	IN	O	of	_	0	SENT_57	[p3l1947t18r2017b77],
3	the	DT	O	the	det	4	SENT_57	[p3l2050t18r2148b77],
4	reaction	NN	O	reaction	prep_of	1	SENT_57	[p3l11t121r267b179],
5	and	CC	O	and	_	0	SENT_57	[p3l300t119r418b179],
6	treatment	NN	O	treatment	prep_of	1	SENT_57	[p3l448t131r758b179],
7	performed	VBN	O	perform	partmod	4	SENT_57	[p3l789t119r1125b196],
8	were	VBD	O	be	auxpass	10	SENT_57	[p3l1155t140r1303b179],
9	also	RB	O	also	advmod	10	SENT_57	[p3l1337t119r1454b179],
10	recorded	VBN	O	record	_	0	SENT_57	[p3l1489t119r1783b179],
11	.	.	O	.	_	0	SENT_57	[p3l1489t119r1783b179],

1	For	IN	O	for	_	0	SENT_58	[p3l1819t123r1928b179],
2	severe	JJ	O	severe	amod	4	SENT_58	[p3l1960t140r2148b179],
3	cutaneous	JJ	O	cutaneous	amod	4	SENT_58	[p3l12t232r331b279],
4	ADR	NN	MISC	adr	prep_for	9	SENT_58	[p3l373t223r550b288],
5	,	,	O	,	_	0	SENT_58	[p3l373t223r550b288],
6	additional	JJ	O	additional	amod	7	SENT_58	[p3l597t220r918b279],
7	information	NN	O	information	nsubjpass	9	SENT_58	[p3l960t220r1345b279],
8	was	VBD	O	be	auxpass	9	SENT_58	[p3l1386t241r1502b279],
9	collected	VBN	O	collect	_	0	SENT_58	[p3l1547t220r1823b279],
10	adopting	VBG	O	adopt	xcomp	9	SENT_58	[p3l1866t220r2149b298],
11	the	DT	O	the	det	13	SENT_58	[p3l10t320r108b380],
12	REGISCAR	NN	O	regiscar	nn	13	SENT_58	[p3l133t324r501b380],
13	criteria	NNS	O	criterion	dobj	10	SENT_58	[p3l524t322r745b380],
14	for	IN	O	for	_	0	SENT_58	[p3l769t320r860b380],
15	DRESS	NN	O	dress	prep_for	13	SENT_58	[p3l884t324r1109b380],
16	and	CC	O	and	_	0	SENT_58	[p3l1135t320r1253b380],
17	the	DT	O	the	det	20	SENT_58	[p3l1275t320r1373b380],
18	illness	NN	O	illness	nn	20	SENT_58	[p3l1398t320r1586b380],
19	severity	NN	O	severity	nn	20	SENT_58	[p3l1612t322r1851b398],
20	score	NN	NUMBER	score	dobj	10	SENT_58	[p3l1873t342r2033b380],
21	for	IN	O	for	_	0	SENT_58	[p3l2058t320r2149b380],
22	toxic	JJ	O	toxic	amod	26	SENT_58	[p3l10t432r166b490],
23	epidermal	JJ	O	epidermal	amod	26	SENT_58	[p3l193t430r510b508],
24	necrolysis	NN	O	necrolysis	nn	26	SENT_58	[p3l535t430r842b508],
25	(	NN	O	(	nn	26	SENT_58	[p3l873t417r1437b502],
26	SCORTEN	NN	O	scorten	prep_for	20	SENT_58	[p3l873t417r1437b502],
27	)	CD	NUMBER	)	number	28	SENT_58	[p3l873t417r1437b502],
28	.14	CD	NUMBER	.14	num	29	SENT_58	[p3l873t417r1437b502],
29	_	NN	O	_	tmod	10	SENT_58	[p3l873t417r1437b502],
30	19	CD	NUMBER	19	num	33	SENT_58	[p3l873t417r1437b502],
31	Final	JJ	O	final	amod	33	SENT_58	[p3l1465t430r1622b490],
32	causality	NN	O	causality	nn	33	SENT_58	[p3l1648t430r1920b508],
33	assessment	NN	O	assessment	nsubj	34	SENT_58	[p3l1944t452r2145b490, p3l11t543r176b590],
34	followed	VBD	O	follow	rcmod	29	SENT_58	[p3l202t531r473b590],
35	the	DT	O	the	dobj	34	SENT_58	[p3l498t531r596b590],
36	WHO	WP	O	who	nsubj	37	SENT_58	[p3l620t534r818b590],
37	Collaborating	VBG	O	collaborate	rcmod	35	SENT_58	[p3l846t531r1280b609],
38	Centre	NNP	O	Centre	dobj	37	SENT_58	[p3l1306t534r1516b590],
39	for	IN	O	for	_	0	SENT_58	[p3l1542t531r1634b590],
40	Drug	NNP	O	Drug	prep_for	38	SENT_58	[p3l1660t535r1824b609],
41	Monitoring	VBG	O	monitor	partmod	40	SENT_58	[p3l1849t533r2144b590, p3l11t634r110b710],
42	criteria	NNS	O	criterion	dobj	41	SENT_58	[p3l137t619r431b691],
43	.20	CD	NUMBER	.20	num	44	SENT_58	[p3l137t619r431b691],
44	Mortality	NN	O	mortality	nsubjpass	46	SENT_58	[p3l457t632r760b710],
45	was	VBD	O	be	auxpass	46	SENT_58	[p3l780t653r896b691],
46	calculated	VBN	O	calculate	rcmod	42	SENT_58	[p3l924t632r1237b691],
47	on	IN	O	on	_	0	SENT_58	[p3l1263t653r1345b691],
48	the	DT	O	the	det	51	SENT_58	[p3l1370t632r1469b691],
49	total	JJ	O	total	amod	51	SENT_58	[p3l1494t632r1637b691],
50	sample	NN	O	sample	nn	51	SENT_58	[p3l1663t632r1883b709],
51	(	NN	O	(	prep_on	46	SENT_58	[p3l1914t632r2149b704],
52	overall	JJ	O	overall	amod	54	SENT_58	[p3l1914t632r2149b704],
53	mortality	NN	O	mortality	nn	54	SENT_58	[p3l11t733r328b811],
54	)	NN	O	)	dep	29	SENT_58	[p3l11t733r328b811],
55	and	CC	O	and	_	0	SENT_58	[p3l358t733r475b793],
56	speciﬁcally	RB	O	speciﬁcally	conj_and	9	SENT_58	[p3l500t733r842b811],
57	in	IN	O	in	_	0	SENT_58	[p3l863t735r924b792],
58	the	DT	O	the	det	62	SENT_58	[p3l948t733r1046b793],
59	severe	JJ	O	severe	amod	62	SENT_58	[p3l1071t755r1259b793],
60	cutaneous	JJ	O	cutaneous	amod	62	SENT_58	[p3l1284t745r1603b793],
61	ADR	NN	O	adr	nn	62	SENT_58	[p3l1626t737r1789b792],
62	subgroup	NN	O	subgroup	prep_in	56	SENT_58	[p3l1811t733r2126b811],
63	.	.	O	.	_	0	SENT_58	[p3l1811t733r2126b811],

1	The	DT	O	the	det	3	SENT_59	[p3l91t834r212b894],
2	case	NN	O	case	nn	3	SENT_59	[p3l243t856r368b894],
3	study	NN	O	study	nsubjpass	5	SENT_59	[p3l398t834r571b912],
4	was	VBD	O	be	auxpass	5	SENT_59	[p3l595t856r711b894],
5	designed	VBN	O	design	_	0	SENT_59	[p3l741t834r1017b912],
6	to	TO	O	to	aux	7	SENT_59	[p3l1045t846r1107b894],
7	collect	VB	O	collect	ccomp	5	SENT_59	[p3l1140t834r1340b894],
8	as	RB	O	as	advmod	9	SENT_59	[p3l1369t856r1427b894],
9	much	JJ	O	much	amod	10	SENT_59	[p3l1458t834r1641b894],
10	information	NN	O	information	dobj	7	SENT_59	[p3l1669t834r2053b894],
11	as	IN	O	as	_	0	SENT_59	[p3l2084t856r2142b894],
12	possible	JJ	O	possible	amod	16	SENT_59	[p3l9t935r259b1012],
13	on	IN	O	on	_	0	SENT_59	[p3l305t956r387b994],
14	allopurinol	NN	O	allopurinol	nn	15	SENT_59	[p3l433t935r783b1012],
15	skin	NN	O	skin	prep_on	12	SENT_59	[p3l829t935r956b994],
16	ADR	NN	O	adr	prep_as	7	SENT_59	[p3l999t938r1176b1003],
17	,	,	O	,	_	0	SENT_59	[p3l999t938r1176b1003],
18	and	CC	O	and	_	0	SENT_59	[p3l1224t935r1342b994],
19	to	TO	O	to	aux	21	SENT_59	[p3l1385t947r1448b994],
20	extensively	RB	O	extensively	advmod	21	SENT_59	[p3l1496t935r1839b1013],
21	generate	VB	O	generate	conj_and	7	SENT_59	[p3l1881t947r2143b1013],
22	hypothesis	NN	O	hypothesis	dobj	21	SENT_59	[p3l9t1035r344b1113],
23	which	WDT	O	which	nsubjpass	26	SENT_59	[p3l380t1035r572b1095],
24	might	MD	O	might	aux	26	SENT_59	[p3l610t1035r798b1114],
25	be	VB	O	be	auxpass	26	SENT_59	[p3l833t1035r906b1095],
26	tested	VBN	O	test	rcmod	22	SENT_59	[p3l944t1035r1127b1095],
27	in	IN	O	in	_	0	SENT_59	[p3l1165t1037r1228b1094],
28	future	JJ	DATE	future	prep_in	26	SENT_59	[p3l1265t1035r1457b1095],
29	researches	VBZ	O	research	dep	28	SENT_59	[p3l1495t1035r1827b1095],
30	.	.	O	.	_	0	SENT_59	[p3l1495t1035r1827b1095],

1	The	DT	O	the	det	3	SENT_60	[p3l1869t1035r1990b1095],
2	raw	JJ	O	raw	amod	3	SENT_60	[p3l2028t1057r2146b1095],
3	data	NNS	O	datum	nsubjpass	5	SENT_60	[p3l10t1137r143b1197],
4	are	VBP	O	be	auxpass	5	SENT_60	[p3l182t1159r275b1197],
5	expressed	VBN	O	express	_	0	SENT_60	[p3l315t1137r617b1215],
6	in	IN	O	in	_	0	SENT_60	[p3l656t1139r718b1196],
7	numbers	NNS	O	number	prep_in	5	SENT_60	[p3l757t1137r1036b1197],
8	and	CC	O	and	_	0	SENT_60	[p3l1076t1137r1194b1197],
9	percentages	NNS	O	percentage	prep_in	5	SENT_60	[p3l1232t1149r1614b1215],
10	,	,	O	,	_	0	SENT_60	[p3l1232t1149r1614b1215],
11	not	RB	O	not	neg	13	SENT_60	[p3l1655t1149r1762b1197],
12	statistically	RB	O	statistically	advmod	13	SENT_60	[p3l1801t1137r2147b1215],
13	valuable	JJ	O	valuable	amod	7	SENT_60	[p3l7t1238r267b1297],
14	in	IN	O	in	_	0	SENT_60	[p3l294t1240r356b1296],
15	the	DT	O	the	det	16	SENT_60	[p3l382t1238r480b1297],
16	absence	NN	O	absence	prep_in	13	SENT_60	[p3l509t1238r750b1297],
17	of	IN	O	of	_	0	SENT_60	[p3l778t1238r848b1297],
18	parameters	NNS	O	parameter	prep_of	16	SENT_60	[p3l865t1250r1232b1315],
19	,	,	O	,	_	0	SENT_60	[p3l865t1250r1232b1315],
20	such	JJ	O	such	_	0	SENT_60	[p3l1262t1238r1405b1297],
21	as	IN	O	as	_	0	SENT_60	[p3l1433t1259r1492b1297],
22	the	DT	O	the	det	23	SENT_60	[p3l1519t1238r1617b1297],
23	number	NN	O	number	prep_such_as	13	SENT_60	[p3l1645t1238r1898b1297],
24	of	IN	O	of	_	0	SENT_60	[p3l1925t1238r1995b1297],
25	prescriptions	NNS	O	prescription	prep_of	23	SENT_60	[p3l2013t1259r2140b1315, p3l10t1341r316b1416],
26	and	CC	O	and	_	0	SENT_60	[p3l351t1339r469b1399],
27	the	DT	O	the	det	29	SENT_60	[p3l501t1339r599b1399],
28	effective	JJ	O	effective	amod	29	SENT_60	[p3l634t1339r889b1399],
29	users	NNS	O	user	prep_such_as	13	SENT_60	[p3l923t1360r1080b1399],
30	of	IN	O	of	_	0	SENT_60	[p3l1115t1339r1185b1399],
31	allopurinol	NN	O	allopurinol	prep_of	29	SENT_60	[p3l1211t1339r1576b1416],
32	,	,	O	,	_	0	SENT_60	[p3l1211t1339r1576b1416],
33	in	IN	O	in	_	0	SENT_60	[p3l1612t1341r1674b1398],
34	the	DT	O	the	det	36	SENT_60	[p3l1707t1339r1805b1399],
35	Sardinian	JJ	LOCATION	sardinian	amod	36	SENT_60	[p3l1840t1339r2142b1399],
36	population	NN	O	population	prep_in	7	SENT_60	[p3l9t1440r359b1517],
37	during	IN	O	during	_	0	SENT_60	[p3l384t1440r596b1518],
38	the	DT	O	the	det	41	SENT_60	[p3l618t1440r716b1499],
39	speciﬁed	JJ	O	speciﬁed	amod	41	SENT_60	[p3l741t1440r1014b1517],
40	time	NN	O	time	nn	41	SENT_60	[p3l1036t1442r1179b1499],
41	period	NN	O	period	prep_during	5	SENT_60	[p3l1202t1440r1424b1517],
42	.	.	O	.	_	0	SENT_60	[p3l1202t1440r1424b1517],

1	Resuﬂs	NNS	O	resuﬂs	_	0	SENT_61	[p3l13t1655r329b1718],

1	Of	IN	O	of	_	0	SENT_62	[p3l11t1760r99b1819],
2	780	CD	NUMBER	780	num	4	SENT_62	[p3l122t1765r231b1819],
3	consecutive	JJ	O	consecutive	amod	4	SENT_62	[p3l263t1762r627b1819],
4	patients	NNS	O	patient	prep_of	14	SENT_62	[p3l657t1762r904b1837],
5	affected	VBN	O	affect	partmod	4	SENT_62	[p3l936t1760r1179b1819],
6	by	IN	O	by	_	0	SENT_62	[p3l1205t1760r1286b1838],
7	cutaneous	JJ	O	cutaneous	amod	8	SENT_62	[p3l1313t1772r1631b1819],
8	ADR	NN	O	adr	agent	5	SENT_62	[p3l1659t1763r1835b1828],
9	,	,	O	,	_	0	SENT_62	[p3l1659t1763r1835b1828],
10	allopurinol	NN	O	allopurinol	nsubj	14	SENT_62	[p3l1868t1760r2140b1837, p3l9t1861r112b1920],
11	was	VBD	O	be	cop	14	SENT_62	[p3l143t1882r258b1920],
12	the	DT	O	the	det	14	SENT_62	[p3l292t1861r390b1920],
13	culprit	NN	O	culprit	nn	14	SENT_62	[p3l425t1861r634b1938],
14	drug	NN	O	drug	dep	18	SENT_62	[p3l668t1860r816b1939],
15	in	IN	O	in	_	0	SENT_62	[p3l849t1863r911b1919],
16	84	CD	NUMBER	84	num	17	SENT_62	[p3l947t1866r1018b1920],
17	cases	NNS	O	case	prep_in	14	SENT_62	[p3l1054t1882r1206b1920],
18	(	VBP	O	(	_	0	SENT_62	[p3l1246t1861r1514b1933],
19	10.7	CD	PERCENT	10.7	num	20	SENT_62	[p3l1246t1861r1514b1933],
20	%	NN	PERCENT	%	dobj	18	SENT_62	[p3l1246t1861r1514b1933],
21	)	CD	NUMBER	)	nsubj	18	SENT_62	[p3l1246t1861r1514b1933],
22	,	,	O	,	_	0	SENT_62	[p3l1246t1861r1514b1933],
23	with	IN	O	with	_	0	SENT_62	[p3l1548t1861r1690b1920],
24	a	DT	O	a	det	26	SENT_62	[p3l1724t1882r1757b1920],
25	mean	JJ	O	mean	amod	26	SENT_62	[p3l1791t1882r1965b1920],
26	incidence	NN	O	incidence	prep_with	21	SENT_62	[p3l1999t1863r2140b1920, p3l10t1962r191b2022],
27	of	IN	O	of	_	0	SENT_62	[p3l227t1962r298b2022],
28	8.4	CD	NUMBER	8.4	num	29	SENT_62	[p3l326t1968r416b2022],
29	cases/year	NN	O	cases/year	prep_of	26	SENT_62	[p3l446t1964r782b2040],
30	.	.	O	.	_	0	SENT_62	[p3l446t1964r782b2040],

1	Distribution	NN	O	distribution	nsubjpass	11	SENT_63	[p3l822t1962r1213b2022],
2	of	IN	O	of	_	0	SENT_63	[p3l1249t1962r1320b2022],
3	cases	NNS	O	case	prep_of	1	SENT_63	[p3l1347t1984r1499b2022],
4	over	IN	O	over	_	0	SENT_63	[p3l1536t1984r1673b2022],
5	the	DT	O	the	det	6	SENT_63	[p3l1707t1962r1804b2022],
6	period	NN	O	period	prep_over	3	SENT_63	[p3l1839t1962r2046b2040],
7	of	IN	O	of	_	0	SENT_63	[p3l2082t1962r2153b2022],
8	intensive	JJ	O	intensive	amod	9	SENT_63	[p3l10t2065r289b2122],
9	monitoring	NN	O	monitoring	prep_of	6	SENT_63	[p3l317t2065r681b2141],
10	is	VBZ	O	be	auxpass	11	SENT_63	[p3l710t2065r755b2122],
11	illustrated	VBN	O	illustrate	_	0	SENT_63	[p3l785t2063r1099b2122],
12	in	IN	O	in	_	0	SENT_63	[p3l1129t2065r1190b2121],
13	Fig	NN	O	fig	prep_in	11	SENT_63	[p3l1220t2065r1329b2141],
14	.	.	O	.	_	0	SENT_63	[p3l1220t2065r1329b2141],

1	1	LS	NUMBER	1	_	0	SENT_64	[p3l1369t2069r1413b2122],
2	.	.	O	.	_	0	SENT_64	[p3l1369t2069r1413b2122],

1	Mean	NN	O	mean	nn	2	SENT_65	[p3l1444t2067r1626b2122],
2	age	NN	O	age	nsubj	9	SENT_65	[p3l1655t2084r1755b2141],
3	of	IN	O	of	_	0	SENT_65	[p3l1786t2063r1856b2122],
4	the	DT	O	the	det	6	SENT_65	[p3l1874t2063r1973b2122],
5	total	JJ	O	total	amod	6	SENT_65	[p3l2000t2063r2143b2122],
6	sample	NN	O	sample	prep_of	2	SENT_65	[p3l10t2164r230b2241],
7	was	VBD	O	be	cop	9	SENT_65	[p3l264t2185r380b2223],
8	74	CD	DURATION	74	num	9	SENT_65	[p3l420t2170r491b2223],
9	year	NN	NUMBER	year	_	0	SENT_65	[p3l518t2164r797b2242],
10	—	CD	NUMBER	—	npadvmod	11	SENT_65	[p3l518t2164r797b2242],
11	old	JJ	O	old	amod	9	SENT_65	[p3l518t2164r797b2242],
12	,	,	O	,	_	0	SENT_65	[p3l518t2164r797b2242],
13	ranging	VBG	O	range	partmod	9	SENT_65	[p3l836t2166r1077b2242],
14	from	IN	O	from	_	0	SENT_65	[p3l1113t2164r1269b2223],
15	62	CD	DURATION	62	number	17	SENT_65	[p3l1307t2169r1377b2223],
16	to	TO	DURATION	to	dep	17	SENT_65	[p3l1416t2176r1478b2223],
17	96	CD	DURATION	96	num	18	SENT_65	[p3l1518t2169r1590b2224],
18	years	NNS	NUMBER	year	prep_from	13	SENT_65	[p3l1617t2185r1793b2242],
19	;	:	O	;	_	0	SENT_65	[p3l1617t2185r1793b2242],
20	50	CD	PERCENT	50	number	21	SENT_65	[p3l1834t2170r1904b2223],
21	(	CD	PERCENT	(	nsubj	27	SENT_65	[p3l1948t2164r2137b2236],
22	59	CD	PERCENT	59	num	23	SENT_65	[p3l1948t2164r2137b2236],
23	%	NN	PERCENT	%	dep	21	SENT_65	[p3l1948t2164r2137b2236],
24	)	CD	NUMBER	)	num	25	SENT_65	[p3l1948t2164r2137b2236],
25	patients	NNS	O	patient	dep	21	SENT_65	[p3l9t2267r256b2342],
26	were	VBD	O	be	cop	27	SENT_65	[p3l283t2286r431b2324],
27	female	JJ	O	female	parataxis	9	SENT_65	[p3l459t2265r680b2324],
28	.	.	O	.	_	0	SENT_65	[p3l459t2265r680b2324],

1	For	IN	O	for	_	0	SENT_66	[p3l712t2269r820b2324],
2	reasons	NNS	O	reason	prep_for	16	SENT_66	[p3l848t2286r1081b2324],
3	of	IN	O	of	_	0	SENT_66	[p3l1110t2265r1180b2324],
4	the	DT	O	the	det	5	SENT_66	[p3l1198t2265r1296b2324],
5	extension	NN	O	extension	prep_of	2	SENT_66	[p3l1325t2267r1626b2324],
6	of	IN	O	of	_	0	SENT_66	[p3l1654t2265r1725b2324],
7	the	DT	O	the	det	8	SENT_66	[p3l1743t2265r1841b2324],
8	eruption	NN	O	eruption	prep_of	5	SENT_66	[p3l1870t2267r2143b2342],
9	and	CC	O	and	_	0	SENT_66	[p3l10t2365r128b2425],
10	severity	NN	O	severity	prep_of	5	SENT_66	[p3l176t2367r415b2444],
11	of	IN	O	of	_	0	SENT_66	[p3l461t2365r531b2425],
12	symptoms	NNS	O	symptom	prep_of	8	SENT_66	[p3l571t2377r915b2443],
13	,	,	O	,	_	0	SENT_66	[p3l571t2377r915b2443],
14	hospitalization	NN	O	hospitalization	nsubjpass	16	SENT_66	[p3l964t2365r1432b2443],
15	was	VBD	O	be	auxpass	16	SENT_66	[p3l1478t2387r1594b2425],
16	required	VBN	O	require	_	0	SENT_66	[p3l1643t2365r1911b2443],
17	in	IN	O	in	_	0	SENT_66	[p3l1959t2367r2020b2424],
18	81	CD	PERCENT	81	num	19	SENT_66	[p3l2071t2371r2136b2425],
19	(	CD	PERCENT	(	prep_in	16	SENT_66	[p3l14t2467r204b2539],
20	96	CD	PERCENT	96	num	21	SENT_66	[p3l14t2467r204b2539],
21	%	NN	PERCENT	%	tmod	16	SENT_66	[p3l14t2467r204b2539],
22	)	CD	NUMBER	)	num	23	SENT_66	[p3l14t2467r204b2539],
23	patients	NNS	O	patient	dep	21	SENT_66	[p3l233t2469r496b2545],
24	.	.	O	.	_	0	SENT_66	[p3l233t2469r496b2545],

1	Clinical	JJ	O	clinical	amod	2	SENT_67	[p3l92t2568r333b2627],
2	forms	NNS	O	form	nsubjpass	4	SENT_67	[p3l360t2568r543b2627],
3	are	VBP	O	be	auxpass	4	SENT_67	[p3l573t2589r665b2627],
4	described	VBN	O	describe	_	0	SENT_67	[p3l694t2568r993b2627],
5	and	CC	O	and	_	0	SENT_67	[p3l1020t2568r1138b2627],
6	listed	VBN	O	list	conj_and	4	SENT_67	[p3l1164t2568r1331b2627],
7	by	IN	O	by	_	0	SENT_67	[p3l1356t2568r1435b2646],
8	frequency	NN	O	frequency	agent	4	SENT_67	[p3l1460t2568r1772b2646],
9	in	IN	O	in	_	0	SENT_67	[p3l1797t2570r1859b2626],
10	Table	NNP	O	Table	prep_in	8	SENT_67	[p3l1886t2568r2059b2627],
11	1	CD	NUMBER	1	num	10	SENT_67	[p3l2096t2573r2140b2627],
12	.	.	O	.	_	0	SENT_67	[p3l2096t2573r2140b2627],

1	Main	NNP	O	Main	nn	2	SENT_68	[p3l9t2671r178b2728],
2	reactions	NNS	O	reaction	nsubjpass	8	SENT_68	[p3l216t2671r500b2728],
3	were	VBD	O	be	auxpass	8	SENT_68	[p3l537t2690r685b2728],
4	maculo-papular	JJ	O	maculo-papular	amod	5	SENT_68	[p3l724t2669r1232b2746],
5	eruptions	NNS	O	eruption	attr	8	SENT_68	[p3l1270t2671r1587b2746],
6	,	,	O	,	_	0	SENT_68	[p3l1270t2671r1587b2746],
7	closely	RB	O	closely	advmod	8	SENT_68	[p3l1628t2669r1837b2747],
8	followed	VBN	O	follow	_	0	SENT_68	[p3l1873t2668r2143b2728],
9	by	IN	O	by	_	0	SENT_68	[p3l7t2770r87b2848],
10	the	DT	O	the	det	11	SENT_68	[p3l116t2770r213b2830],
11	spectrum	NN	O	spectrum	agent	8	SENT_68	[p3l248t2782r542b2848],
12	of	IN	O	of	_	0	SENT_68	[p3l577t2770r648b2830],
13	Stevens-Johnson	NN	MISC	stevens-johnson	nn	14	SENT_68	[p3l673t2770r1197b2840],
14	syndrome	NN	O	syndrome	prep_of	11	SENT_68	[p3l1231t2770r1545b2848],
15	and	CC	O	and	_	0	SENT_68	[p3l1579t2770r1697b2830],
16	toxic	JJ	O	toxic	amod	18	SENT_68	[p3l1729t2772r1885b2830],
17	epidermal	JJ	O	epidermal	amod	18	SENT_68	[p3l1918t2770r2140b2848, p3l9t2871r128b2930],
18	necrolysis	NN	O	necrolysis	conj_and	11	SENT_68	[p3l163t2871r471b2949],
19	(	CD	NUMBER	(	number	20	SENT_68	[p3l511t2871r730b2943],
20	TEN	CD	NUMBER	ten	num	21	SENT_68	[p3l511t2871r730b2943],
21	)	NN	O	)	dep	18	SENT_68	[p3l511t2871r730b2943],
22	.	.	O	.	_	0	SENT_68	[p3l511t2871r730b2943],

1	The	DT	O	the	det	3	SENT_69	[p3l768t2871r890b2930],
2	drug	NN	O	drug	nn	3	SENT_69	[p3l927t2871r1075b2949],
3	rash	NN	O	rash	nsubjpass	27	SENT_69	[p3l1110t2871r1241b2930],
4	with	IN	O	with	_	0	SENT_69	[p3l1275t2871r1416b2930],
5	eosinophilia	NN	O	eosinophilia	nn	8	SENT_69	[p3l1453t2871r1837b2948],
6	and	CC	O	and	_	0	SENT_69	[p3l1873t2871r1990b2930],
7	systemic	JJ	O	systemic	nn	8	SENT_69	[p3l2027t2892r2140b2949, p3l9t2974r184b3031],
8	symptom	NN	O	symptom	prep_with	3	SENT_69	[p3l211t2984r511b3050],
9	(	CD	NUMBER	(	num	11	SENT_69	[p3l542t2972r818b3044],
10	DRESS	NN	O	dress	nn	11	SENT_69	[p3l542t2972r818b3044],
11	)	NN	O	)	nsubj	12	SENT_69	[p3l542t2972r818b3044],
12	resulted	VBD	O	result	rcmod	8	SENT_69	[p3l849t2972r1099b3031],
13	less	JJR	O	less	dobj	12	SENT_69	[p3l1123t2972r1229b3031],
14	frequent	JJ	O	frequent	amod	13	SENT_69	[p3l1257t2972r1523b3049],
15	than	IN	O	than	advmod	16	SENT_69	[p3l1548t2972r1690b3031],
16	expected	VBN	O	expect	partmod	13	SENT_69	[p3l1718t2972r2008b3049],
17	,	,	O	,	_	0	SENT_69	[p3l1718t2972r2008b3049],
18	but	CC	O	but	_	0	SENT_69	[p3l2034t2972r2143b3031],
19	only	RB	O	only	_	0	SENT_69	[p3l10t3073r150b3151],
20	deﬁnite	JJ	O	deﬁnite	amod	21	SENT_69	[p3l177t3073r414b3132],
21	cases	NNS	O	case	conj_only	13	SENT_69	[p3l444t3094r597b3132],
22	following	VBG	O	follow	partmod	21	SENT_69	[p3l627t3073r924b3151],
23	the	DT	O	the	det	24	SENT_69	[p3l951t3073r1049b3132],
24	REGISCAR	NN	O	regiscar	dobj	22	SENT_69	[p3l1079t3076r1447b3132],
25	scoring	VBG	O	score	amod	24	SENT_69	[p3l1475t3075r1704b3151],
26	were	VBD	O	be	auxpass	27	SENT_69	[p3l1731t3094r1879b3132],
27	considered	VBN	O	consider	_	0	SENT_69	[p3l1909t3073r2140b3132, p3l10t3173r159b3233],
28	.	.	O	.	_	0	SENT_69	[p3l1909t3073r2140b3132, p3l10t3173r159b3233],

1	Diagnostic	JJ	O	diagnostic	amod	2	SENT_70	[p3l206t3175r544b3252],
2	challenge	NN	O	challenge	nsubjpass	4	SENT_70	[p3l588t3173r877b3252],
3	was	VBD	O	be	auxpass	4	SENT_70	[p3l919t3195r1035b3233],
4	represented	VBN	O	represent	_	0	SENT_70	[p3l1080t3173r1446b3251],
5	by	IN	O	by	_	0	SENT_70	[p3l1487t3173r1566b3251],
6	several	JJ	O	several	amod	7	SENT_70	[p3l1608t3173r1817b3233],
7	reactions	NNS	O	reaction	agent	4	SENT_70	[p3l1860t3175r2142b3233],
8	simulating	VBG	O	simulate	partmod	7	SENT_70	[p3l10t3275r344b3353],
9	more	RBR	O	more	advmod	10	SENT_70	[p3l372t3297r539b3335],
10	common	JJ	O	common	amod	11	SENT_70	[p3l568t3297r856b3335],
11	dermatitis	NN	O	dermatitis	dobj	8	SENT_70	[p3l885t3275r1221b3344],
12	,	,	O	,	_	0	SENT_70	[p3l885t3275r1221b3344],
13	such	JJ	O	such	_	0	SENT_70	[p3l1253t3275r1396b3335],
14	as	IN	O	as	_	0	SENT_70	[p3l1425t3297r1484b3335],
15	the	DT	O	the	det	18	SENT_70	[p3l1513t3275r1610b3335],
16	Pityriasis	NN	O	pityriasis	nn	18	SENT_70	[p3l1640t3277r1922b3353],
17	rosealike	JJ	O	rosealike	amod	18	SENT_70	[p3l1952t3297r2140b3335, p3l8t3376r119b3435],
18	eruption	NN	O	eruption	prep_such_as	11	SENT_70	[p3l163t3378r436b3453],
19	and	CC	O	and	_	0	SENT_70	[p3l480t3376r597b3435],
20	the	DT	O	the	det	22	SENT_70	[p3l639t3376r737b3435],
21	lichenoid	NN	O	lichenoid	nn	22	SENT_70	[p3l779t3376r1073b3435],
22	dermatitis	NN	O	dermatitis	prep_such_as	11	SENT_70	[p3l1117t3376r1451b3435],
23	.	.	O	.	_	0	SENT_70	[p3l1117t3376r1451b3435],

1	Some	DT	O	some	det	2	SENT_71	[p3l1498t3379r1673b3436],
2	examples	NNS	O	example	nsubjpass	4	SENT_71	[p3l1717t3376r2006b3453],
3	are	VBP	O	be	auxpass	4	SENT_71	[p3l2050t3397r2143b3435],
4	shown	VBN	O	show	_	0	SENT_71	[p3l10t3476r216b3536],
5	in	IN	O	in	_	0	SENT_71	[p3l261t3478r324b3535],
6	the	DT	O	the	det	7	SENT_71	[p3l368t3476r466b3536],
7	ﬁgures	NNS	O	ﬁgures	prep_in	4	SENT_71	[p3l512t3476r737b3555],
8	:	:	O	:	_	0	SENT_71	[p3l512t3476r737b3555],
9	progression	NN	O	progression	dep	19	SENT_71	[p3l785t3478r1154b3555],
10	from	IN	O	from	_	0	SENT_71	[p3l1200t3476r1356b3536],
11	severe	JJ	O	severe	amod	13	SENT_71	[p3l1402t3498r1590b3536],
12	maculo-papular	JJ	O	maculo-papular	amod	13	SENT_71	[p3l1635t3476r2144b3554],
13	reaction	NN	O	reaction	prep_from	9	SENT_71	[p3l10t3580r266b3638],
14	towards	IN	O	towards	_	0	SENT_71	[p3l305t3578r555b3638],
15	SIS/T	NNP	O	SIS/T	nn	16	SENT_71	[p3l597t3580r782b3648],
16	EN	NNP	O	EN	prep_towards	13	SENT_71	[p3l784t3583r885b3637],
17	syndrome	NN	O	syndrome	dep	19	SENT_71	[p3l926t3578r1240b3656],
18	(	CD	NUMBER	(	num	17	SENT_71	[p3l1285t3578r1432b3656],
19	Figs	NNS	O	fig	dep	42	SENT_71	[p3l1285t3578r1432b3656],
20	2	CD	NUMBER	2	num	19	SENT_71	[p3l1462t3584r1495b3637],
21	and	CC	O	and	_	0	SENT_71	[p3l1539t3578r1656b3638],
22	3	CD	NUMBER	3	dep	42	SENT_71	[p3l1697t3578r1777b3650],
23	)	NN	O	)	dep	19	SENT_71	[p3l1697t3578r1777b3650],
24	,	,	O	,	_	0	SENT_71	[p3l1697t3578r1777b3650],
25	as	RB	O	as	_	0	SENT_71	[p3l1820t3600r1879b3638],
26	well	RB	O	well	_	0	SENT_71	[p3l1917t3578r2044b3638],
27	as	IN	O	as	_	0	SENT_71	[p3l2084t3600r2142b3638],
28	peculiar	JJ	O	peculiar	amod	29	SENT_71	[p3l9t3679r262b3756],
29	features	NNS	O	feature	conj_and	23	SENT_71	[p3l285t3679r546b3747],
30	,	,	O	,	_	0	SENT_71	[p3l285t3679r546b3747],
31	such	JJ	O	such	_	0	SENT_71	[p3l573t3679r718b3738],
32	as	IN	O	as	_	0	SENT_71	[p3l742t3700r800b3738],
33	red	JJ	O	red	amod	41	SENT_71	[p3l826t3679r1163b3756],
34	—	NN	O	—	nn	41	SENT_71	[p3l826t3679r1163b3756],
35	purple	JJ	O	purple	amod	41	SENT_71	[p3l826t3679r1163b3756],
36	hue	NN	O	hue	nn	38	SENT_71	[p3l1187t3679r1320b3747],
37	,	,	O	,	_	0	SENT_71	[p3l1187t3679r1320b3747],
38	groin	NN	O	groin	nn	41	SENT_71	[p3l1347t3681r1515b3757],
39	and	CC	O	and	_	0	SENT_71	[p3l1540t3679r1657b3738],
40	genital	JJ	O	genital	nn	41	SENT_71	[p3l1682t3679r1891b3757],
41	regions	NNS	O	region	prep_such_as	23	SENT_71	[p3l1915t3681r2142b3757],
42	involvement	NN	O	involvement	dep	4	SENT_71	[p4l10t18r417b77],
43	.	.	O	.	_	0	SENT_71	[p4l10t18r417b77],

1	Peculiar	JJ	O	peculiar	amod	2	SENT_72	[p4l460t18r715b77],
2	reactions	NNS	O	reaction	nsubj	27	SENT_72	[p4l753t20r1052b86],
3	,	,	O	,	_	0	SENT_72	[p4l753t20r1052b86],
4	such	JJ	O	such	_	0	SENT_72	[p4l1094t18r1237b77],
5	as	IN	O	as	_	0	SENT_72	[p4l1277t39r1335b77],
6	acute	JJ	O	acute	prep_such_as	2	SENT_72	[p4l1375t30r1539b77],
7	generalized	VBN	O	generalize	partmod	6	SENT_72	[p4l1578t18r1932b96],
8	eXan	NN	O	exan	nn	9	SENT_72	[p4l1970t39r2140b77],
9	—	NN	O	—	dobj	7	SENT_72	[p4l1970t39r2140b77],
10	thematous	JJ	O	thematous	amod	9	SENT_72	[p4l9t119r343b178],
11	pustolosis	NN	O	pustolosis	nn	14	SENT_72	[p4l371t119r685b196],
12	(	CD	NUMBER	(	num	14	SENT_72	[p4l717t119r982b191],
13	AGEP	NN	O	agep	nn	14	SENT_72	[p4l717t119r982b191],
14	)	NN	O	)	tmod	10	SENT_72	[p4l717t119r982b191],
15	,	,	O	,	_	0	SENT_72	[p4l717t119r982b191],
16	and	CC	O	and	_	0	SENT_72	[p4l1013t119r1130b178],
17	confusing	JJ	O	confusing	amod	18	SENT_72	[p4l1159t119r1467b197],
18	features	NNS	O	feature	conj_and	14	SENT_72	[p4l1495t119r1754b187],
19	,	,	O	,	_	0	SENT_72	[p4l1495t119r1754b187],
20	such	JJ	O	such	_	0	SENT_72	[p4l1785t119r1930b178],
21	as	IN	O	as	_	0	SENT_72	[p4l1958t140r2016b178],
22	the	DT	O	the	det	23	SENT_72	[p4l2044t119r2142b178],
23	presence	NN	O	presence	prep_such_as	2	SENT_72	[p4l9t240r281b297],
24	of	IN	O	of	_	0	SENT_72	[p4l315t219r386b279],
25	detachment	NN	O	detachment	nn	26	SENT_72	[p4l412t219r785b279],
26	area	NN	O	area	prep_of	23	SENT_72	[p4l819t241r949b279],
27	intermingled	VBD	O	intermingle	_	0	SENT_72	[p4l982t219r1390b298],
28	with	IN	O	with	_	0	SENT_72	[p4l1422t219r1563b279],
29	a	DT	O	a	det	31	SENT_72	[p4l1599t241r1631b279],
30	micro-pustular	JJ	O	micro-pustular	amod	31	SENT_72	[p4l1665t219r2144b297],
31	eruption	NN	O	eruption	prep_with	27	SENT_72	[p4l10t323r299b399],
32	,	,	O	,	_	0	SENT_72	[p4l10t323r299b399],
33	mucositis	NN	O	mucositis	appos	31	SENT_72	[p4l368t323r669b381],
34	without	IN	O	without	_	0	SENT_72	[p4l734t321r985b381],
35	skin	NN	O	skin	nn	36	SENT_72	[p4l1051t321r1180b381],
36	detachment	NN	O	detachment	prep_without	33	SENT_72	[p4l1246t321r1618b381],
37	(	CD	NUMBER	(	num	38	SENT_72	[p4l1689t321r1836b399],
38	Figs	NNS	O	fig	tmod	27	SENT_72	[p4l1689t321r1836b399],
39	4-6	CD	NUMBER	4-6	num	40	SENT_72	[p4l1865t321r2003b393],
40	)	CD	NUMBER	)	dep	38	SENT_72	[p4l1865t321r2003b393],
41	or	CC	O	or	_	0	SENT_72	[p4l2076t343r2143b381],
42	suspected	VBN	O	suspect	conj_or	27	SENT_72	[p4l10t422r314b499],
43	Vasculitis	NNP	O	Vasculitis	nsubj	44	SENT_72	[p4l341t422r627b481],
44	required	VBD	O	require	ccomp	42	SENT_72	[p4l659t422r926b499],
45	biopsy	NN	O	biopsy	dobj	44	SENT_72	[p4l954t422r1166b500],
46	and	CC	O	and	_	0	SENT_72	[p4l1193t422r1311b481],
47	histological	JJ	O	histological	amod	48	SENT_72	[p4l1340t422r1699b500],
48	examination	NN	O	examination	dobj	44	SENT_72	[p4l1730t424r2141b490],
49	,	,	O	,	_	0	SENT_72	[p4l1730t424r2141b490],
50	as	RB	O	as	_	0	SENT_72	[p4l10t544r69b582],
51	well	RB	O	well	_	0	SENT_72	[p4l102t522r229b582],
52	as	IN	O	as	_	0	SENT_72	[p4l263t544r322b582],
53	blood	NN	O	blood	nn	54	SENT_72	[p4l356t522r541b582],
54	analysis	NN	O	analysis	dobj	44	SENT_72	[p4l576t522r816b600],
55	for	IN	O	for	_	0	SENT_72	[p4l851t522r943b582],
56	the	DT	O	the	det	58	SENT_72	[p4l976t522r1074b582],
57	ﬁnal	JJ	O	ﬁnal	amod	58	SENT_72	[p4l1109t522r1248b582],
58	assessment	NN	O	assessment	prep_for	54	SENT_72	[p4l1283t534r1640b582],
59	.	.	O	.	_	0	SENT_72	[p4l1283t534r1640b582],

1	The	DT	O	the	det	3	SENT_73	[p4l1677t522r1799b582],
2	31	CD	NUMBER	31	num	3	SENT_73	[p4l1836t528r1902b582],
3	(	NN	O	(	_	0	SENT_73	[p4l1948t522r2138b595],
4	37	CD	PERCENT	37	num	5	SENT_73	[p4l1948t522r2138b595],
5	%	NN	PERCENT	%	dep	3	SENT_73	[p4l1948t522r2138b595],
6	)	CD	NUMBER	)	dep	3	SENT_73	[p4l1948t522r2138b595],

1	1	CD	NUMBER	1	number	2	SENT_74	[p4l169t766r246b827],
2	“	CD	NUMBER	“	num	6	SENT_74	[p4l169t766r246b827],
3	El	NNP	O	El	nn	6	SENT_74	[p4l323t804r383b865],
4	1315	CD	DATE	1315	num	6	SENT_74	[p4l400t799r565b860],
5	H	NN	O	h	nn	6	SENT_74	[p4l207t881r246b942],
6	Eijﬂ	NN	O	eijﬂ	_	0	SENT_74	[p4l1175t898r1246b936],
7	:	:	O	:	_	0	SENT_74	[p4l1338t925r1340b942],
8	:7	CD	NUMBER	:7	dep	6	SENT_74	[p4l1370t898r1412b903],
9	.	.	O	.	_	0	SENT_74	[p4l1370t898r1412b903],

1	,	,	O	,	_	0	SENT_75	[p4l1682t898r1752b903],
2	,	,	O	,	_	0	SENT_75	[p4l1682t898r1752b903],
3	:1	CD	NUMBER	:1	nsubj	4	SENT_75	[p4l1682t898r1752b903],
4	»	NN	O	»	_	0	SENT_75	[p4l1846t895r1848b897],
5	II	CD	NUMBER	ii	num	7	SENT_75	[p4l1912t898r1917b903],
6	c	NN	O	c	nn	7	SENT_75	[p4l219t991r235b1018],
7	_	NN	O	_	iobj	4	SENT_75	[p4l263t1018r267b1024],
8	2	CD	NUMBER	2	dobj	4	SENT_75	[p4l521t1013r570b1018],
9	,	,	O	,	_	0	SENT_75	[p4l521t1013r570b1018],
10	gm	NN	O	gm	dobj	4	SENT_75	[p4l846t1013r906b1025],
11	.	.	O	.	_	0	SENT_75	[p4l1000t1018r1003b1022],

1	,2	NN	O	,2	_	0	SENT_76	[p4l1027t1013r1071b1018],
2	2	CD	NUMBER	2	dep	1	SENT_76	[p4l1527t1013r1576b1018],
3	.	.	O	.	_	0	SENT_76	[p4l1527t1013r1576b1018],

1	.	.	O	.	_	0	SENT_77	[p4l1527t1013r1576b1018],

1	1	CD	NUMBER	1	num	2	SENT_78	[p4l245t1958r246b1961],
2	EM	NN	O	em	_	0	SENT_78	[p4l290t1977r434b2027],
3	‘	NN	O	‘	dep	2	SENT_78	[p4l290t1977r434b2027],
4	!	.	O	!	_	0	SENT_78	[p4l290t1977r434b2027],

1	2	LS	NUMBER	2	_	0	SENT_79	[p4l461t1977r609b2027],
2	.	.	O	.	_	0	SENT_79	[p4l461t1977r609b2027],

1	Eﬂﬂﬂa	NNP	O	Eﬂﬂﬂa	nn	2	SENT_80	[p4l625t1977r774b2027],
2	EH5	NN	O	eh5	_	0	SENT_80	[p4l966t1977r1109b2027],
3	6	CD	NUMBER	6	num	4	SENT_80	[p4l1131t1977r1279b2027],
4	D	NN	O	d	dep	2	SENT_80	[p4l1131t1977r1279b2027],
5	+	CC	O	+	_	0	SENT_80	[p4l1131t1977r1279b2027],
6	2	CD	NUMBER	2	dep	2	SENT_80	[p4l1302t1977r1445b2027],
7	?	.	O	?	_	0	SENT_80	[p4l1302t1977r1445b2027],

1	Eﬂﬂ	NN	O	eﬂﬂ	_	0	SENT_81	[p4l1467t1977r1615b2027],
2	аM	NN	O	аm	nn	3	SENT_81	[p4l1636t1977r1786b2027],
3	D	NN	O	d	dep	1	SENT_81	[p4l1636t1977r1786b2027],
4	+	CC	O	+	_	0	SENT_81	[p4l1636t1977r1786b2027],
5	2111	CD	DATE	2111	num	6	SENT_81	[p4l1807t1977r1950b2027],
6	!?!	CD	NUMBER	!?!	dep	1	SENT_81	[p4l1807t1977r1950b2027],

1	Figure	NNP	O	Figure	nsubj	11	SENT_82	[p4l12t2083r225b2149],
2	1	CD	NUMBER	1	num	1	SENT_82	[p4l256t2083r280b2135],
3	Annual	JJ	SET	annual	amod	4	SENT_82	[p4l340t2083r560b2136],
4	distribution	NN	O	distribution	dep	1	SENT_82	[p4l590t2083r946b2136],
5	of	IN	O	of	_	0	SENT_82	[p4l976t2082r1037b2136],
6	the	DT	O	the	det	7	SENT_82	[p4l1061t2083r1161b2136],
7	allopurinol	NN	O	allopurinol	prep_of	4	SENT_82	[p4l1189t2083r1516b2149],
8	cutaneous	JJ	O	cutaneous	amod	10	SENT_82	[p4l1547t2085r1882b2136],
9	adverse	JJ	O	adverse	amod	10	SENT_82	[p4l10t2172r264b2226],
10	reactions	NNS	O	reaction	dep	1	SENT_82	[p4l294t2172r586b2226],
11	observed	VBN	O	observe	_	0	SENT_82	[p4l615t2172r912b2226],
12	at	IN	O	at	_	0	SENT_82	[p4l943t2175r1001b2226],
13	the	DT	O	the	det	15	SENT_82	[p4l1027t2172r1127b2226],
14	Dermatology	NNP	O	Dermatology	nn	15	SENT_82	[p4l1158t2172r1568b2240],
15	Department	NNP	O	Department	prep_at	11	SENT_82	[p4l1599t2172r1977b2239],
16	of	IN	O	of	_	0	SENT_82	[p4l2005t2172r2065b2226],
17	Cagliari	NNP	ORGANIZATION	Cagliari	nn	18	SENT_82	[p4l10t2261r248b2330],
18	University	NNP	ORGANIZATION	University	prep_of	15	SENT_82	[p4l281t2262r610b2330],
19	.	.	O	.	_	0	SENT_82	[p4l281t2262r610b2330],

1	Emmi	NNP	O	Emmi	_	0	SENT_83	[p4l207t996r251b1857],
2	:	:	O	:	_	0	SENT_83	[p4l207t996r251b1857],
3	-	:	O	-	_	0	SENT_83	[p4l207t996r251b1857],
4	rennin-din	NN	O	rennin-din	dep	1	SENT_83	[p4l207t996r251b1857],

1	©	RB	O	©	dep	2	SENT_84	[p4l1618t2550r1660b2592],
2	2011	CD	DATE	2011	dep	4	SENT_84	[p4l1684t2549r1800b2592],
3	The	DT	O	the	det	4	SENT_84	[p4l1832t2548r1926b2592],
4	Authors	NNPS	O	Authors	_	0	SENT_84	[p4l1947t2548r2143b2592],

1	IEADV	NNP	O	IEADV	dep	19	SENT_85	[p4l79t2607r178b2634],
2	2012	CD	DATE	2012	num	1	SENT_85	[p4l185t2610r249b2633],
3	,	,	O	,	_	0	SENT_85	[p4l185t2610r249b2633],
4	26	CD	NUMBER	26	num	1	SENT_85	[p4l260t2610r295b2633],
5	,	,	O	,	_	0	SENT_85	[p4l260t2610r295b2633],
6	1424-1430	CD	DATE	1424-1430	num	7	SENT_85	[p4l308t2610r438b2630],
7	Journal	NNP	O	Journal	appos	1	SENT_85	[p4l558t2610r641b2630],
8	of	IN	O	of	_	0	SENT_85	[p4l652t2610r674b2630],
9	the	DT	O	the	det	11	SENT_85	[p4l682t2610r718b2630],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_85	[p4l729t2610r838b2635],
11	Academy	NN	ORGANIZATION	academy	prep_of	1	SENT_85	[p4l848t2610r958b2635],
12	of	IN	ORGANIZATION	of	_	0	SENT_85	[p4l967t2610r989b2630],
13	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	11	SENT_85	[p4l999t2610r1145b2635],
14	and	CC	O	and	_	0	SENT_85	[p4l1155t2610r1197b2630],
15	Venereology	NNP	O	Venereology	prep_of	11	SENT_85	[p4l1207t2610r1350b2635],
16	©	CD	NUMBER	©	dep	19	SENT_85	[p4l1360t2611r1379b2630],
17	2011	CD	DATE	2011	num	19	SENT_85	[p4l1390t2610r1444b2630],
18	European	JJ	ORGANIZATION	european	amod	19	SENT_85	[p4l1459t2610r1568b2635],
19	Academy	NN	ORGANIZATION	academy	_	0	SENT_85	[p4l1579t2610r1688b2635],
20	of	IN	ORGANIZATION	of	_	0	SENT_85	[p4l1698t2610r1719b2630],
21	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	19	SENT_85	[p4l1730t2610r1875b2635],
22	and	CC	O	and	_	0	SENT_85	[p4l1885t2610r1927b2630],
23	Venereology	NNP	O	Venereology	prep_of	19	SENT_85	[p4l1937t2610r2080b2635],

1	1426	CD	DATE	1426	num	2	SENT_86	[p4l82t2716r143b2738],
2	Atzori	NNP	O	Atzori	_	0	SENT_86	[p4l1889t2710r1983b2738],
3	et	FW	O	et	nn	4	SENT_86	[p4l1997t2712r2030b2738],
4	al.	FW	O	al.	dep	2	SENT_86	[p4l2041t2710r2075b2738],
5	.	.	O	.	_	0	SENT_86	[p4l2041t2710r2075b2738],

1	Tab	NN	O	tab	nn	4	SENT_87	[p4l7t2937r252b2991],
2	|	CD	NUMBER	|	num	4	SENT_87	[p4l7t2937r252b2991],
3	e1	NN	O	e1	nn	4	SENT_87	[p4l7t2937r252b2991],
4	Allopurinol	NN	O	allopurinol	_	0	SENT_87	[p4l313t2937r652b3004],
5	cutaneous	JJ	O	cutaneous	amod	7	SENT_87	[p4l692t2940r1029b2991],
6	adverse	JJ	O	adverse	amod	7	SENT_87	[p4l1066t2937r1322b2991],
7	reactions	NNS	O	reaction	dep	4	SENT_87	[p4l1361t2937r1672b2991],
8	:	:	O	:	_	0	SENT_87	[p4l1361t2937r1672b2991],
9	clinical	JJ	O	clinical	amod	10	SENT_87	[p4l1713t2937r1929b2991],
10	manifestations	NNS	O	manifestation	dep	4	SENT_87	[p4l1971t2937r2151b2991, p4l7t3027r322b3081],
11	ordered	VBN	O	order	partmod	4	SENT_87	[p4l350t3027r600b3081],
12	by	IN	O	by	_	0	SENT_87	[p4l633t3027r708b3095],
13	frequency	NN	O	frequency	agent	11	SENT_87	[p4l733t3027r1056b3095],
14	in	IN	O	in	_	0	SENT_87	[p4l1085t3027r1133b3080],
15	a	DT	O	a	det	18	SENT_87	[p4l1164t3041r1200b3081],
16	10	CD	DURATION	10	num	18	SENT_87	[p4l1232t3028r1304b3081],
17	year	NN	NUMBER	year	nn	18	SENT_87	[p4l1331t3041r1471b3095],
18	period	NN	O	period	prep_in	13	SENT_87	[p4l1499t3027r1699b3094],

1	Clinical	JJ	O	clinical	amod	2	SENT_88	[p4l8t3178r244b3230],
2	form	NN	O	form	_	0	SENT_88	[p4l270t3179r421b3230],
3	Males	NNPS	O	Males	dep	2	SENT_88	[p4l917t3179r1147b3231],
4	/	:	O	/	punct	2	SENT_88	[p4l917t3179r1147b3231],
5	Number	NN	O	number	dep	2	SENT_88	[p4l1302t3179r1560b3230],
6	of	IN	O	of	_	0	SENT_88	[p4l1584t3179r1649b3230],
7	Number	NNP	O	Number	prep_of	5	SENT_88	[p4l1760t3179r2018b3230],
8	of	IN	O	of	_	0	SENT_88	[p4l2043t3179r2106b3230],
9	Females	NNPS	O	Females	nn	10	SENT_88	[p4l917t3260r1186b3311],
10	cases	NNS	O	case	prep_of	2	SENT_88	[p4l1300t3273r1488b3311],
11	(	CD	PERCENT	(	num	12	SENT_88	[p4l1516t3259r1619b3323],
12	%	NN	PERCENT	%	dep	10	SENT_88	[p4l1516t3259r1619b3323],
13	)	CD	NUMBER	)	dep	10	SENT_88	[p4l1516t3259r1619b3323],
14	hospitalized	VBN	O	hospitalize	partmod	10	SENT_88	[p4l1759t3260r2150b3323],
15	patient	NN	O	patient	dobj	14	SENT_88	[p4l1759t3342r1983b3404],
16	(	CD	PERCENT	(	num	17	SENT_88	[p4l2011t3341r2113b3404],
17	%	NN	PERCENT	%	tmod	14	SENT_88	[p4l2011t3341r2113b3404],
18	)	CD	NUMBER	)	dep	17	SENT_88	[p4l2011t3341r2113b3404],

1	Maculo-papular	JJ	O	maculo-papular	amod	2	SENT_89	[p4l11t3429r491b3492],
2	eruption	NN	O	eruption	dep	17	SENT_89	[p4l516t3429r762b3492],
3	10/24	CD	NUMBER	10/24	num	4	SENT_89	[p4l918t3430r1100b3480],
4	34	CD	NUMBER	34	dep	2	SENT_89	[p4l1300t3430r1371b3480],
5	(	CD	NUMBER	(	number	6	SENT_89	[p4l1399t3428r1505b3492],
6	40	CD	NUMBER	40	num	7	SENT_89	[p4l1399t3428r1505b3492],
7	)	NN	O	)	dep	4	SENT_89	[p4l1399t3428r1505b3492],
8	34	CD	NUMBER	34	number	9	SENT_89	[p4l1758t3430r1829b3480],
9	(	CD	NUMBER	(	num	11	SENT_89	[p4l1858t3428r1963b3493],
10	40	CD	NUMBER	40	number	11	SENT_89	[p4l1858t3428r1963b3493],
11	)	CD	NUMBER	)	npadvmod	12	SENT_89	[p4l1858t3428r1963b3493],
12	Severe	JJ	O	severe	amod	7	SENT_89	[p4l8t3530r217b3582],
13	cutaneous	JJ	O	cutaneous	amod	14	SENT_89	[p4l244t3533r561b3581],
14	ADR	NN	O	adr	dep	17	SENT_89	[p4l585t3531r723b3581],
15	12/19	CD	NUMBER	12/19	num	17	SENT_89	[p4l918t3531r1100b3581],
16	31	CD	NUMBER	31	num	17	SENT_89	[p4l1300t3531r1361b3581],
17	(	NN	O	(	dep	23	SENT_89	[p4l1399t3530r1505b3594],
18	37	CD	NUMBER	37	number	19	SENT_89	[p4l1399t3530r1505b3594],
19	)	CD	NUMBER	)	dep	17	SENT_89	[p4l1399t3530r1505b3594],
20	31	CD	NUMBER	31	num	21	SENT_89	[p4l1758t3531r1818b3581],
21	(	NN	O	(	dep	19	SENT_89	[p4l1858t3530r1963b3594],
22	37	CD	NUMBER	37	num	23	SENT_89	[p4l1858t3530r1963b3594],
23	)	NN	O	)	_	0	SENT_89	[p4l1858t3530r1963b3594],

1	Stevens	NNP	PERSON	Stevens	_	0	SENT_90	[p4l77t3633r615b3685],
2	.	.	O	.	_	0	SENT_90	[p4l77t3633r615b3685],

1	—	NN	O	—	_	0	SENT_91	[p4l77t3633r615b3685],
2	.	.	O	.	_	0	SENT_91	[p4l77t3633r615b3685],

1	Johnson	NNP	PERSON	Johnson	_	0	SENT_92	[p4l77t3633r615b3685],
2	18	CD	NUMBER	18	dep	1	SENT_92	[p4l1304t3635r1371b3685],
3	(	CD	NUMBER	(	number	4	SENT_92	[p4l1399t3633r1505b3698],
4	21	CD	NUMBER	21	num	9	SENT_92	[p4l1399t3633r1505b3698],
5	)	NN	O	)	nn	9	SENT_92	[p4l1399t3633r1505b3698],
6	syndrome	NN	O	syndrome	nn	9	SENT_92	[p4l77t3721r378b3785],
7	(	CD	NUMBER	(	num	9	SENT_92	[p4l407t3720r560b3784],
8	SJS	NN	O	sj	nn	9	SENT_92	[p4l407t3720r560b3784],
9	)	NN	O	)	dep	2	SENT_92	[p4l407t3720r560b3784],

1	Overlap	NN	O	overlap	nn	2	SENT_93	[p5l77t18r312b82],
2	SJS/TEN	NN	O	sjs/ten	_	0	SENT_93	[p5l340t18r625b70],
3	4	CD	NUMBER	4	num	4	SENT_93	[p5l1337t20r1371b69],
4	(	NN	O	(	dep	2	SENT_93	[p5l1399t18r1524b82],
5	4.7	CD	NUMBER	4.7	number	6	SENT_93	[p5l1399t18r1524b82],
6	)	CD	NUMBER	)	num	13	SENT_93	[p5l1399t18r1524b82],
7	Toxic	JJ	O	toxic	amod	13	SENT_93	[p5l75t109r239b159],
8	epidermal	JJ	O	epidermal	amod	13	SENT_93	[p5l267t109r565b172],
9	9	CD	NUMBER	9	amod	13	SENT_93	[p5l1338t109r1371b159],
10	(	NN	O	(	nn	13	SENT_93	[p5l1399t108r1562b172],
11	10.7	CD	NUMBER	10.7	number	12	SENT_93	[p5l1399t108r1562b172],
12	)	CD	NUMBER	)	num	13	SENT_93	[p5l1399t108r1562b172],
13	necrolysis	NN	O	necrolysis	dep	4	SENT_93	[p5l79t191r380b254],
14	(	CD	NUMBER	(	num	16	SENT_93	[p5l408t189r569b254],
15	TEN	CD	NUMBER	ten	num	16	SENT_93	[p5l408t189r569b254],
16	)	NN	O	)	dep	2	SENT_93	[p5l408t189r569b254],

1	Cutaneous	JJ	O	cutaneous	amod	12	SENT_94	[p5l9t293r337b345],
2	vasculitis	NN	O	vasculitis	nn	12	SENT_94	[p5l363t294r641b344],
3	3/3	CD	NUMBER	3/3	num	12	SENT_94	[p5l949t294r1058b344],
4	6	CD	NUMBER	6	num	12	SENT_94	[p5l1338t294r1371b344],
5	(	NN	O	(	nn	12	SENT_94	[p5l1399t293r1524b357],
6	7.1	CD	NUMBER	7.1	num	12	SENT_94	[p5l1399t293r1524b357],
7	)	NN	O	)	nn	12	SENT_94	[p5l1399t293r1524b357],
8	6	CD	NUMBER	6	num	12	SENT_94	[p5l1796t294r1830b344],
9	(	NN	O	(	nn	12	SENT_94	[p5l1858t293r1982b357],
10	7.1	CD	NUMBER	7.1	num	12	SENT_94	[p5l1858t293r1982b357],
11	)	NN	O	)	nn	12	SENT_94	[p5l1858t293r1982b357],
12	Pityriasis	NN	O	pityriasis	dep	13	SENT_94	[p5l11t398r278b461],
13	rosea-like	JJ	O	rosea-like	_	0	SENT_94	[p5l307t398r602b448],
14	3/0	CD	NUMBER	3/0	num	15	SENT_94	[p5l949t398r1058b448],
15	3	CD	NUMBER	3	dep	25	SENT_94	[p5l1337t398r1371b448],
16	(	NN	O	(	dep	15	SENT_94	[p5l1399t397r1524b461],
17	3.5	CD	NUMBER	3.5	num	16	SENT_94	[p5l1399t397r1524b461],
18	)	NN	O	)	dep	25	SENT_94	[p5l1399t397r1524b461],
19	1	CD	NUMBER	1	num	18	SENT_94	[p5l1799t398r1818b447],
20	(	CD	NUMBER	(	number	21	SENT_94	[p5l1858t397r1982b461],
21	1.2	CD	NUMBER	1.2	num	25	SENT_94	[p5l1858t397r1982b461],
22	)	NN	O	)	nn	25	SENT_94	[p5l1858t397r1982b461],
23	eruption	NN	O	eruption	nn	25	SENT_94	[p5l8t480r254b543],
24	Drug	NN	O	drug	nn	25	SENT_94	[p5l11t582r151b646],
25	rash	NN	O	rash	dep	29	SENT_94	[p5l182t582r306b632],
26	with	IN	O	with	_	0	SENT_94	[p5l334t582r456b632],
27	2/1	CD	NUMBER	2/1	number	28	SENT_94	[p5l949t582r1047b632],
28	3	CD	NUMBER	3	prep_with	25	SENT_94	[p5l1337t582r1371b632],
29	(	NN	O	(	dep	31	SENT_94	[p5l1399t581r1524b645],
30	3.5	CD	NUMBER	3.5	num	29	SENT_94	[p5l1399t581r1524b645],
31	)	NN	O	)	dep	36	SENT_94	[p5l1399t581r1524b645],
32	3	CD	NUMBER	3	num	31	SENT_94	[p5l1796t582r1829b632],
33	(	NN	O	(	nn	36	SENT_94	[p5l1858t581r1982b645],
34	3.5	CD	NUMBER	3.5	num	36	SENT_94	[p5l1858t581r1982b645],
35	)	NN	O	)	nn	36	SENT_94	[p5l1858t581r1982b645],
36	eosinophilia	NN	O	eosinophilia	dep	41	SENT_94	[p5l8t664r369b727],
37	and	CC	O	and	_	0	SENT_94	[p5l395t664r504b714],
38	systemic	JJ	O	systemic	amod	40	SENT_94	[p5l534t664r802b727],
39	symptom	NN	O	symptom	nn	40	SENT_94	[p5l8t748r289b809],
40	(	NN	O	(	dep	41	SENT_94	[p5l319t744r576b809],
41	DRESS	NN	O	dress	dep	67	SENT_94	[p5l319t744r576b809],
42	)	CD	NUMBER	)	num	41	SENT_94	[p5l319t744r576b809],
43	Acute	JJ	O	acute	nsubj	67	SENT_94	[p5l6t847r182b897],
44	generalized	VBN	O	generalize	partmod	43	SENT_94	[p5l209t847r555b911],
45	1/2	CD	NUMBER	1/2	number	46	SENT_94	[p5l953t847r1057b897],
46	3	CD	NUMBER	3	num	47	SENT_94	[p5l1337t847r1371b897],
47	(	NN	O	(	dobj	44	SENT_94	[p5l1399t846r1524b910],
48	3.5	CD	NUMBER	3.5	num	49	SENT_94	[p5l1399t846r1524b910],
49	)	NN	O	)	dep	55	SENT_94	[p5l1399t846r1524b910],
50	3	CD	NUMBER	3	num	51	SENT_94	[p5l1796t847r1829b897],
51	(	NN	O	(	dep	49	SENT_94	[p5l1858t846r1982b910],
52	3.5	CD	NUMBER	3.5	num	53	SENT_94	[p5l1858t846r1982b910],
53	)	NN	O	)	dep	55	SENT_94	[p5l1858t846r1982b910],
54	exanthematous	JJ	O	exanthematous	amod	55	SENT_94	[p5l8t929r478b979],
55	pustolosis	NN	O	pustolosis	dep	60	SENT_94	[p5l10t1010r316b1073],
56	(	CD	NUMBER	(	num	57	SENT_94	[p5l344t1009r556b1073],
57	AGEP	NN	O	agep	dep	55	SENT_94	[p5l344t1009r556b1073],
58	)	CD	NUMBER	)	num	60	SENT_94	[p5l344t1009r556b1073],
59	Lichenoid	JJ	O	lichenoid	amod	60	SENT_94	[p5l11t1112r299b1162],
60	dermatitis	NN	O	dermatitis	dep	47	SENT_94	[p5l330t1112r629b1162],
61	1/1	CD	NUMBER	1/1	num	62	SENT_94	[p5l953t1112r1047b1162],
62	2	CD	NUMBER	2	dep	60	SENT_94	[p5l1337t1112r1370b1162],
63	(	CD	NUMBER	(	number	64	SENT_94	[p5l1399t1111r1524b1175],
64	2.4	CD	NUMBER	2.4	num	66	SENT_94	[p5l1399t1111r1524b1175],
65	)	NN	O	)	nn	66	SENT_94	[p5l1399t1111r1524b1175],
66	o	NN	O	o	dep	62	SENT_94	[p5l1796t1112r1829b1162],
67	Fixed	VBN	O	fix	ccomp	13	SENT_94	[p5l11t1213r169b1264],
68	drug	NN	O	drug	nn	69	SENT_94	[p5l200t1213r334b1277],
69	eruption	NN	O	eruption	dobj	67	SENT_94	[p5l363t1213r610b1276],
70	1/0	CD	NUMBER	1/0	number	71	SENT_94	[p5l953t1213r1058b1264],
71	1	CD	NUMBER	1	num	72	SENT_94	[p5l1341t1213r1360b1263],
72	(	NN	O	(	dep	69	SENT_94	[p5l1399t1212r1524b1276],
73	1.2	CD	NUMBER	1.2	number	74	SENT_94	[p5l1399t1212r1524b1276],
74	)	CD	NUMBER	)	num	79	SENT_94	[p5l1399t1212r1524b1276],
75	O	NN	O	o	nn	79	SENT_94	[p5l1796t1214r1829b1264],
76	Erytroderma	NN	O	erytroderma	nn	79	SENT_94	[p5l11t1315r384b1378],
77	1/0	CD	NUMBER	1/0	number	78	SENT_94	[p5l953t1315r1058b1365],
78	1	CD	NUMBER	1	num	79	SENT_94	[p5l1341t1315r1360b1365],
79	(	NN	O	(	dep	84	SENT_94	[p5l1399t1314r1439b1378],
80	1	CD	NUMBER	1	dep	79	SENT_94	[p5l1399t1314r1439b1378],
81	.2	NN	NUMBER	.2	nn	82	SENT_94	[p5l1457t1314r1524b1378],
82	)	NN	O	)	dep	84	SENT_94	[p5l1457t1314r1524b1378],
83	1	CD	NUMBER	1	num	84	SENT_94	[p5l1799t1315r1818b1365],
84	(	NN	O	(	dep	69	SENT_94	[p5l1858t1314r1898b1378],
85	1	CD	NUMBER	1	num	87	SENT_94	[p5l1858t1314r1898b1378],
86	.2	NN	NUMBER	.2	nn	87	SENT_94	[p5l1916t1314r1982b1378],
87	)	NN	O	)	dep	84	SENT_94	[p5l1916t1314r1982b1378],

1	Total	JJ	O	total	_	0	SENT_95	[p5l6t1462r154b1513],
2	34/50	CD	NUMBER	34/50	number	3	SENT_95	[p5l915t1463r1100b1513],
3	84	CD	NUMBER	84	dep	1	SENT_95	[p5l1300t1463r1371b1513],
4	81	CD	NUMBER	81	num	5	SENT_95	[p5l1758t1463r1818b1513],
5	(	NN	O	(	dep	3	SENT_95	[p5l1858t1461r2021b1525],
6	96.4	CD	NUMBER	96.4	num	7	SENT_95	[p5l1858t1461r2021b1525],
7	)	NN	O	)	dep	1	SENT_95	[p5l1858t1461r2021b1525],

1	patients	NNS	O	patient	nsubj	8	SENT_96	[p5l7t1713r256b1788],
2	affected	VBN	O	affect	partmod	1	SENT_96	[p5l290t1711r533b1770],
3	by	IN	O	by	_	0	SENT_96	[p5l563t1711r643b1789],
4	severe	JJ	O	severe	amod	7	SENT_96	[p5l672t1732r861b1770],
5	cutaneous	JJ	O	cutaneous	amod	7	SENT_96	[p5l895t1723r1215b1770],
6	adverse	JJ	O	adverse	amod	7	SENT_96	[p5l1249t1711r1482b1770],
7	reactions	NNS	O	reaction	agent	2	SENT_96	[p5l1515t1713r1798b1770],
8	(	VBP	O	(	_	0	SENT_96	[p5l1837t1711r2048b1783],
9	SIS/T	NN	O	sis/t	nn	11	SENT_96	[p5l1837t1711r2048b1783],
10	EN	NN	O	en	nn	11	SENT_96	[p5l2050t1715r2152b1770],
11	patients	NNS	O	patient	dobj	8	SENT_96	[p5l7t1811r280b1889],
12	)	CD	NUMBER	)	nsubjpass	15	SENT_96	[p5l7t1811r280b1889],
13	were	VBD	O	be	auxpass	15	SENT_96	[p5l309t1833r458b1871],
14	also	RB	O	also	advmod	15	SENT_96	[p5l484t1811r602b1871],
15	evaluated	VBN	O	evaluate	rcmod	11	SENT_96	[p5l630t1811r929b1871],
16	following	VBG	O	follow	_	0	SENT_96	[p5l953t1811r1251b1890],
17	the	DT	O	the	det	20	SENT_96	[p5l1274t1811r1372b1871],
18	illness	NN	O	illness	nn	20	SENT_96	[p5l1398t1811r1586b1871],
19	severity	NN	O	severity	nn	20	SENT_96	[p5l1613t1813r1853b1889],
20	score	NN	NUMBER	score	prep_following	15	SENT_96	[p5l1875t1833r2037b1871],
21	for	IN	O	for	_	0	SENT_96	[p5l2061t1811r2152b1871],
22	toxic	JJ	O	toxic	amod	26	SENT_96	[p5l8t1915r164b1973],
23	epidermal	JJ	O	epidermal	amod	26	SENT_96	[p5l214t1913r532b1990],
24	necrolysis	NN	O	necrolysis	nn	26	SENT_96	[p5l581t1913r888b1991],
25	(	NN	O	(	nn	26	SENT_96	[p5l943t1900r1509b1985],
26	SCORTEN	NN	O	scorten	prep_for	20	SENT_96	[p5l943t1900r1509b1985],
27	)	CD	NUMBER	)	number	28	SENT_96	[p5l943t1900r1509b1985],
28	,14	CD	NUMBER	,14	num	26	SENT_96	[p5l943t1900r1509b1985],
29	"	``	O	"	punct	26	SENT_96	[p5l943t1900r1509b1985],
30	16	CD	NUMBER	16	dep	26	SENT_96	[p5l943t1900r1509b1985],
31	whose	WP$	O	whose	dep	34	SENT_96	[p5l1557t1913r1756b1973],
32	results	NNS	O	result	nsubjpass	34	SENT_96	[p5l1806t1913r2008b1973],
33	are	VBP	O	be	auxpass	34	SENT_96	[p5l2058t1934r2152b1972],
34	reported	VBN	O	report	dep	20	SENT_96	[p5l9t2014r280b2091],
35	in	IN	O	in	_	0	SENT_96	[p5l304t2016r368b2072],
36	Table	NNP	O	Table	prep_in	34	SENT_96	[p5l390t2013r564b2073],
37	2	CD	NUMBER	2	num	36	SENT_96	[p5l594t2019r644b2073],
38	.	.	O	.	_	0	SENT_96	[p5l594t2019r644b2073],

1	Lesion	NN	O	lesion	nn	2	SENT_97	[p5l91t2116r297b2174],
2	onset	NN	O	onset	nsubj	4	SENT_97	[p5l341t2126r508b2174],
3	generally	RB	O	generally	advmod	4	SENT_97	[p5l550t2114r834b2193],
4	occurred	VBD	O	occur	_	0	SENT_97	[p5l873t2114r1154b2174],
5	2-4	CD	NUMBER	2-4	num	6	SENT_97	[p5l1196t2120r1309b2173],
6	weeks	NNS	NUMBER	week	tmod	4	SENT_97	[p5l1337t2114r1523b2174],
7	after	IN	O	after	_	0	SENT_97	[p5l1567t2114r1708b2174],
8	drug	NN	O	drug	nn	9	SENT_97	[p5l1751t2114r1899b2193],
9	intake	NN	O	intake	prep_after	4	SENT_97	[p5l1940t2114r2150b2183],
10	,	,	O	,	_	0	SENT_97	[p5l1940t2114r2150b2183],
11	but	CC	O	but	_	0	SENT_97	[p5l6t2216r115b2275],
12	referral	NN	O	referral	nsubj	16	SENT_97	[p5l147t2216r374b2275],
13	to	TO	O	to	_	0	SENT_97	[p5l404t2228r467b2275],
14	a	DT	O	a	det	15	SENT_97	[p5l502t2238r534b2275],
15	dermatologist	NN	O	dermatologist	prep_to	12	SENT_97	[p5l567t2216r1004b2294],
16	occurred	VBD	O	occur	conj_but	4	SENT_97	[p5l1037t2216r1318b2276],
17	2-3	CD	NUMBER	2-3	num	18	SENT_97	[p5l1350t2222r1459b2275],
18	Weeks	NNS	DATE	week	npadvmod	19	SENT_97	[p5l1490t2216r1677b2275],
19	later	RB	DATE	later	advmod	16	SENT_97	[p5l1708t2216r1861b2275],
20	.	.	O	.	_	0	SENT_97	[p5l1708t2216r1861b2275],

1	Prodromic	JJ	O	prodromic	amod	3	SENT_98	[p5l1897t2216r2148b2275, p5l8t2319r128b2376],
2	ﬂu	NN	O	ﬂu	nn	3	SENT_98	[p5l158t2317r384b2376],
3	—	NN	O	—	nsubjpass	7	SENT_98	[p5l158t2317r384b2376],
4	like	IN	O	like	_	0	SENT_98	[p5l158t2317r384b2376],
5	symptoms	NNS	O	symptom	prep_like	3	SENT_98	[p5l416t2329r744b2395],
6	were	VBD	O	be	auxpass	7	SENT_98	[p5l774t2338r923b2376],
7	reported	VBN	O	report	_	0	SENT_98	[p5l955t2317r1227b2394],
8	by	IN	O	by	_	0	SENT_98	[p5l1256t2317r1335b2395],
9	24	CD	PERCENT	24	num	10	SENT_98	[p5l1363t2322r1437b2375],
10	(	CD	PERCENT	(	agent	7	SENT_98	[p5l1473t2317r1664b2389],
11	28	CD	PERCENT	28	num	12	SENT_98	[p5l1473t2317r1664b2389],
12	%	NN	PERCENT	%	tmod	7	SENT_98	[p5l1473t2317r1664b2389],
13	)	CD	NUMBER	)	num	14	SENT_98	[p5l1473t2317r1664b2389],
14	patients	NNS	O	patient	dep	12	SENT_98	[p5l1701t2319r1966b2394],
15	;	:	O	;	_	0	SENT_98	[p5l1701t2319r1966b2394],
16	fever	NN	O	fever	nsubj	20	SENT_98	[p5l2000t2317r2152b2376],
17	at	IN	O	at	_	0	SENT_98	[p5l9t2429r66b2477],
18	referral	NN	O	referral	prep_at	16	SENT_98	[p5l98t2417r325b2477],
19	was	VBD	O	be	cop	20	SENT_98	[p5l355t2439r471b2477],
20	present	JJ	DATE	present	parataxis	7	SENT_98	[p5l505t2429r736b2495],
21	in	IN	O	in	_	0	SENT_98	[p5l769t2419r831b2476],
22	a	DT	O	a	det	23	SENT_98	[p5l865t2439r897b2477],
23	minority	NN	O	minority	prep_in	20	SENT_98	[p5l930t2419r1212b2495],
24	of	IN	O	of	_	0	SENT_98	[p5l1243t2417r1314b2477],
25	cases	NNS	O	case	prep_of	23	SENT_98	[p5l1338t2439r1491b2477],
26	(	CD	NUMBER	(	number	27	SENT_98	[p5l1529t2417r1627b2489],
27	16	CD	NUMBER	16	num	28	SENT_98	[p5l1529t2417r1627b2489],
28	patients	NNS	O	patient	dep	25	SENT_98	[p5l1660t2419r1926b2495],
29	;	:	O	;	_	0	SENT_98	[p5l1660t2419r1926b2495],
30	19	CD	PERCENT	19	num	31	SENT_98	[p5l1968t2417r2148b2489],
31	%	NN	PERCENT	%	dep	25	SENT_98	[p5l1968t2417r2148b2489],
32	)	CD	NUMBER	)	dep	31	SENT_98	[p5l1968t2417r2148b2489],
33	.	.	O	.	_	0	SENT_98	[p5l1968t2417r2148b2489],

1	Peripheral	JJ	O	peripheral	amod	4	SENT_99	[p5l9t2519r335b2596],
2	blood	NN	O	blood	nn	4	SENT_99	[p5l373t2519r558b2578],
3	eosinophilia	NN	O	eosinophilia	nn	4	SENT_99	[p5l598t2519r984b2596],
4	(	NN	O	(	_	0	SENT_99	[p5l1028t2519r1363b2597],
5	exceeding	VBG	O	exceed	partmod	4	SENT_99	[p5l1028t2519r1363b2597],
6	0.45	CD	NUMBER	0.45	num	8	SENT_99	[p5l1403t2525r1530b2578],
7	X	NN	O	x	nn	8	SENT_99	[p5l1562t2534r1605b2577],
8	109/L	NN	O	109/l	dobj	5	SENT_99	[p5l1641t2521r1827b2579],
9	(	CD	NUMBER	(	num	10	SENT_99	[p5l1872t2519r2150b2595],
10	450/uL	NN	O	450/ul	dep	8	SENT_99	[p5l1872t2519r2150b2595],
11	;	:	O	;	_	0	SENT_99	[p5l1872t2519r2150b2595],
12	only	RB	O	only	advmod	14	SENT_99	[p5l9t2620r149b2698],
13	three	CD	NUMBER	three	num	14	SENT_99	[p5l169t2620r329b2680],
14	patients	NNS	O	patient	nsubj	15	SENT_99	[p5l352t2622r600b2698],
15	had	VBD	O	have	dep	8	SENT_99	[p5l624t2620r743b2680],
16	value	NN	O	value	npadvmod	17	SENT_99	[p5l764t2620r930b2680],
17	>	JJR	O	>	amod	18	SENT_99	[p5l957t2626r1095b2680],
18	O.	NNP	O	O.	dobj	15	SENT_99	[p5l957t2626r1095b2680],
19	7	CD	NUMBER	7	number	20	SENT_99	[p5l957t2626r1095b2680],
20	X	NN	O	x	amod	18	SENT_99	[p5l1125t2635r1167b2678],
21	109	CD	NUMBER	109	dep	5	SENT_99	[p5l1204t2622r1350b2680],
22	/	:	O	/	punct	21	SENT_99	[p5l1204t2622r1350b2680],
23	L	NN	O	l	nn	24	SENT_99	[p5l1350t2620r1413b2692],
24	)	NN	O	)	nsubj	31	SENT_99	[p5l1350t2620r1413b2692],
25	was	VBD	O	be	cop	31	SENT_99	[p5l1441t2642r1557b2680],
26	the	DT	O	the	det	31	SENT_99	[p5l1581t2620r1680b2680],
27	most	RBS	O	most	advmod	28	SENT_99	[p5l1703t2632r1862b2680],
28	frequent	JJ	O	frequent	amod	31	SENT_99	[p5l1886t2620r2153b2698],
29	haematological	JJ	O	haematological	amod	31	SENT_99	[p5l7t2721r489b2799],
30	alteration	NN	O	alteration	nn	31	SENT_99	[p5l532t2721r834b2780],
31	(	NN	O	(	dep	21	SENT_99	[p5l882t2721r979b2793],
32	56	CD	NUMBER	56	num	33	SENT_99	[p5l882t2721r979b2793],
33	cases	NNS	O	case	dep	31	SENT_99	[p5l1025t2742r1195b2790],
34	;	:	O	;	_	0	SENT_99	[p5l1025t2742r1195b2790],
35	66	CD	PERCENT	66	num	36	SENT_99	[p5l1241t2721r1428b2793],
36	%	NN	PERCENT	%	dep	31	SENT_99	[p5l1241t2721r1428b2793],
37	)	CD	NUMBER	)	dep	36	SENT_99	[p5l1241t2721r1428b2793],
38	,	,	O	,	_	0	SENT_99	[p5l1241t2721r1428b2793],
39	followed	VBN	O	follow	_	0	SENT_99	[p5l1474t2721r1746b2780],
40	by	IN	O	by	prepc_followed_by	31	SENT_99	[p5l1787t2721r1866b2799],
41	a	DT	O	a	det	42	SENT_99	[p5l1907t2742r1940b2780],
42	slight	JJ	O	slight	pobj	31	SENT_99	[p5l1983t2721r2152b2799],

1	Figure	NNP	O	Figure	_	0	SENT_100	[p6l11t1480r225b1547],
2	2	CD	NUMBER	2	num	1	SENT_100	[p6l252t1480r290b1533],
3	Allopurinol	NNP	O	Allopurinol	nn	5	SENT_100	[p6l341t1480r679b1548],
4	maculo-papular	JJ	O	maculo-papular	amod	5	SENT_100	[p6l713t1480r1222b1547],
5	eruption	NN	O	eruption	dep	1	SENT_100	[p6l1249t1480r1511b1547],
6	at	IN	O	at	_	0	SENT_100	[p6l1542t1483r1600b1534],
7	the	DT	O	the	det	8	SENT_100	[p6l1626t1480r1727b1534],
8	moment	NN	O	moment	prep_at	5	SENT_100	[p6l1757t1483r2021b1534],
9	of	IN	O	of	_	0	SENT_100	[p6l2049t1480r2110b1534],
10	referral	NN	O	referral	prep_of	8	SENT_100	[p6l10t1571r250b1625],
11	.	.	O	.	_	0	SENT_100	[p6l10t1571r250b1625],

1	Figure	NNP	O	Figure	_	0	SENT_101	[p6l12t3173r226b3240],
2	3	CD	NUMBER	3	num	1	SENT_101	[p6l252t3173r290b3227],
3	Same	JJ	O	same	amod	4	SENT_101	[p6l344t3172r528b3227],
4	patient	NN	O	patient	tmod	1	SENT_101	[p6l558t3173r775b3240],
5	24	CD	NUMBER	24	num	6	SENT_101	[p6l802t3173r879b3226],
6	h	NN	O	h	npadvmod	7	SENT_101	[p6l909t3173r941b3226],
7	later	RB	O	later	advmod	4	SENT_101	[p6l974t3173r1125b3227],
8	:	:	O	:	_	0	SENT_101	[p6l974t3173r1125b3227],
9	dramatic	JJ	O	dramatic	amod	10	SENT_101	[p6l1157t3173r1439b3227],
10	evolution	NN	O	evolution	dep	1	SENT_101	[p6l1468t3173r1755b3227],
11	into	IN	O	into	_	0	SENT_101	[p6l1788t3173r1901b3227],
12	a	DT	O	a	det	14	SENT_101	[p6l1930t3187r1966b3227],
13	TEN	CD	NUMBER	ten	num	14	SENT_101	[p6l1991t3173r2125b3226],
14	case	NN	O	case	prep_into	10	SENT_101	[p6l10t3278r177b3317],
15	.	.	O	.	_	0	SENT_101	[p6l10t3278r177b3317],

1	Figure	NNP	O	Figure	nsubj	18	SENT_102	[p7l12t1308r226b1375],
2	4	CD	NUMBER	4	num	7	SENT_102	[p7l252t1309r291b1361],
3	Atypical	JJ	O	atypical	amod	7	SENT_102	[p7l341t1308r597b1376],
4	wide	JJ	O	wide	amod	7	SENT_102	[p7l626t1308r777b1362],
5	spread	NN	O	spread	nn	7	SENT_102	[p7l805t1308r1024b1375],
6	target	NN	O	target	nn	7	SENT_102	[p7l1053t1311r1241b1376],
7	lesions	NNS	O	lesion	npadvmod	1	SENT_102	[p7l1271t1308r1491b1362],
8	on	IN	O	on	_	0	SENT_102	[p7l1519t1322r1594b1362],
9	the	DT	O	the	det	10	SENT_102	[p7l1623t1308r1723b1362],
10	abdomen	NN	O	abdomen	prep_on	1	SENT_102	[p7l1751t1308r2054b1362],
11	in	IN	O	in	_	0	SENT_102	[p7l2086t1308r2133b1361],
12	a	DT	O	a	det	15	SENT_102	[p7l10t1413r46b1453],
13	82	CD	NUMBER	82	num	15	SENT_102	[p7l74t1400r148b1453],
14	year-old	JJ	O	year-old	amod	15	SENT_102	[p7l176t1399r439b1467],
15	lady	NN	O	lady	prep_in	10	SENT_102	[p7l473t1399r617b1467],
16	,	,	O	,	_	0	SENT_102	[p7l473t1399r617b1467],
17	finally	RB	O	finally	advmod	18	SENT_102	[p7l647t1399r832b1467],
18	diagnosed	VBD	O	diagnose	_	0	SENT_102	[p7l859t1399r1193b1467],
19	as	IN	O	as	_	0	SENT_102	[p7l1223t1413r1295b1453],
20	SJS	NN	O	sj	prep_as	18	SENT_102	[p7l1324t1398r1467b1453],
21	.	.	O	.	_	0	SENT_102	[p7l1324t1398r1467b1453],

1	anaemia	NN	O	anaemia	nsubj	40	SENT_103	[p7l10t1688r275b1745],
2	and	CC	O	and	_	0	SENT_103	[p7l308t1685r426b1745],
3	lymphocytosis	NN	O	lymphocytosis	conj_and	1	SENT_103	[p7l458t1685r912b1764],
4	(	CD	NUMBER	(	number	5	SENT_103	[p7l951t1686r1047b1758],
5	45	CD	NUMBER	45	num	6	SENT_103	[p7l951t1686r1047b1758],
6	cases	NNS	O	case	dep	3	SENT_103	[p7l1084t1707r1253b1754],
7	;	:	O	;	_	0	SENT_103	[p7l1084t1707r1253b1754],
8	53	CD	PERCENT	53	num	9	SENT_103	[p7l1291t1686r1477b1758],
9	%	NN	PERCENT	%	dep	3	SENT_103	[p7l1291t1686r1477b1758],
10	)	CD	NUMBER	)	dep	9	SENT_103	[p7l1291t1686r1477b1758],
11	;	:	O	;	_	0	SENT_103	[p7l1291t1686r1477b1758],
12	slight	JJ	O	slight	amod	15	SENT_103	[p7l1512t1685r1681b1764],
13	renal	JJ	O	renal	amod	15	SENT_103	[p7l1714t1686r1871b1745],
14	impairment	NN	O	impairment	nn	15	SENT_103	[p7l1904t1688r2140b1763, p7l10t1798r175b1846],
15	(	NN	O	(	dep	3	SENT_103	[p7l218t1786r314b1859],
16	62	CD	NUMBER	62	num	17	SENT_103	[p7l218t1786r314b1859],
17	cases	NNS	O	case	dep	15	SENT_103	[p7l357t1808r526b1855],
18	;	:	O	;	_	0	SENT_103	[p7l357t1808r526b1855],
19	74	CD	PERCENT	74	num	20	SENT_103	[p7l569t1787r732b1858],
20	%	NN	PERCENT	%	dep	3	SENT_103	[p7l569t1787r732b1858],
21	)	CD	NUMBER	)	dep	20	SENT_103	[p7l569t1787r732b1858],
22	and	CC	O	and	_	0	SENT_103	[p7l778t1786r895b1846],
23	hepatic	JJ	O	hepatic	amod	25	SENT_103	[p7l933t1786r1162b1864],
24	enzymes	NNS	O	enzyme	nn	25	SENT_103	[p7l1201t1807r1467b1865],
25	elevation	NN	O	elevation	conj_and	20	SENT_103	[p7l1508t1786r1790b1846],
26	(	CD	NUMBER	(	number	27	SENT_103	[p7l1833t1787r1931b1858],
27	36	CD	NUMBER	36	num	28	SENT_103	[p7l1833t1787r1931b1858],
28	cases	NNS	O	case	dep	25	SENT_103	[p7l1972t1808r2141b1855],
29	;	:	O	;	_	0	SENT_103	[p7l1972t1808r2141b1855],
30	43	CD	PERCENT	43	num	31	SENT_103	[p7l9t1893r167b1957],
31	%	NN	PERCENT	%	dep	3	SENT_103	[p7l9t1893r167b1957],
32	;	:	O	;	_	0	SENT_103	[p7l9t1893r167b1957],
33	only	RB	O	only	advmod	39	SENT_103	[p7l205t1888r344b1966],
34	three	CD	NUMBER	three	num	35	SENT_103	[p7l374t1888r534b1948],
35	patients	NNS	O	patient	pobj	33	SENT_103	[p7l567t1890r814b1965],
36	with	IN	O	with	_	0	SENT_103	[p7l848t1888r990b1948],
37	Value	NNP	O	Value	prep_with	33	SENT_103	[p7l1021t1888r1187b1948],
38	>	JJR	O	>	amod	37	SENT_103	[p7l1224t1900r1386b1948],
39	two	CD	NUMBER	two	dep	31	SENT_103	[p7l1224t1900r1386b1948],
40	folds	VBZ	O	fold	_	0	SENT_103	[p7l1422t1888r1572b1947],
41	the	DT	O	the	det	43	SENT_103	[p7l1606t1888r1705b1948],
42	normal	JJ	O	normal	amod	43	SENT_103	[p7l1738t1888r2013b1960],
43	)	NN	O	)	dobj	40	SENT_103	[p7l1738t1888r2013b1960],
44	.	.	O	.	_	0	SENT_103	[p7l1738t1888r2013b1960],

1	An	DT	O	a	det	2	SENT_104	[p7l2048t1891r2143b1947],
2	history	NN	O	history	nsubj	13	SENT_104	[p7l9t1989r232b2067],
3	of	IN	O	of	_	0	SENT_104	[p7l266t1989r336b2048],
4	chronic	JJ	O	chronic	amod	6	SENT_104	[p7l364t1989r605b2048],
5	renal	JJ	O	renal	amod	6	SENT_104	[p7l640t1989r797b2048],
6	impairment	NN	O	impairment	prep_of	2	SENT_104	[p7l832t1991r1210b2066],
7	prior	RB	O	prior	_	0	SENT_104	[p7l1245t1991r1406b2066],
8	to	TO	O	to	_	0	SENT_104	[p7l1441t2001r1504b2048],
9	the	DT	O	the	det	11	SENT_104	[p7l1541t1989r1639b2048],
10	ADR	NN	O	adr	nn	11	SENT_104	[p7l1674t1992r1835b2048],
11	development	NN	O	development	prep_prior_to	6	SENT_104	[p7l1871t1989r2140b2066, p7l10t2101r175b2149],
12	was	VBD	O	be	cop	13	SENT_104	[p7l199t2111r314b2149],
13	positive	JJ	O	positive	_	0	SENT_104	[p7l341t2091r586b2167],
14	in	IN	O	in	_	0	SENT_104	[p7l613t2091r675b2148],
15	59	CD	NUMBER	59	num	16	SENT_104	[p7l704t2095r775b2149],
16	cases	NNS	O	case	prep_in	13	SENT_104	[p7l804t2111r956b2149],
17	(	VBP	O	(	rcmod	16	SENT_104	[p7l988t2089r1200b2162],
18	70	CD	PERCENT	70	num	19	SENT_104	[p7l988t2089r1200b2162],
19	%	NN	PERCENT	%	dobj	17	SENT_104	[p7l988t2089r1200b2162],
20	)	CD	NUMBER	)	tmod	17	SENT_104	[p7l988t2089r1200b2162],
21	,	,	O	,	_	0	SENT_104	[p7l988t2089r1200b2162],
22	and	CC	O	and	_	0	SENT_104	[p7l1230t2089r1348b2149],
23	there	EX	O	there	expl	24	SENT_104	[p7l1373t2089r1533b2149],
24	was	VBD	O	be	conj_and	13	SENT_104	[p7l1557t2111r1674b2149],
25	not	RB	O	not	neg	24	SENT_104	[p7l1701t2101r1808b2149],
26	a	DT	O	a	det	27	SENT_104	[p7l1836t2111r1868b2149],
27	relevant	JJ	O	relevant	nsubj	24	SENT_104	[p7l1895t2089r2144b2149],
28	worsening	VBG	O	worsen	amod	27	SENT_104	[p7l8t2193r336b2269],
29	during	IN	O	during	_	0	SENT_104	[p7l365t2191r578b2269],
30	the	DT	O	the	det	32	SENT_104	[p7l606t2191r704b2251],
31	reaction	NN	O	reaction	nn	32	SENT_104	[p7l733t2193r990b2251],
32	course	NN	O	course	prep_during	27	SENT_104	[p7l1020t2212r1238b2251],
33	.	.	O	.	_	0	SENT_104	[p7l1020t2212r1238b2251],

1	Only	RB	O	only	quantmod	2	SENT_105	[p7l1272t2191r1430b2269],
2	three	CD	NUMBER	three	num	3	SENT_105	[p7l1455t2191r1615b2251],
3	patients	NNS	O	patient	_	0	SENT_105	[p7l1644t2193r1891b2268],
4	had	VBD	O	have	partmod	3	SENT_105	[p7l1920t2191r2039b2251],
5	an	DT	O	a	det	10	SENT_105	[p7l2068t2212r2143b2251],
6	acute	JJ	O	acute	amod	10	SENT_105	[p7l10t2303r175b2351],
7	renal	JJ	O	renal	amod	10	SENT_105	[p7l209t2292r365b2351],
8	and	CC	O	and	_	0	SENT_105	[p7l398t2292r516b2351],
9	hepatic	JJ	O	hepatic	conj_and	7	SENT_105	[p7l548t2292r778b2369],
10	involvement	NN	O	involvement	dobj	4	SENT_105	[p7l810t2292r1220b2360],
11	,	,	O	,	_	0	SENT_105	[p7l810t2292r1220b2360],
12	persistent	JJ	O	persistent	amod	10	SENT_105	[p7l1255t2294r1558b2369],
13	behind	IN	O	behind	_	0	SENT_105	[p7l1589t2292r1811b2351],
14	drug	NN	O	drug	nn	15	SENT_105	[p7l1846t2292r1993b2370],
15	discontinuation	NN	O	discontinuation	prep_behind	12	SENT_105	[p7l2027t2292r2140b2351, p7l10t2395r420b2453],
16	and	CC	O	and	_	0	SENT_105	[p7l443t2393r561b2453],
17	accompanied	VBN	O	accompany	conj_and	12	SENT_105	[p7l584t2393r1005b2470],
18	by	IN	O	by	_	0	SENT_105	[p7l1025t2393r1104b2471],
19	hypereosinophilia	NN	O	hypereosinophilia	prep_by	17	SENT_105	[p7l1123t2393r1706b2471],
20	,	,	O	,	_	0	SENT_105	[p7l1123t2393r1706b2471],
21	atypical	JJ	O	atypical	amod	22	SENT_105	[p7l1732t2393r1973b2471],
22	lymphocytes	NNS	O	lymphocyte	appos	19	SENT_105	[p7l1995t2393r2140b2471, p7l9t2493r302b2572],
23	,	,	O	,	_	0	SENT_105	[p7l1995t2393r2140b2471, p7l9t2493r302b2572],
24	lymph	NN	O	lymph	nn	25	SENT_105	[p7l342t2493r547b2572],
25	nodes	NNS	O	node	appos	22	SENT_105	[p7l586t2494r769b2553],
26	enlargement	NN	O	enlargement	dep	3	SENT_105	[p7l810t2494r1201b2572],
27	in	IN	O	in	_	0	SENT_105	[p7l1239t2496r1302b2552],
28	more	JJR	O	more	mwe	29	SENT_105	[p7l1340t2515r1506b2553],
29	than	IN	O	than	quantmod	30	SENT_105	[p7l1544t2494r1687b2553],
30	two	CD	NUMBER	two	num	31	SENT_105	[p7l1725t2505r1843b2553],
31	stations	NNS	O	station	prep_in	26	SENT_105	[p7l1884t2496r2141b2562],
32	,	,	O	,	_	0	SENT_105	[p7l1884t2496r2141b2562],
33	fever	NN	O	fever	appos	3	SENT_105	[p7l10t2594r176b2654],
34	.	.	O	.	_	0	SENT_105	[p7l10t2594r176b2654],

1	Cutaneous	JJ	O	cutaneous	amod	2	SENT_106	[p7l231t2598r570b2654],
2	biopsy	NN	O	biopsy	nsubj	4	SENT_106	[p7l619t2594r830b2673],
3	also	RB	O	also	advmod	4	SENT_106	[p7l879t2594r996b2654],
4	suggested	VBD	O	suggest	_	0	SENT_106	[p7l1050t2594r1350b2673],
5	the	DT	O	the	det	7	SENT_106	[p7l1399t2594r1497b2654],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_106	[p7l1549t2594r1688b2654],
7	diagnosis	NN	O	diagnosis	dobj	4	SENT_106	[p7l1739t2594r2030b2673],
8	of	IN	O	of	_	0	SENT_106	[p7l2082t2594r2153b2654],
9	DRESS	NN	O	dress	prep_of	7	SENT_106	[p7l10t2699r234b2756],
10	(	CD	NUMBER	(	num	9	SENT_106	[p7l278t2696r470b2768],
11	more	JJR	O	more	mwe	12	SENT_106	[p7l278t2696r470b2768],
12	than	IN	O	than	quantmod	13	SENT_106	[p7l507t2696r651b2756],
13	ﬁve	CD	NUMBER	ﬁve	num	14	SENT_106	[p7l689t2696r800b2755],
14	points	NNS	O	point	npadvmod	4	SENT_106	[p7l837t2698r1035b2773],
15	at	IN	O	at	_	0	SENT_106	[p7l1074t2708r1131b2756],
16	the	DT	O	the	det	19	SENT_106	[p7l1167t2696r1266b2755],
17	REGISCAR	NN	O	regiscar	nn	19	SENT_106	[p7l1305t2699r1671b2756],
18	scoring	VBG	O	score	amod	19	SENT_106	[p7l1709t2696r1980b2774],
19	)	NN	O	)	prep_at	4	SENT_106	[p7l1709t2696r1980b2774],
20	.	.	O	.	_	0	SENT_106	[p7l1709t2696r1980b2774],

1	The	DT	O	the	det	4	SENT_107	[p7l2022t2696r2143b2755],
2	remaining	VBG	O	remain	amod	4	SENT_107	[p7l10t2799r335b2875],
3	four	CD	NUMBER	four	num	4	SENT_107	[p7l362t2797r496b2856],
4	patient	NN	O	patient	nsubj	12	SENT_107	[p7l523t2799r744b2874],
5	with	IN	O	with	_	0	SENT_107	[p7l770t2797r912b2856],
6	a	DT	O	a	det	10	SENT_107	[p7l941t2818r973b2856],
7	slight	JJ	O	slight	amod	8	SENT_107	[p7l1001t2797r1170b2875],
8	acute	JJ	O	acute	amod	10	SENT_107	[p7l1198t2809r1363b2856],
9	renal	JJ	O	renal	amod	10	SENT_107	[p7l1392t2797r1548b2856],
10	involvement	NN	O	involvement	prep_with	4	SENT_107	[p7l1576t2797r1970b2856],
11	were	VBD	O	be	cop	12	SENT_107	[p7l1995t2818r2143b2856],
12	elderly	JJ	O	elderly	_	0	SENT_107	[p7l10t2897r234b2975],
13	,	,	O	,	_	0	SENT_107	[p7l10t2897r234b2975],
14	with	IN	O	with	_	0	SENT_107	[p7l271t2897r413b2957],
15	a	DT	O	a	det	18	SENT_107	[p7l450t2919r483b2957],
16	diffuse	JJ	O	diffuse	amod	18	SENT_107	[p7l520t2897r729b2957],
17	maculo-papular	JJ	O	maculo-papular	amod	18	SENT_107	[p7l766t2897r1275b2975],
18	eruption	NN	O	eruption	prep_with	12	SENT_107	[p7l1312t2899r1585b2975],
19	(	CD	NUMBER	(	number	20	SENT_107	[p7l1627t2897r1767b2970],
20	two	CD	NUMBER	two	num	21	SENT_107	[p7l1627t2897r1767b2970],
21	cases	NNS	O	case	dep	18	SENT_107	[p7l1807t2898r1984b2969],
22	)	CD	NUMBER	)	dep	18	SENT_107	[p7l1807t2898r1984b2969],
23	and	CC	O	and	_	0	SENT_107	[p7l2027t2897r2145b2957],
24	cutaneous	JJ	O	cutaneous	amod	25	SENT_107	[p7l10t3011r330b3059],
25	Vasculitis	NN	O	vasculitis	conj_and	18	SENT_107	[p7l365t2999r652b3059],
26	(	CD	NUMBER	(	number	27	SENT_107	[p7l694t2999r835b3071],
27	two	CD	NUMBER	two	num	28	SENT_107	[p7l694t2999r835b3071],
28	cases	NNS	O	case	dep	25	SENT_107	[p7l875t2999r1073b3071],
29	)	RB	O	)	advmod	18	SENT_107	[p7l875t2999r1073b3071],
30	,	,	O	,	_	0	SENT_107	[p7l875t2999r1073b3071],
31	whose	WP$	O	whose	dep	35	SENT_107	[p7l1110t2999r1308b3059],
32	creatinine	NN	O	creatinine	nn	33	SENT_107	[p7l1347t3001r1657b3059],
33	values	NNS	O	value	nsubj	35	SENT_107	[p7l1692t2999r1886b3059],
34	rapidly	RB	O	rapidly	advmod	35	SENT_107	[p7l1924t2999r2148b3077],
35	recover	VB	O	recover	dep	18	SENT_107	[p7l10t3121r241b3159],
36	after	IN	O	after	_	0	SENT_107	[p7l265t3100r406b3159],
37	simple	JJ	O	simple	amod	39	SENT_107	[p7l430t3100r636b3177],
38	saline	NN	O	saline	nn	39	SENT_107	[p7l661t3100r836b3159],
39	infusion	NN	O	infusion	prep_after	35	SENT_107	[p7l860t3100r1135b3159],
40	.	.	O	.	_	0	SENT_107	[p7l860t3100r1135b3159],

1	The	DT	O	the	det	4	SENT_108	[p7l91t3201r212b3261],
2	HLA	NN	O	hlum	nn	4	SENT_108	[p7l260t3204r415b3259],
3	sequence	NN	O	sequence	nn	4	SENT_108	[p7l461t3201r950b3278],
4	—	NN	O	—	nsubj	7	SENT_108	[p7l461t3201r950b3278],
5	based	VBN	O	base	partmod	4	SENT_108	[p7l461t3201r950b3278],
6	typing	NN	O	typing	dobj	5	SENT_108	[p7l996t3203r1198b3279],
7	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_108	[p7l1245t3201r1574b3261],
8	the	DT	O	the	det	9	SENT_108	[p7l1619t3201r1716b3261],
9	presence	NN	O	presence	dobj	7	SENT_108	[p7l1763t3222r2034b3278],
10	of	IN	O	of	_	0	SENT_108	[p7l2082t3201r2153b3260],
11	HLA	NN	O	hlum	nn	12	SENT_108	[p7l10t3305r165b3360],
12	B	NN	O	b	prep_of	9	SENT_108	[p7l191t3304r414b3361],
13	*	CD	NUMBER	*	number	14	SENT_108	[p7l191t3304r414b3361],
14	5801	CD	NUMBER	5801	npadvmod	7	SENT_108	[p7l191t3304r414b3361],
15	in	IN	O	in	_	0	SENT_108	[p7l449t3304r512b3360],
16	all	PDT	O	all	predet	19	SENT_108	[p7l539t3301r610b3361],
17	the	DT	O	the	det	19	SENT_108	[p7l636t3302r734b3361],
18	18	CD	NUMBER	18	num	19	SENT_108	[p7l769t3307r834b3361],
19	patients	NNS	O	patient	prep_in	7	SENT_108	[p7l863t3304r1110b3379],
20	affected	VBN	O	affect	partmod	19	SENT_108	[p7l1140t3301r1383b3361],
21	by	IN	O	by	_	0	SENT_108	[p7l1407t3302r1487b3380],
22	SIS/T	NNP	O	SIS/T	nn	24	SENT_108	[p7l1512t3304r1698b3371],
23	EN	NNP	O	EN	nn	24	SENT_108	[p7l1699t3306r1801b3361],
24	syndrome	NN	O	syndrome	agent	20	SENT_108	[p7l1829t3301r2143b3380],
25	that	WDT	O	that	nsubjpass	27	SENT_108	[p7l9t3402r133b3462],
26	were	VBD	O	be	auxpass	27	SENT_108	[p7l172t3424r321b3462],
27	tested	VBN	O	test	rcmod	24	SENT_108	[p7l361t3402r559b3462],
28	.	.	O	.	_	0	SENT_108	[p7l361t3402r559b3462],

1	Considering	VBG	O	consider	_	0	SENT_109	[p7l605t3402r991b3481],
2	the	DT	O	the	det	4	SENT_109	[p7l1031t3402r1129b3462],
3	HLA	NN	O	hlum	nn	4	SENT_109	[p7l1171t3406r1326b3461],
4	B	NN	O	b	pobj	1	SENT_109	[p7l1366t3405r1589b3462],
5	*	CD	NUMBER	*	number	6	SENT_109	[p7l1366t3405r1589b3462],
6	5801	CD	DATE	5801	num	22	SENT_109	[p7l1366t3405r1589b3462],
7	allele	NN	O	allele	nn	22	SENT_109	[p7l1638t3402r1792b3462],
8	frequency	NN	O	frequency	nn	22	SENT_109	[p7l1835t3402r2147b3481],
9	(	CD	NUMBER	(	number	10	SENT_109	[p7l14t3504r154b3576],
10	28	CD	NUMBER	28	amod	22	SENT_109	[p7l14t3504r154b3576],
11	/	:	O	/	punct	12	SENT_109	[p7l14t3504r154b3576],
12	1822	CD	DATE	1822	dep	10	SENT_109	[p7l160t3510r319b3573],
13	;	:	O	;	_	0	SENT_109	[p7l160t3510r319b3573],
14	1.5	CD	PERCENT	1.5	num	15	SENT_109	[p7l357t3504r534b3576],
15	%	NN	PERCENT	%	dep	12	SENT_109	[p7l357t3504r534b3576],
16	)	CD	NUMBER	)	dep	15	SENT_109	[p7l357t3504r534b3576],
17	in	IN	O	in	_	0	SENT_109	[p7l568t3506r630b3563],
18	the	DT	O	the	det	21	SENT_109	[p7l658t3504r756b3564],
19	European	JJ	MISC	european	amod	21	SENT_109	[p7l785t3508r1093b3581],
20	populations	NNS	O	population	nn	21	SENT_109	[p7l1121t3504r1497b3581],
21	data	NNS	O	datum	prep_in	16	SENT_109	[p7l1528t3504r1661b3564],
22	bank	NN	O	bank	dep	4	SENT_109	[p7l1688t3504r1847b3564],
23	available	JJ	O	available	amod	22	SENT_109	[p7l1873t3504r2143b3564],
24	on	IN	O	on	dep	23	SENT_109	[p7l10t3626r92b3664],
25	dbMHC	NN	O	dbmhc	nn	28	SENT_109	[p7l124t3605r391b3665],
26	(	CD	NUMBER	(	num	28	SENT_109	[p7l426t3605r2141b3683],
27	http://www.ncbi.nlm.nih.gov/projects/mhc/ihwg.cgi	NN	O	http://www.ncbi.nlm.nih.gov/projects/mhc/ihwg.cgi	nn	28	SENT_109	[p7l426t3605r2141b3683],
28	)	NN	O	)	pobj	24	SENT_109	[p7l426t3605r2141b3683],
29	,	,	O	,	_	0	SENT_109	[p7l426t3605r2141b3683],

1	©	RB	O	©	dep	2	SENT_110	[p8l1840t45r1859b64],
2	2011	CD	DATE	2011	dep	4	SENT_110	[p8l1870t44r1923b64],
3	The	DT	O	the	det	4	SENT_110	[p8l1937t44r1980b64],
4	Authors	NNPS	O	Authors	dep	5	SENT_110	[p8l1990t44r2079b64],
5	IEADV	NNP	O	IEADV	dep	20	SENT_110	[p8l79t77r178b104],
6	2012	CD	DATE	2012	num	5	SENT_110	[p8l185t80r249b103],
7	,	,	O	,	_	0	SENT_110	[p8l185t80r249b103],
8	26	CD	NUMBER	26	num	5	SENT_110	[p8l260t80r295b103],
9	,	,	O	,	_	0	SENT_110	[p8l260t80r295b103],
10	1424-1430	CD	DATE	1424-1430	num	11	SENT_110	[p8l309t80r438b100],
11	Journal	NNP	O	Journal	appos	5	SENT_110	[p8l558t80r641b100],
12	of	IN	O	of	_	0	SENT_110	[p8l652t80r674b100],
13	the	DT	O	the	det	15	SENT_110	[p8l682t80r718b100],
14	European	JJ	ORGANIZATION	european	amod	15	SENT_110	[p8l729t80r838b105],
15	Academy	NN	ORGANIZATION	academy	prep_of	5	SENT_110	[p8l848t80r958b105],
16	of	IN	ORGANIZATION	of	_	0	SENT_110	[p8l967t80r989b100],
17	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	15	SENT_110	[p8l999t80r1145b105],
18	and	CC	O	and	_	0	SENT_110	[p8l1154t80r1197b100],
19	Venereology	NNP	O	Venereology	conj_and	17	SENT_110	[p8l1206t80r1350b105],
20	©	CD	NUMBER	©	dep	23	SENT_110	[p8l1360t81r1379b100],
21	2011	CD	DATE	2011	num	23	SENT_110	[p8l1390t80r1443b100],
22	European	JJ	ORGANIZATION	european	amod	23	SENT_110	[p8l1459t80r1568b105],
23	Academy	NN	ORGANIZATION	academy	_	0	SENT_110	[p8l1578t80r1688b105],
24	of	IN	ORGANIZATION	of	_	0	SENT_110	[p8l1697t80r1719b100],
25	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	23	SENT_110	[p8l1729t80r1875b105],
26	and	CC	O	and	_	0	SENT_110	[p8l1884t80r1926b100],
27	Venereology	NNP	O	Venereology	prep_of	23	SENT_110	[p8l1936t80r2080b105],

1	Cutaneous	JJ	O	cutaneous	amod	3	SENT_111	[p8l81t180r260b208],
2	adverse	JJ	O	adverse	amod	3	SENT_111	[p8l275t180r405b208],
3	reactions	NNS	O	reaction	_	0	SENT_111	[p8l421t180r571b208],
4	to	TO	O	to	_	0	SENT_111	[p8l585t182r617b208],
5	allopurinol	NN	O	allopurinol	prep_to	3	SENT_111	[p8l631t180r800b215],
6	1427	CD	DATE	1427	num	5	SENT_111	[p8l2018t186r2079b208],

1	Figure	NNP	O	Figure	nsubj	9	SENT_112	[p8l14t2222r228b2289],
2	5	CD	NUMBER	5	num	1	SENT_112	[p8l255t2223r293b2276],
3	Red	NNP	O	Red	nn	6	SENT_112	[p8l350t2222r473b2276],
4	purple	JJ	O	purple	amod	6	SENT_112	[p8l505t2222r706b2290],
5	diffuse	JJ	O	diffuse	amod	6	SENT_112	[p8l734t2222r948b2276],
6	erythema	NN	O	erythema	dep	1	SENT_112	[p8l976t2222r1294b2290],
7	,	,	O	,	_	0	SENT_112	[p8l976t2222r1294b2290],
8	rapidly	RB	O	rapidly	advmod	9	SENT_112	[p8l1327t2222r1542b2290],
9	evolved	VBD	O	evolve	_	0	SENT_112	[p8l1569t2222r1814b2276],
10	in	IN	O	in	_	0	SENT_112	[p8l1848t2222r1896b2275],
11	a	DT	O	a	det	13	SENT_112	[p8l1926t2236r1962b2276],
12	micro-pustules	JJ	O	micro-pustules	amod	13	SENT_112	[p8l14t2314r494b2381],
13	eruption	NN	O	eruption	prep_in	9	SENT_112	[p8l523t2314r804b2381],
14	,	,	O	,	_	0	SENT_112	[p8l523t2314r804b2381],
15	with	IN	O	with	_	0	SENT_112	[p8l834t2314r964b2367],
16	areas	NNS	O	area	prep_with	9	SENT_112	[p8l994t2327r1169b2367],
17	of	IN	O	of	_	0	SENT_112	[p8l1197t2313r1259b2367],
18	detachment	NN	O	detachment	nn	21	SENT_112	[p8l1285t2314r1670b2367],
19	and	CC	O	and	_	0	SENT_112	[p8l1698t2314r1814b2367],
20	genital	JJ	O	genital	nn	21	SENT_112	[p8l1846t2314r2055b2381],
21	involvement	NN	O	involvement	prep_of	16	SENT_112	[p8l14t2415r415b2468],
22	.	.	O	.	_	0	SENT_112	[p8l14t2415r415b2468],

1	Histology	NNP	O	Histology	nsubj	2	SENT_113	[p8l450t2415r750b2483],
2	confirmed	VBD	O	confirm	_	0	SENT_113	[p8l777t2414r1099b2468],
3	the	DT	O	the	det	4	SENT_113	[p8l1128t2415r1228b2468],
4	diagnosis	NN	O	diagnosis	dobj	2	SENT_113	[p8l1256t2415r1564b2483],
5	of	IN	O	of	_	0	SENT_113	[p8l1592t2414r1654b2468],
6	AGEP	NN	O	agep	prep_of	4	SENT_113	[p8l1677t2414r1886b2469],
7	.	.	O	.	_	0	SENT_113	[p8l1677t2414r1886b2469],

1	Figure	NNP	O	Figure	_	0	SENT_114	[p9l11t1455r226b1522],
2	6	CD	NUMBER	6	num	1	SENT_114	[p9l252t1455r291b1508],
3	Severe	JJ	O	severe	amod	4	SENT_114	[p9l344t1453r566b1509],
4	mucositis	NN	O	mucositis	dep	1	SENT_114	[p9l596t1455r901b1508],
5	in	IN	O	in	_	0	SENT_114	[p9l932t1455r980b1508],
6	a	DT	O	a	det	8	SENT_114	[p9l1010t1468r1047b1508],
7	DRESS	NN	O	dress	nn	8	SENT_114	[p9l1077t1453r1311b1509],
8	case	NN	O	case	prep_in	4	SENT_114	[p9l1339t1468r1506b1508],
9	.	.	O	.	_	0	SENT_114	[p9l1339t1468r1506b1508],

1	Table	NNP	O	Table	nn	3	SENT_115	[p9l8t1742r198b1795],
2	2	CD	NUMBER	2	num	3	SENT_115	[p9l225t1742r263b1794],
3	Distribution	NN	O	distribution	_	0	SENT_115	[p9l319t1742r681b1795],
4	of	IN	O	of	_	0	SENT_115	[p9l718t1741r779b1795],
5	the	DT	O	the	det	7	SENT_115	[p9l810t1742r910b1795],
6	SJS/TEN	NN	O	sjs/ten	nn	7	SENT_115	[p9l945t1740r1248b1795],
7	cases	NNS	O	case	prep_of	3	SENT_115	[p9l1285t1755r1472b1795],
8	on	IN	O	on	dep	3	SENT_115	[p9l1507t1755r1583b1795],
9	the	DT	O	the	det	10	SENT_115	[p9l1618t1742r1719b1795],
10	basis	NN	O	basis	pobj	8	SENT_115	[p9l1756t1742r1921b1795],
11	of	IN	O	of	_	0	SENT_115	[p9l1956t1741r2018b1795],
12	the	DT	O	the	det	15	SENT_115	[p9l2048t1742r2149b1795],
13	SCORTEN	JJ	O	scorten	amod	15	SENT_115	[p9l9t1830r347b1885],
14	score	NN	NUMBER	score	nn	15	SENT_115	[p9l377t1845r555b1885],
15	evaluation	NN	O	evaluation	prep_of	10	SENT_115	[p9l583t1831r928b1895],
16	,	,	O	,	_	0	SENT_115	[p9l583t1831r928b1895],
17	following	VBG	O	follow	_	0	SENT_115	[p9l958t1831r1244b1899],
18	Bastuji-Garin	NNP	O	Bastuji-Garin	prep_following	10	SENT_115	[p9l1276t1830r1691b1898],
19	et	FW	O	et	nn	23	SENT_115	[p9l1720t1834r1783b1885],
20	al.	FW	O	al.	nn	23	SENT_115	[p9l1805t1817r1940b1885],
21	”	FW	O	”	nn	23	SENT_115	[p9l1805t1817r1940b1885],
22	SCURTEN	NN	O	scurten	nn	23	SENT_115	[p9l7t1929r337b1991],
23	score	NN	NUMBER	score	dep	32	SENT_115	[p9l366t1942r547b1981],
24	Number	NNP	O	Number	nn	25	SENT_115	[p9l701t1930r959b1981],
25	Type	NN	O	type	dep	23	SENT_115	[p9l1102t1930r1260b1992],
26	of	IN	O	of	_	0	SENT_115	[p9l1287t1930r1350b1981],
27	treatment	NN	O	treatment	prep_of	25	SENT_115	[p9l1373t1932r1691b1981],
28	Final	JJ	O	final	dep	32	SENT_115	[p9l1822t1929r1971b1981],
29	[	CD	NUMBER	[	number	30	SENT_115	[p9l7t2010r317b2074],
30	(	CD	NUMBER	(	num	32	SENT_115	[p9l7t2010r317b2074],
31	mortality	NN	O	mortality	nn	32	SENT_115	[p9l7t2010r317b2074],
32	risk	NN	O	risk	dep	37	SENT_115	[p9l342t2010r461b2062],
33	%	NN	O	%	dep	32	SENT_115	[p9l488t2010r569b2074],
34	)	CD	NUMBER	)	num	33	SENT_115	[p9l488t2010r569b2074],
35	of	IN	O	of	_	0	SENT_115	[p9l699t2010r763b2062],
36	cases	NNS	O	case	prep_of	32	SENT_115	[p9l787t2024r975b2062],
37	outcome	NN	O	outcome	dep	39	SENT_115	[p9l1820t2014r2106b2062],
38	0-1	CD	NUMBER	0-1	num	37	SENT_115	[p9l9t2108r104b2158],
39	(	NN	O	(	dep	42	SENT_115	[p9l143t2107r268b2171],
40	3.2	CD	NUMBER	3.2	num	39	SENT_115	[p9l143t2107r268b2171],
41	)	CD	NUMBER	)	num	42	SENT_115	[p9l143t2107r268b2171],
42	O	NN	O	o	dep	43	SENT_115	[p9l737t2108r771b2158],
43	—	CD	NUMBER	—	dep	18	SENT_115	[p9l1102t2135r1137b2141],
44	—	NN	O	—	num	48	SENT_115	[p9l1817t2135r1853b2141],
45	2	CD	NUMBER	2	number	44	SENT_115	[p9l8t2212r41b2261],
46	(	CD	NUMBER	(	number	44	SENT_115	[p9l71t2210r233b2274],
47	12.1	CD	NUMBER	12.1	number	44	SENT_115	[p9l71t2210r233b2274],
48	)	NN	O	)	dep	43	SENT_115	[p9l71t2210r233b2274],
49	6	CD	NUMBER	6	num	52	SENT_115	[p9l737t2212r771b2262],
50	Supportive	JJ	O	supportive	amod	52	SENT_115	[p9l1105t2210r1434b2274],
51	Recovered	JJ	O	recovered	amod	52	SENT_115	[p9l1823t2211r2146b2262],
52	treatment	NN	O	treatment	dep	48	SENT_115	[p9l1102t2297r1396b2344],

1	3	CD	NUMBER	3	num	2	SENT_116	[p9l9t2397r42b2447],
2	(	NN	O	(	_	0	SENT_116	[p9l71t2396r233b2460],
3	35.8	CD	NUMBER	35.8	number	4	SENT_116	[p9l71t2396r233b2460],
4	)	CD	NUMBER	)	dep	2	SENT_116	[p9l71t2396r233b2460],
5	10	CD	NUMBER	10	num	8	SENT_116	[p9l703t2397r771b2447],
6	Supportive	JJ	O	supportive	amod	8	SENT_116	[p9l1105t2396r1434b2460],
7	Recovered	JJ	O	recovered	amod	8	SENT_116	[p9l1823t2397r2146b2447],
8	treatment	NN	O	treatment	dep	4	SENT_116	[p9l1102t2482r1396b2530],
9	+	CC	O	+	_	0	SENT_116	[p9l1423t2493r1458b2529],
10	|	NN	O	|	nn	11	SENT_116	[p9l1489t2479r1597b2543],
11	V	NN	O	v	conj_+	8	SENT_116	[p9l1489t2479r1597b2543],
12	|	CD	NUMBER	|	num	13	SENT_116	[p9l1489t2479r1597b2543],
13	g	NN	O	g	dep	2	SENT_116	[p9l1489t2479r1597b2543],

1	4	CD	NUMBER	4	_	0	SENT_117	[p9l9t2583r42b2633],
2	(	CD	NUMBER	(	number	3	SENT_117	[p9l71t2582r233b2646],
3	58.3	CD	NUMBER	58.3	num	4	SENT_117	[p9l71t2582r233b2646],
4	)	NN	O	)	dep	1	SENT_117	[p9l71t2582r233b2646],
5	5	CD	NUMBER	5	num	8	SENT_117	[p9l737t2584r770b2633],
6	Supportive	JJ	O	supportive	amod	8	SENT_117	[p9l1105t2582r1434b2646],
7	Recovered	JJ	O	recovered	amod	8	SENT_117	[p9l1823t2583r2146b2633],
8	treatment	NN	O	treatment	dep	4	SENT_117	[p9l1102t2668r1396b2716],
9	+	CC	O	+	_	0	SENT_117	[p9l1423t2680r1458b2715],
10	|	NN	O	|	nn	11	SENT_117	[p9l1489t2665r1597b2729],
11	V	NN	O	v	conj_+	8	SENT_117	[p9l1489t2665r1597b2729],
12	|	CD	NUMBER	|	num	13	SENT_117	[p9l1489t2665r1597b2729],
13	g	NN	O	g	dep	1	SENT_117	[p9l1489t2665r1597b2729],

1	>	JJR	O	>	dep	3	SENT_118	[p9l10t2770r83b2819],
2	5	CD	NUMBER	5	num	3	SENT_118	[p9l10t2770r83b2819],
3	(	NN	O	(	dep	30	SENT_118	[p9l112t2768r217b2832],
4	90	CD	NUMBER	90	number	5	SENT_118	[p9l112t2768r217b2832],
5	)	CD	NUMBER	)	num	6	SENT_118	[p9l112t2768r217b2832],
6	10	CD	NUMBER	10	nsubj	27	SENT_118	[p9l703t2769r771b2819],
7	Transferred	VBN	O	transfer	partmod	6	SENT_118	[p9l1102t2769r1450b2819],
8	to	TO	O	to	_	0	SENT_118	[p9l1478t2772r1536b2819],
9	Deceased	JJ	MISC	deceased	amod	12	SENT_118	[p9l1823t2769r2122b2819],
10	intensive	JJ	O	intensive	amod	12	SENT_118	[p9l1107t2852r1370b2901],
11	care	NN	O	care	nn	12	SENT_118	[p9l1398t2864r1528b2901],
12	unit	NN	O	unit	prep_to	7	SENT_118	[p9l1557t2852r1663b2901],
13	there	EX	O	there	expl	14	SENT_118	[p9l8t3083r168b3142],
14	was	VBD	O	be	rcmod	12	SENT_118	[p9l198t3104r314b3142],
15	a	DT	O	a	det	18	SENT_118	[p9l349t3104r381b3142],
16	highly	RB	O	highly	advmod	17	SENT_118	[p9l412t3082r611b3161],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_118	[p9l641t3082r966b3161],
18	increase	NN	O	increase	nsubj	14	SENT_118	[p9l998t3084r1249b3142],
19	of	IN	O	of	_	0	SENT_118	[p9l1282t3082r1353b3142],
20	the	DT	O	the	det	22	SENT_118	[p9l1375t3083r1473b3142],
21	carrier	NN	O	carrier	nn	22	SENT_118	[p9l1507t3085r1712b3142],
22	frequency	NN	O	frequency	prep_of	18	SENT_118	[p9l1744t3082r2058b3161],
23	in	IN	O	in	_	0	SENT_118	[p9l2087t3085r2149b3141],
24	the	DT	O	the	det	26	SENT_118	[p9l8t3189r106b3248],
25	allopurinol	NN	O	allopurinol	nn	26	SENT_118	[p9l150t3189r501b3266],
26	patients	NNS	O	patient	prep_in	22	SENT_118	[p9l542t3191r790b3266],
27	(	VBP	O	(	rcmod	3	SENT_118	[p9l838t3189r977b3261],
28	18	CD	NUMBER	18	dobj	27	SENT_118	[p9l838t3189r977b3261],
29	/	:	O	/	punct	30	SENT_118	[p9l838t3189r977b3261],
30	18	CD	NUMBER	18	_	0	SENT_118	[p9l984t3194r1068b3257],
31	;	:	O	;	_	0	SENT_118	[p9l984t3194r1068b3257],
32	100	CD	PERCENT	100	num	33	SENT_118	[p9l1119t3193r1308b3258],
33	%	NN	PERCENT	%	dep	30	SENT_118	[p9l1119t3193r1308b3258],
34	,	,	O	,	_	0	SENT_118	[p9l1119t3193r1308b3258],
35	P	NN	O	p	dep	36	SENT_118	[p9l1350t3193r1397b3247],
36	<	JJR	O	<	appos	30	SENT_118	[p9l1426t3202r1468b3247],
37	o.	CD	NUMBER	o.	num	38	SENT_118	[p9l1501t3194r1723b3258],
38	oooo	NN	O	oooo	dep	36	SENT_118	[p9l1501t3194r1723b3258],
39	,	,	O	,	_	0	SENT_118	[p9l1501t3194r1723b3258],
40	OR	NN	O	or	appos	36	SENT_118	[p9l1768t3192r1877b3249],
41	=	JJ	O	=	amod	40	SENT_118	[p9l1906t3214r1950b3235],
42	65.07	CD	NUMBER	65.07	number	43	SENT_118	[p9l1981t3194r2149b3248],
43	(	CD	NUMBER	(	dep	41	SENT_118	[p9l13t3293r499b3366],
44	30.66	CD	NUMBER	30.66	number	45	SENT_118	[p9l13t3293r499b3366],
45	—	CD	NUMBER	—	dep	40	SENT_118	[p9l13t3293r499b3366],
46	138.09	CD	NUMBER	138.09	num	47	SENT_118	[p9l13t3293r499b3366],
47	)	NN	O	)	dep	45	SENT_118	[p9l13t3293r499b3366],
48	.	.	O	.	_	0	SENT_118	[p9l13t3293r499b3366],

1	Table	NNP	O	Table	nn	3	SENT_119	[p9l8t3390r197b3444],
2	3	CD	NUMBER	3	num	3	SENT_119	[p9l224t3390r263b3444],
3	Indication	NN	O	indication	_	0	SENT_119	[p9l319t3390r627b3444],
4	to	TO	O	to	_	0	SENT_119	[p9l656t3393r718b3444],
5	allopurinol	NN	O	allopurinol	nn	6	SENT_119	[p9l748t3390r1075b3457],
6	administration	NN	O	administration	prep_to	3	SENT_119	[p9l1108t3390r1561b3444],
7	and	CC	O	and	_	0	SENT_119	[p9l1594t3390r1709b3444],
8	concomitant	JJ	O	concomitant	amod	11	SENT_119	[p9l1742t3390r2143b3444],
9	chronic	JJ	O	chronic	amod	11	SENT_119	[p9l10t3480r246b3534],
10	renal	JJ	O	renal	amod	11	SENT_119	[p9l276t3480r427b3534],
11	insufficiency	NN	O	insufficiency	prep_to	3	SENT_119	[p9l460t3480r857b3548],
12	in	IN	O	in	dep	3	SENT_119	[p9l886t3480r934b3533],
13	the	DT	O	the	det	15	SENT_119	[p9l962t3480r1062b3534],
14	studied	VBN	O	study	amod	15	SENT_119	[p9l1090t3480r1324b3534],
15	population	NN	O	population	pobj	12	SENT_119	[p9l1358t3480r1693b3547],

1	Indication	NN	O	indication	dep	6	SENT_120	[p10l11t23r327b74],
2	to	TO	O	to	_	0	SENT_120	[p10l353t25r417b74],
3	Number	NNP	O	Number	prep_to	1	SENT_120	[p10l668t23r925b74],
4	Chronic	JJ	O	chronic	amod	5	SENT_120	[p10l1131t22r1384b74],
5	Adjustment	NNP	O	Adjustment	dep	6	SENT_120	[p10l1726t23r2102b85],
6	allopurinol	NN	O	allopurinol	dep	14	SENT_120	[p10l9t104r347b167],
7	of	IN	O	of	_	0	SENT_120	[p10l666t104r729b155],
8	cases	NNS	O	case	prep_of	6	SENT_120	[p10l753t117r942b155],
9	renal	JJ	O	renal	amod	8	SENT_120	[p10l1132t104r1288b155],
10	of	IN	O	of	_	0	SENT_120	[p10l1729t104r1793b155],
11	dosage	NN	O	dosage	nn	12	SENT_120	[p10l1817t104r2055b168],
12	administration	NN	O	administration	prep_of	8	SENT_120	[p10l9t186r475b237],
13	(	CD	PERCENT	(	num	14	SENT_120	[p10l667t185r769b248],
14	%	NN	PERCENT	%	dep	17	SENT_120	[p10l667t185r769b248],
15	)	CD	NUMBER	)	num	16	SENT_120	[p10l667t185r769b248],
16	insufficiency	NN	O	insufficiency	dep	14	SENT_120	[p10l1132t186r1541b248],
17	according	VBG	O	accord	_	0	SENT_120	[p10l1729t186r2051b249],
18	to	TO	O	to	pcomp	17	SENT_120	[p10l2078t189r2142b237],

1	(	CD	PERCENT	(	num	2	SENT_121	[p10l1132t266r1234b330],
2	%	NN	PERCENT	%	dep	11	SENT_121	[p10l1132t266r1234b330],
3	)	CD	NUMBER	)	num	5	SENT_121	[p10l1132t266r1234b330],
4	creatinine	NN	O	creatinine	nn	5	SENT_121	[p10l1729t268r2049b319],
5	clearance	NN	O	clearance	dep	2	SENT_121	[p10l1729t333r2045b383],
6	Asymptomatic	JJ	O	asymptomatic	amod	8	SENT_121	[p10l7t443r445b506],
7	80	CD	NUMBER	80	number	8	SENT_121	[p10l666t443r737b493],
8	(	CD	NUMBER	(	dep	5	SENT_121	[p10l765t441r927b506],
9	95.3	CD	NUMBER	95.3	num	10	SENT_121	[p10l765t441r927b506],
10	)	NN	O	)	dep	11	SENT_121	[p10l765t441r927b506],
11	55	CD	NUMBER	55	dep	18	SENT_121	[p10l1131t444r1202b493],
12	(	CD	NUMBER	(	number	13	SENT_121	[p10l1231t441r1392b506],
13	65.4	CD	NUMBER	65.4	dep	11	SENT_121	[p10l1231t441r1392b506],
14	)	NN	O	)	dep	13	SENT_121	[p10l1231t441r1392b506],
15	12	CD	PERCENT	12	num	14	SENT_121	[p10l1733t443r1799b492],
16	(	CD	PERCENT	(	num	18	SENT_121	[p10l1828t441r2058b506],
17	14.3	CD	PERCENT	14.3	num	18	SENT_121	[p10l1828t441r2058b506],
18	%	NN	PERCENT	%	dep	23	SENT_121	[p10l1828t441r2058b506],
19	)	CD	NUMBER	)	num	22	SENT_121	[p10l1828t441r2058b506],
20	hyper	JJ	O	hyper	amod	22	SENT_121	[p10l11t525r465b588],
21	—	NN	O	—	nn	22	SENT_121	[p10l11t525r465b588],
22	uricemia	NN	O	uricemia	dep	18	SENT_121	[p10l11t525r465b588],
23	Gout	NN	O	gout	dep	25	SENT_121	[p10l10t626r156b678],
24	3	CD	NUMBER	3	num	23	SENT_121	[p10l703t628r736b678],
25	(	NN	O	(	dep	27	SENT_121	[p10l765t626r890b690],
26	3.5	CD	NUMBER	3.5	num	25	SENT_121	[p10l765t626r890b690],
27	)	NN	O	)	dep	29	SENT_121	[p10l765t626r890b690],
28	3	CD	NUMBER	3	num	27	SENT_121	[p10l1169t628r1202b678],
29	(	NN	O	(	dep	32	SENT_121	[p10l1231t626r1355b690],
30	3.5	CD	NUMBER	3.5	num	29	SENT_121	[p10l1231t626r1355b690],
31	)	NN	O	)	nn	32	SENT_121	[p10l1231t626r1355b690],
32	o	NN	O	o	_	0	SENT_121	[p10l1766t628r1799b678],

1	Secondary	JJ	O	secondary	amod	2	SENT_122	[p10l10t778r336b843],
2	1	CD	NUMBER	1	_	0	SENT_122	[p10l707t780r726b829],
3	(	CD	NUMBER	(	number	4	SENT_122	[p10l765t778r890b842],
4	1.2	CD	NUMBER	1.2	num	5	SENT_122	[p10l765t778r890b842],
5	)	NN	O	)	dep	2	SENT_122	[p10l765t778r890b842],
6	1	CD	NUMBER	1	num	7	SENT_122	[p10l1173t780r1192b829],
7	(	NN	O	(	dep	2	SENT_122	[p10l1231t778r1355b842],
8	1.2	CD	NUMBER	1.2	number	9	SENT_122	[p10l1231t778r1355b842],
9	)	CD	NUMBER	)	num	10	SENT_122	[p10l1231t778r1355b842],
10	O	NN	O	o	npadvmod	11	SENT_122	[p10l1766t780r1799b830],
11	hyper	JJ	O	hyper	amod	13	SENT_122	[p10l11t862r465b926],
12	—	NN	O	—	nn	13	SENT_122	[p10l11t862r465b926],
13	uricemia	NN	O	uricemia	dep	7	SENT_122	[p10l11t862r465b926],

1	Table	NNP	O	Table	_	0	SENT_123	[p10l8t1111r197b1165],
2	4	CD	NUMBER	4	num	4	SENT_123	[p10l224t1112r263b1164],
3	Concomitant	JJ	O	concomitant	amod	4	SENT_123	[p10l316t1110r729b1165],
4	diseases	NNS	O	disease	nsubj	7	SENT_123	[p10l757t1111r1040b1165],
5	in	IN	O	in	_	0	SENT_123	[p10l1070t1111r1117b1164],
6	the	DT	O	the	prep_in	4	SENT_123	[p10l1145t1111r1245b1165],
7	studied	VBN	O	study	rcmod	1	SENT_123	[p10l1273t1111r1508b1165],
8	population	NN	O	population	dobj	7	SENT_123	[p10l1541t1111r1876b1178],
9	Concomitant	JJ	O	concomitant	amod	10	SENT_123	[p10l9t1209r429b1261],
10	diseases	NNS	O	disease	dep	8	SENT_123	[p10l454t1210r738b1261],
11	Number	NN	O	number	dep	19	SENT_123	[p10l1455t1210r1712b1261],
12	of	IN	O	of	_	0	SENT_123	[p10l1737t1210r1800b1261],
13	cases	NNS	O	case	prep_of	11	SENT_123	[p10l1824t1222r2012b1261],
14	(	CD	PERCENT	(	num	15	SENT_123	[p10l2039t1209r2141b1272],
15	%	NN	PERCENT	%	dep	19	SENT_123	[p10l2039t1209r2141b1272],
16	)	CD	NUMBER	)	num	19	SENT_123	[p10l2039t1209r2141b1272],
17	Hypertensive	JJ	O	hypertensive	amod	19	SENT_123	[p10l12t1306r405b1370],
18	heart	NN	O	heart	nn	19	SENT_123	[p10l434t1306r584b1357],
19	disease	NN	O	disease	dep	8	SENT_123	[p10l611t1306r842b1357],
20	68	CD	NUMBER	68	number	21	SENT_123	[p10l1453t1306r1525b1357],
21	(	CD	NUMBER	(	dep	19	SENT_123	[p10l1552t1305r1657b1369],
22	81	CD	NUMBER	81	num	23	SENT_123	[p10l1552t1305r1657b1369],
23	)	NN	O	)	dep	21	SENT_123	[p10l1552t1305r1657b1369],

1	Chronic	JJ	O	chronic	amod	3	SENT_124	[p10l10t1466r243b1518],
2	renal	JJ	O	renal	amod	3	SENT_124	[p10l272t1467r414b1518],
3	failure	NN	O	failure	_	0	SENT_124	[p10l441t1467r623b1518],
4	59	CD	NUMBER	59	number	5	SENT_124	[p10l1453t1468r1524b1518],
5	(	CD	NUMBER	(	num	7	SENT_124	[p10l1552t1466r1714b1530],
6	70.2	CD	NUMBER	70.2	number	7	SENT_124	[p10l1552t1466r1714b1530],
7	)	CD	NUMBER	)	dep	3	SENT_124	[p10l1552t1466r1714b1530],
8	Diabetes	NNP	O	Diabetes	nn	9	SENT_124	[p10l12t1571r276b1621],
9	mellitus	NN	O	mellitus	dep	3	SENT_124	[p10l305t1571r532b1621],
10	36	CD	NUMBER	36	num	9	SENT_124	[p10l1453t1571r1525b1621],
11	(	CD	NUMBER	(	number	12	SENT_124	[p10l1552t1570r1657b1634],
12	43	CD	NUMBER	43	num	13	SENT_124	[p10l1552t1570r1657b1634],
13	)	NN	O	)	dep	9	SENT_124	[p10l1552t1570r1657b1634],

1	Chronic	JJ	O	chronic	amod	3	SENT_125	[p10l10t1731r243b1783],
2	obstructive	JJ	O	obstructive	amod	3	SENT_125	[p10l271t1732r607b1783],
3	bronchopathy	NN	O	bronchopathy	dep	11	SENT_125	[p10l636t1732r1056b1796],
4	12	CD	NUMBER	12	dep	3	SENT_125	[p10l1457t1733r1523b1782],
5	(	NN	O	(	dep	11	SENT_125	[p10l1552t1731r1714b1795],
6	14.2	CD	NUMBER	14.2	num	5	SENT_125	[p10l1552t1731r1714b1795],
7	)	CD	NUMBER	)	num	11	SENT_125	[p10l1552t1731r1714b1795],
8	Other	JJ	O	other	amod	11	SENT_125	[p10l10t1837r178b1888],
9	chronic	JJ	O	chronic	amod	11	SENT_125	[p10l203t1838r425b1888],
10	heart	NN	O	heart	nn	11	SENT_125	[p10l454t1838r605b1888],
11	diseases	NNS	O	disease	dep	22	SENT_125	[p10l631t1838r896b1888],
12	7	CD	NUMBER	7	num	13	SENT_125	[p10l1492t1839r1524b1887],
13	(	NN	O	(	dep	11	SENT_125	[p10l1552t1837r1676b1901],
14	8.3	CD	NUMBER	8.3	number	15	SENT_125	[p10l1552t1837r1676b1901],
15	)	CD	NUMBER	)	num	19	SENT_125	[p10l1552t1837r1676b1901],
16	Lymphoma	NN	ORGANIZATION	lymphoma	nn	19	SENT_125	[p10l12t1954r349b2018],
17	(	NN	O	(	nn	19	SENT_125	[p10l376t1953r512b2017],
18	final	JJ	O	final	amod	19	SENT_125	[p10l376t1953r512b2017],
19	stage	NN	O	stage	dep	13	SENT_125	[p10l541t1953r723b2018],
20	)	CD	NUMBER	)	number	21	SENT_125	[p10l541t1953r723b2018],
21	1	CD	NUMBER	1	num	19	SENT_125	[p10l1494t1955r1513b2004],
22	(	NN	O	(	dep	24	SENT_125	[p10l1552t1953r1676b2017],
23	1.2	CD	NUMBER	1.2	num	22	SENT_125	[p10l1552t1953r1676b2017],
24	)	NN	O	)	_	0	SENT_125	[p10l1552t1953r1676b2017],

1	Indication	NN	O	indication	nsubj	11	SENT_126	[p10l92t2202r418b2262],
2	to	TO	O	to	_	0	SENT_126	[p10l450t2214r513b2262],
3	allopurinol	NN	O	allopurinol	nn	4	SENT_126	[p10l549t2202r898b2280],
4	administration	NN	O	administration	prep_to	1	SENT_126	[p10l931t2202r1401b2262],
5	(	CD	NUMBER	(	num	8	SENT_126	[p10l1438t2202r1636b2274],
6	Table	NNP	O	Table	nn	8	SENT_126	[p10l1438t2202r1636b2274],
7	3	CD	NUMBER	3	num	8	SENT_126	[p10l1667t2202r1725b2274],
8	)	NN	O	)	nsubj	11	SENT_126	[p10l1667t2202r1725b2274],
9	was	VBD	O	be	cop	11	SENT_126	[p10l1761t2224r1877b2262],
10	asymptomatic	JJ	O	asymptomatic	amod	11	SENT_126	[p10l1912t2223r2140b2280, p10l9t2305r253b2362],
11	hyper-uricemia	NN	O	hyper-uricemia	_	0	SENT_126	[p10l285t2303r774b2381],
12	in	IN	O	in	_	0	SENT_126	[p10l807t2305r869b2361],
13	the	DT	O	the	det	15	SENT_126	[p10l903t2303r1001b2362],
14	Vast	JJ	O	vast	amod	15	SENT_126	[p10l1034t2315r1157b2362],
15	majority	NN	O	majority	prep_in	11	SENT_126	[p10l1191t2305r1462b2381],
16	of	IN	O	of	_	0	SENT_126	[p10l1494t2303r1564b2362],
17	the	DT	O	the	det	18	SENT_126	[p10l1589t2303r1687b2362],
18	patients	NNS	O	patient	prep_of	15	SENT_126	[p10l1721t2305r1983b2380],
19	.	.	O	.	_	0	SENT_126	[p10l1721t2305r1983b2380],

1	The	DT	O	the	det	3	SENT_127	[p10l2021t2303r2143b2362],
2	single	JJ	O	single	amod	3	SENT_127	[p10l10t2404r187b2482],
3	case	NN	O	case	nsubj	10	SENT_127	[p10l223t2425r347b2463],
4	of	IN	O	of	_	0	SENT_127	[p10l383t2403r454b2463],
5	secondary	JJ	O	secondary	amod	8	SENT_127	[p10l480t2403r799b2482],
6	hyper	JJ	O	hyper	amod	8	SENT_127	[p10l829t2404r1318b2482],
7	—	NN	O	—	nn	8	SENT_127	[p10l829t2404r1318b2482],
8	uricemia	NN	O	uricemia	prep_of	3	SENT_127	[p10l829t2404r1318b2482],
9	was	VBD	O	be	cop	10	SENT_127	[p10l1349t2425r1465b2463],
10	due	JJ	O	due	_	0	SENT_127	[p10l1501t2404r1616b2463],
11	to	TO	O	to	_	0	SENT_127	[p10l1649t2415r1712b2463],
12	a	DT	O	a	det	15	SENT_127	[p10l1749t2425r1782b2463],
13	ﬁnal	JJ	O	ﬁnal	amod	15	SENT_127	[p10l1816t2403r1955b2463],
14	stage	NN	O	stage	nn	15	SENT_127	[p10l1990t2415r2142b2482],
15	lymphoma	NN	O	lymphoma	prep_to	10	SENT_127	[p10l8t2505r369b2583],
16	.	.	O	.	_	0	SENT_127	[p10l8t2505r369b2583],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_128	[p10l400t2507r821b2565],
2	diseases	NNS	O	disease	nsubj	3	SENT_128	[p10l847t2505r1090b2565],
3	(	VBP	O	(	_	0	SENT_128	[p10l1122t2505r1319b2577],
4	Table	NNP	O	Table	dobj	3	SENT_128	[p10l1122t2505r1319b2577],
5	4	CD	NUMBER	4	number	6	SENT_128	[p10l1347t2505r1429b2577],
6	)	CD	NUMBER	)	dep	4	SENT_128	[p10l1347t2505r1429b2577],
7	,	,	O	,	_	0	SENT_128	[p10l1347t2505r1429b2577],
8	preceding	VBG	O	precede	dep	4	SENT_128	[p10l1457t2505r1768b2583],
9	the	DT	O	the	det	11	SENT_128	[p10l1793t2505r1891b2565],
10	allopurinol	NN	O	allopurinol	nn	11	SENT_128	[p10l1918t2505r2140b2583, p10l10t2606r161b2665],
11	ADR	NN	O	adr	nsubj	17	SENT_128	[p10l204t2609r366b2665],
12	of	IN	O	of	_	0	SENT_128	[p10l411t2606r482b2665],
13	several	JJ	DURATION	several	amod	14	SENT_128	[p10l520t2606r729b2665],
14	years	NNS	DURATION	year	prep_of	11	SENT_128	[p10l772t2627r930b2684],
15	were	VBD	O	be	cop	17	SENT_128	[p10l975t2627r1123b2665],
16	Very	RB	O	very	advmod	17	SENT_128	[p10l1167t2627r1303b2684],
17	frequent	JJ	O	frequent	ccomp	8	SENT_128	[p10l1346t2606r1612b2683],
18	and	CC	O	and	_	0	SENT_128	[p10l1658t2606r1775b2665],
19	related	JJ	O	related	ccomp	8	SENT_128	[p10l1821t2606r2034b2665],
20	to	TO	O	to	_	0	SENT_128	[p10l2078t2618r2141b2665],
21	patient	NN	O	patient	nn	22	SENT_128	[p10l9t2709r230b2784],
22	age	NN	O	age	prep_to	17	SENT_128	[p10l259t2728r375b2785],
23	,	,	O	,	_	0	SENT_128	[p10l259t2728r375b2785],
24	ranging	VBG	O	range	dep	8	SENT_128	[p10l406t2709r647b2785],
25	from	IN	O	from	_	0	SENT_128	[p10l674t2706r830b2766],
26	hypertensive	JJ	O	hypertensive	amod	29	SENT_128	[p10l857t2706r1254b2785],
27	or	CC	O	or	_	0	SENT_128	[p10l1283t2728r1351b2766],
28	chronic	JJ	O	chronic	conj_or	26	SENT_128	[p10l1380t2707r1618b2766],
29	heart	NN	O	heart	prep_from	24	SENT_128	[p10l1645t2707r1808b2766],
30	disease	NN	O	disease	dobj	8	SENT_128	[p10l1836t2706r2051b2766],
31	to	TO	O	to	_	0	SENT_128	[p10l2079t2718r2141b2766],
32	diabetes	NN	O	diabetes	nn	33	SENT_128	[p10l10t2808r262b2868],
33	mellitus	NN	O	mellitus	prep_to	8	SENT_128	[p10l287t2808r554b2877],
34	,	,	O	,	_	0	SENT_128	[p10l287t2808r554b2877],
35	and	CC	O	and	_	0	SENT_128	[p10l581t2808r699b2868],
36	chronic	JJ	O	chronic	amod	38	SENT_128	[p10l723t2808r962b2868],
37	obstructive	JJ	O	obstructive	amod	38	SENT_128	[p10l987t2808r1335b2868],
38	bronchopathy	NN	O	bronchopathy	prep_to	8	SENT_128	[p10l1358t2808r1820b2886],
39	.	.	O	.	_	0	SENT_128	[p10l1358t2808r1820b2886],

1	Fifty	CD	NUMBER	fifty	num	2	SENT_129	[p10l1848t2808r1992b2886],
2	percentage	NN	O	percentage	nsubj	6	SENT_129	[p10l2012t2829r2140b2886, p10l10t2921r244b2987],
3	of	IN	O	of	_	0	SENT_129	[p10l287t2909r357b2968],
4	the	DT	O	the	det	5	SENT_129	[p10l390t2909r488b2968],
5	patients	NNS	O	patient	prep_of	2	SENT_129	[p10l529t2911r777b2986],
6	presented	VBD	O	present	_	0	SENT_129	[p10l819t2909r1125b2986],
7	three	CD	NUMBER	three	num	8	SENT_129	[p10l1166t2909r1325b2968],
8	conditions	NNS	O	condition	dobj	6	SENT_129	[p10l1369t2909r1702b2968],
9	at	IN	O	at	_	0	SENT_129	[p10l1746t2921r1802b2968],
10	the	DT	O	the	det	12	SENT_129	[p10l1844t2909r1942b2968],
11	same	JJ	O	same	amod	12	SENT_129	[p10l1985t2930r2143b2968],
12	time	NN	O	time	prep_at	6	SENT_129	[p10l9t3012r167b3070],
13	.	.	O	.	_	0	SENT_129	[p10l9t3012r167b3070],

1	Only	RB	O	only	quantmod	3	SENT_130	[p10l203t3010r361b3088],
2	10	CD	PERCENT	10	number	3	SENT_130	[p10l397t3016r463b3070],
3	(	CD	PERCENT	(	nsubj	9	SENT_130	[p10l501t3010r690b3082],
4	12	CD	PERCENT	12	num	5	SENT_130	[p10l501t3010r690b3082],
5	%	NN	PERCENT	%	dep	3	SENT_130	[p10l501t3010r690b3082],
6	)	CD	NUMBER	)	num	7	SENT_130	[p10l501t3010r690b3082],
7	patients	NNS	O	patient	dep	3	SENT_130	[p10l728t3012r975b3088],
8	were	VBD	O	be	aux	9	SENT_130	[p10l1006t3032r1155b3070],
9	taking	VBG	O	take	_	0	SENT_130	[p10l1187t3010r1384b3088],
10	just	RB	O	just	advmod	12	SENT_130	[p10l1412t3012r1528b3088],
11	one	CD	NUMBER	one	num	12	SENT_130	[p10l1561t3032r1675b3070],
12	drug	NN	O	drug	npadvmod	9	SENT_130	[p10l1708t3010r1856b3088],
13	prior	RB	O	prior	_	0	SENT_130	[p10l1887t3012r2048b3088],
14	to	TO	O	to	_	0	SENT_130	[p10l2079t3022r2141b3070],
15	allopurinol	NN	O	allopurinol	prep_prior_to	9	SENT_130	[p10l10t3111r360b3188],
16	being	VBG	O	be	auxpass	17	SENT_130	[p10l393t3111r567b3189],
17	prescribed	VBN	O	prescribe	partmod	15	SENT_130	[p10l600t3111r943b3188],
18	.	.	O	.	_	0	SENT_130	[p10l600t3111r943b3188],

1	All	DT	O	all	det	3	SENT_131	[p10l978t3111r1070b3169],
2	other	JJ	O	other	amod	3	SENT_131	[p10l1105t3111r1272b3170],
3	patients	NNS	O	patient	nsubj	4	SENT_131	[p10l1305t3113r1552b3188],
4	were	VBD	O	be	_	0	SENT_131	[p10l1586t3132r1734b3170],
5	on	IN	O	on	_	0	SENT_131	[p10l1770t3132r1852b3170],
6	three	CD	NUMBER	three	prep_on	4	SENT_131	[p10l1886t3111r2046b3170],
7	to	TO	O	to	_	0	SENT_131	[p10l2079t3123r2142b3170],
8	more	JJR	O	more	amod	9	SENT_131	[p10l9t3233r176b3271],
9	drugs	NNS	O	drug	prep_to	4	SENT_131	[p10l214t3211r388b3290],
10	daily	RB	SET	daily	advmod	9	SENT_131	[p10l427t3211r590b3290],
11	.	.	O	.	_	0	SENT_131	[p10l427t3211r590b3290],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_132	[p10l632t3214r1052b3271],
2	drugs	NNS	O	drug	nsubjpass	19	SENT_132	[p10l1089t3212r1263b3290],
3	had	VBD	O	have	aux	6	SENT_132	[p10l1300t3211r1419b3271],
4	not	RB	O	not	neg	6	SENT_132	[p10l1455t3223r1562b3271],
5	been	VBN	O	be	auxpass	6	SENT_132	[p10l1597t3211r1745b3271],
6	changed	VBN	O	change	_	0	SENT_132	[p10l1783t3211r2045b3290],
7	in	IN	O	in	_	0	SENT_132	[p10l2081t3214r2143b3270],
8	the	DT	DATE	the	det	9	SENT_132	[p10l9t3313r107b3373],
9	month	NN	DATE	month	prep_in	6	SENT_132	[p10l138t3313r354b3373],
10	prior	RB	O	prior	_	0	SENT_132	[p10l384t3315r545b3391],
11	to	TO	O	to	_	0	SENT_132	[p10l575t3325r637b3373],
12	the	DT	O	the	det	14	SENT_132	[p10l670t3313r768b3373],
13	skin	NN	O	skin	nn	14	SENT_132	[p10l800t3313r928b3373],
14	ADR	NN	MISC	adr	prep_prior_to	9	SENT_132	[p10l957t3317r1134b3382],
15	,	,	O	,	_	0	SENT_132	[p10l957t3317r1134b3382],
16	and	CC	O	and	_	0	SENT_132	[p10l1168t3313r1286b3373],
17	were	VBD	O	be	auxpass	19	SENT_132	[p10l1314t3335r1462b3373],
18	not	RB	O	not	neg	19	SENT_132	[p10l1494t3325r1601b3373],
19	discontinued	VBN	O	discontinue	conj_and	6	SENT_132	[p10l1633t3313r2044b3373],
20	or	CC	O	or	_	0	SENT_132	[p10l2076t3335r2144b3373],
21	reduced	VBN	O	reduce	conj_and	6	SENT_132	[p10l10t3414r262b3473],
22	in	IN	O	in	_	0	SENT_132	[p10l300t3416r363b3472],
23	dosage	NN	O	dosage	prep_in	19	SENT_132	[p10l401t3414r629b3492],
24	,	,	O	,	_	0	SENT_132	[p10l401t3414r629b3492],
25	with	IN	O	with	conj_and	6	SENT_132	[p10l667t3414r809b3473],
26	no	DT	O	no	det	28	SENT_132	[p10l847t3435r927b3473],
27	apparent	JJ	O	apparent	amod	28	SENT_132	[p10l967t3426r1248b3491],
28	inﬂuence	NN	O	inﬂuence	pobj	25	SENT_132	[p10l1285t3414r1576b3473],
29	on	IN	O	on	_	0	SENT_132	[p10l1614t3435r1696b3473],
30	the	DT	O	the	det	32	SENT_132	[p10l1733t3414r1831b3473],
31	eruption	NN	O	eruption	nn	32	SENT_132	[p10l1870t3416r2143b3491],
32	recovery	NN	O	recovery	prep_on	28	SENT_132	[p10l10t3536r291b3593],
33	.	.	O	.	_	0	SENT_132	[p10l10t3536r291b3593],

1	Chronic	JJ	O	chronic	amod	3	SENT_133	[p10l318t3514r576b3574],
2	renal	JJ	O	renal	amod	3	SENT_133	[p10l600t3515r756b3574],
3	insufﬁciency	NN	O	insufﬁciency	nsubj	9	SENT_133	[p10l779t3514r1178b3593],
4	was	VBD	O	be	cop	9	SENT_133	[p10l1196t3536r1311b3574],
5	the	DT	O	the	det	9	SENT_133	[p10l1334t3514r1432b3574],
6	second	JJ	ORDINAL	second	amod	9	SENT_133	[p10l1457t3515r1675b3574],
7	most	RBS	O	most	advmod	8	SENT_133	[p10l1697t3526r1855b3574],
8	frequent	JJ	O	frequent	amod	9	SENT_133	[p10l1878t3514r2143b3592],
9	co-morbidity	NN	O	co-morbidity	_	0	SENT_133	[p10l10t3616r434b3694],
10	and	CC	O	and	_	0	SENT_133	[p10l455t3616r573b3676],
11	only	RB	O	only	advmod	9	SENT_133	[p10l598t3616r737b3694],
12	12	CD	NUMBER	12	num	13	SENT_133	[p10l766t3622r830b3675],
13	patients	NNS	O	patient	pobj	11	SENT_133	[p10l857t3618r1104b3694],
14	(	IN	O	(	_	0	SENT_133	[p10l1134t3616r1380b3688],
15	14.3	CD	PERCENT	14.3	num	16	SENT_133	[p10l1134t3616r1380b3688],
16	%	NN	PERCENT	%	prep_(	11	SENT_133	[p10l1134t3616r1380b3688],
17	)	CD	NUMBER	)	conj_and	9	SENT_133	[p10l1134t3616r1380b3688],
18	were	VBD	O	be	rcmod	17	SENT_133	[p10l1408t3638r1556b3676],
19	under	IN	O	under	_	0	SENT_133	[p10l1581t3616r1769b3676],
20	allopurinol	NN	O	allopurinol	nn	22	SENT_133	[p10l1794t3616r2144b3694],
21	dosage	NN	O	dosage	nn	22	SENT_133	[p10l10t3717r222b3795],
22	adjustment	NN	O	adjustment	prep_under	18	SENT_133	[p10l247t3717r602b3795],
23	according	VBG	O	accord	_	0	SENT_133	[p10l625t3717r936b3795],
24	to	TO	O	to	prepc_according_to	18	SENT_133	[p10l958t3729r1021b3776],
25	creatinine	NN	O	creatinine	nn	26	SENT_133	[p10l1047t3719r1358b3776],
26	clearance	NN	O	clearance	pobj	18	SENT_133	[p10l1383t3717r1685b3776],
27	.	.	O	.	_	0	SENT_133	[p10l1383t3717r1685b3776],

1	Ten	CD	PERCENT	ten	num	2	SENT_134	[p11l91t21r213b78],
2	(	CD	PERCENT	(	nsubj	7	SENT_134	[p11l254t18r444b90],
3	12	CD	PERCENT	12	number	4	SENT_134	[p11l254t18r444b90],
4	%	NN	PERCENT	%	amod	2	SENT_134	[p11l254t18r444b90],
5	)	CD	NUMBER	)	num	6	SENT_134	[p11l254t18r444b90],
6	patients	NNS	O	patient	dep	2	SENT_134	[p11l485t20r733b96],
7	reported	VBD	O	report	_	0	SENT_134	[p11l770t18r1041b96],
8	previous	JJ	O	previous	amod	9	SENT_134	[p11l1075t20r1346b96],
9	use	NN	O	use	dobj	7	SENT_134	[p11l1383t40r1484b78],
10	of	IN	O	of	_	0	SENT_134	[p11l1521t18r1592b78],
11	allopurinol	NN	O	allopurinol	prep_of	9	SENT_134	[p11l1619t18r1969b96],
12	with	IN	O	with	_	0	SENT_134	[p11l2001t18r2143b78],
13	some	DT	O	some	det	14	SENT_134	[p11l10t140r175b178],
14	kind	NN	O	kind	prep_with	7	SENT_134	[p11l204t119r349b178],
15	of	IN	O	of	_	0	SENT_134	[p11l380t119r450b178],
16	transitory	JJ	O	transitory	amod	19	SENT_134	[p11l470t121r781b197],
17	or	CC	O	or	_	0	SENT_134	[p11l808t140r876b178],
18	mild	JJ	O	mild	conj_or	16	SENT_134	[p11l905t119r1052b178],
19	reaction	NN	O	reaction	prep_of	14	SENT_134	[p11l1082t121r1354b187],
20	,	,	O	,	_	0	SENT_134	[p11l1082t121r1354b187],
21	and	CC	O	and	_	0	SENT_134	[p11l1387t119r1504b178],
22	were	VBD	O	be	auxpass	23	SENT_134	[p11l1532t140r1680b178],
23	considered	VBN	O	consider	conj_and	7	SENT_134	[p11l1711t119r2053b178],
24	as	IN	O	as	_	0	SENT_134	[p11l2084t140r2142b178],
25	exposed	VBN	O	expose	prep_as	23	SENT_134	[p11l10t219r264b297],
26	to	TO	O	to	_	0	SENT_134	[p11l296t231r359b279],
27	an	DT	O	a	det	29	SENT_134	[p11l395t241r470b279],
28	involuntary	JJ	O	involuntary	amod	29	SENT_134	[p11l504t220r874b298],
29	rechallenge	NN	O	rechallenge	prep_to	25	SENT_134	[p11l904t220r1272b298],
30	.	.	O	.	_	0	SENT_134	[p11l904t220r1272b298],

1	Final	JJ	O	final	amod	3	SENT_135	[p11l1309t220r1465b279],
2	causality	NN	O	causality	nn	3	SENT_135	[p11l1498t220r1770b298],
3	assessment	NN	O	assessment	nsubj	4	SENT_135	[p11l1801t231r2143b279],
4	classiﬁed	VBN	O	classiﬁed	_	0	SENT_135	[p11l10t321r291b381],
5	as	IN	O	as	_	0	SENT_135	[p11l326t343r384b381],
6	deﬁnite	NN	O	deﬁnite	prep_as	4	SENT_135	[p11l422t321r675b390],
7	,	,	O	,	_	0	SENT_135	[p11l422t321r675b390],
8	12	CD	PERCENT	12	num	9	SENT_135	[p11l720t326r853b383],
9	%	NN	PERCENT	%	nsubj	13	SENT_135	[p11l720t326r853b383],
10	of	IN	O	of	_	0	SENT_135	[p11l892t321r962b381],
11	the	DT	O	the	det	12	SENT_135	[p11l988t321r1086b381],
12	cases	NNS	O	case	prep_of	9	SENT_135	[p11l1123t343r1275b381],
13	(	VBP	O	(	dep	4	SENT_135	[p11l1316t321r1711b399],
14	involuntary	JJ	O	involuntary	amod	16	SENT_135	[p11l1316t321r1711b399],
15	rechallenge	NN	O	rechallenge	nn	16	SENT_135	[p11l1744t321r2141b399],
16	)	NN	O	)	dobj	13	SENT_135	[p11l1744t321r2141b399],
17	,	,	O	,	_	0	SENT_135	[p11l1744t321r2141b399],
18	and	CC	O	and	_	0	SENT_135	[p11l10t422r128b481],
19	as	IN	O	as	_	0	SENT_135	[p11l152t443r210b481],
20	probable	JJ	O	probable	conj_and	6	SENT_135	[p11l234t422r529b499],
21	,	,	O	,	_	0	SENT_135	[p11l234t422r529b499],
22	the	DT	O	the	det	25	SENT_135	[p11l554t422r652b481],
23	remaining	VBG	O	remain	amod	25	SENT_135	[p11l677t424r1001b500],
24	88	CD	PERCENT	88	num	25	SENT_135	[p11l1026t427r1181b483],
25	%	NN	PERCENT	%	appos	20	SENT_135	[p11l1026t427r1181b483],
26	.	.	O	.	_	0	SENT_135	[p11l1026t427r1181b483],

1	The	DT	O	the	det	4	SENT_136	[p11l91t523r212b582],
2	main	JJ	O	main	amod	4	SENT_136	[p11l264t525r427b582],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_136	[p11l477t523r834b600],
4	measures	NNS	O	measure	nsubj	7	SENT_136	[p11l885t544r1176b582],
5	were	VBD	O	be	cop	7	SENT_136	[p11l1226t544r1374b582],
6	drug	NN	O	drug	nn	7	SENT_136	[p11l1426t523r1574b601],
7	discontinuation	NN	O	discontinuation	_	0	SENT_136	[p11l1625t523r2141b591],
8	,	,	O	,	_	0	SENT_136	[p11l1625t523r2141b591],
9	antihistamine	NN	O	antihistamine	nn	10	SENT_136	[p11l10t624r442b684],
10	administration	NN	O	administration	appos	7	SENT_136	[p11l483t624r968b693],
11	,	,	O	,	_	0	SENT_136	[p11l483t624r968b693],
12	supportive	JJ	O	supportive	amod	13	SENT_136	[p11l1010t626r1346b702],
13	care	NN	O	care	appos	7	SENT_136	[p11l1387t646r1513b684],
14	in	IN	O	in	_	0	SENT_136	[p11l1552t626r1616b683],
15	all	DT	O	all	det	16	SENT_136	[p11l1655t624r1726b684],
16	cases	NNS	O	case	prep_in	7	SENT_136	[p11l1766t646r1934b693],
17	,	,	O	,	_	0	SENT_136	[p11l1766t646r1934b693],
18	while	IN	O	while	mark	21	SENT_136	[p11l1974t624r2143b684],
19	general	JJ	O	general	amod	20	SENT_136	[p11l10t725r235b803],
20	corticosteroids	NNS	O	corticosteroid	nsubj	21	SENT_136	[p11l281t725r744b784],
21	(	VBP	O	(	advcl	7	SENT_136	[p11l794t725r909b797],
22	0.5	CD	NUMBER	0.5	num	24	SENT_136	[p11l794t725r909b797],
23	mg	NN	O	mg	nn	24	SENT_136	[p11l941t746r1042b803],
24	prednisone	NN	O	prednisone	nsubjpass	29	SENT_136	[p11l1086t725r1438b802],
25	or	CC	O	or	_	0	SENT_136	[p11l1485t746r1552b784],
26	equivalent	JJ	O	equivalent	amod	27	SENT_136	[p11l1598t725r1946b802],
27	)	NN	O	)	nsubjpass	29	SENT_136	[p11l1598t725r1946b802],
28	were	VBD	O	be	auxpass	29	SENT_136	[p11l1994t746r2143b784],
29	used	VBN	O	use	ccomp	21	SENT_136	[p11l10t826r155b886],
30	in	IN	O	in	_	0	SENT_136	[p11l184t828r246b885],
31	non-responsive	JJ	O	non-responsive	amod	33	SENT_136	[p11l275t828r762b904],
32	severe	JJ	O	severe	amod	33	SENT_136	[p11l793t848r981b886],
33	eruptions	NNS	O	eruption	prep_in	29	SENT_136	[p11l1012t828r1312b904],
34	and	CC	O	and	_	0	SENT_136	[p11l1344t826r1461b886],
35	DRESS	NN	O	dress	prep_in	29	SENT_136	[p11l1491t829r1731b886],
36	.	.	O	.	_	0	SENT_136	[p11l1491t829r1731b886],

1	Intravenous	JJ	O	intravenous	amod	2	SENT_137	[p11l1766t831r2142b886],
2	immunoglobulines	NNS	O	immunoglobuline	nsubj	3	SENT_137	[p11l10t927r610b1005],
3	(	VBP	O	(	_	0	SENT_137	[p11l687t927r875b1005],
4	IVIg	NN	O	ivig	nn	5	SENT_137	[p11l687t927r875b1005],
5	)	NN	O	)	dobj	3	SENT_137	[p11l687t927r875b1005],
6	2	CD	NUMBER	2	num	7	SENT_137	[p11l952t932r985b985],
7	g/kg	NN	O	g/kg	nsubjpass	9	SENT_137	[p11l1017t927r1165b1005],
8	were	VBD	O	be	auxpass	9	SENT_137	[p11l1233t948r1381b986],
9	administered	VBN	O	administer	rcmod	5	SENT_137	[p11l1452t927r1867b986],
10	in	IN	O	in	_	0	SENT_137	[p11l1937t929r2000b985],
11	15	CD	NUMBER	15	num	14	SENT_137	[p11l2076t933r2141b986],
12	SIS/T	NN	O	sis/t	nn	14	SENT_137	[p11l10t1030r196b1097],
13	EN	NN	O	en	nn	14	SENT_137	[p11l197t1032r299b1087],
14	patients	NNS	O	patient	prep_in	9	SENT_137	[p11l347t1029r610b1105],
15	,	,	O	,	_	0	SENT_137	[p11l347t1029r610b1105],
16	with	IN	O	with	mark	25	SENT_137	[p11l660t1027r801b1087],
17	a	DT	O	a	det	19	SENT_137	[p11l851t1049r884b1087],
18	SCORTEN	JJ	MISC	scorten	amod	19	SENT_137	[p11l933t1030r1282b1087],
19	index	NN	O	index	nsubj	25	SENT_137	[p11l1331t1027r1507b1087],
20	of	IN	O	of	_	0	SENT_137	[p11l1555t1027r1626b1087],
21	3-4	CD	NUMBER	3-4	num	22	SENT_137	[p11l1667t1033r1778b1087],
22	(	CD	NUMBER	(	prep_of	19	SENT_137	[p11l1833t1027r2030b1100],
23	Table	NNP	O	Table	dep	25	SENT_137	[p11l1833t1027r2030b1100],
24	2	CD	NUMBER	2	num	25	SENT_137	[p11l2060t1028r2139b1099],
25	)	CD	NUMBER	)	advcl	3	SENT_137	[p11l2060t1028r2139b1099],
26	.	.	O	.	_	0	SENT_137	[p11l2060t1028r2139b1099],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_138	[p11l10t1131r258b1188],
2	with	IN	O	with	_	0	SENT_138	[p11l292t1129r434b1188],
3	a	DT	O	a	det	5	SENT_138	[p11l470t1151r503b1188],
4	low	JJ	O	low	amod	5	SENT_138	[p11l535t1129r652b1188],
5	SCORTEN	NN	O	scorten	prep_with	1	SENT_138	[p11l685t1132r1034b1188],
6	were	VBD	O	be	auxpass	7	SENT_138	[p11l1067t1151r1215b1188],
7	excluded	VBN	O	exclude	_	0	SENT_138	[p11l1251t1129r1530b1188],
8	from	IN	O	from	_	0	SENT_138	[p11l1565t1129r1721b1188],
9	this	DT	O	this	det	10	SENT_138	[p11l1755t1129r1868b1188],
10	kind	NN	O	kind	prep_from	7	SENT_138	[p11l1903t1129r2047b1188],
11	of	IN	O	of	_	0	SENT_138	[p11l2083t1129r2153b1188],
12	therapy	NN	O	therapy	prep_of	10	SENT_138	[p11l9t1230r251b1308],
13	as	IN	O	as	mark	16	SENT_138	[p11l302t1251r360b1289],
14	recovery	NN	O	recovery	nsubj	16	SENT_138	[p11l416t1251r685b1308],
15	is	VBZ	O	be	cop	16	SENT_138	[p11l735t1232r780b1289],
16	frequent	JJ	O	frequent	advcl	7	SENT_138	[p11l835t1230r1102b1307],
17	with	IN	O	with	_	0	SENT_138	[p11l1153t1230r1294b1289],
18	simple	JJ	O	simple	amod	19	SENT_138	[p11l1348t1230r1554b1307],
19	supportive	JJ	O	supportive	amod	20	SENT_138	[p11l1609t1232r1945b1307],
20	care	NN	O	care	prep_with	16	SENT_138	[p11l1999t1251r2140b1289],
21	.	.	O	.	_	0	SENT_138	[p11l1999t1251r2140b1289],

1	©	RB	O	©	dep	2	SENT_139	[p11l1618t1475r1660b1517],
2	2011	CD	DATE	2011	dep	4	SENT_139	[p11l1684t1474r1800b1517],
3	The	DT	O	the	det	4	SENT_139	[p11l1832t1473r1926b1517],
4	Authors	NNPS	O	Authors	_	0	SENT_139	[p11l1947t1473r2143b1517],

1	IEADV	NNP	O	IEADV	dep	19	SENT_140	[p11l79t1532r178b1559],
2	2012	CD	DATE	2012	num	1	SENT_140	[p11l185t1535r249b1558],
3	,	,	O	,	_	0	SENT_140	[p11l185t1535r249b1558],
4	26	CD	NUMBER	26	num	1	SENT_140	[p11l260t1535r295b1558],
5	,	,	O	,	_	0	SENT_140	[p11l260t1535r295b1558],
6	1424-1430	CD	DATE	1424-1430	num	7	SENT_140	[p11l308t1535r438b1555],
7	Journal	NNP	O	Journal	appos	1	SENT_140	[p11l558t1535r641b1555],
8	of	IN	O	of	_	0	SENT_140	[p11l652t1535r674b1555],
9	the	DT	O	the	det	11	SENT_140	[p11l682t1535r718b1555],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_140	[p11l729t1535r838b1560],
11	Academy	NN	ORGANIZATION	academy	prep_of	1	SENT_140	[p11l849t1535r958b1560],
12	of	IN	ORGANIZATION	of	_	0	SENT_140	[p11l967t1535r989b1555],
13	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	11	SENT_140	[p11l999t1535r1145b1560],
14	and	CC	O	and	_	0	SENT_140	[p11l1155t1535r1197b1555],
15	Venereology	NNP	O	Venereology	prep_of	11	SENT_140	[p11l1207t1535r1350b1560],
16	©	CD	NUMBER	©	dep	19	SENT_140	[p11l1360t1536r1379b1555],
17	2011	CD	DATE	2011	num	19	SENT_140	[p11l1390t1535r1444b1555],
18	European	JJ	ORGANIZATION	european	amod	19	SENT_140	[p11l1459t1535r1568b1560],
19	Academy	NN	ORGANIZATION	academy	_	0	SENT_140	[p11l1579t1535r1688b1560],
20	of	IN	ORGANIZATION	of	_	0	SENT_140	[p11l1698t1535r1719b1555],
21	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	19	SENT_140	[p11l1730t1535r1875b1560],
22	and	CC	O	and	_	0	SENT_140	[p11l1885t1535r1927b1555],
23	Venereology	NNP	O	Venereology	prep_of	19	SENT_140	[p11l1937t1535r2080b1560],

1	1428	CD	DATE	1428	num	2	SENT_141	[p11l82t1641r143b1663],
2	Atzori	NNP	O	Atzori	_	0	SENT_141	[p11l1889t1635r1982b1663],
3	et	FW	O	et	nn	4	SENT_141	[p11l1997t1637r2030b1663],
4	al.	FW	O	al.	dep	2	SENT_141	[p11l2041t1635r2075b1663],
5	.	.	O	.	_	0	SENT_141	[p11l2041t1635r2075b1663],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_142	[p11l10t1864r258b1922],
2	with	IN	O	with	_	0	SENT_142	[p11l281t1862r423b1922],
3	SCORTEN	NN	O	scorten	nn	4	SENT_142	[p11l447t1865r796b1922],
4	values	NNS	O	value	prep_with	1	SENT_142	[p11l817t1862r1010b1922],
5	25	CD	NUMBER	25	dep	4	SENT_142	[p11l1034t1868r1111b1922],
6	were	VBD	O	be	auxpass	7	SENT_142	[p11l1135t1884r1284b1922],
7	excluded	VBN	O	exclude	_	0	SENT_142	[p11l1308t1862r1604b1931],
8	,	,	O	,	_	0	SENT_142	[p11l1308t1862r1604b1931],
9	as	IN	O	as	mark	16	SENT_142	[p11l1631t1884r1689b1922],
10	mortality	NN	O	mortality	nn	11	SENT_142	[p11l1714t1862r2009b1940],
11	risk	NN	O	risk	nsubj	16	SENT_142	[p11l2029t1862r2145b1922],
12	would	MD	O	would	aux	16	SENT_142	[p11l7t1963r208b2022],
13	have	VB	O	have	aux	16	SENT_142	[p11l246t1963r391b2022],
14	had	VBD	O	have	aux	16	SENT_142	[p11l429t1963r548b2022],
15	negatively	RB	O	negatively	advmod	16	SENT_142	[p11l587t1963r903b2041],
16	affected	VBN	O	affect	advcl	7	SENT_142	[p11l941t1963r1183b2022],
17	the	DT	O	the	det	20	SENT_142	[p11l1222t1963r1320b2022],
18	drug	NN	O	drug	nn	20	SENT_142	[p11l1361t1963r1508b2041],
19	efﬁcacy	NN	O	efﬁcacy	nn	20	SENT_142	[p11l1548t1963r1785b2041],
20	judgment	NN	O	judgment	dobj	16	SENT_142	[p11l1816t1963r2139b2041],
21	.	.	O	.	_	0	SENT_142	[p11l1816t1963r2139b2041],

1	Considering	VBG	O	consider	_	0	SENT_143	[p11l10t2064r397b2142],
2	the	DT	O	the	det	5	SENT_143	[p11l431t2064r530b2123],
3	total	JJ	O	total	amod	5	SENT_143	[p11l565t2063r709b2123],
4	case	NN	O	case	nn	5	SENT_143	[p11l745t2085r869b2123],
5	study	NN	O	study	prep_considering	10	SENT_143	[p11l907t2064r1093b2142],
6	,	,	O	,	_	0	SENT_143	[p11l907t2064r1093b2142],
7	complete	JJ	O	complete	amod	8	SENT_143	[p11l1132t2064r1421b2141],
8	recovery	NN	O	recovery	nsubjpass	10	SENT_143	[p11l1457t2085r1727b2142],
9	was	VBD	O	be	auxpass	10	SENT_143	[p11l1758t2085r1873b2123],
10	seen	VBN	O	see	_	0	SENT_143	[p11l1911t2085r2045b2123],
11	in	IN	O	in	_	0	SENT_143	[p11l2081t2066r2143b2122],
12	88	CD	PERCENT	88	num	13	SENT_143	[p11l11t2170r149b2227],
13	%	NN	PERCENT	%	prep_in	10	SENT_143	[p11l11t2170r149b2227],
14	of	IN	O	of	_	0	SENT_143	[p11l182t2165r253b2225],
15	the	DT	O	the	det	16	SENT_143	[p11l273t2165r371b2225],
16	cases	NNS	O	case	prep_of	13	SENT_143	[p11l402t2187r570b2225],
17	.	.	O	.	_	0	SENT_143	[p11l402t2187r570b2225],

1	Hospitalization	NN	O	hospitalization	nn	2	SENT_144	[p11l603t2165r1089b2243],
2	time	NN	O	time	nsubj	3	SENT_144	[p11l1119t2167r1262b2225],
3	ranged	VBD	O	range	_	0	SENT_144	[p11l1292t2165r1507b2243],
4	from	IN	O	from	_	0	SENT_144	[p11l1538t2165r1694b2225],
5	7	CD	DURATION	7	number	7	SENT_144	[p11l1726t2172r1759b2225],
6	to	TO	DURATION	to	dep	7	SENT_144	[p11l1790t2177r1852b2225],
7	43	CD	DURATION	43	num	8	SENT_144	[p11l1883t2171r1955b2225],
8	days	NNS	NUMBER	day	prep_from	3	SENT_144	[p11l1988t2165r2140b2243],
9	.	.	O	.	_	0	SENT_144	[p11l1988t2165r2140b2243],

1	Ten	CD	PERCENT	ten	num	2	SENT_145	[p11l9t2268r131b2325],
2	(	CD	PERCENT	(	nsubj	23	SENT_145	[p11l168t2266r358b2338],
3	12	CD	PERCENT	12	number	4	SENT_145	[p11l168t2266r358b2338],
4	%	NN	PERCENT	%	amod	2	SENT_145	[p11l168t2266r358b2338],
5	)	CD	NUMBER	)	num	6	SENT_145	[p11l168t2266r358b2338],
6	patients	NNS	O	patient	dep	2	SENT_145	[p11l395t2268r643b2343],
7	affected	VBN	O	affect	partmod	6	SENT_145	[p11l677t2266r919b2325],
8	by	IN	O	by	_	0	SENT_145	[p11l949t2266r1028b2344],
9	SIS/T	NNP	O	SIS/T	nn	11	SENT_145	[p11l1058t2268r1243b2335],
10	EN	NNP	O	EN	nn	11	SENT_145	[p11l1245t2270r1347b2325],
11	syndrome	NN	O	syndrome	agent	7	SENT_145	[p11l1380t2266r1710b2344],
12	,	,	O	,	_	0	SENT_145	[p11l1380t2266r1710b2344],
13	with	IN	O	with	_	0	SENT_145	[p11l1742t2266r1884b2325],
14	SCORTEN	NN	O	scorten	nn	15	SENT_145	[p11l1917t2269r2140b2325, p11l9t2369r159b2426],
15	values	NNS	O	value	prep_with	7	SENT_145	[p11l182t2367r375b2426],
16	25	CD	NUMBER	25	number	17	SENT_145	[p11l402t2373r479b2426],
17	(	CD	NUMBER	(	num	18	SENT_145	[p11l512t2367r710b2439],
18	Table	NNP	O	Table	dep	15	SENT_145	[p11l512t2367r710b2439],
19	2	CD	NUMBER	2	number	20	SENT_145	[p11l740t2367r821b2439],
20	)	CD	NUMBER	)	num	18	SENT_145	[p11l740t2367r821b2439],
21	,	,	O	,	_	0	SENT_145	[p11l740t2367r821b2439],
22	unfortunately	RB	O	unfortunately	advmod	23	SENT_145	[p11l849t2367r1285b2445],
23	died	VBD	O	die	_	0	SENT_145	[p11l1308t2367r1459b2436],
24	,	,	O	,	_	0	SENT_145	[p11l1308t2367r1459b2436],
25	despite	IN	O	despite	_	0	SENT_145	[p11l1488t2367r1708b2444],
26	the	DT	O	the	det	27	SENT_145	[p11l1733t2367r1831b2426],
27	efforts	NNS	O	effort	prep_despite	23	SENT_145	[p11l1858t2367r2054b2426],
28	of	IN	O	of	_	0	SENT_145	[p11l2082t2367r2152b2426],
29	the	DT	O	the	det	33	SENT_145	[p11l8t2468r107b2527],
30	local	JJ	O	local	amod	33	SENT_145	[p11l132t2468r279b2527],
31	intensive	JJ	O	intensive	amod	33	SENT_145	[p11l305t2470r584b2527],
32	care	NN	O	care	nn	33	SENT_145	[p11l611t2489r737b2527],
33	unit	NN	O	unit	prep_of	27	SENT_145	[p11l764t2470r909b2536],
34	,	,	O	,	_	0	SENT_145	[p11l764t2470r909b2536],
35	where	WRB	O	where	advmod	41	SENT_145	[p11l936t2468r1126b2527],
36	the	DT	O	the	det	37	SENT_145	[p11l1152t2468r1250b2527],
37	patients	NNS	O	patient	nsubjpass	41	SENT_145	[p11l1276t2470r1524b2545],
38	had	VBD	O	have	aux	41	SENT_145	[p11l1550t2468r1668b2527],
39	been	VBN	O	be	auxpass	41	SENT_145	[p11l1692t2468r1843b2527],
40	immediately	RB	O	immediately	advmod	41	SENT_145	[p11l1868t2468r2140b2527, p11l10t2568r156b2646],
41	moved	VBN	O	move	advcl	23	SENT_145	[p11l186t2568r403b2628],
42	from	IN	O	from	_	0	SENT_145	[p11l435t2568r591b2628],
43	the	DT	O	the	det	45	SENT_145	[p11l623t2568r721b2628],
44	dermatology	NN	O	dermatology	nn	45	SENT_145	[p11l755t2568r1157b2647],
45	ward	NN	O	ward	prep_from	41	SENT_145	[p11l1184t2568r1359b2628],
46	.	.	O	.	_	0	SENT_145	[p11l1184t2568r1359b2628],

1	All	PDT	O	all	predet	3	SENT_146	[p11l1393t2568r1483b2627],
2	the	DT	O	the	det	3	SENT_146	[p11l1515t2568r1613b2628],
3	patients	NNS	O	patient	nsubj	8	SENT_146	[p11l1644t2570r1892b2646],
4	treated	VBN	O	treat	partmod	3	SENT_146	[p11l1925t2568r2145b2628],
5	with	IN	O	with	_	0	SENT_146	[p11l7t2670r149b2730],
6	IV	CD	NUMBER	iv	num	7	SENT_146	[p11l176t2675r255b2729],
7	Ig	NN	MISC	ig	prep_with	4	SENT_146	[p11l256t2675r316b2748],
8	recovered	VBD	O	recover	_	0	SENT_146	[p11l343t2670r648b2730],
9	completely	RB	O	completely	advmod	8	SENT_146	[p11l676t2670r1032b2748],
10	.	.	O	.	_	0	SENT_146	[p11l676t2670r1032b2748],

1	Mild	JJ	O	mild	amod	2	SENT_147	[p11l1063t2670r1216b2730],
2	sequelae	NN	O	sequela	nsubj	11	SENT_147	[p11l1243t2670r1521b2748],
3	,	,	O	,	_	0	SENT_147	[p11l1243t2670r1521b2748],
4	such	JJ	O	such	_	0	SENT_147	[p11l1550t2670r1693b2730],
5	as	IN	O	as	_	0	SENT_147	[p11l1721t2692r1779b2730],
6	hyperpigmentation	NN	O	hyperpigmentation	prep_such_as	2	SENT_147	[p11l1806t2670r2139b2748, p11l9t2773r337b2830],
7	and	CC	O	and	_	0	SENT_147	[p11l367t2771r484b2830],
8	adnexial	JJ	O	adnexial	amod	9	SENT_147	[p11l513t2771r775b2830],
9	atrophy	NN	O	atrophy	prep_such_as	2	SENT_147	[p11l803t2771r1051b2849],
10	were	VBD	O	be	cop	11	SENT_147	[p11l1075t2792r1222b2830],
11	present	JJ	DATE	present	conj_and	11	SENT_147	[p11l1251t2783r1481b2848],
12	in	IN	O	in	prep	11	SENT_147	[p11l1509t2773r1572b2829],
13	about	IN	O	about	_	0	SENT_147	[p11l1600t2771r1782b2830],
14	half	NN	O	half	prep_about	11	SENT_147	[p11l1809t2771r1936b2830],
15	of	IN	O	of	_	0	SENT_147	[p11l1956t2771r2026b2830],
16	the	DT	O	the	det	17	SENT_147	[p11l2045t2771r2143b2830],
17	patients	NNS	O	patient	prep_of	14	SENT_147	[p11l8t2873r256b2949],
18	treated	VBN	O	treat	partmod	17	SENT_147	[p11l290t2871r510b2931],
19	with	IN	O	with	_	0	SENT_147	[p11l541t2871r682b2931],
20	high	JJ	O	high	amod	22	SENT_147	[p11l715t2871r856b2950],
21	dose	NN	O	dose	nn	22	SENT_147	[p11l891t2871r1032b2931],
22	IVIg	NN	O	ivig	prep_with	18	SENT_147	[p11l1067t2876r1207b2950],
23	and	CC	O	and	_	0	SENT_147	[p11l1241t2871r1358b2931],
24	in	IN	O	in	_	0	SENT_147	[p11l1393t2873r1455b2930],
25	all	PDT	O	all	predet	27	SENT_147	[p11l1489t2871r1561b2931],
26	the	DT	O	the	det	27	SENT_147	[p11l1594t2871r1691b2931],
27	patients	NNS	O	patient	prep_in	11	SENT_147	[p11l1725t2873r1972b2949],
28	who	WP	O	who	nsubj	29	SENT_147	[p11l2005t2871r2141b2931],
29	survived	VBD	O	survive	ccomp	27	SENT_147	[p11l10t2973r277b3033],
30	with	IN	O	with	_	0	SENT_147	[p11l301t2973r442b3033],
31	supportive	JJ	O	supportive	amod	32	SENT_147	[p11l471t2975r807b3051],
32	care	NN	O	care	prep_with	29	SENT_147	[p11l836t2995r976b3033],
33	.	.	O	.	_	0	SENT_147	[p11l836t2995r976b3033],

1	Mortality	NN	O	mortality	nsubjpass	4	SENT_148	[p11l1006t2973r1309b3051],
2	can	MD	O	can	aux	4	SENT_148	[p11l1334t2995r1441b3033],
3	be	VB	O	be	auxpass	4	SENT_148	[p11l1467t2973r1540b3033],
4	estimated	VBN	O	estimate	_	0	SENT_148	[p11l1569t2973r1872b3033],
5	at	IN	O	at	_	0	SENT_148	[p11l1900t2985r1957b3033],
6	12	CD	NUMBER	12	number	7	SENT_148	[p11l1991t2978r2142b3042],
7	°	CD	NUMBER	°	prep_at	4	SENT_148	[p11l1991t2978r2142b3042],
8	/	:	O	/	punct	9	SENT_148	[p11l1991t2978r2142b3042],
9	o	NN	O	o	dep	7	SENT_148	[p11l1991t2978r2142b3042],
10	,	,	O	,	_	0	SENT_148	[p11l1991t2978r2142b3042],
11	overall	JJ	O	overall	dep	7	SENT_148	[p11l10t3074r220b3133],
12	and	CC	O	and	_	0	SENT_148	[p11l246t3074r364b3133],
13	32	CD	PERCENT	32	num	14	SENT_148	[p11l391t3079r548b3142],
14	%	NN	PERCENT	%	conj_and	9	SENT_148	[p11l391t3079r548b3142],
15	,	,	O	,	_	0	SENT_148	[p11l391t3079r548b3142],
16	considering	VBG	O	consider	_	0	SENT_148	[p11l576t3074r944b3152],
17	the	DT	O	the	det	20	SENT_148	[p11l969t3074r1066b3133],
18	SIS/T	NNP	O	SIS/T	nn	20	SENT_148	[p11l1094t3076r1278b3143],
19	EN	NNP	O	EN	nn	20	SENT_148	[p11l1280t3078r1382b3133],
20	population	NN	O	population	prep_considering	7	SENT_148	[p11l1407t3074r1773b3151],
21	.	.	O	.	_	0	SENT_148	[p11l1407t3074r1773b3151],

1	All	DT	O	all	det	3	SENT_149	[p11l1800t3074r1891b3132],
2	DRESS	NN	O	dress	nn	3	SENT_149	[p11l1917t3077r2141b3133],
3	cases	NNS	O	case	nsubj	4	SENT_149	[p11l10t3196r162b3234],
4	recovered	VBD	O	recover	_	0	SENT_149	[p11l187t3175r508b3244],
5	,	,	O	,	_	0	SENT_149	[p11l187t3175r508b3244],
6	but	CC	O	but	cc	4	SENT_149	[p11l533t3175r641b3234],
7	after	IN	O	after	_	0	SENT_149	[p11l666t3175r806b3234],
8	a	DT	O	a	det	10	SENT_149	[p11l830t3197r863b3234],
9	long	JJ	O	long	amod	10	SENT_149	[p11l885t3175r1025b3253],
10	period	NN	O	period	prep_after	4	SENT_149	[p11l1046t3175r1254b3252],
11	exceeding	VBG	O	exceed	partmod	10	SENT_149	[p11l1278t3175r1586b3253],
12	the	DT	DURATION	the	det	14	SENT_149	[p11l1609t3175r1707b3234],
13	6	CD	DURATION	6	num	14	SENT_149	[p11l1732t3180r1765b3234],
14	weeks	NNS	NUMBER	week	tmod	11	SENT_149	[p11l1794t3175r1995b3234],
15	.	.	O	.	_	0	SENT_149	[p11l1794t3175r1995b3234],

1	Discussion	NN	O	discussion	nn	4	SENT_150	[p11l12t3390r475b3454],
2	Adverse	JJ	O	adverse	amod	4	SENT_150	[p11l7t3496r258b3556],
3	cutaneous	JJ	O	cutaneous	amod	4	SENT_150	[p11l306t3508r625b3556],
4	reactions	NNS	O	reaction	nsubj	8	SENT_150	[p11l673t3498r956b3556],
5	to	TO	O	to	_	0	SENT_150	[p11l1002t3508r1065b3556],
6	allopurinol	NN	O	allopurinol	prep_to	4	SENT_150	[p11l1114t3496r1463b3574],
7	are	VBP	O	be	cop	8	SENT_150	[p11l1510t3518r1603b3556],
8	frequent	JJ	O	frequent	dep	23	SENT_150	[p11l1651t3496r1932b3574],
9	,	,	O	,	_	0	SENT_150	[p11l1651t3496r1932b3574],
10	often	RB	O	often	advmod	8	SENT_150	[p11l1982t3496r2143b3556],
11	severe	JJ	O	severe	acomp	8	SENT_150	[p11l10t3618r198b3656],
12	especially	RB	O	especially	advmod	11	SENT_150	[p11l224t3597r521b3675],
13	in	IN	O	in	_	0	SENT_150	[p11l542t3599r604b3655],
14	elderly	JJ	O	elderly	amod	18	SENT_150	[p11l629t3597r840b3675],
15	and	CC	O	and	_	0	SENT_150	[p11l861t3597r979b3656],
16	medicated	JJ	O	medicated	conj_and	14	SENT_150	[p11l1003t3597r1331b3656],
17	patients	NNS	O	patient	nn	18	SENT_150	[p11l1353t3584r1704b3674],
18	.2	NN	NUMBER	.2	prep_in	11	SENT_150	[p11l1353t3584r1704b3674],
19	"	''	O	"	punct	8	SENT_150	[p11l1353t3584r1704b3674],
20	5	CD	NUMBER	5	num	21	SENT_150	[p11l1353t3584r1704b3674],
21	Prescriptions	NNS	O	prescription	nsubj	23	SENT_150	[p11l1730t3599r2142b3674],
22	have	VBP	O	have	aux	23	SENT_150	[p11l8t3697r153b3757],
23	increased	VBN	O	increase	_	0	SENT_150	[p11l185t3697r479b3757],
24	worldwide	RB	O	worldwide	advmod	23	SENT_150	[p11l507t3697r843b3757],
25	in	IN	O	in	_	0	SENT_150	[p11l875t3700r937b3756],
26	the	DT	DATE	the	det	28	SENT_150	[p11l968t3697r1066b3757],
27	last	JJ	DATE	last	amod	28	SENT_150	[p11l1097t3698r1203b3757],
28	decade	NN	DATE	decade	prep_in	23	SENT_150	[p11l1234t3697r1466b3766],
29	,	,	O	,	_	0	SENT_150	[p11l1234t3697r1466b3766],
30	especially	RB	O	especially	advmod	23	SENT_150	[p11l1500t3697r1798b3776],
31	under	IN	O	under	_	0	SENT_150	[p11l1826t3698r2015b3757],
32	the	DT	O	the	det	33	SENT_150	[p11l2045t3698r2142b3757],
33	boost	NN	O	boost	prep_under	23	SENT_150	[p12l7t18r183b78],
34	of	IN	O	of	_	0	SENT_150	[p12l208t18r278b78],
35	low-cost	JJ	O	low-cost	amod	37	SENT_150	[p12l293t18r561b78],
36	generic	JJ	O	generic	amod	37	SENT_150	[p12l587t20r811b96],
37	drugs	NNS	O	drug	prep_of	33	SENT_150	[p12l837t18r1028b96],
38	,	,	O	,	_	0	SENT_150	[p12l837t18r1028b96],
39	because	IN	O	because	mark	46	SENT_150	[p12l1053t18r1297b78],
40	it	PRP	O	it	nsubj	46	SENT_150	[p12l1322t20r1366b78],
41	remains	VBZ	O	remain	cop	46	SENT_150	[p12l1391t20r1641b78],
42	the	DT	O	the	det	46	SENT_150	[p12l1666t18r1764b78],
43	most	RBS	O	most	advmod	46	SENT_150	[p12l1789t30r1947b78],
44	effective	JJ	O	effective	amod	46	SENT_150	[p12l1973t18r2138b78, p12l8t121r137b187],
45	,	,	O	,	_	0	SENT_150	[p12l1973t18r2138b78, p12l8t121r137b187],
46	economic	JJ	O	economic	advcl	23	SENT_150	[p12l164t121r487b187],
47	,	,	O	,	_	0	SENT_150	[p12l164t121r487b187],
48	orally	RB	O	orally	advmod	49	SENT_150	[p12l513t119r691b197],
49	administered	VBN	O	administer	amod	50	SENT_150	[p12l712t119r1126b178],
50	treatment	NN	O	treatment	appos	46	SENT_150	[p12l1147t131r1457b178],
51	for	IN	O	for	_	0	SENT_150	[p12l1479t119r1571b178],
52	all	PDT	O	all	predet	54	SENT_150	[p12l1594t119r1664b178],
53	the	DT	O	the	det	54	SENT_150	[p12l1686t119r1784b178],
54	conditions	NNS	O	condition	prep_for	46	SENT_150	[p12l1808t119r2141b178],
55	characterized	VBN	O	characterize	partmod	54	SENT_150	[p12l10t220r426b279],
56	by	IN	O	by	_	0	SENT_150	[p12l452t220r532b298],
57	urate	NN	O	urate	nn	58	SENT_150	[p12l557t232r718b279],
58	excess	NN	O	excess	agent	55	SENT_150	[p12l747t241r950b279],
59	.	.	O	.	_	0	SENT_150	[p12l747t241r950b279],

1	An	DT	O	a	det	5	SENT_151	[p12l979t223r1074b278],
2	intensive	JJ	O	intensive	amod	5	SENT_151	[p12l1103t222r1382b279],
3	cutaneous	JJ	O	cutaneous	amod	5	SENT_151	[p12l1411t232r1730b279],
4	ADR	NN	O	adr	nn	5	SENT_151	[p12l1756t224r1919b279],
5	monitoring	NN	O	monitoring	nsubj	7	SENT_151	[p12l1945t222r2140b279, p12l8t323r202b399],
6	has	VBZ	O	have	aux	7	SENT_151	[p12l238t321r340b380],
7	been	VBN	O	be	_	0	SENT_151	[p12l376t321r527b380],
8	in	IN	O	in	_	0	SENT_151	[p12l564t323r626b379],
9	place	NN	O	place	prep_in	7	SENT_151	[p12l662t321r823b398],
10	at	IN	O	at	_	0	SENT_151	[p12l861t333r918b380],
11	our	PRP$	O	we	poss	13	SENT_151	[p12l956t342r1067b380],
12	Dermatology	NNP	O	Dermatology	nn	13	SENT_151	[p12l1104t321r1523b399],
13	Clinic	NNP	MISC	Clinic	prep_at	9	SENT_151	[p12l1558t321r1745b380],
14	since	IN	O	since	_	0	SENT_151	[p12l1782t323r1937b380],
15	1995	CD	DATE	1995	prep_since	7	SENT_151	[p12l1981t326r2141b389],
16	,	,	O	,	_	0	SENT_151	[p12l1981t326r2141b389],
17	which	WDT	O	which	nsubj	22	SENT_151	[p12l7t421r199b481],
18	is	VBZ	O	be	cop	22	SENT_151	[p12l235t423r280b481],
19	the	DT	O	the	det	22	SENT_151	[p12l316t421r414b481],
20	reference	NN	O	reference	nn	22	SENT_151	[p12l450t421r734b481],
21	public	JJ	O	public	amod	22	SENT_151	[p12l769t421r966b499],
22	institution	NN	O	institution	rcmod	15	SENT_151	[p12l1001t423r1332b481],
23	with	IN	O	with	_	0	SENT_151	[p12l1365t421r1507b481],
24	inpatients	NNS	O	inpatient	nn	25	SENT_151	[p12l1543t423r1853b499],
25	facilities	NNS	O	facility	prep_with	22	SENT_151	[p12l1889t421r2143b481],
26	for	IN	O	for	_	0	SENT_151	[p12l9t523r100b583],
27	the	DT	O	the	det	31	SENT_151	[p12l145t523r243b583],
28	approximate	JJ	O	approximate	amod	31	SENT_151	[p12l291t525r691b601],
29	560	CD	NUMBER	560	number	30	SENT_151	[p12l740t528r848b583],
30	836	CD	NUMBER	836	num	31	SENT_151	[p12l881t528r990b583],
31	inhabitants	NNS	O	inhabitant	prep_for	25	SENT_151	[p12l1038t523r1390b583],
32	in	IN	O	in	_	0	SENT_151	[p12l1437t525r1499b582],
33	Southern	NNP	LOCATION	Southern	nn	36	SENT_151	[p12l1546t523r1836b583],
34	Sardinia	NNP	LOCATION	Sardinia	nn	36	SENT_151	[p12l1883t523r2144b583],
35	(	NNP	O	(	nn	36	SENT_151	[p12l14t624r173b695],
36	data	NNS	O	datum	prep_in	25	SENT_151	[p12l14t624r173b695],
37	from	IN	O	from	_	0	SENT_151	[p12l235t624r391b683],
38	the	DT	O	the	det	42	SENT_151	[p12l452t624r550b683],
39	Italian	JJ	O	italian	amod	42	SENT_151	[p12l611t624r816b683],
40	National	NNP	ORGANIZATION	National	nn	42	SENT_151	[p12l877t624r1153b683],
41	Statistics	NNPS	ORGANIZATION	Statistics	nn	42	SENT_151	[p12l1215t626r1479b683],
42	Institute	NNP	ORGANIZATION	Institute	prep_from	22	SENT_151	[p12l1539t626r1795b683],
43	(	CD	NUMBER	(	num	44	SENT_151	[p12l1861t624r2141b695],
44	ISTAT	NNP	ORGANIZATION	ISTAT	dep	42	SENT_151	[p12l1861t624r2141b695],
45	)	CD	NUMBER	)	num	44	SENT_151	[p12l1861t624r2141b695],
46	,	,	O	,	_	0	SENT_151	[p12l1861t624r2141b695],
47	updated	VBN	O	update	partmod	42	SENT_151	[p12l9t725r269b802],
48	the	DT	O	the	det	50	SENT_151	[p12l303t725r401b784],
49	31/10/2009	CD	NUMBER	31/10/2009	num	50	SENT_151	[p12l438t725r859b796],
50	)	NN	O	)	dobj	47	SENT_151	[p12l438t725r859b796],
51	.	.	O	.	_	0	SENT_151	[p12l438t725r859b796],

1	Considering	VBG	O	consider	_	0	SENT_152	[p12l899t725r1286b803],
2	this	DT	O	this	det	4	SENT_152	[p12l1319t724r1432b784],
3	catchments	NNS	O	catchment	nn	4	SENT_152	[p12l1469t725r1825b784],
4	area	NN	O	area	prep_considering	19	SENT_152	[p12l1862t746r1991b784],
5	and	CC	O	and	_	0	SENT_152	[p12l2026t725r2143b784],
6	the	DT	O	the	det	8	SENT_152	[p12l9t826r107b886],
7	10-year	JJ	DURATION	10-year	amod	8	SENT_152	[p12l146t832r373b904],
8	period	NN	O	period	conj_and	4	SENT_152	[p12l404t826r611b904],
9	of	IN	O	of	_	0	SENT_152	[p12l644t826r714b886],
10	observation	NN	O	observation	prep_of	8	SENT_152	[p12l738t826r1122b895],
11	,	,	O	,	_	0	SENT_152	[p12l738t826r1122b895],
12	the	DT	O	the	det	15	SENT_152	[p12l1155t826r1253b886],
13	mean	JJ	O	mean	amod	15	SENT_152	[p12l1285t848r1460b886],
14	annual	JJ	SET	annual	amod	15	SENT_152	[p12l1493t826r1708b886],
15	frequency	NN	O	frequency	nsubj	19	SENT_152	[p12l1740t826r2052b904],
16	of	IN	O	of	_	0	SENT_152	[p12l2082t826r2153b886],
17	8.4	CD	NUMBER	8.4	num	18	SENT_152	[p12l11t932r100b986],
18	cases	NNS	O	case	prep_of	15	SENT_152	[p12l135t948r287b986],
19	suggests	VBZ	O	suggest	_	0	SENT_152	[p12l321t939r573b1005],
20	a	DT	O	a	det	21	SENT_152	[p12l607t948r640b986],
21	forecast	NN	O	forecast	dobj	19	SENT_152	[p12l672t927r914b986],
22	of	IN	O	of	_	0	SENT_152	[p12l947t927r1018b986],
23	1.5	CD	NUMBER	1.5	prep_of	21	SENT_152	[p12l1048t929r1174b986],
24	/	:	O	/	punct	27	SENT_152	[p12l1048t929r1174b986],
25	100	CD	NUMBER	100	num	27	SENT_152	[p12l1181t932r1284b986],
26	ooo	NN	O	ooo	nn	27	SENT_152	[p12l1315t932r1425b986],
27	inhabitants	NNS	O	inhabitant	dep	21	SENT_152	[p12l1460t927r1812b986],
28	at	IN	O	at	_	0	SENT_152	[p12l1846t939r1903b986],
29	risk	NN	O	risk	prep_at	27	SENT_152	[p12l1935t927r2051b986],
30	of	IN	O	of	_	0	SENT_152	[p12l2082t927r2152b986],
31	allopurinol	NN	O	allopurinol	nn	33	SENT_152	[p12l10t1028r359b1105],
32	skin	NN	O	skin	nn	33	SENT_152	[p12l410t1028r538b1087],
33	ADR	NN	O	adr	prep_of	29	SENT_152	[p12l585t1031r748b1087],
34	per	IN	O	per	_	0	SENT_152	[p12l795t1049r899b1105],
35	year	NN	DURATION	year	prep_per	33	SENT_152	[p12l945t1049r1093b1106],
36	,	,	O	,	_	0	SENT_152	[p12l945t1049r1093b1106],
37	and	CC	O	and	_	0	SENT_152	[p12l1146t1028r1264b1087],
38	in	IN	O	in	_	0	SENT_152	[p12l1314t1030r1376b1086],
39	particular	JJ	O	particular	amod	40	SENT_152	[p12l1425t1028r1733b1105],
40	5.5	CD	NUMBER	5.5	prep_in	27	SENT_152	[p12l1784t1030r1915b1087],
41	/	:	O	/	punct	27	SENT_152	[p12l1784t1030r1915b1087],
42	million	CD	NUMBER	million	num	43	SENT_152	[p12l1915t1028r2143b1087],
43	inhabitants	NNS	O	inhabitant	dep	21	SENT_152	[p12l9t1129r362b1188],
44	could	MD	O	could	aux	45	SENT_152	[p12l406t1129r582b1188],
45	manifest	VB	O	manifest	rcmod	43	SENT_152	[p12l624t1129r894b1188],
46	SIS/T	NNP	O	SIS/T	nn	48	SENT_152	[p12l937t1131r1122b1198],
47	EN	NN	O	en	nn	48	SENT_152	[p12l1124t1133r1226b1188],
48	syndrome	NN	O	syndrome	dobj	45	SENT_152	[p12l1269t1129r1599b1207],
49	,	,	O	,	_	0	SENT_152	[p12l1269t1129r1599b1207],
50	with	IN	O	with	_	0	SENT_152	[p12l1642t1129r1784b1188],
51	its	PRP$	O	its	poss	55	SENT_152	[p12l1826t1131r1896b1188],
52	consequent	JJ	O	consequent	amod	55	SENT_152	[p12l1940t1150r2140b1188, p12l10t1250r191b1316],
53	high	JJ	O	high	amod	55	SENT_152	[p12l216t1238r356b1317],
54	mortality	NN	O	mortality	nn	55	SENT_152	[p12l382t1238r677b1317],
55	risk	NN	O	risk	prep_with	45	SENT_152	[p12l699t1238r827b1298],
56	.	.	O	.	_	0	SENT_152	[p12l699t1238r827b1298],

1	Allopurinol	NN	O	allopurinol	nsubj	2	SENT_153	[p12l854t1238r1224b1316],
2	induced	VBD	O	induce	_	0	SENT_153	[p12l1249t1238r1504b1298],
3	DRESS	NN	O	dress	nn	5	SENT_153	[p12l1529t1242r1753b1298],
4	7	CD	NUMBER	7	num	5	SENT_153	[p12l1781t1225r2003b1268],
5	’	NN	O	’	nsubj	13	SENT_153	[p12l1781t1225r2003b1268],
6	8	CD	NUMBER	8	num	7	SENT_153	[p12l1781t1225r2003b1268],
7	’	NN	O	’	dep	5	SENT_153	[p12l1781t1225r2003b1268],
8	14	CD	NUMBER	14	number	9	SENT_153	[p12l1781t1225r2003b1268],
9	‘	CD	NUMBER	‘	dep	5	SENT_153	[p12l1781t1225r2003b1268],
10	16	CD	NUMBER	16	dep	9	SENT_153	[p12l1781t1225r2003b1268],
11	was	VBD	O	be	cop	13	SENT_153	[p12l2027t1260r2142b1298],
12	quite	RB	O	quite	advmod	13	SENT_153	[p12l10t1342r168b1418],
13	uncommon	JJ	O	uncommon	ccomp	2	SENT_153	[p12l198t1362r573b1400],
14	in	IN	O	in	_	0	SENT_153	[p12l603t1342r665b1399],
15	our	PRP$	O	we	poss	16	SENT_153	[p12l696t1362r806b1400],
16	experience	NN	O	experience	prep_in	13	SENT_153	[p12l836t1342r1168b1418],
17	(	CD	PERCENT	(	number	18	SENT_153	[p12l1203t1340r1404b1412],
18	3.5	CD	PERCENT	3.5	num	19	SENT_153	[p12l1203t1340r1404b1412],
19	%	NN	PERCENT	%	dep	16	SENT_153	[p12l1203t1340r1404b1412],
20	;	:	O	;	_	0	SENT_153	[p12l1203t1340r1404b1412],
21	0.3	CD	NUMBER	0.3	num	22	SENT_153	[p12l1437t1346r1526b1400],
22	cases	NNS	O	case	dep	16	SENT_153	[p12l1559t1362r1711b1400],
23	per	IN	O	per	_	0	SENT_153	[p12l1741t1361r1844b1418],
24	year	NN	DURATION	year	prep_per	22	SENT_153	[p12l1871t1362r2018b1418],
25	,	,	O	,	_	0	SENT_153	[p12l1871t1362r2018b1418],
26	0.5	CD	NUMBER	0.5	num	27	SENT_153	[p12l2051t1346r2140b1400],
27	cases	NNS	O	case	appos	16	SENT_153	[p12l10t1443r203b1500],
28	/	:	O	/	punct	30	SENT_153	[p12l10t1443r203b1500],
29	million	CD	NUMBER	million	num	30	SENT_153	[p12l203t1441r432b1500],
30	inhabitants	NNS	O	inhabitant	dep	27	SENT_153	[p12l469t1441r868b1513],
31	)	RB	O	)	advmod	13	SENT_153	[p12l469t1441r868b1513],
32	,	,	O	,	_	0	SENT_153	[p12l469t1441r868b1513],
33	although	IN	O	although	mark	43	SENT_153	[p12l907t1441r1187b1519],
34	eosinophilia	NN	O	eosinophilia	nsubj	43	SENT_153	[p12l1225t1441r1626b1518],
35	,	,	O	,	_	0	SENT_153	[p12l1225t1441r1626b1518],
36	diffuse	JJ	O	diffuse	amod	37	SENT_153	[p12l1666t1441r1874b1500],
37	lymphadenopathy	NN	O	lymphadenopathy	conj_and	34	SENT_153	[p12l1910t1441r2140b1519, p12l10t1541r383b1620],
38	and	CC	O	and	_	0	SENT_153	[p12l427t1542r545b1601],
39	transitory	JJ	O	transitory	amod	41	SENT_153	[p12l590t1544r901b1620],
40	renal/hepatic	JJ	O	renal/hepatic	amod	41	SENT_153	[p12l945t1541r1368b1619],
41	impairment	NN	O	impairment	conj_and	34	SENT_153	[p12l1416t1544r1792b1619],
42	were	VBD	O	be	cop	43	SENT_153	[p12l1837t1563r1985b1601],
43	frequent	JJ	O	frequent	advcl	13	SENT_153	[p12l2032t1541r2140b1601, p12l10t1655r191b1721],
44	in	IN	O	in	_	0	SENT_153	[p12l230t1645r292b1702],
45	several	JJ	O	several	amod	47	SENT_153	[p12l331t1643r541b1703],
46	other	JJ	O	other	amod	47	SENT_153	[p12l580t1643r748b1703],
47	cases	NNS	O	case	prep_in	43	SENT_153	[p12l786t1665r953b1703],
48	.	.	O	.	_	0	SENT_153	[p12l786t1665r953b1703],

1	Extremely	RB	O	extremely	advmod	2	SENT_154	[p12l996t1643r1317b1721],
2	restricted	JJ	O	restricted	amod	3	SENT_154	[p12l1353t1643r1646b1703],
3	criteria	NNS	O	criterion	nsubjpass	11	SENT_154	[p12l1685t1645r1907b1703],
4	in	IN	O	in	_	0	SENT_154	[p12l1944t1645r2006b1702],
5	the	DT	O	the	det	6	SENT_154	[p12l2044t1643r2142b1703],
6	diagnosis	NN	O	diagnosis	prep_in	3	SENT_154	[p12l10t1744r301b1822],
7	of	IN	O	of	_	0	SENT_154	[p12l338t1744r409b1803],
8	DRESS1446	NN	O	dress1446	prep_of	6	SENT_154	[p12l436t1730r803b1804],
9	have	VBP	O	have	aux	11	SENT_154	[p12l838t1744r983b1804],
10	been	VBN	O	be	auxpass	11	SENT_154	[p12l1017t1744r1166b1804],
11	adopted	VBN	O	adopt	_	0	SENT_154	[p12l1203t1744r1460b1821],
12	at	IN	O	at	_	0	SENT_154	[p12l1496t1756r1552b1804],
13	our	PRP$	O	we	poss	14	SENT_154	[p12l1588t1766r1699b1804],
14	centre	NN	O	centre	prep_at	11	SENT_154	[p12l1735t1756r1942b1804],
15	:	:	O	:	_	0	SENT_154	[p12l1735t1756r1942b1804],
16	especially	RB	O	especially	advmod	17	SENT_154	[p12l1982t1765r2139b1821, p12l10t1845r173b1923],
17	regarding	VBG	O	regard	parataxis	11	SENT_154	[p12l204t1845r506b1923],
18	the	DT	O	the	det	19	SENT_154	[p12l539t1845r637b1905],
19	Worsening	NNP	O	Worsening	nsubj	43	SENT_154	[p12l670t1847r998b1923],
20	of	IN	O	of	_	0	SENT_154	[p12l1033t1845r1104b1905],
21	chronic	JJ	O	chronic	amod	23	SENT_154	[p12l1131t1845r1369b1905],
22	renal	JJ	O	renal	amod	23	SENT_154	[p12l1405t1845r1561b1905],
23	insufﬁciency	NN	O	insufﬁciency	prep_of	19	SENT_154	[p12l1596t1845r2008b1923],
24	,	,	O	,	_	0	SENT_154	[p12l1596t1845r2008b1923],
25	the	DT	O	the	det	26	SENT_154	[p12l2045t1845r2143b1905],
26	assessment	NN	O	assessment	appos	23	SENT_154	[p12l10t1958r352b2005],
27	of	IN	O	of	_	0	SENT_154	[p12l376t1946r447b2005],
28	acute	JJ	O	acute	amod	30	SENT_154	[p12l463t1957r628b2005],
29	renal/hepatic	JJ	O	renal/hepatic	amod	30	SENT_154	[p12l653t1946r1076b2023],
30	impairment	NN	O	impairment	prep_of	26	SENT_154	[p12l1101t1948r1493b2023],
31	,	,	O	,	_	0	SENT_154	[p12l1101t1948r1493b2023],
32	the	DT	O	the	det	35	SENT_154	[p12l1519t1946r1617b2005],
33	skin	NN	O	skin	nn	35	SENT_154	[p12l1643t1946r1772b2005],
34	rash	NN	O	rash	nn	35	SENT_154	[p12l1795t1946r1926b2005],
35	evaluation	NN	O	evaluation	appos	30	SENT_154	[p12l1952t1946r2140b2005, p12l10t2048r187b2115],
36	,	,	O	,	_	0	SENT_154	[p12l1952t1946r2140b2005, p12l10t2048r187b2115],
37	including	VBG	O	include	_	0	SENT_154	[p12l222t2046r521b2125],
38	skin	NN	O	skin	nn	39	SENT_154	[p12l553t2046r682b2106],
39	biopsy	NN	O	biopsy	prep_including	26	SENT_154	[p12l710t2046r922b2125],
40	and	CC	O	and	_	0	SENT_154	[p12l951t2046r1068b2106],
41	time	NN	O	time	prep_including	26	SENT_154	[p12l1098t2048r1241b2106],
42	to	TO	O	to	aux	43	SENT_154	[p12l1271t2058r1334b2106],
43	recover	VB	O	recover	xcomp	17	SENT_154	[p12l1368t2068r1614b2106],
44	.	.	O	.	_	0	SENT_154	[p12l1368t2068r1614b2106],

1	Therefore	RB	O	therefore	advmod	8	SENT_155	[p12l1648t2046r1973b2115],
2	,	,	O	,	_	0	SENT_155	[p12l1648t2046r1973b2115],
3	only	RB	O	only	advmod	5	SENT_155	[p12l2007t2046r2146b2125],
4	deﬁnite	JJ	O	deﬁnite	amod	5	SENT_155	[p12l10t2148r247b2208],
5	cases	NNS	O	case	nsubjpass	8	SENT_155	[p12l274t2170r427b2208],
6	have	VBP	O	have	aux	8	SENT_155	[p12l452t2148r596b2208],
7	been	VBN	O	be	auxpass	8	SENT_155	[p12l620t2148r770b2208],
8	considered	VBN	O	consider	_	0	SENT_155	[p12l797t2148r1138b2208],
9	and	CC	O	and	_	0	SENT_155	[p12l1165t2148r1282b2208],
10	underestimation	NN	O	underestimation	nsubj	12	SENT_155	[p12l1308t2148r1830b2208],
11	is	VBZ	O	be	cop	12	SENT_155	[p12l1856t2150r1902b2208],
12	plausible	JJ	O	plausible	conj_and	8	SENT_155	[p12l1928t2148r2139b2226, p12l7t2249r116b2317],
13	,	,	O	,	_	0	SENT_155	[p12l1928t2148r2139b2226, p12l7t2249r116b2317],
14	but	CC	O	but	_	0	SENT_155	[p12l157t2249r266b2308],
15	our	PRP$	O	we	poss	17	SENT_155	[p12l307t2270r418b2308],
16	experience	NN	O	experience	nn	17	SENT_155	[p12l459t2251r791b2326],
17	highlight	NN	O	highlight	nsubj	34	SENT_155	[p12l832t2249r1115b2327],
18	that	WDT	O	that	dobj	24	SENT_155	[p12l1155t2249r1280b2308],
19	eventual	JJ	O	eventual	amod	22	SENT_155	[p12l1322t2249r1585b2308],
20	possible	JJ	O	possible	amod	22	SENT_155	[p12l1624t2249r1875b2326],
21	DRESS	NN	O	dress	nn	22	SENT_155	[p12l1916t2252r2141b2308],
22	cases	NNS	O	case	nsubj	24	SENT_155	[p12l10t2371r162b2409],
23	do	VBP	O	do	aux	24	SENT_155	[p12l194t2350r273b2409],
24	recover	VB	O	recover	rcmod	17	SENT_155	[p12l306t2371r537b2409],
25	without	IN	O	without	_	0	SENT_155	[p12l564t2349r815b2409],
26	major	JJ	O	major	amod	27	SENT_155	[p12l845t2352r1033b2428],
27	concern	NN	O	concern	prep_without	24	SENT_155	[p12l1064t2371r1331b2418],
28	,	,	O	,	_	0	SENT_155	[p12l1064t2371r1331b2418],
29	when	WRB	O	when	advmod	33	SENT_155	[p12l1361t2349r1534b2409],
30	the	DT	O	the	det	31	SENT_155	[p12l1563t2350r1661b2409],
31	drug	NN	O	drug	nsubj	33	SENT_155	[p12l1692t2350r1841b2428],
32	is	VBZ	O	be	cop	33	SENT_155	[p12l1870t2352r1915b2409],
33	timely	JJ	O	timely	dep	27	SENT_155	[p12l1946t2350r2146b2428],
34	withdrawn	VBN	O	withdraw	conj_and	8	SENT_155	[p12l7t2451r367b2511],
35	.	.	O	.	_	0	SENT_155	[p12l7t2451r367b2511],

1	Medical	JJ	O	medical	amod	3	SENT_156	[p12l406t2451r659b2511],
2	major	JJ	O	major	amod	3	SENT_156	[p12l695t2453r883b2529],
3	concern	NN	O	concern	nsubj	6	SENT_156	[p12l919t2473r1172b2511],
4	is	VBZ	O	be	cop	6	SENT_156	[p12l1208t2453r1254b2511],
5	the	DT	O	the	det	6	SENT_156	[p12l1290t2451r1388b2511],
6	evolution	NN	O	evolution	_	0	SENT_156	[p12l1425t2451r1724b2511],
7	of	IN	O	of	_	0	SENT_156	[p12l1761t2451r1832b2511],
8	unrecognized	JJ	O	unrecognized	prep_of	6	SENT_156	[p12l1859t2473r2140b2529, p12l9t2552r178b2611],
9	and	CC	O	and	_	0	SENT_156	[p12l203t2552r321b2611],
10	undervalued	VBN	O	undervalue	amod	12	SENT_156	[p12l344t2552r740b2611],
11	cutaneous	JJ	O	cutaneous	amod	12	SENT_156	[p12l764t2564r1083b2611],
12	rashes	NNS	O	rash	conj_and	8	SENT_156	[p12l1108t2552r1298b2611],
13	into	IN	O	into	_	0	SENT_156	[p12l1323t2554r1448b2611],
14	DRESS	NN	O	dress	prep_into	12	SENT_156	[p12l1475t2555r1715b2612],
15	.	.	O	.	_	0	SENT_156	[p12l1475t2555r1715b2612],

1	In	IN	O	in	_	0	SENT_157	[p12l1743t2556r1810b2610],
2	our	PRP$	O	we	poss	3	SENT_157	[p12l1835t2573r1946b2611],
3	opinion	NN	O	opinion	prep_in	19	SENT_157	[p12l1970t2554r2140b2629, p12l9t2655r129b2722],
4	,	,	O	,	_	0	SENT_157	[p12l1970t2554r2140b2629, p12l9t2655r129b2722],
5	a	DT	O	a	det	9	SENT_157	[p12l199t2675r231b2713],
6	correct	JJ	O	correct	amod	9	SENT_157	[p12l298t2665r518b2713],
7	intensive	JJ	O	intensive	amod	9	SENT_157	[p12l584t2655r862b2713],
8	surveillance	NN	O	surveillance	nn	9	SENT_157	[p12l930t2653r1297b2713],
9	programme	NN	O	programme	nsubj	19	SENT_157	[p12l1363t2674r1738b2731],
10	in	IN	O	in	_	0	SENT_157	[p12l1805t2655r1869b2712],
11	elderly	JJ	O	elderly	amod	13	SENT_157	[p12l1935t2653r2146b2731],
12	medicated	JJ	O	medicated	amod	13	SENT_157	[p12l9t2754r336b2813],
13	patients	NNS	O	patient	prep_in	9	SENT_157	[p12l360t2756r608b2831],
14	taking	VBG	O	take	partmod	13	SENT_157	[p12l633t2754r831b2832],
15	allopurinol	NN	O	allopurinol	dobj	14	SENT_157	[p12l856t2754r1206b2831],
16	is	VBZ	O	be	cop	19	SENT_157	[p12l1231t2756r1277b2813],
17	the	DT	O	the	det	19	SENT_157	[p12l1302t2754r1400b2813],
18	ﬁnal	JJ	O	ﬁnal	amod	19	SENT_157	[p12l1426t2754r1565b2813],
19	clue	NN	O	clue	_	0	SENT_157	[p12l1591t2754r1715b2813],
20	to	TO	O	to	aux	21	SENT_157	[p12l1740t2766r1803b2813],
21	avoid	VB	O	avoid	infmod	19	SENT_157	[p12l1832t2754r2004b2813],
22	this	DT	O	this	det	23	SENT_157	[p12l2028t2754r2142b2813],
23	risk	NN	O	risk	dobj	21	SENT_157	[p12l10t2854r138b2914],
24	.	.	O	.	_	0	SENT_157	[p12l10t2854r138b2914],

1	Susceptibility	NN	O	susceptibility	nsubjpass	16	SENT_158	[p12l174t2854r596b2932],
2	to	TO	O	to	_	0	SENT_158	[p12l623t2866r686b2914],
3	such	PDT	O	such	predet	6	SENT_158	[p12l721t2854r863b2914],
4	an	DT	O	a	det	6	SENT_158	[p12l896t2876r970b2914],
5	idiosyncratic	JJ	O	idiosyncratic	amod	6	SENT_158	[p12l1001t2854r1404b2933],
6	reaction	NN	O	reaction	prep_to	1	SENT_158	[p12l1436t2856r1707b2923],
7	,	,	O	,	_	0	SENT_158	[p12l1436t2856r1707b2923],
8	as	RB	O	as	_	0	SENT_158	[p12l1741t2876r1800b2914],
9	well	RB	O	well	_	0	SENT_158	[p12l1830t2854r1956b2914],
10	as	IN	O	as	_	0	SENT_158	[p12l1988t2876r2046b2914],
11	to	TO	O	to	_	0	SENT_158	[p12l2078t2866r2140b2914],
12	SIS/T	NNP	O	SIS/T	nn	14	SENT_158	[p12l10t2958r195b3026],
13	EN	NNP	O	EN	nn	14	SENT_158	[p12l197t2961r299b3015],
14	syndrome	NN	O	syndrome	conj_and	6	SENT_158	[p12l332t2956r645b3034],
15	is	VBZ	O	be	auxpass	16	SENT_158	[p12l679t2958r725b3016],
16	thought	VBN	O	think	_	0	SENT_158	[p12l758t2956r1010b3034],
17	to	TO	O	to	aux	20	SENT_158	[p12l1042t2968r1105b3016],
18	be	VB	O	be	auxpass	20	SENT_158	[p12l1137t2956r1211b3016],
19	genetically	RB	O	genetically	advmod	20	SENT_158	[p12l1245t2956r1576b3034],
20	determined	VBN	O	determine	xcomp	16	SENT_158	[p12l1607t2956r1984b3016],
21	.	.	O	.	_	0	SENT_158	[p12l1607t2956r1984b3016],

1	The	DT	O	the	det	2	SENT_159	[p12l2021t2956r2142b3016],
2	polymorphisms	NNS	O	polymorphism	nsubj	16	SENT_159	[p12l8t3057r507b3135],
3	of	IN	O	of	_	0	SENT_159	[p12l561t3057r631b3116],
4	the	DT	O	the	det	5	SENT_159	[p12l673t3057r771b3116],
5	genes	NNS	O	gene	prep_of	2	SENT_159	[p12l824t3078r994b3135],
6	involved	VBN	O	involve	partmod	5	SENT_159	[p12l1046t3057r1316b3116],
7	in	IN	O	in	_	0	SENT_159	[p12l1368t3059r1430b3115],
8	allopurinol	NN	O	allopurinol	prep_in	6	SENT_159	[p12l1483t3057r1848b3134],
9	,	,	O	,	_	0	SENT_159	[p12l1483t3057r1848b3134],
10	and	CC	O	and	_	0	SENT_159	[p12l1903t3057r2021b3116],
11	its	PRP$	O	its	poss	13	SENT_159	[p12l2072t3059r2142b3116],
12	metabolite	NN	O	metabolite	nn	13	SENT_159	[p12l9t3157r344b3217],
13	oxypurinol	NN	O	oxypurinol	conj_and	5	SENT_159	[p12l407t3158r771b3236],
14	,	,	O	,	_	0	SENT_159	[p12l407t3158r771b3236],
15	detoxiﬁcation	NN	O	detoxiﬁcation	appos	13	SENT_159	[p12l836t3157r1273b3217],
16	are	VBP	O	be	_	0	SENT_159	[p12l1335t3179r1427b3217],
17	under	IN	O	under	_	0	SENT_159	[p12l1490t3157r1679b3217],
18	investigation	NN	O	investigation	prep_under	16	SENT_159	[p12l1740t3160r2143b3236],
19	world-wide	JJ	O	world-wide	advmod	16	SENT_159	[p12l7t3259r387b3319],
20	.	.	O	.	_	0	SENT_159	[p12l7t3259r387b3319],

1	The	DT	O	the	det	2	SENT_160	[p12l413t3259r534b3319],
2	role	NN	O	role	_	0	SENT_160	[p12l558t3259r677b3319],
3	of	IN	O	of	_	0	SENT_160	[p12l702t3259r773b3319],
4	HLA	NN	O	hlum	prep_of	2	SENT_160	[p12l787t3262r1194b3319],
5	.	.	O	.	_	0	SENT_160	[p12l787t3262r1194b3319],

1	—	NN	O	—	_	0	SENT_161	[p12l787t3262r1194b3319],
2	.	.	O	.	_	0	SENT_161	[p12l787t3262r1194b3319],

1	B	NN	O	b	nsubj	51	SENT_162	[p12l787t3262r1194b3319],
2	*	CD	NUMBER	*	number	3	SENT_162	[p12l787t3262r1194b3319],
3	5801	CD	NUMBER	5801	num	4	SENT_162	[p12l787t3262r1194b3319],
4	allele	NN	O	allele	nsubj	50	SENT_162	[p12l1224t3259r1379b3319],
5	in	IN	O	in	_	0	SENT_162	[p12l1403t3261r1465b3318],
6	predisposing	VBG	O	predispose	prepc_in	4	SENT_162	[p12l1487t3259r1892b3337],
7	to	TO	O	to	_	0	SENT_162	[p12l1915t3271r1977b3319],
8	allopurinol	NN	O	allopurinol	prep_to	6	SENT_162	[p12l2003t3259r2140b3319, p12l8t3355r245b3432],
9	severe	JJ	O	severe	amod	12	SENT_162	[p12l280t3376r468b3415],
10	cutaneous	JJ	O	cutaneous	amod	12	SENT_162	[p12l504t3367r822b3415],
11	adverse	JJ	O	adverse	amod	12	SENT_162	[p12l858t3355r1090b3415],
12	reactions	NNS	O	reaction	nsubj	17	SENT_162	[p12l1125t3357r1408b3415],
13	is	VBZ	O	be	cop	17	SENT_162	[p12l1443t3357r1489b3415],
14	still	RB	O	still	advmod	17	SENT_162	[p12l1524t3355r1633b3415],
15	a	DT	O	a	det	17	SENT_162	[p12l1668t3377r1700b3415],
16	controversial	JJ	O	controversial	amod	17	SENT_162	[p12l1735t3355r2143b3415],
17	point	NN	O	point	rcmod	8	SENT_162	[p12l8t3458r179b3533],
18	in	IN	O	in	_	0	SENT_162	[p12l204t3458r266b3514],
19	literature	NN	O	literature	prep_in	17	SENT_162	[p12l291t3456r595b3524],
20	,	,	O	,	_	0	SENT_162	[p12l291t3456r595b3524],
21	especially	RB	O	especially	advmod	6	SENT_162	[p12l624t3456r921b3534],
22	in	IN	O	in	_	0	SENT_162	[p12l943t3458r1005b3514],
23	European	JJ	MISC	european	amod	24	SENT_162	[p12l1031t3460r1338b3533],
24	studies	NNS	O	study	prep_in	6	SENT_162	[p12l1365t3443r1738b3515],
25	.21	CD	NUMBER	.21	dobj	6	SENT_162	[p12l1365t3443r1738b3515],
26	"	``	O	"	punct	25	SENT_162	[p12l1365t3443r1738b3515],
27	23	CD	NUMBER	23	dep	25	SENT_162	[p12l1365t3443r1738b3515],
28	Our	PRP$	O	we	poss	29	SENT_162	[p12l1768t3459r1897b3516],
29	experience	NN	O	experience	nsubj	36	SENT_162	[p12l1923t3458r2139b3533, p12l9t3578r149b3616],
30	in	IN	O	in	_	0	SENT_162	[p12l179t3559r241b3615],
31	this	DT	O	this	det	32	SENT_162	[p12l270t3557r383b3616],
32	ﬁeld	NN	O	ﬁeld	prep_in	29	SENT_162	[p12l414t3556r551b3616],
33	is	VBZ	O	be	cop	34	SENT_162	[p12l581t3559r627b3616],
34	recent	JJ	O	recent	rcmod	27	SENT_162	[p12l658t3568r851b3616],
35	and	CC	O	and	_	0	SENT_162	[p12l881t3557r999b3616],
36	preliminary	JJ	O	preliminary	conj_and	34	SENT_162	[p12l1029t3556r1415b3635],
37	,	,	O	,	_	0	SENT_162	[p12l1029t3556r1415b3635],
38	but	CC	O	but	_	0	SENT_162	[p12l1445t3557r1553b3616],
39	HLA	NN	O	hlum	nn	40	SENT_162	[p12l1584t3560r1739b3615],
40	B	NN	O	b	conj_but	34	SENT_162	[p12l1768t3559r1992b3616],
41	*	CD	NUMBER	*	number	42	SENT_162	[p12l1768t3559r1992b3616],
42	5801	CD	NUMBER	5801	dep	40	SENT_162	[p12l1768t3559r1992b3616],
43	was	VBD	O	be	cop	50	SENT_162	[p12l2026t3578r2141b3616],
44	positive	JJ	O	positive	amod	50	SENT_162	[p12l8t3660r252b3736],
45	in	IN	O	in	_	0	SENT_162	[p12l289t3660r352b3717],
46	all	PDT	O	all	predet	49	SENT_162	[p12l387t3658r458b3718],
47	the	DT	O	the	det	49	SENT_162	[p12l493t3658r591b3718],
48	SIS/T	NNP	O	SIS/T	nn	49	SENT_162	[p12l628t3660r813b3728],
49	EN	NN	O	en	prep_in	44	SENT_162	[p12l814t3663r916b3717],
50	patients	NNS	O	patient	rcmod	1	SENT_162	[p12l951t3660r1198b3736],
51	(	VBP	O	(	_	0	SENT_162	[p12l1239t3658r1476b3730],
52	18/18	CD	NUMBER	18/18	number	53	SENT_162	[p12l1239t3658r1476b3730],
53	)	CD	NUMBER	)	dobj	51	SENT_162	[p12l1239t3658r1476b3730],
54	in	IN	O	in	_	0	SENT_162	[p12l1518t3660r1580b3717],
55	whom	WP	O	whom	dobj	59	SENT_162	[p12l1613t3658r1818b3718],
56	the	DT	O	the	det	57	SENT_162	[p12l1852t3658r1950b3718],
57	essay	NN	O	essay	nsubjpass	59	SENT_162	[p12l1987t3680r2146b3736],
58	was	VBD	O	be	auxpass	59	SENT_162	[p13l7t39r122b77],
59	performed	VBN	O	perform	prepc_in	53	SENT_162	[p13l157t18r507b95],
60	.	.	O	.	_	0	SENT_162	[p13l157t18r507b95],

1	The	DT	O	the	det	2	SENT_163	[p13l544t18r665b77],
2	comparison	NN	O	comparison	nsubj	19	SENT_163	[p13l701t20r1076b95],
3	with	IN	O	with	_	0	SENT_163	[p13l1108t18r1250b77],
4	the	DT	O	the	det	6	SENT_163	[p13l1283t18r1381b77],
5	allele	NN	O	allele	nn	6	SENT_163	[p13l1416t18r1571b77],
6	frequency	NN	O	frequency	prep_with	2	SENT_163	[p13l1605t18r1917b96],
7	in	IN	O	in	_	0	SENT_163	[p13l1949t20r2011b76],
8	the	DT	O	the	det	11	SENT_163	[p13l2044t18r2142b77],
9	general	JJ	O	general	amod	11	SENT_163	[p13l9t119r234b197],
10	European	JJ	LOCATION	european	amod	11	SENT_163	[p13l263t123r571b196],
11	population	NN	O	population	prep_in	6	SENT_163	[p13l599t119r966b196],
12	,	,	O	,	_	0	SENT_163	[p13l599t119r966b196],
13	according	VBG	O	accord	_	0	SENT_163	[p13l999t119r1309b197],
14	to	TO	O	to	prepc_according_to	19	SENT_163	[p13l1337t131r1400b178],
15	the	DT	O	the	det	17	SENT_163	[p13l1430t119r1528b178],
16	dbMHC	NN	O	dbmhc	nn	17	SENT_163	[p13l1560t119r1825b179],
17	database	NN	O	database	pobj	19	SENT_163	[p13l1856t119r2140b187],
18	,	,	O	,	_	0	SENT_163	[p13l1856t119r2140b187],
19	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_163	[p13l9t220r337b279],
20	a	DT	O	a	det	22	SENT_163	[p13l367t241r399b279],
21	strong	JJ	O	strong	amod	22	SENT_163	[p13l427t232r627b298],
22	association	NN	O	association	dobj	19	SENT_163	[p13l655t222r1017b288],
23	,	,	O	,	_	0	SENT_163	[p13l655t222r1017b288],
24	similar	JJ	O	similar	amod	22	SENT_163	[p13l1048t220r1264b279],
25	to	TO	O	to	_	0	SENT_163	[p13l1290t232r1353b279],
26	what	WP	O	what	nsubjpass	29	SENT_163	[p13l1381t220r1537b279],
27	has	VBZ	O	have	aux	29	SENT_163	[p13l1564t220r1666b279],
28	been	VBN	O	be	auxpass	29	SENT_163	[p13l1693t220r1843b279],
29	reported	VBN	O	report	prepc_to	24	SENT_163	[p13l1871t220r2144b297],
30	in	IN	O	in	_	0	SENT_163	[p13l9t331r71b388],
31	Han	NNP	LOCATION	Han	nn	33	SENT_163	[p13l101t334r238b389],
32	Chinese	NNP	LOCATION	Chinese	nn	33	SENT_163	[p13l269t329r517b389],
33	patients	NNS	O	patient	prep_in	29	SENT_163	[p13l546t317r870b407],
34	.	.	O	.	_	0	SENT_163	[p13l546t317r870b407],

1	”	NN	O	”	ccomp	20	SENT_164	[p13l546t317r870b407],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_164	[p13l900t329r1321b398],
3	,	,	O	,	_	0	SENT_164	[p13l900t329r1321b398],
4	association	NN	O	association	nsubj	20	SENT_164	[p13l1355t331r1700b389],
5	of	IN	O	of	_	0	SENT_164	[p13l1731t329r1801b389],
6	this	DT	O	this	det	9	SENT_164	[p13l1822t329r1934b389],
7	peculiar	JJ	O	peculiar	amod	9	SENT_164	[p13l1964t350r2139b407, p13l8t431r110b491],
8	HLA	NN	O	hlum	nn	9	SENT_164	[p13l154t435r309b490],
9	allele	NN	O	allele	prep_of	4	SENT_164	[p13l352t431r507b491],
10	with	IN	O	with	_	0	SENT_164	[p13l550t431r691b491],
11	natural	JJ	O	natural	amod	14	SENT_164	[p13l735t431r961b491],
12	killer	NN	O	killer	nn	14	SENT_164	[p13l1004t431r1163b491],
13	cells	NNS	O	cell	nn	14	SENT_164	[p13l1208t431r1335b491],
14	function	NN	O	function	prep_with	9	SENT_164	[p13l1381t431r1649b491],
15	and	CC	O	and	_	0	SENT_164	[p13l1694t431r1811b491],
16	cytotoxic	JJ	O	cytotoxic	amod	18	SENT_164	[p13l1856t433r2143b509],
17	response	NN	O	response	nn	18	SENT_164	[p13l9t553r282b609],
18	2435	NN	DATE	2435	prep_with	9	SENT_164	[p13l309t519r432b561],
19	might	MD	O	might	aux	20	SENT_164	[p13l461t532r649b610],
20	represent	VB	O	represent	_	0	SENT_164	[p13l676t544r967b609],
21	a	DT	O	a	det	23	SENT_164	[p13l994t553r1027b591],
22	missing	VBG	O	miss	amod	23	SENT_164	[p13l1053t534r1294b610],
23	link	NN	O	link	dobj	20	SENT_164	[p13l1320t532r1443b590],
24	to	TO	O	to	_	0	SENT_164	[p13l1467t544r1529b591],
25	the	DT	O	the	det	26	SENT_164	[p13l1558t532r1656b591],
26	understanding	NN	O	understanding	prep_to	20	SENT_164	[p13l1684t532r2143b610],
27	of	IN	O	of	_	0	SENT_164	[p13l9t632r80b692],
28	the	DT	O	the	det	31	SENT_164	[p13l96t633r194b692],
29	complex	NN	O	complex	nn	31	SENT_164	[p13l221t632r492b710],
30	allopurinol	NN	O	allopurinol	nn	31	SENT_164	[p13l516t632r866b710],
31	capacity	NN	O	capacity	prep_of	26	SENT_164	[p13l892t635r1150b711],
32	to	TO	O	to	aux	33	SENT_164	[p13l1172t644r1234b692],
33	induce	VB	O	induce	xcomp	20	SENT_164	[p13l1263t633r1475b692],
34	skin	NN	O	skin	nn	35	SENT_164	[p13l1502t633r1631b692],
35	lesions	NNS	O	lesion	dobj	33	SENT_164	[p13l1655t633r1881b692],
36	.	.	O	.	_	0	SENT_164	[p13l1655t633r1881b692],

1	Experimental	JJ	O	experimental	amod	2	SENT_165	[p13l1910t635r2139b710, p13l9t734r228b794],
2	studies	NNS	O	study	nsubj	4	SENT_165	[p13l251t734r468b794],
3	had	VBD	O	have	aux	4	SENT_165	[p13l490t734r608b794],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_165	[p13l632t734r1069b794],
5	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_165	[p13l1092t734r1416b812],
6	T	NN	O	t	nn	8	SENT_165	[p13l1439t737r1486b793],
7	lymphocyte	NN	O	lymphocyte	nn	8	SENT_165	[p13l1508t734r1879b812],
8	inﬁltration	NN	O	inﬁltration	nsubj	13	SENT_165	[p13l1902t734r2139b794, p13l8t837r136b894],
9	of	IN	O	of	_	0	SENT_165	[p13l170t835r240b894],
10	the	DT	O	the	det	12	SENT_165	[p13l263t835r361b894],
11	affected	VBN	O	affect	amod	12	SENT_165	[p13l395t835r638b894],
12	tissue	NN	O	tissue	prep_of	8	SENT_165	[p13l668t837r843b894],
13	26	CD	NUMBER	26	xcomp	4	SENT_165	[p13l876t821r930b857],
14	and	CC	O	and	_	0	SENT_165	[p13l964t835r1082b894],
15	positive	JJ	O	positive	amod	18	SENT_165	[p13l1113t837r1357b912],
16	interferon	NN	O	interferon	nn	18	SENT_165	[p13l1391t835r1706b894],
17	gamma	NN	O	gamma	nn	18	SENT_165	[p13l1739t856r1975b913],
18	tests	NNS	O	test	nn	22	SENT_165	[p13l2006t847r2141b894],
19	on	IN	O	on	_	0	SENT_165	[p13l9t957r91b996],
20	patients	NNS	O	patient	prep_on	18	SENT_165	[p13l125t936r390b1013],
21	’	JJ	O	’	amod	22	SENT_165	[p13l125t936r390b1013],
22	lymphocytes	NNS	O	lymphocyte	xcomp	4	SENT_165	[p13l427t923r899b1014],
23	.	.	O	.	_	0	SENT_165	[p13l427t923r899b1014],

1	”	NN	O	”	ccomp	11	SENT_166	[p13l427t923r899b1014],
2	Probably	RB	O	probably	advmod	1	SENT_166	[p13l935t936r1233b1014],
3	,	,	O	,	_	0	SENT_166	[p13l935t936r1233b1014],
4	certain	JJ	O	certain	amod	5	SENT_166	[p13l1272t938r1486b996],
5	components	NNS	O	component	nsubjpass	11	SENT_166	[p13l1522t948r1912b1013],
6	of	IN	O	of	_	0	SENT_166	[p13l1949t936r2019b995],
7	the	DT	O	the	det	9	SENT_166	[p13l2044t936r2142b996],
8	immune	JJ	O	immune	amod	9	SENT_166	[p13l9t1039r278b1096],
9	system	NN	O	system	prep_of	5	SENT_166	[p13l306t1049r518b1115],
10	are	VBP	O	be	auxpass	11	SENT_166	[p13l544t1058r638b1096],
11	affected	VBN	O	affect	_	0	SENT_166	[p13l665t1037r907b1096],
12	differently	RB	O	differently	advmod	11	SENT_166	[p13l935t1037r1259b1115],
13	by	IN	O	by	_	0	SENT_166	[p13l1281t1037r1360b1115],
14	allopurinol	NN	O	allopurinol	agent	11	SENT_166	[p13l1384t1037r1749b1114],
15	,	,	O	,	_	0	SENT_166	[p13l1384t1037r1749b1114],
16	with	IN	O	with	_	0	SENT_166	[p13l1776t1037r1918b1096],
17	a	DT	O	a	det	19	SENT_166	[p13l1946t1058r1978b1096],
18	ﬁnal	JJ	O	ﬁnal	amod	19	SENT_166	[p13l2004t1037r2143b1096],
19	disequilibrium	NN	O	disequilibrium	prep_with	11	SENT_166	[p13l9t1137r474b1215],
20	predisposing	VBG	O	predispose	partmod	19	SENT_166	[p13l512t1137r917b1216],
21	to	TO	O	to	_	0	SENT_166	[p13l955t1149r1017b1197],
22	drug	NN	O	drug	nn	23	SENT_166	[p13l1060t1137r1208b1216],
23	reactions	NNS	O	reaction	prep_to	20	SENT_166	[p13l1246t1139r1544b1197],
24	.	.	O	.	_	0	SENT_166	[p13l1246t1139r1544b1197],

1	Recent	JJ	O	recent	amod	2	SENT_167	[p13l1587t1142r1801b1197],
2	investigations	NNS	O	investigation	nsubj	4	SENT_167	[p13l1839t1139r2139b1216, p13l8t1241r163b1299],
3	have	VBP	O	have	aux	4	SENT_167	[p13l190t1239r335b1299],
4	suggested	VBN	O	suggest	_	0	SENT_167	[p13l363t1239r664b1317],
5	that	IN	O	that	complm	8	SENT_167	[p13l690t1239r814b1299],
6	allopurinol	NN	O	allopurinol	nsubj	8	SENT_167	[p13l842t1239r1192b1317],
7	directly	RB	O	directly	advmod	8	SENT_167	[p13l1219t1239r1456b1317],
8	inhibits	VBZ	O	inhibit	ccomp	4	SENT_167	[p13l1480t1239r1717b1299],
9	the	DT	O	the	det	10	SENT_167	[p13l1745t1239r1842b1299],
10	lymphocytes	NNS	O	lymphocyte	dobj	8	SENT_167	[p13l1869t1239r2139b1317, p13l9t1352r159b1418],
11	enzyme	NN	O	enzyme	nn	14	SENT_167	[p13l185t1361r424b1418],
12	purine	NN	O	purine	nn	14	SENT_167	[p13l448t1342r657b1417],
13	nucleoside	NN	O	nucleoside	nn	14	SENT_167	[p13l681t1340r1015b1399],
14	phosphorylase	NN	O	phosphorylase	dep	8	SENT_167	[p13l1039t1340r1494b1418],
15	28	CD	NUMBER	28	dep	14	SENT_167	[p13l1519t1327r1573b1363],
16	and	CC	O	and	_	0	SENT_167	[p13l1599t1340r1717b1399],
17	an	DT	O	a	det	18	SENT_167	[p13l1742t1361r1817b1399],
18	alteration	NN	O	alteration	nsubjpass	25	SENT_167	[p13l1842t1340r2142b1399],
19	of	IN	O	of	_	0	SENT_167	[p13l9t1439r80b1499],
20	CDAV	NN	O	cdav	nn	22	SENT_167	[p13l101t1442r288b1499],
21	CD8	NN	O	cd8	nn	22	SENT_167	[p13l288t1443r431b1499],
22	rate	NN	O	rate	prep_of	18	SENT_167	[p13l464t1451r581b1499],
23	has	VBZ	O	have	aux	25	SENT_167	[p13l610t1440r713b1499],
24	been	VBN	O	be	auxpass	25	SENT_167	[p13l741t1440r890b1499],
25	documented	VBN	O	document	conj_and	8	SENT_167	[p13l921t1439r1318b1499],
26	under	IN	O	under	_	0	SENT_167	[p13l1348t1440r1536b1499],
27	chronic	JJ	O	chronic	amod	28	SENT_167	[p13l1566t1439r1805b1499],
28	treatment	NN	O	treatment	prep_under	25	SENT_167	[p13l1833t1451r2143b1499],
29	with	IN	O	with	_	0	SENT_167	[p13l7t1541r148b1601],
30	allopurinol	NN	O	allopurinol	prep_with	25	SENT_167	[p13l190t1541r555b1619],
31	,	,	O	,	_	0	SENT_167	[p13l190t1541r555b1619],
32	affecting	VBG	O	affect	xcomp	25	SENT_167	[p13l599t1541r867b1619],
33	the	DT	O	the	det	35	SENT_167	[p13l906t1541r1004b1601],
34	CD4	NN	O	cd4	nn	35	SENT_167	[p13l1046t1544r1191b1601],
35	component	NN	O	component	dobj	32	SENT_167	[p13l1234t1553r1612b1619],
36	.	.	O	.	_	0	SENT_167	[p13l1234t1553r1612b1619],

1	An	DT	O	a	det	4	SENT_168	[p13l1654t1545r1749b1600],
2	augmented	JJ	O	augmented	amod	4	SENT_168	[p13l1791t1541r2143b1619],
3	antibody	NN	O	antibody	nn	4	SENT_168	[p13l9t1642r292b1720],
4	response	NN	O	response	_	0	SENT_168	[p13l333t1663r624b1719],
5	,	,	O	,	_	0	SENT_168	[p13l333t1663r624b1719],
6	with	IN	O	with	dep	4	SENT_168	[p13l667t1642r809b1701],
7	IgM	NN	O	igm	nn	8	SENT_168	[p13l854t1646r984b1720],
8	deposits	NNS	O	deposit	pobj	6	SENT_168	[p13l1031t1642r1286b1719],
9	and	CC	O	and	_	0	SENT_168	[p13l1332t1642r1449b1701],
10	circulating	VBG	O	circulate	conj_and	6	SENT_168	[p13l1494t1642r1829b1720],
11	immune	JJ	O	immune	amod	12	SENT_168	[p13l1872t1644r2141b1701],
12	complexes	NNS	O	complex	dobj	10	SENT_168	[p13l9t1751r338b1828],
13	29	CD	NUMBER	29	nsubj	16	SENT_168	[p13l378t1738r432b1774],
14	is	VBZ	O	be	cop	16	SENT_168	[p13l473t1753r518b1811],
15	probably	RB	O	probably	advmod	16	SENT_168	[p13l558t1751r843b1829],
16	secondary	JJ	O	secondary	rcmod	12	SENT_168	[p13l880t1751r1199b1829],
17	to	TO	O	to	_	0	SENT_168	[p13l1235t1763r1297b1811],
18	altered	JJ	O	altered	amod	19	SENT_168	[p13l1340t1751r1552b1811],
19	interactions	NNS	O	interaction	prep_to	16	SENT_168	[p13l1592t1753r1962b1811],
20	with	IN	O	with	_	0	SENT_168	[p13l2001t1751r2143b1811],
21	the	DT	O	the	det	23	SENT_168	[p13l8t1852r106b1911],
22	B	NN	O	b	nn	23	SENT_168	[p13l136t1856r179b1910],
23	cells	NNS	O	cell	prep_with	19	SENT_168	[p13l211t1839r385b1911],
24	.7	CD	NUMBER	.7	tmod	10	SENT_168	[p13l211t1839r385b1911],
25	The	DT	O	the	det	27	SENT_168	[p13l415t1852r536b1911],
26	allopurinol	NN	O	allopurinol	nn	27	SENT_168	[p13l567t1852r917b1929],
27	metabolite	NN	O	metabolite	dep	24	SENT_168	[p13l946t1852r1297b1920],
28	,	,	O	,	_	0	SENT_168	[p13l946t1852r1297b1920],
29	oxypurinol	NN	O	oxypurinol	nsubj	30	SENT_168	[p13l1329t1852r1678b1930],
30	has	VBZ	O	have	dep	4	SENT_168	[p13l1707t1852r1809b1911],
31	a	DT	O	a	det	33	SENT_168	[p13l1840t1873r1873b1911],
32	marked	JJ	O	marked	amod	33	SENT_168	[p13l1902t1852r2142b1911],
33	ability	NN	O	ability	dobj	30	SENT_168	[p13l9t1952r206b2031],
34	to	TO	O	to	aux	35	SENT_168	[p13l285t1964r347b2012],
35	stimulate	VB	O	stimulate	infmod	33	SENT_168	[p13l434t1952r724b2012],
36	lymphocytes	NNS	O	lymphocyte	dobj	35	SENT_168	[p13l807t1952r1204b2031],
37	compared	VBN	O	compare	_	0	SENT_168	[p13l1290t1952r1608b2030],
38	with	IN	O	with	prepc_compared_with	35	SENT_168	[p13l1689t1952r1831b2012],
39	control	NN	O	control	nn	40	SENT_168	[p13l1916t1952r2143b2012],
40	groups	NNS	O	group	pobj	35	SENT_168	[p13l9t2049r477b2140],
41	.7	CD	NUMBER	.7	number	42	SENT_168	[p13l9t2049r477b2140],
42	’	CD	NUMBER	’	dep	40	SENT_168	[p13l9t2049r477b2140],
43	10	CD	NUMBER	10	num	44	SENT_168	[p13l9t2049r477b2140],
44	’	NN	O	’	dep	42	SENT_168	[p13l9t2049r477b2140],
45	30	CD	NUMBER	30	number	46	SENT_168	[p13l9t2049r477b2140],
46	’31	CD	NUMBER	’31	num	49	SENT_168	[p13l9t2049r477b2140],
47	The	DT	O	the	det	49	SENT_168	[p13l507t2062r629b2122],
48	concomitant	JJ	O	concomitant	amod	49	SENT_168	[p13l656t2064r1058b2122],
49	release	NN	O	release	dep	42	SENT_168	[p13l1085t2062r1290b2122],
50	of	IN	O	of	_	0	SENT_168	[p13l1318t2062r1389b2122],
51	several	JJ	O	several	amod	52	SENT_168	[p13l1407t2062r1617b2122],
52	mediators	NNS	O	mediator	prep_of	49	SENT_168	[p13l1643t2062r1958b2122],
53	from	IN	O	from	_	0	SENT_168	[p13l1986t2062r2142b2122],
54	eosinophils	NNS	O	eosinophil	prep_from	52	SENT_168	[p13l9t2163r365b2240],
55	and	CC	O	and	_	0	SENT_168	[p13l399t2163r557b2222],
56	/	:	O	/	punct	57	SENT_168	[p13l399t2163r557b2222],
57	or	CC	O	or	dep	63	SENT_168	[p13l557t2184r626b2222],
58	activation	NN	O	activation	dep	57	SENT_168	[p13l659t2165r969b2222],
59	of	IN	O	of	dep	57	SENT_168	[p13l1003t2163r1073b2222],
60	neutrophils	NNS	O	neutrophil	pobj	59	SENT_168	[p13l1097t2163r1459b2240],
61	might	MD	O	might	aux	63	SENT_168	[p13l1494t2163r1682b2241],
62	be	VB	O	be	cop	63	SENT_168	[p13l1713t2163r1786b2222],
63	important	JJ	O	important	dep	4	SENT_168	[p13l1820t2165r2142b2240],
64	for	IN	O	for	_	0	SENT_168	[p13l9t2263r100b2323],
65	the	DT	O	the	det	67	SENT_168	[p13l125t2264r223b2323],
66	clinical	JJ	O	clinical	amod	67	SENT_168	[p13l252t2264r473b2323],
67	evolution	NN	O	evolution	prep_for	63	SENT_168	[p13l500t2264r799b2323],
68	of	IN	O	of	_	0	SENT_168	[p13l827t2263r898b2323],
69	lesions	NNS	O	lesion	prep_of	67	SENT_168	[p13l914t2263r1142b2332],
70	,	,	O	,	_	0	SENT_168	[p13l914t2263r1142b2332],
71	with	IN	O	with	_	0	SENT_168	[p13l1169t2264r1311b2323],
72	appearance	NN	O	appearance	prep_with	4	SENT_168	[p13l1339t2285r1694b2341],
73	of	IN	O	of	_	0	SENT_168	[p13l1722t2263r1792b2323],
74	pustules	NNS	O	pustule	prep_of	72	SENT_168	[p13l1809t2251r2141b2341],
75	,28	CD	NUMBER	,28	num	74	SENT_168	[p13l1809t2251r2141b2341],
76	or	CC	O	or	_	0	SENT_168	[p13l9t2387r77b2425],
77	aggravation	NN	O	aggravation	conj_or	74	SENT_168	[p13l127t2367r494b2443],
78	of	IN	O	of	_	0	SENT_168	[p13l544t2365r615b2425],
79	skin	NN	O	skin	nn	80	SENT_168	[p13l656t2365r784b2425],
80	detachment	NN	O	detachment	prep_of	77	SENT_168	[p13l834t2365r1222b2434],
81	,	,	O	,	_	0	SENT_168	[p13l834t2365r1222b2434],
82	as	RB	O	as	_	0	SENT_168	[p13l1275t2387r1334b2425],
83	well	RB	O	well	_	0	SENT_168	[p13l1382t2365r1508b2425],
84	as	IN	O	as	_	0	SENT_168	[p13l1558t2387r1616b2425],
85	internal	JJ	O	internal	amod	87	SENT_168	[p13l1667t2365r1911b2425],
86	organ	NN	O	organ	nn	87	SENT_168	[p13l1961t2387r2142b2443],
87	involvement	NN	O	involvement	prep_with	4	SENT_168	[p13l9t2475r403b2534],
88	in	IN	O	in	_	0	SENT_168	[p13l426t2477r488b2533],
89	DRESS	NN	O	dress	prep_in	87	SENT_168	[p13l512t2462r784b2534],
90	.7	CD	NUMBER	.7	num	89	SENT_168	[p13l512t2462r784b2534],

1	Considering	VBG	O	consider	_	0	SENT_169	[p13l91t2576r478b2654],
2	the	DT	O	the	det	3	SENT_169	[p13l521t2576r619b2636],
3	spectrum	NN	O	spectrum	prep_considering	18	SENT_169	[p13l665t2588r959b2654],
4	of	IN	O	of	_	0	SENT_169	[p13l1005t2576r1075b2636],
5	clinical	JJ	O	clinical	amod	6	SENT_169	[p13l1112t2576r1333b2636],
6	manifestations	NNS	O	manifestation	prep_of	3	SENT_169	[p13l1377t2576r1837b2636],
7	and	CC	O	and	_	0	SENT_169	[p13l1883t2576r2000b2636],
8	the	DT	O	the	det	9	SENT_169	[p13l2044t2576r2142b2636],
9	severity	NN	O	severity	conj_and	3	SENT_169	[p13l9t2679r249b2755],
10	of	IN	O	of	_	0	SENT_169	[p13l278t2677r348b2736],
11	the	DT	O	the	det	13	SENT_169	[p13l370t2677r468b2736],
12	skin	NN	O	skin	nn	13	SENT_169	[p13l500t2677r628b2736],
13	involvement	NN	O	involvement	prep_of	9	SENT_169	[p13l659t2677r1069b2745],
14	,	,	O	,	_	0	SENT_169	[p13l659t2677r1069b2745],
15	our	PRP$	O	we	poss	16	SENT_169	[p13l1103t2698r1214b2736],
16	survey	NN	O	survey	nsubjpass	18	SENT_169	[p13l1245t2698r1449b2755],
17	is	VBZ	O	be	auxpass	18	SENT_169	[p13l1477t2679r1523b2736],
18	characterized	VBN	O	characterize	_	0	SENT_169	[p13l1556t2677r1972b2736],
19	by	IN	O	by	_	0	SENT_169	[p13l2002t2677r2081b2755],
20	a	DT	O	a	det	22	SENT_169	[p13l2110t2698r2143b2736],
21	high	JJ	O	high	amod	22	SENT_169	[p13l8t2777r148b2856],
22	incidence	NN	O	incidence	agent	18	SENT_169	[p13l187t2777r485b2837],
23	of	IN	O	of	_	0	SENT_169	[p13l524t2777r595b2837],
24	severe	JJ	O	severe	amod	25	SENT_169	[p13l624t2799r812b2837],
25	reactions	NNS	O	reaction	prep_of	22	SENT_169	[p13l850t2779r1150b2846],
26	,	,	O	,	_	0	SENT_169	[p13l850t2779r1150b2846],
27	requiring	VBG	O	require	xcomp	18	SENT_169	[p13l1190t2779r1484b2856],
28	hospitalization	NN	O	hospitalization	nn	31	SENT_169	[p13l1519t2777r1987b2855],
29	and	CC	O	and	_	0	SENT_169	[p13l2025t2777r2143b2837],
30	close	JJ	O	close	conj_and	28	SENT_169	[p13l9t2879r161b2939],
31	monitoring	NN	O	monitoring	dobj	27	SENT_169	[p13l193t2881r558b2957],
32	for	IN	O	for	_	0	SENT_169	[p13l588t2879r679b2939],
33	eventual	JJ	O	eventual	amod	34	SENT_169	[p13l711t2879r975b2939],
34	progression	NN	O	progression	prep_for	31	SENT_169	[p13l1006t2881r1375b2957],
35	towards	IN	O	towards	_	0	SENT_169	[p13l1406t2879r1656b2939],
36	SIS/T	NNP	O	SIS/T	nn	38	SENT_169	[p13l1690t2881r1874b2949],
37	EN	NNP	O	EN	nn	38	SENT_169	[p13l1876t2884r1978b2938],
38	syndrome	NN	O	syndrome	prep_towards	34	SENT_169	[p13l2010t2901r2139b2957, p13l9t2980r232b3039],
39	.	.	O	.	_	0	SENT_169	[p13l2010t2901r2139b2957, p13l9t2980r232b3039],

1	A	DT	O	a	det	3	SENT_170	[p13l262t2983r316b3038],
2	certain	JJ	O	certain	amod	3	SENT_170	[p13l345t2982r559b3039],
3	selection	NN	O	selection	nsubj	8	SENT_170	[p13l589t2980r861b3039],
4	of	IN	O	of	_	0	SENT_170	[p13l891t2980r961b3039],
5	cases	NNS	O	case	prep_of	3	SENT_170	[p13l983t3001r1134b3039],
6	might	MD	O	might	aux	8	SENT_170	[p13l1165t2980r1353b3058],
7	have	VB	O	have	aux	8	SENT_170	[p13l1381t2980r1525b3039],
8	affected	VBN	O	affect	_	0	SENT_170	[p13l1556t2980r1798b3039],
9	the	DT	O	the	det	10	SENT_170	[p13l1825t2980r1924b3039],
10	study	NN	O	study	dobj	8	SENT_170	[p13l1954t2980r2140b3058],
11	,	,	O	,	_	0	SENT_170	[p13l1954t2980r2140b3058],
12	as	IN	O	as	mark	21	SENT_170	[p13l9t3102r68b3140],
13	patients	NNS	O	patient	nsubjpass	21	SENT_170	[p13l101t3083r348b3158],
14	with	IN	O	with	_	0	SENT_170	[p13l380t3080r521b3140],
15	very	RB	O	very	advmod	16	SENT_170	[p13l552t3102r688b3159],
16	mild	JJ	O	mild	amod	17	SENT_170	[p13l718t3081r865b3140],
17	reactions	NNS	O	reaction	prep_with	13	SENT_170	[p13l898t3083r1181b3140],
18	are	VBP	O	be	auxpass	21	SENT_170	[p13l1215t3102r1308b3140],
19	not	RB	O	not	neg	21	SENT_170	[p13l1341t3092r1449b3140],
20	normally	RB	O	normally	advmod	21	SENT_170	[p13l1481t3081r1770b3159],
21	referred	VBN	O	refer	advcl	8	SENT_170	[p13l1800t3080r2046b3140],
22	to	TO	O	to	_	0	SENT_170	[p13l2078t3092r2141b3140],
23	our	PRP$	O	we	poss	25	SENT_170	[p13l9t3204r120b3242],
24	specialized	VBN	O	specialize	amod	25	SENT_170	[p13l143t3182r479b3260],
25	centre	NN	O	centre	prep_to	21	SENT_170	[p13l503t3194r710b3251],
26	,	,	O	,	_	0	SENT_170	[p13l503t3194r710b3251],
27	being	VBG	O	be	auxpass	28	SENT_170	[p13l734t3182r909b3260],
28	cared	VBN	O	care	partmod	25	SENT_170	[p13l931t3182r1100b3242],
29	after	IN	O	after	prep	28	SENT_170	[p13l1123t3182r1264b3242],
30	by	IN	O	by	pcomp	29	SENT_170	[p13l1284t3182r1364b3260],
31	the	DT	O	the	det	33	SENT_170	[p13l1383t3182r1481b3242],
32	general	JJ	O	general	amod	33	SENT_170	[p13l1505t3182r1730b3260],
33	practitioner	NN	O	practitioner	pobj	30	SENT_170	[p13l1752t3184r2139b3260],
34	.	.	O	.	_	0	SENT_170	[p13l1752t3184r2139b3260],

1	The	DT	O	the	det	2	SENT_171	[p13l8t3283r130b3342],
2	incidence	NN	O	incidence	nsubj	8	SENT_171	[p13l161t3283r459b3342],
3	of	IN	O	of	_	0	SENT_171	[p13l491t3283r561b3342],
4	severe	JJ	O	severe	amod	5	SENT_171	[p13l583t3304r770b3342],
5	manifestations	NNS	O	manifestation	prep_of	2	SENT_171	[p13l802t3283r1262b3342],
6	is	VBZ	O	be	cop	8	SENT_171	[p13l1293t3285r1339b3342],
7	probably	RB	O	probably	advmod	8	SENT_171	[p13l1370t3283r1654b3361],
8	low	JJ	O	low	_	0	SENT_171	[p13l1680t3283r1797b3342],
9	compared	VBN	O	compare	_	0	SENT_171	[p13l1825t3283r2144b3360],
10	with	IN	O	with	prepc_compared_with	8	SENT_171	[p13l7t3384r148b3444],
11	the	DT	O	the	det	12	SENT_171	[p13l171t3384r268b3444],
12	millions	NNS	O	million	pobj	8	SENT_171	[p13l292t3384r547b3444],
13	of	IN	O	of	_	0	SENT_171	[p13l572t3384r643b3444],
14	persons	NNS	O	person	prep_of	12	SENT_171	[p13l655t3405r897b3462],
15	receiving	VBG	O	receive	partmod	14	SENT_171	[p13l921t3386r1204b3462],
16	the	DT	O	the	det	17	SENT_171	[p13l1225t3384r1323b3444],
17	drug	NN	O	drug	dobj	15	SENT_171	[p13l1347t3384r1510b3462],
18	,	,	O	,	_	0	SENT_171	[p13l1347t3384r1510b3462],
19	but	CC	O	but	_	0	SENT_171	[p13l1533t3384r1641b3444],
20	taking	VBG	O	take	partmod	37	SENT_171	[p13l1663t3384r1860b3462],
21	together	RB	O	together	prt	20	SENT_171	[p13l1881t3384r2144b3462],
22	our	PRP$	O	we	poss	23	SENT_171	[p13l9t3506r120b3544],
23	results	NNS	O	result	dobj	20	SENT_171	[p13l155t3485r355b3544],
24	with	IN	O	with	_	0	SENT_171	[p13l389t3485r531b3544],
25	prior	JJ	O	prior	amod	26	SENT_171	[p13l565t3487r726b3562],
26	studies	NNS	O	study	prep_with	20	SENT_171	[p13l761t3485r993b3553],
27	,	,	O	,	_	0	SENT_171	[p13l761t3485r993b3553],
28	the	DT	O	the	det	29	SENT_171	[p13l1030t3485r1128b3544],
29	use	NN	O	use	nsubjpass	37	SENT_171	[p13l1164t3506r1265b3544],
30	of	IN	O	of	_	0	SENT_171	[p13l1302t3485r1372b3544],
31	allopurinol	NN	O	allopurinol	prep_of	29	SENT_171	[p13l1399t3485r1749b3562],
32	for	IN	O	for	_	0	SENT_171	[p13l1783t3485r1875b3544],
33	asymptomatic	JJ	O	asymptomatic	amod	34	SENT_171	[p13l1910t3506r2138b3563, p13l8t3596r252b3654],
34	hyper-uricemia	NN	O	hyper-uricemia	prep_for	31	SENT_171	[p13l283t3594r771b3673],
35	should	MD	O	should	aux	37	SENT_171	[p13l804t3594r1017b3654],
36	be	VB	O	be	auxpass	37	SENT_171	[p13l1047t3594r1120b3654],
37	avoided	VBN	O	avoid	conj_but	8	SENT_171	[p13l1154t3582r1532b3654],
38	.7	CD	NUMBER	.7	number	39	SENT_171	[p13l1154t3582r1532b3654],
39	_	CD	NUMBER	_	num	40	SENT_171	[p13l1154t3582r1532b3654],
40	12	CD	NUMBER	12	dobj	37	SENT_171	[p13l1154t3582r1532b3654],
41	Our	PRP$	O	we	poss	42	SENT_171	[p13l1568t3598r1697b3654],
42	experience	NN	O	experience	nsubj	44	SENT_171	[p13l1730t3596r2064b3672],
43	is	VBZ	O	be	cop	44	SENT_171	[p13l2096t3596r2142b3654],
44	emblematic	JJ	O	emblematic	rcmod	40	SENT_171	[p13l9t3696r377b3756],
45	of	IN	O	of	_	0	SENT_171	[p13l415t3696r485b3756],
46	the	DT	O	the	det	48	SENT_171	[p13l511t3696r609b3756],
47	incongruous	JJ	O	incongruous	amod	48	SENT_171	[p13l647t3698r1045b3774],
48	prescription	NN	O	prescription	prep_of	40	SENT_171	[p13l1081t3698r1466b3774],
49	of	IN	O	of	_	0	SENT_171	[p13l1503t3696r1573b3756],
50	allopurinol	NN	O	allopurinol	prep_of	48	SENT_171	[p13l1601t3696r1966b3774],
51	:	:	O	:	_	0	SENT_171	[p13l1601t3696r1966b3774],
52	only	RB	O	only	advmod	54	SENT_171	[p13l2007t3696r2146b3774],
53	four	CD	NUMBER	four	num	54	SENT_171	[p14l9t18r143b77],
54	patients	NNS	O	patient	nsubj	55	SENT_171	[p14l170t20r417b95],
55	had	VBD	O	have	parataxis	8	SENT_171	[p14l446t18r564b77],
56	primary	JJ	O	primary	amod	57	SENT_171	[p14l591t20r849b96],
57	indications	NNS	O	indication	dobj	55	SENT_171	[p14l875t18r1222b77],
58	for	IN	O	for	_	0	SENT_171	[p14l1252t18r1344b77],
59	the	DT	O	the	det	60	SENT_171	[p14l1371t18r1469b77],
60	treatment	NN	O	treatment	prep_for	57	SENT_171	[p14l1496t30r1821b77],
61	.	.	O	.	_	0	SENT_171	[p14l1496t30r1821b77],

1	A	DT	O	a	det	3	SENT_172	[p14l1850t21r1904b76],
2	careful	JJ	O	careful	amod	3	SENT_172	[p14l1932t18r2143b77],
3	evaluation	NN	O	evaluation	nsubjpass	10	SENT_172	[p14l9t119r336b178],
4	of	IN	O	of	_	0	SENT_172	[p14l366t118r437b178],
5	the	DT	O	the	det	7	SENT_172	[p14l455t119r553b178],
6	ADR	NN	O	adr	nn	7	SENT_172	[p14l580t122r743b178],
7	risk	NN	O	risk	prep_of	3	SENT_172	[p14l770t118r886b178],
8	should	MD	O	should	aux	10	SENT_172	[p14l914t118r1127b178],
9	be	VB	O	be	auxpass	10	SENT_172	[p14l1154t118r1227b178],
10	performed	VBN	O	perform	_	0	SENT_172	[p14l1256t118r1592b196],
11	in	IN	O	in	_	0	SENT_172	[p14l1620t121r1682b177],
12	every	DT	O	every	det	13	SENT_172	[p14l1712t140r1878b197],
13	patient	NN	O	patient	prep_in	10	SENT_172	[p14l1903t121r2139b196],
14	:	:	O	:	_	0	SENT_172	[p14l1903t121r2139b196],
15	advanced	JJ	O	advanced	amod	16	SENT_172	[p14l9t220r305b280],
16	age	NN	O	age	dep	13	SENT_172	[p14l359t242r459b298],
17	and	CC	O	and	_	0	SENT_172	[p14l513t220r631b280],
18	number	NN	O	number	conj_and	16	SENT_172	[p14l683t220r936b280],
19	of	IN	O	of	_	0	SENT_172	[p14l989t220r1060b280],
20	medications	NNS	O	medication	prep_of	16	SENT_172	[p14l1103t220r1486b280],
21	(	RB	O	(	advmod	22	SENT_172	[p14l1544t220r1736b292],
22	more	RBR	O	more	amod	20	SENT_172	[p14l1544t220r1736b292],
23	than	IN	O	than	_	0	SENT_172	[p14l1788t220r1931b280],
24	three	CD	NUMBER	three	num	25	SENT_172	[p14l1984t220r2142b280],
25	drugs	NNS	O	drug	prep_than	20	SENT_172	[p14l9t321r230b399],
26	)	RB	O	)	advmod	25	SENT_172	[p14l9t321r230b399],
27	,	,	O	,	_	0	SENT_172	[p14l9t321r230b399],
28	including	VBG	O	include	_	0	SENT_172	[p14l257t321r557b399],
29	thiazide	JJ	O	thiazide	amod	30	SENT_172	[p14l579t321r827b380],
30	diuretics	NNS	O	diuretic	prep_including	20	SENT_172	[p14l853t321r1139b389],
31	,	,	O	,	_	0	SENT_172	[p14l853t321r1139b389],
32	which	WDT	O	which	nsubjpass	35	SENT_172	[p14l1164t321r1357b380],
33	have	VBP	O	have	aux	35	SENT_172	[p14l1380t321r1524b380],
34	been	VBN	O	be	auxpass	35	SENT_172	[p14l1547t321r1697b380],
35	implicated	VBN	O	implicate	rcmod	30	SENT_172	[p14l1722t321r2056b398],
36	in	IN	O	in	_	0	SENT_172	[p14l2080t323r2142b379],
37	a	DT	O	a	det	38	SENT_172	[p14l9t452r42b490],
38	reduction	NN	O	reduction	prep_in	35	SENT_172	[p14l66t430r373b490],
39	of	IN	O	of	_	0	SENT_172	[p14l399t430r469b490],
40	allopurinol	NN	O	allopurinol	nn	41	SENT_172	[p14l486t430r835b508],
41	elimination	NN	O	elimination	prep_of	38	SENT_172	[p14l860t417r1299b490],
42	.	.	O	.	_	0	SENT_172	[p14l860t417r1299b490],

1	”	NN	O	”	nsubj	19	SENT_173	[p14l860t417r1299b490],
2	Although	IN	O	although	mark	3	SENT_173	[p14l1321t430r1620b508],
3	performed	VBN	O	perform	dep	19	SENT_173	[p14l1644t430r1982b508],
4	only	RB	O	only	advmod	3	SENT_173	[p14l2006t430r2145b508],
5	in	IN	O	in	_	0	SENT_173	[p14l9t533r71b589],
6	a	DT	O	a	det	7	SENT_173	[p14l101t552r133b590],
7	minority	NN	O	minority	prep_in	3	SENT_173	[p14l161t533r443b609],
8	of	IN	O	of	_	0	SENT_173	[p14l469t531r539b590],
9	patients	NNS	O	patient	prep_of	7	SENT_173	[p14l558t533r823b608],
10	,	,	O	,	_	0	SENT_173	[p14l558t533r823b608],
11	dosage	NN	O	dosage	nn	12	SENT_173	[p14l855t531r1066b609],
12	adjustment	NN	O	adjustment	appos	9	SENT_173	[p14l1097t531r1451b609],
13	on	IN	O	on	_	0	SENT_173	[p14l1480t552r1562b590],
14	the	DT	O	the	det	15	SENT_173	[p14l1590t531r1687b590],
15	basis	NN	O	basis	prep_on	12	SENT_173	[p14l1715t531r1866b590],
16	of	IN	O	of	_	0	SENT_173	[p14l1896t531r1967b590],
17	renal	JJ	O	renal	amod	18	SENT_173	[p14l1986t531r2143b590],
18	function9	NN	O	function9	prep_of	15	SENT_173	[p14l9t628r304b700],
19	resulted	VBD	O	result	_	0	SENT_173	[p14l337t640r587b700],
20	ineffective	JJ	O	ineffective	acomp	19	SENT_173	[p14l616t640r935b700],
21	in	IN	O	in	_	0	SENT_173	[p14l966t642r1028b699],
22	preventing	VBG	O	prevent	prepc_in	20	SENT_173	[p14l1058t642r1398b719],
23	ADR	NNP	O	ADR	nn	24	SENT_173	[p14l1426t644r1587b699],
24	occurrence	NN	O	occurrence	dobj	22	SENT_173	[p14l1618t662r1979b700],
25	.	.	O	.	_	0	SENT_173	[p14l1618t662r1979b700],

1	Our	PRP$	O	we	poss	2	SENT_174	[p14l2014t644r2143b700],
2	experience	NN	O	experience	nsubj	3	SENT_174	[p14l9t744r342b820],
3	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_174	[p14l376t742r655b802],
4	the	DT	O	the	det	5	SENT_174	[p14l688t742r786b802],
5	opinion	NN	O	opinion	dobj	3	SENT_174	[p14l820t744r1069b820],
6	of	IN	O	of	_	0	SENT_174	[p14l1103t742r1174b802],
7	several	JJ	O	several	amod	8	SENT_174	[p14l1198t742r1408b802],
8	authors	NNS	O	author	prep_of	5	SENT_174	[p14l1440t742r1678b802],
9	regarding	VBG	O	regard	_	0	SENT_174	[p14l1712t742r2013b820],
10	the	DT	O	the	det	11	SENT_174	[p14l2044t742r2142b802],
11	futility	NN	O	futility	prep_regarding	8	SENT_174	[p14l9t843r220b921],
12	of	IN	O	of	_	0	SENT_174	[p14l242t843r312b902],
13	this	DT	O	this	det	15	SENT_174	[p14l326t843r439b902],
14	preventive	JJ	O	preventive	amod	15	SENT_174	[p14l463t845r791b920],
15	measure	NN	O	measure	prep_of	11	SENT_174	[p14l815t864r1093b902],
16	.	.	O	.	_	0	SENT_174	[p14l815t864r1093b902],

1	Cutaneous	JJ	O	cutaneous	amod	3	SENT_175	[p14l91t947r430b1003],
2	ADR	NN	O	adr	nn	3	SENT_175	[p14l456t947r619b1003],
3	treatment	NN	O	treatment	nsubj	4	SENT_175	[p14l644t955r955b1003],
4	relies	VBZ	O	rely	_	0	SENT_175	[p14l982t944r1141b1003],
5	on	IN	O	on	_	0	SENT_175	[p14l1171t965r1253b1003],
6	prompt	JJ	O	prompt	amod	7	SENT_175	[p14l1280t955r1524b1021],
7	discontinuation	NN	O	discontinuation	prep_on	4	SENT_175	[p14l1552t943r2052b1003],
8	of	IN	O	of	_	0	SENT_175	[p14l2082t943r2152b1003],
9	the	DT	O	the	det	10	SENT_175	[p14l8t1053r106b1113],
10	drug	NN	O	drug	prep_of	7	SENT_175	[p14l138t1053r301b1131],
11	,	,	O	,	_	0	SENT_175	[p14l138t1053r301b1131],
12	and	CC	O	and	_	0	SENT_175	[p14l336t1053r454b1113],
13	supportive	JJ	O	supportive	amod	15	SENT_175	[p14l486t1055r822b1131],
14	care	NN	O	care	nn	15	SENT_175	[p14l854t1040r1183b1113],
15	.2	NN	NUMBER	.2	conj_and	7	SENT_175	[p14l854t1040r1183b1113],
16	’	CD	NUMBER	’	num	17	SENT_175	[p14l854t1040r1183b1113],
17	32	CD	NUMBER	32	dobj	4	SENT_175	[p14l854t1040r1183b1113],
18	"	``	O	"	punct	17	SENT_175	[p14l854t1040r1183b1113],
19	34	CD	NUMBER	34	num	21	SENT_175	[p14l854t1040r1183b1113],
20	DRESS	NN	O	dress	nn	21	SENT_175	[p14l1214t1057r1438b1113],
21	cases	NNS	O	case	nsubj	22	SENT_175	[p14l1473t1075r1624b1113],
22	responded	VBD	O	respond	rcmod	17	SENT_175	[p14l1657t1053r1988b1131],
23	well	RB	O	well	advmod	22	SENT_175	[p14l2017t1053r2143b1113],

1	©	RB	O	©	dep	2	SENT_176	[p14l1617t1298r1659b1340],
2	2011	CD	DATE	2011	dep	4	SENT_176	[p14l1683t1297r1800b1340],
3	The	DT	O	the	det	4	SENT_176	[p14l1831t1296r1925b1340],
4	Authors	NNPS	O	Authors	_	0	SENT_176	[p14l1946t1296r2142b1340],

1	IEADV	NNP	O	IEADV	dep	19	SENT_177	[p14l79t1355r178b1382],
2	2012	CD	DATE	2012	num	1	SENT_177	[p14l185t1358r249b1381],
3	,	,	O	,	_	0	SENT_177	[p14l185t1358r249b1381],
4	26	CD	NUMBER	26	num	1	SENT_177	[p14l260t1358r295b1381],
5	,	,	O	,	_	0	SENT_177	[p14l260t1358r295b1381],
6	1424-1430	CD	DATE	1424-1430	num	7	SENT_177	[p14l309t1358r438b1378],
7	Journal	NNP	O	Journal	appos	1	SENT_177	[p14l558t1358r641b1378],
8	of	IN	O	of	_	0	SENT_177	[p14l652t1358r674b1378],
9	the	DT	O	the	det	11	SENT_177	[p14l682t1358r718b1378],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_177	[p14l729t1358r838b1383],
11	Academy	NN	ORGANIZATION	academy	prep_of	1	SENT_177	[p14l848t1358r958b1383],
12	of	IN	ORGANIZATION	of	_	0	SENT_177	[p14l967t1358r989b1378],
13	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	11	SENT_177	[p14l999t1358r1145b1383],
14	and	CC	O	and	_	0	SENT_177	[p14l1154t1358r1197b1378],
15	Venereology	NNP	O	Venereology	prep_of	11	SENT_177	[p14l1207t1358r1350b1383],
16	©	CD	NUMBER	©	dep	19	SENT_177	[p14l1360t1359r1379b1378],
17	2011	CD	DATE	2011	num	19	SENT_177	[p14l1390t1358r1443b1378],
18	European	JJ	ORGANIZATION	european	amod	19	SENT_177	[p14l1459t1358r1568b1383],
19	Academy	NN	ORGANIZATION	academy	_	0	SENT_177	[p14l1578t1358r1688b1383],
20	of	IN	ORGANIZATION	of	_	0	SENT_177	[p14l1697t1358r1719b1378],
21	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	19	SENT_177	[p14l1729t1358r1875b1383],
22	and	CC	O	and	_	0	SENT_177	[p14l1884t1358r1926b1378],
23	Venereology	NNP	O	Venereology	prep_of	19	SENT_177	[p14l1936t1358r2080b1383],

1	Cutaneous	JJ	O	cutaneous	amod	3	SENT_178	[p14l81t1458r260b1486],
2	adverse	JJ	O	adverse	amod	3	SENT_178	[p14l275t1458r405b1486],
3	reactions	NNS	O	reaction	_	0	SENT_178	[p14l421t1458r571b1486],
4	to	TO	O	to	_	0	SENT_178	[p14l585t1460r617b1486],
5	allopurinol	NN	O	allopurinol	prep_to	3	SENT_178	[p14l631t1458r800b1493],
6	1429	CD	DATE	1429	num	5	SENT_178	[p14l2018t1464r2079b1486],

1	to	TO	O	to	_	0	SENT_179	[p14l8t1697r71b1745],
2	corticosteroids	NNS	O	corticosteroid	prep_to	11	SENT_179	[p14l106t1685r587b1754],
3	,	,	O	,	_	0	SENT_179	[p14l106t1685r587b1754],
4	especially	RB	O	especially	advmod	7	SENT_179	[p14l621t1685r920b1763],
5	the	DT	O	the	det	7	SENT_179	[p14l948t1685r1046b1745],
6	renal	JJ	O	renal	amod	7	SENT_179	[p14l1078t1685r1236b1745],
7	functionality	NN	O	functionality	nsubj	11	SENT_179	[p14l1267t1685r1687b1763],
8	,	,	O	,	_	0	SENT_179	[p14l1267t1685r1687b1763],
9	but	CC	O	but	prep	7	SENT_179	[p14l1719t1685r1828b1745],
10	complete	JJ	O	complete	dep	9	SENT_179	[p14l1859t1685r2149b1763],
11	recover	VB	O	recover	_	0	SENT_179	[p14l9t1807r241b1845],
12	required	VBN	O	require	dep	11	SENT_179	[p14l279t1786r548b1863],
13	a	DT	O	a	det	14	SENT_179	[p14l586t1807r619b1845],
14	period	NN	O	period	dobj	12	SENT_179	[p14l655t1786r863b1863],
15	of	IN	O	of	_	0	SENT_179	[p14l901t1786r972b1845],
16	6-9	CD	NUMBER	6-9	num	17	SENT_179	[p14l1001t1791r1113b1846],
17	weeks	NNS	NUMBER	week	prep_of	14	SENT_179	[p14l1141t1786r1343b1845],
18	.	.	O	.	_	0	SENT_179	[p14l1141t1786r1343b1845],

1	Our	PRP$	O	we	poss	3	SENT_180	[p14l1385t1789r1515b1846],
2	limited	JJ	O	limited	amod	3	SENT_180	[p14l1551t1786r1777b1845],
3	experience	NN	O	experience	nsubj	13	SENT_180	[p14l1816t1788r2149b1863],
4	with	IN	O	with	_	0	SENT_180	[p14l7t1886r149b1946],
5	high	JJ	O	high	amod	7	SENT_180	[p14l173t1886r313b1965],
6	dose	NN	O	dose	nn	7	SENT_180	[p14l339t1886r480b1946],
7	IVIg	NN	O	ivig	prep_with	3	SENT_180	[p14l505t1891r645b1965],
8	in	IN	O	in	_	0	SENT_180	[p14l669t1889r731b1945],
9	SIS/T	NNP	O	SIS/T	nn	11	SENT_180	[p14l756t1889r941b1956],
10	EN	NNP	O	EN	nn	11	SENT_180	[p14l943t1891r1045b1945],
11	syndrome	NN	O	syndrome	prep_in	7	SENT_180	[p14l1070t1887r1385b1965],
12	was	VBD	O	be	cop	13	SENT_180	[p14l1407t1908r1523b1946],
13	encouraging	JJ	O	encouraging	_	0	SENT_180	[p14l1549t1889r1955b1965],
14	:	:	O	:	_	0	SENT_180	[p14l1549t1889r1955b1965],
15	rapid	JJ	O	rapid	amod	16	SENT_180	[p14l1983t1887r2150b1964],
16	improvement	NN	O	improvement	nsubjpass	21	SENT_180	[p14l9t1990r443b2066],
17	and	CC	O	and	_	0	SENT_180	[p14l468t1988r586b2048],
18	full	JJ	O	full	amod	19	SENT_180	[p14l610t1988r712b2048],
19	recovery	NN	O	recovery	conj_and	16	SENT_180	[p14l736t2010r1007b2066],
20	was	VBD	O	be	auxpass	21	SENT_180	[p14l1026t2010r1142b2048],
21	seen	VBN	O	see	parataxis	13	SENT_180	[p14l1168t2010r1302b2048],
22	in	IN	O	in	_	0	SENT_180	[p14l1327t1990r1389b2047],
23	all	PDT	O	all	predet	26	SENT_180	[p14l1414t1988r1485b2048],
24	the	DT	O	the	det	26	SENT_180	[p14l1508t1988r1606b2048],
25	15	CD	NUMBER	15	num	26	SENT_180	[p14l1638t1994r1702b2048],
26	patients	NNS	O	patient	prep_in	21	SENT_180	[p14l1729t1990r1977b2066],
27	treated	VBN	O	treat	partmod	26	SENT_180	[p14l2002t2000r2146b2048, p14l8t2089r123b2157],
28	,	,	O	,	_	0	SENT_180	[p14l2002t2000r2146b2048, p14l8t2089r123b2157],
29	with	IN	O	with	_	0	SENT_180	[p14l155t2089r298b2148],
30	a	DT	O	a	det	32	SENT_180	[p14l331t2110r364b2148],
31	SCORTEN	JJ	MISC	scorten	amod	32	SENT_180	[p14l397t2091r747b2148],
32	index	NN	O	index	prep_with	27	SENT_180	[p14l780t2089r956b2148],
33	of	IN	O	of	_	0	SENT_180	[p14l988t2089r1059b2148],
34	3-4	CD	NUMBER	3-4	prep_of	32	SENT_180	[p14l1084t2094r1212b2157],
35	,	,	O	,	_	0	SENT_180	[p14l1084t2094r1212b2157],
36	and	CC	O	and	_	0	SENT_180	[p14l1248t2089r1366b2148],
37	a	DT	O	a	det	40	SENT_180	[p14l1399t2110r1432b2148],
38	consequent	JJ	O	consequent	amod	40	SENT_180	[p14l1464t2100r1824b2166],
39	mortality	NN	O	mortality	nn	40	SENT_180	[p14l1857t2089r2153b2167],
40	risk	NN	O	risk	prep_with	27	SENT_180	[p14l9t2190r126b2250],
41	of	IN	O	of	_	0	SENT_180	[p14l152t2190r223b2250],
42	30-60	CD	PERCENT	30-60	num	43	SENT_180	[p14l243t2195r503b2252],
43	%	NN	PERCENT	%	prep_of	40	SENT_180	[p14l243t2195r503b2252],
44	.	.	O	.	_	0	SENT_180	[p14l243t2195r503b2252],

1	Given	VBN	O	give	prep	33	SENT_181	[p14l536t2192r722b2250],
2	the	DT	O	the	det	3	SENT_181	[p14l750t2190r849b2250],
3	absence	NN	O	absence	dep	1	SENT_181	[p14l878t2190r1121b2250],
4	of	IN	O	of	_	0	SENT_181	[p14l1150t2190r1220b2250],
5	validated	VBN	O	validate	prepc_of	3	SENT_181	[p14l1237t2190r1526b2250],
6	therapies	NNS	O	therapy	nsubj	17	SENT_181	[p14l1552t2190r1854b2267],
7	,	,	O	,	_	0	SENT_181	[p14l1552t2190r1854b2267],
8	the	DT	O	the	det	9	SENT_181	[p14l1884t2190r1982b2250],
9	proﬁle	NN	O	proﬁle	appos	6	SENT_181	[p14l2010t2211r2146b2267, p14l9t2300r103b2359],
10	of	IN	O	of	_	0	SENT_181	[p14l135t2300r206b2359],
11	IVIg	NN	ORGANIZATION	ivig	prep_of	9	SENT_181	[p14l228t2304r369b2378],
12	in	IN	O	in	_	0	SENT_181	[p14l399t2302r461b2358],
13	an	DT	O	a	det	15	SENT_181	[p14l493t2321r568b2359],
14	hospital	NN	O	hospital	nn	15	SENT_181	[p14l598t2300r851b2377],
15	settings	NNS	O	setting	prep_in	11	SENT_181	[p14l882t2302r1116b2378],
16	is	VBZ	O	be	cop	17	SENT_181	[p14l1148t2302r1194b2359],
17	promising	JJ	O	promising	ccomp	5	SENT_181	[p14l1225t2302r1552b2378],
18	and	CC	O	and	_	0	SENT_181	[p14l1583t2300r1701b2359],
19	effective	JJ	O	effective	prepc_of	3	SENT_181	[p14l1733t2287r2149b2359],
20	.35	CD	NUMBER	.35	dep	19	SENT_181	[p14l1733t2287r2149b2359],
21	"	``	O	"	punct	20	SENT_181	[p14l1733t2287r2149b2359],
22	37	CD	NUMBER	37	dep	20	SENT_181	[p14l1733t2287r2149b2359],
23	Furthermore	RB	O	furthermore	advmod	19	SENT_181	[p14l10t2400r433b2469],
24	,	,	O	,	_	0	SENT_181	[p14l10t2400r433b2469],
25	transfer	NN	O	transfer	nsubj	33	SENT_181	[p14l475t2400r717b2460],
26	to	TO	O	to	_	0	SENT_181	[p14l756t2412r819b2460],
27	the	DT	O	the	det	30	SENT_181	[p14l860t2400r959b2460],
28	intensive	JJ	O	intensive	amod	30	SENT_181	[p14l1000t2402r1280b2460],
29	care	NN	O	care	nn	30	SENT_181	[p14l1322t2422r1448b2460],
30	units	NNS	O	unit	prep_to	25	SENT_181	[p14l1489t2402r1645b2460],
31	was	VBD	O	be	cop	33	SENT_181	[p14l1684t2422r1800b2460],
32	extremely	RB	O	extremely	advmod	33	SENT_181	[p14l1843t2400r2153b2479],
33	ineffective	JJ	O	ineffective	_	0	SENT_181	[p14l9t2502r329b2562],
34	in	IN	O	in	_	0	SENT_181	[p14l355t2504r417b2561],
35	ameliorating	VBG	O	ameliorate	prepc_in	33	SENT_181	[p14l443t2502r844b2580],
36	the	DT	O	the	det	38	SENT_181	[p14l867t2502r965b2562],
37	recovery	NN	O	recovery	nn	38	SENT_181	[p14l991t2524r1261b2580],
38	rate	NN	O	rate	dobj	35	SENT_181	[p14l1283t2514r1401b2562],
39	in	IN	O	in	_	0	SENT_181	[p14l1427t2504r1489b2561],
40	our	PRP$	O	we	poss	41	SENT_181	[p14l1515t2524r1625b2562],
41	experience	NN	O	experience	prep_in	35	SENT_181	[p14l1651t2504r1999b2580],
42	.	.	O	.	_	0	SENT_181	[p14l1651t2504r1999b2580],

1	The	DT	O	the	det	3	SENT_182	[p14l2028t2502r2150b2562],
2	SCORTEN	NNP	MISC	SCORTEN	nn	3	SENT_182	[p14l10t2605r360b2662],
3	index	NN	O	index	nsubj	6	SENT_182	[p14l384t2603r561b2662],
4	was	VBD	O	be	cop	6	SENT_182	[p14l580t2624r696b2662],
5	very	RB	O	very	advmod	6	SENT_182	[p14l719t2624r856b2681],
6	helpful	JJ	O	helpful	_	0	SENT_182	[p14l876t2603r1097b2680],
7	to	TO	O	to	aux	8	SENT_182	[p14l1120t2615r1183b2662],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_182	[p14l1209t2603r1464b2662],
9	prognosis	NN	O	prognosis	dobj	8	SENT_182	[p14l1488t2605r1811b2681],
10	.	.	O	.	_	0	SENT_182	[p14l1488t2605r1811b2681],

1	Conclusion	NN	O	conclusion	nn	2	SENT_183	[p14l10t2817r488b2881],
2	Awareness	NN	O	awareness	nsubj	8	SENT_183	[p14l7t2926r340b2982],
3	of	IN	O	of	_	0	SENT_183	[p14l370t2923r440b2982],
4	iatrogenic	JJ	O	iatrogenic	amod	6	SENT_183	[p14l459t2925r773b3001],
5	skin	NN	O	skin	nn	6	SENT_183	[p14l801t2923r929b2982],
6	reaction	NN	O	reaction	prep_of	2	SENT_183	[p14l958t2925r1215b2982],
7	is	VBZ	O	be	cop	8	SENT_183	[p14l1243t2925r1289b2982],
8	necessary	JJ	O	necessary	_	0	SENT_183	[p14l1318t2944r1614b3001],
9	to	TO	O	to	aux	10	SENT_183	[p14l1638t2935r1701b2982],
10	suspect	VB	O	suspect	xcomp	8	SENT_183	[p14l1732t2935r1961b3000],
11	diagnosis	NN	O	diagnosis	dobj	10	SENT_183	[p14l1989t2923r2146b3001, p14l9t3026r184b3092],
12	,	,	O	,	_	0	SENT_183	[p14l1989t2923r2146b3001, p14l9t3026r184b3092],
13	and	CC	O	and	_	0	SENT_183	[p14l222t3024r339b3083],
14	avoid	VB	O	avoid	xcomp	8	SENT_183	[p14l374t3024r548b3084],
15	any	DT	O	any	det	16	SENT_183	[p14l583t3045r697b3102],
16	delay	NN	O	delay	dobj	14	SENT_183	[p14l729t3024r894b3102],
17	in	IN	O	in	_	0	SENT_183	[p14l926t3026r987b3082],
18	taking	VBG	O	take	prepc_in	14	SENT_183	[p14l1021t3024r1221b3102],
19	the	DT	O	the	det	20	SENT_183	[p14l1252t3024r1350b3083],
20	decision	NN	O	decision	dobj	18	SENT_183	[p14l1386t3024r1646b3083],
21	to	TO	O	to	aux	22	SENT_183	[p14l1679t3036r1742b3083],
22	discontinue	VB	O	discontinue	infmod	20	SENT_183	[p14l1780t3024r2149b3083],
23	the	DT	O	the	det	25	SENT_183	[p14l8t3125r106b3184],
24	responsible	JJ	O	responsible	amod	25	SENT_183	[p14l131t3125r486b3202],
25	drug	NN	O	drug	dobj	22	SENT_183	[p14l511t3125r675b3203],
26	,	,	O	,	_	0	SENT_183	[p14l511t3125r675b3203],
27	which	WDT	O	which	nsubj	32	SENT_183	[p14l699t3125r893b3184],
28	remains	VBZ	O	remain	cop	32	SENT_183	[p14l917t3127r1167b3184],
29	the	DT	O	the	det	32	SENT_183	[p14l1191t3125r1290b3184],
30	main	JJ	O	main	amod	32	SENT_183	[p14l1313t3127r1477b3184],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_183	[p14l1499t3125r1858b3202],
32	option	NN	O	option	rcmod	25	SENT_183	[p14l1883t3127r2109b3202],
33	.	.	O	.	_	0	SENT_183	[p14l1883t3127r2109b3202],

1	Allopurinol	NNP	O	Allopurinol	nsubj	4	SENT_184	[p14l89t3225r459b3303],
2	is	VBZ	O	be	cop	4	SENT_184	[p14l506t3227r552b3285],
3	a	DT	O	a	det	4	SENT_184	[p14l601t3247r634b3285],
4	worldwide	JJ	O	worldwide	_	0	SENT_184	[p14l678t3225r1014b3285],
5	marketed	VBN	O	market	partmod	4	SENT_184	[p14l1061t3225r1361b3285],
6	drug	NN	O	drug	dobj	5	SENT_184	[p14l1408t3225r1571b3304],
7	,	,	O	,	_	0	SENT_184	[p14l1408t3225r1571b3304],
8	economical	JJ	O	economical	amod	4	SENT_184	[p14l1621t3225r1985b3285],
9	and	CC	O	and	_	0	SENT_184	[p14l2032t3225r2150b3285],
10	effective	JJ	O	effective	amod	4	SENT_184	[p14l10t3335r282b3404],
11	,	,	O	,	_	0	SENT_184	[p14l10t3335r282b3404],
12	but	CC	O	but	_	0	SENT_184	[p14l315t3335r423b3395],
13	inappropriate	JJ	O	inappropriate	amod	14	SENT_184	[p14l456t3337r890b3413],
14	prescription	NN	O	prescription	nsubj	18	SENT_184	[p14l922t3337r1307b3413],
15	is	VBZ	O	be	cop	18	SENT_184	[p14l1340t3337r1386b3395],
16	an	DT	O	a	det	18	SENT_184	[p14l1420t3357r1496b3395],
17	increasing	VBG	O	increase	amod	18	SENT_184	[p14l1528t3337r1848b3413],
18	problem	NN	O	problem	conj_but	4	SENT_184	[p14l1879t3335r2149b3413],
19	affecting	VBG	O	affect	partmod	18	SENT_184	[p14l10t3436r278b3514],
20	morbidity	NN	O	morbidity	dobj	19	SENT_184	[p14l305t3436r627b3514],
21	and	CC	O	and	_	0	SENT_184	[p14l652t3436r770b3495],
22	mortality	NN	O	mortality	conj_and	20	SENT_184	[p14l798t3436r1105b3514],
23	.	.	O	.	_	0	SENT_184	[p14l798t3436r1105b3514],

1	Clear	JJ	O	clear	amod	2	SENT_185	[p14l1138t3436r1303b3495],
2	indication	NN	O	indication	nsubjpass	7	SENT_185	[p14l1330t3436r1653b3495],
3	for	IN	O	for	_	0	SENT_185	[p14l1680t3436r1771b3495],
4	allopurinol	NN	O	allopurinol	prep_for	2	SENT_185	[p14l1799t3436r2151b3513],
5	should	MD	O	should	aux	7	SENT_185	[p14l10t3536r224b3596],
6	be	VB	O	be	auxpass	7	SENT_185	[p14l269t3536r343b3596],
7	checked	VBN	O	check	_	0	SENT_185	[p14l392t3537r644b3596],
8	and	CC	O	and	_	0	SENT_185	[p14l692t3537r810b3596],
9	the	DT	O	the	det	10	SENT_185	[p14l857t3537r955b3596],
10	patient	NN	O	patient	nsubj	11	SENT_185	[p14l1002t3539r1224b3614],
11	monitored	VBD	O	monitor	conj_and	7	SENT_185	[p14l1271t3536r1610b3596],
12	closely	RB	O	closely	advmod	11	SENT_185	[p14l1659t3536r1867b3615],
13	for	IN	O	for	_	0	SENT_185	[p14l1912t3536r2004b3596],
14	the	DT	O	the	det	15	SENT_185	[p14l2050t3536r2149b3596],
15	appearance	NN	O	appearance	prep_for	11	SENT_185	[p14l10t3659r366b3716],
16	of	IN	O	of	_	0	SENT_185	[p14l401t3638r471b3698],
17	adverse	JJ	O	adverse	amod	18	SENT_185	[p14l497t3638r730b3698],
18	reactions	NNS	O	reaction	prep_of	15	SENT_185	[p14l765t3640r1064b3698],
19	.	.	O	.	_	0	SENT_185	[p14l765t3640r1064b3698],

1	Severe	JJ	O	severe	amod	3	SENT_186	[p14l1103t3641r1302b3698],
2	skin	NN	O	skin	nn	3	SENT_186	[p14l1337t3638r1465b3698],
3	reactions	NNS	O	reaction	nsubjpass	7	SENT_186	[p14l1500t3640r1783b3698],
4	might	MD	O	might	aux	7	SENT_186	[p14l1818t3638r2007b3716],
5	not	RB	O	not	neg	7	SENT_186	[p14l2042t3650r2149b3698],
6	be	VB	O	be	auxpass	7	SENT_186	[p15l7t18r80b77],
7	prevented	VBN	O	prevent	_	0	SENT_186	[p15l120t18r435b95],
8	by	IN	O	by	_	0	SENT_186	[p15l474t18r554b96],
9	dosage	NN	O	dosage	nn	10	SENT_186	[p15l592t18r803b96],
10	adjustment	NN	O	adjustment	agent	7	SENT_186	[p15l845t18r1201b96],
11	according	VBG	O	accord	_	0	SENT_186	[p15l1242t18r1554b96],
12	to	TO	O	to	prepc_according_to	7	SENT_186	[p15l1593t30r1655b77],
13	the	DT	O	the	det	16	SENT_186	[p15l1697t18r1796b77],
14	creatinine	NN	O	creatinine	nn	16	SENT_186	[p15l1838t20r2149b77],
15	clearance	NN	O	clearance	nn	16	SENT_186	[p15l10t119r298b178],
16	rate	NN	O	rate	pobj	7	SENT_186	[p15l347t131r465b178],
17	and	CC	O	and	_	0	SENT_186	[p15l514t119r632b179],
18	referral	NN	O	referral	nsubjpass	24	SENT_186	[p15l680t119r907b178],
19	to	TO	O	to	_	0	SENT_186	[p15l953t131r1016b178],
20	an	DT	O	a	det	22	SENT_186	[p15l1067t140r1142b178],
21	experienced	JJ	O	experienced	amod	22	SENT_186	[p15l1191t119r1569b196],
22	dermatologist	NN	O	dermatologist	prep_to	18	SENT_186	[p15l1616t119r2054b197],
23	is	VBZ	O	be	auxpass	24	SENT_186	[p15l2102t121r2148b178],
24	recommended	VBN	O	recommend	conj_and	7	SENT_186	[p15l9t220r469b279],
25	to	TO	O	to	aux	26	SENT_186	[p15l492t232r555b279],
26	avoid	VB	O	avoid	xcomp	24	SENT_186	[p15l581t220r756b279],
27	life	NN	O	life	nn	28	SENT_186	[p15l778t220r1265b298],
28	—	NN	O	—	nsubj	29	SENT_186	[p15l778t220r1265b298],
29	threatening	JJ	O	threatening	ccomp	26	SENT_186	[p15l778t220r1265b298],
30	conditions	NNS	O	condition	dobj	29	SENT_186	[p15l1289t220r1639b279],
31	.	.	O	.	_	0	SENT_186	[p15l1289t220r1639b279],

1	Acknowledgement	NN	O	acknowledgement	nsubj	3	SENT_187	[p15l7t435r810b513],
2	We	PRP	O	we	nsubj	3	SENT_187	[p15l7t551r118b606],
3	thank	VBP	O	thank	_	0	SENT_187	[p15l146t547r336b606],
4	Dr	NNP	O	Dr	nn	7	SENT_187	[p15l364t551r452b605],
5	Barry	NNP	PERSON	Barry	nn	7	SENT_187	[p15l480t551r661b625],
6	Mark	NNP	PERSON	Mark	nn	7	SENT_187	[p15l686t547r865b606],
7	Wheaton	NNP	PERSON	Wheaton	dobj	3	SENT_187	[p15l890t547r1194b606],
8	for	IN	O	for	_	0	SENT_187	[p15l1224t547r1318b606],
9	the	DT	O	the	det	11	SENT_187	[p15l1346t547r1447b606],
10	linguistic	JJ	O	linguistic	amod	11	SENT_187	[p15l1475t547r1776b625],
11	assistance	NN	O	assistance	prep_for	7	SENT_187	[p15l1807t549r2139b606],
12	.	.	O	.	_	0	SENT_187	[p15l1807t549r2139b606],

1	References	NNS	O	reference	_	0	SENT_188	[p15l12t762r503b825],

1	1	CD	NUMBER	1	num	3	SENT_189	[p15l46t875r65b920],
2	Hunziker	NN	ORGANIZATION	hunziker	nn	3	SENT_189	[p15l113t870r371b920],
3	T	NN	ORGANIZATION	t	_	0	SENT_189	[p15l396t872r449b928],
4	,	,	O	,	_	0	SENT_189	[p15l396t872r449b928],
5	Kiinzi	NNP	ORGANIZATION	Kiinzi	appos	3	SENT_189	[p15l477t872r640b920],
6	UP	RP	ORGANIZATION	up	dep	5	SENT_189	[p15l666t874r766b928],
7	,	,	O	,	_	0	SENT_189	[p15l666t874r766b928],
8	Braunschweig	NNP	LOCATION	Braunschweig	nn	9	SENT_189	[p15l793t870r1174b936],
9	S	NNP	O	S	appos	3	SENT_189	[p15l1200t873r1228b920],
10	et	FW	O	et	nn	11	SENT_189	[p15l1256t881r1304b920],
11	:11	FW	O	:11	dep	9	SENT_189	[p15l1325t870r1383b920],
12	.	.	O	.	_	0	SENT_189	[p15l1325t870r1383b920],

1	Comprehensive	JJ	O	comprehensive	amod	3	SENT_190	[p15l1415t870r1843b935],
2	hospital	NN	O	hospital	nn	3	SENT_190	[p15l1868t870r2086b935],
3	monitoring	NN	O	monitoring	_	0	SENT_190	[p15l113t957r427b1021],
4	(	CD	NUMBER	(	num	5	SENT_190	[p15l456t955r723b1016],
5	CMDH	NN	O	cmdh	dep	3	SENT_190	[p15l456t955r723b1016],
6	)	CD	NUMBER	)	dep	3	SENT_190	[p15l456t955r723b1016],
7	:	:	O	:	_	0	SENT_190	[p15l456t955r723b1016],
8	adverse	JJ	O	adverse	amod	10	SENT_190	[p15l753t955r953b1005],
9	skin	NN	O	skin	nn	10	SENT_190	[p15l980t955r1090b1005],
10	reactions	NNS	O	reaction	dep	3	SENT_190	[p15l1117t957r1377b1013],
11	,	,	O	,	_	0	SENT_190	[p15l1117t957r1377b1013],
12	a	DT	O	a	det	14	SENT_190	[p15l1405t973r1433b1005],
13	20-year	JJ	DURATION	20-year	amod	14	SENT_190	[p15l1458t960r1660b1021],
14	survey	NN	O	survey	appos	10	SENT_190	[p15l1686t973r1873b1021],
15	.	.	O	.	_	0	SENT_190	[p15l1686t973r1873b1021],

1	Allergy	NNP	O	Allergy	_	0	SENT_191	[p15l1897t955r2087b1021],
2	1997	CD	DATE	1997	num	1	SENT_191	[p15l118t1045r256b1097],
3	;	:	O	;	_	0	SENT_191	[p15l118t1045r256b1097],
4	52	CD	NUMBER	52	num	6	SENT_191	[p15l283t1045r361b1089],
5	:	:	O	:	_	0	SENT_191	[p15l283t1045r361b1089],
6	388-393	CD	NUMBER	388-393	dep	1	SENT_191	[p15l391t1045r632b1090],
7	.	.	O	.	_	0	SENT_191	[p15l391t1045r632b1090],

1	2	CD	NUMBER	2	num	3	SENT_192	[p15l41t1130r69b1174],
2	Wolkenstein	NN	ORGANIZATION	wolkenstein	nn	3	SENT_192	[p15l110t1125r456b1175],
3	P	NN	ORGANIZATION	p	nsubj	9	SENT_192	[p15l483t1129r533b1183],
4	,	,	O	,	_	0	SENT_192	[p15l483t1129r533b1183],
5	Revuz	NNP	O	Revuz	nn	7	SENT_192	[p15l561t1129r726b1175],
6	I.	NNP	O	I.	nn	7	SENT_192	[p15l750t1129r785b1183],
7	Drug	NNP	O	Drug	appos	3	SENT_192	[p15l813t1125r1201b1191],
8	—	NN	O	—	dep	7	SENT_192	[p15l813t1125r1201b1191],
9	induced	VBD	O	induce	_	0	SENT_192	[p15l813t1125r1201b1191],
10	severe	JJ	O	severe	amod	12	SENT_192	[p15l1228t1143r1390b1175],
11	skin	NN	O	skin	nn	12	SENT_192	[p15l1417t1125r1527b1175],
12	reactions	NNS	O	reaction	dobj	9	SENT_192	[p15l1553t1127r1812b1175],
13	.	.	O	.	_	0	SENT_192	[p15l1553t1127r1812b1175],

1	Incidence	NN	O	incidence	_	0	SENT_193	[p15l1842t1125r2119b1183],
2	,	,	O	,	_	0	SENT_193	[p15l1842t1125r2119b1183],

1	management	NN	O	management	_	0	SENT_194	[p15l113t1221r467b1276],
2	and	CC	O	and	_	0	SENT_194	[p15l493t1211r593b1261],
3	prevention	NN	O	prevention	conj_and	1	SENT_194	[p15l618t1213r930b1276],
4	.	.	O	.	_	0	SENT_194	[p15l618t1213r930b1276],

1	Drug	NNP	O	Drug	nn	2	SENT_195	[p15l956t1215r1097b1276],
2	Saf	NNP	O	Saf	_	0	SENT_195	[p15l1119t1211r1212b1276],
3	1995	CD	DATE	1995	num	2	SENT_195	[p15l1231t1216r1368b1268],
4	;	:	O	;	_	0	SENT_195	[p15l1231t1216r1368b1268],
5	13	CD	NUMBER	13	num	7	SENT_195	[p15l1400t1216r1473b1261],
6	:	:	O	:	_	0	SENT_195	[p15l1400t1216r1473b1261],
7	56-68	CD	NUMBER	56-68	dep	2	SENT_195	[p15l1504t1215r1679b1261],
8	.	.	O	.	_	0	SENT_195	[p15l1504t1215r1679b1261],

1	3	CD	NUMBER	3	num	3	SENT_196	[p15l42t1301r68b1346],
2	Lin	NNP	O	Lin	nn	3	SENT_196	[p15l113t1298r202b1345],
3	MS	NN	O	m	_	0	SENT_196	[p15l227t1299r334b1353],
4	,	,	O	,	_	0	SENT_196	[p15l227t1299r334b1353],
5	Dai	NNP	PERSON	Dai	nn	6	SENT_196	[p15l361t1298r457b1346],
6	YS	NNP	O	YS	appos	3	SENT_196	[p15l481t1299r568b1354],
7	,	,	O	,	_	0	SENT_196	[p15l481t1299r568b1354],
8	Pwu	NNP	O	Pwu	nn	9	SENT_196	[p15l596t1300r715b1346],
9	RF	NNP	O	RF	appos	3	SENT_196	[p15l741t1300r815b1346],
10	et	FW	O	et	nn	11	SENT_196	[p15l842t1307r889b1346],
11	al.	FW	O	al.	dep	9	SENT_196	[p15l911t1296r970b1346],
12	.	.	O	.	_	0	SENT_196	[p15l911t1296r970b1346],

1	Risk	NN	O	risk	nn	2	SENT_197	[p15l1000t1296r1118b1346],
2	estimates	NNS	O	estimate	nsubj	5	SENT_197	[p15l1143t1298r1392b1346],
3	for	IN	O	for	_	0	SENT_197	[p15l1419t1296r1497b1346],
4	drugs	NNS	O	drug	prep_for	2	SENT_197	[p15l1523t1296r1673b1361],
5	suspected	VBN	O	suspect	_	0	SENT_197	[p15l1700t1296r1962b1361],
6	of	IN	O	of	_	0	SENT_197	[p15l1988t1296r2048b1346],
7	being	VBG	O	be	auxpass	8	SENT_197	[p15l111t1381r261b1446],
8	associated	VBN	O	associate	prepc_of	5	SENT_197	[p15l287t1381r561b1431],
9	with	IN	O	with	_	0	SENT_197	[p15l585t1381r707b1431],
10	Stevens	NNP	PERSON	Stevens	prep_with	8	SENT_197	[p15l734t1381r1188b1439],
11	.	.	O	.	_	0	SENT_197	[p15l734t1381r1188b1439],

1	—	NN	O	—	_	0	SENT_198	[p15l734t1381r1188b1439],
2	.	.	O	.	_	0	SENT_198	[p15l734t1381r1188b1439],

1	Iohnson	NN	MISC	iohnson	nn	2	SENT_199	[p15l734t1381r1188b1439],
2	syndrome	NN	O	syndrome	_	0	SENT_199	[p15l1215t1381r1484b1446],
3	and	CC	O	and	_	0	SENT_199	[p15l1512t1381r1612b1431],
4	toxic	JJ	O	toxic	amod	6	SENT_199	[p15l1637t1382r1771b1431],
5	epidermal	JJ	O	epidermal	amod	6	SENT_199	[p15l1797t1381r2071b1445],
6	necrolysis	NN	O	necrolysis	conj_and	2	SENT_199	[p15l112t1466r393b1531],
7	:	:	O	:	_	0	SENT_199	[p15l112t1466r393b1531],
8	a	DT	O	a	det	12	SENT_199	[p15l423t1484r450b1516],
9	case	NN	O	case	nn	12	SENT_199	[p15l475t1466r809b1516],
10	—	CD	NUMBER	—	num	12	SENT_199	[p15l475t1466r809b1516],
11	control	NN	O	control	nn	12	SENT_199	[p15l475t1466r809b1516],
12	study	NN	O	study	dep	2	SENT_199	[p15l835t1466r995b1531],
13	.	.	O	.	_	0	SENT_199	[p15l835t1466r995b1531],

1	Intern	NNP	O	Intern	nn	2	SENT_200	[p15l1022t1469r1185b1516],
2	Med	NNP	O	Med	_	0	SENT_200	[p15l1210t1466r1332b1516],
3	I	PRP	O	I	dep	2	SENT_200	[p15l1351t1469r1380b1524],
4	2005	CD	DATE	2005	dep	2	SENT_200	[p15l1401t1470r1544b1523],
5	;	:	O	;	_	0	SENT_200	[p15l1401t1470r1544b1523],
6	35	CD	NUMBER	35	num	8	SENT_200	[p15l1572t1470r1649b1516],
7	:	:	O	:	_	0	SENT_200	[p15l1572t1470r1649b1516],
8	188-190	CD	NUMBER	188-190	dep	2	SENT_200	[p15l1683t1470r1920b1516],
9	.	.	O	.	_	0	SENT_200	[p15l1683t1470r1920b1516],

1	4	CD	NUMBER	4	num	3	SENT_201	[p15l40t1556r70b1600],
2	Halevy	NNP	ORGANIZATION	Halevy	nn	3	SENT_201	[p15l113t1550r303b1616],
3	S	NN	ORGANIZATION	s	_	0	SENT_201	[p15l327t1553r371b1608],
4	,	,	O	,	_	0	SENT_201	[p15l327t1553r371b1608],
5	Ghislain	NNP	PERSON	Ghislain	nn	6	SENT_201	[p15l399t1550r625b1601],
6	PD	NN	PERSON	pd	appos	3	SENT_201	[p15l651t1554r752b1608],
7	,	,	O	,	_	0	SENT_201	[p15l651t1554r752b1608],
8	Mockenhaupt	NNP	O	Mockenhaupt	nn	9	SENT_201	[p15l778t1551r1162b1615],
9	M	NNP	O	M	appos	3	SENT_201	[p15l1187t1554r1246b1600],
10	et	FW	O	et	nn	11	SENT_201	[p15l1273t1561r1321b1600],
11	al.	FW	O	al.	dep	9	SENT_201	[p15l1342t1551r1401b1601],
12	.	.	O	.	_	0	SENT_201	[p15l1342t1551r1401b1601],

1	Allopurinol	NNP	O	Allopurinol	nsubj	6	SENT_202	[p15l1429t1551r1750b1615],
2	is	VBZ	O	be	cop	6	SENT_202	[p15l1776t1552r1815b1601],
3	the	DT	O	the	det	6	SENT_202	[p15l1840t1551r1924b1600],
4	most	RBS	O	most	advmod	5	SENT_202	[p15l1950t1561r2085b1601],
5	common	JJ	O	common	amod	6	SENT_202	[p15l113t1653r359b1685],
6	cause	NN	O	cause	_	0	SENT_202	[p15l386t1654r531b1686],
7	of	IN	O	of	_	0	SENT_202	[p15l558t1635r618b1685],
8	Stevens	NNP	PERSON	Stevens	prep_of	6	SENT_202	[p15l636t1636r1092b1694],
9	—	CD	NUMBER	—	number	10	SENT_202	[p15l636t1636r1092b1694],
10	]	CD	NUMBER	]	num	12	SENT_202	[p15l636t1636r1092b1694],
11	ohnson	NN	O	ohnson	nn	12	SENT_202	[p15l636t1636r1092b1694],
12	syndrome	NN	O	syndrome	dep	8	SENT_202	[p15l1117t1636r1388b1701],
13	and	CC	O	and	_	0	SENT_202	[p15l1415t1636r1515b1686],
14	toxic	JJ	O	toxic	amod	16	SENT_202	[p15l1539t1637r1674b1685],
15	epidermal	JJ	O	epidermal	amod	16	SENT_202	[p15l1700t1635r1974b1700],
16	necrolysis	NN	O	necrolysis	prep_of	6	SENT_202	[p15l1999t1654r2138b1685, p15l113t1720r260b1786],
17	in	IN	O	in	_	0	SENT_202	[p15l286t1722r339b1770],
18	Europe	NNP	LOCATION	Europe	prep_in	16	SENT_202	[p15l365t1724r562b1785],
19	and	CC	O	and	_	0	SENT_202	[p15l589t1720r689b1770],
20	Israel	NNP	LOCATION	Israel	conj_and	18	SENT_202	[p15l715t1720r873b1770],
21	.	.	O	.	_	0	SENT_202	[p15l715t1720r873b1770],

1	IAAD	NNP	O	IAAD	_	0	SENT_203	[p15l897t1723r1057b1778],
2	2008	CD	DATE	2008	num	1	SENT_203	[p15l1083t1725r1226b1778],
3	;	:	O	;	_	0	SENT_203	[p15l1083t1725r1226b1778],
4	58	CD	NUMBER	58	num	6	SENT_203	[p15l1253t1725r1331b1770],
5	:	:	O	:	_	0	SENT_203	[p15l1253t1725r1331b1770],
6	25-32	CD	NUMBER	25-32	dep	1	SENT_203	[p15l1360t1725r1536b1770],
7	.	.	O	.	_	0	SENT_203	[p15l1360t1725r1536b1770],

1	5	CD	NUMBER	5	num	9	SENT_204	[p15l42t1811r69b1855],
2	Russmann	NN	O	russmann	nn	9	SENT_204	[p15l113t1809r399b1855],
3	S	NN	O	s	nn	9	SENT_204	[p15l425t1808r469b1863],
4	,	,	O	,	_	0	SENT_204	[p15l425t1808r469b1863],
5	Lauterburg	NNP	PERSON	Lauterburg	dep	9	SENT_204	[p15l497t1805r802b1871],
6	B.	NNP	O	B.	nn	9	SENT_204	[p15l827t1809r877b1855],
7	Life-threatening	JJ	O	life-threatening	amod	9	SENT_204	[p15l907t1805r1347b1871],
8	adverse	JJ	O	adverse	amod	9	SENT_204	[p15l1373t1805r1574b1855],
9	effects	NNS	O	effect	_	0	SENT_204	[p15l1601t1805r1768b1855],
10	of	IN	O	of	_	0	SENT_204	[p15l1795t1805r1855b1855],
11	pharmacologic	JJ	O	pharmacologic	amod	13	SENT_204	[p15l112t1890r520b1956],
12	antihyperuricemic	JJ	O	antihyperuricemic	amod	13	SENT_204	[p15l546t1890r1048b1955],
13	therapy	NN	O	therapy	prep_of	9	SENT_204	[p15l1073t1890r1293b1955],
14	.	.	O	.	_	0	SENT_204	[p15l1073t1890r1293b1955],

1	Ther	NNP	O	Ther	nn	2	SENT_205	[p15l1326t1890r1448b1940],
2	Umsch	NNP	O	Umsch	_	0	SENT_205	[p15l1477t1890r1652b1940],
3	2004	CD	DATE	2004	num	2	SENT_205	[p15l1678t1895r1821b1948],
4	;	:	O	;	_	0	SENT_205	[p15l1678t1895r1821b1948],
5	61	CD	NUMBER	61	num	7	SENT_205	[p15l1849t1894r1927b1940],
6	:	:	O	:	_	0	SENT_205	[p15l1849t1894r1927b1940],
7	575577	CD	NUMBER	575577	dep	2	SENT_205	[p15l1956t1896r2086b1940, p15l114t1982r222b2026],
8	.	.	O	.	_	0	SENT_205	[p15l1956t1896r2086b1940, p15l114t1982r222b2026],

1	6	CD	NUMBER	6	num	3	SENT_206	[p15l41t2065r70b2110],
2	Mockenhaupt	NN	O	mockenhaupt	nn	3	SENT_206	[p15l112t2060r496b2125],
3	M	NN	O	m	_	0	SENT_206	[p15l521t2064r595b2118],
4	,	,	O	,	_	0	SENT_206	[p15l521t2064r595b2118],
5	Viboud	NN	O	viboud	nn	6	SENT_206	[p15l620t2060r828b2111],
6	C	NN	O	c	appos	3	SENT_206	[p15l854t2063r909b2118],
7	,	,	O	,	_	0	SENT_206	[p15l854t2063r909b2118],
8	Dunant	NNP	PERSON	Dunant	nn	9	SENT_206	[p15l937t2064r1147b2111],
9	A	NNP	O	A	appos	3	SENT_206	[p15l1170t2064r1215b2110],
10	et	FW	O	et	nn	11	SENT_206	[p15l1240t2071r1287b2110],
11	al.	FW	O	al.	dep	9	SENT_206	[p15l1309t2061r1367b2110],
12	.	.	O	.	_	0	SENT_206	[p15l1309t2061r1367b2110],

1	Stevens	NNP	PERSON	Stevens	_	0	SENT_207	[p15l1398t2061r1853b2119],
2	.	.	O	.	_	0	SENT_207	[p15l1398t2061r1853b2119],

1	—	NN	O	—	_	0	SENT_208	[p15l1398t2061r1853b2119],
2	.	.	O	.	_	0	SENT_208	[p15l1398t2061r1853b2119],

1	Iohnson	NN	MISC	iohnson	nn	2	SENT_209	[p15l1398t2061r1853b2119],
2	syndrome	NN	O	syndrome	_	0	SENT_209	[p15l1879t2061r2149b2126],
3	and	CC	O	and	_	0	SENT_209	[p15l113t2145r214b2195],
4	toxic	JJ	O	toxic	amod	6	SENT_209	[p15l238t2147r373b2195],
5	epidermal	JJ	O	epidermal	amod	6	SENT_209	[p15l399t2145r673b2210],
6	necrolysis	NN	O	necrolysis	conj_and	2	SENT_209	[p15l699t2145r978b2211],
7	:	:	O	:	_	0	SENT_209	[p15l699t2145r978b2211],
8	assessment	NN	O	assessment	dep	2	SENT_209	[p15l1008t2155r1304b2195],
9	of	IN	O	of	_	0	SENT_209	[p15l1330t2145r1391b2195],
10	medication	NN	O	medication	nn	11	SENT_209	[p15l1408t2145r1716b2195],
11	risks	NNS	O	risk	prep_of	8	SENT_209	[p15l1743t2145r1864b2195],
12	with	IN	O	with	_	0	SENT_209	[p15l1889t2145r2011b2195],
13	emphasis	NN	O	emphasis	prep_with	11	SENT_209	[p15l113t2230r364b2295],
14	on	IN	O	on	_	0	SENT_209	[p15l391t2248r460b2280],
15	recently	RB	DATE	recently	advmod	16	SENT_209	[p15l486t2230r703b2296],
16	marketed	VBN	O	market	amod	17	SENT_209	[p15l726t2230r984b2280],
17	drugs	NNS	O	drug	prep_on	13	SENT_209	[p15l1010t2230r1174b2296],
18	.	.	O	.	_	0	SENT_209	[p15l1010t2230r1174b2296],

1	The	DT	O	the	det	2	SENT_210	[p15l1202t2230r1306b2280],
2	EuroSCAR-study	NNP	O	EuroSCAR-study	_	0	SENT_210	[p15l1332t2230r1818b2296],
3	.	.	O	.	_	0	SENT_210	[p15l1332t2230r1818b2296],

1	I	PRP	O	I	nsubj	2	SENT_211	[p15l1842t2234r1871b2288],
2	Invest	VBP	O	invest	_	0	SENT_211	[p15l1890t2234r2051b2280],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_211	[p15l111t2315r366b2365],
4	2008	CD	DATE	2008	dobj	2	SENT_211	[p15l390t2320r533b2372],
5	;	:	O	;	_	0	SENT_211	[p15l390t2320r533b2372],
6	128	CD	NUMBER	128	num	8	SENT_211	[p15l565t2320r672b2365],
7	:	:	O	:	_	0	SENT_211	[p15l565t2320r672b2365],
8	35-44	CD	NUMBER	35-44	dep	4	SENT_211	[p15l701t2320r877b2365],
9	.	.	O	.	_	0	SENT_211	[p15l701t2320r877b2365],

1	7	CD	NUMBER	7	num	3	SENT_212	[p15l43t2406r70b2450],
2	Arellano	NN	O	arellano	nn	3	SENT_212	[p15l111t2400r343b2450],
3	F	NN	O	f	_	0	SENT_212	[p15l371t2404r417b2457],
4	,	,	O	,	_	0	SENT_212	[p15l371t2404r417b2457],
5	Sacristan	NNP	LOCATION	Sacristan	nn	6	SENT_212	[p15l446t2400r690b2450],
6	IA	NNP	LOCATION	IA	appos	3	SENT_212	[p15l715t2403r793b2458],
7	.	.	O	.	_	0	SENT_212	[p15l715t2403r793b2458],

1	Allopurinol	NN	O	allopurinol	nn	3	SENT_213	[p15l820t2400r1141b2465],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_213	[p15l1165t2400r1597b2466],
3	syndrome	NN	O	syndrome	_	0	SENT_213	[p15l1621t2400r1905b2465],
4	:	:	O	:	_	0	SENT_213	[p15l1621t2400r1905b2465],
5	a	DT	O	a	det	6	SENT_213	[p15l1935t2418r1962b2450],
6	review	NN	O	review	dep	3	SENT_213	[p15l113t2488r302b2535],
7	.	.	O	.	_	0	SENT_213	[p15l113t2488r302b2535],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_214	[p15l326t2489r442b2535],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_214	[p15l466t2486r846b2535],
3	1993	CD	DATE	1993	num	2	SENT_214	[p15l874t2491r1011b2543],
4	;	:	O	;	_	0	SENT_214	[p15l874t2491r1011b2543],
5	27	CD	NUMBER	27	num	7	SENT_214	[p15l1038t2491r1117b2535],
6	:	:	O	:	_	0	SENT_214	[p15l1038t2491r1117b2535],
7	337-343	CD	NUMBER	337-343	dep	2	SENT_214	[p15l1146t2491r1387b2536],
8	.	.	O	.	_	0	SENT_214	[p15l1146t2491r1387b2536],

1	8	CD	NUMBER	8	num	3	SENT_215	[p15l42t2576r69b2621],
2	Begon	NNP	O	Begon	nn	3	SENT_215	[p15l113t2575r282b2636],
3	E	NNP	O	E	_	0	SENT_215	[p15l308t2575r358b2628],
4	,	,	O	,	_	0	SENT_215	[p15l308t2575r358b2628],
5	Roujeau	NNP	O	Roujeau	nn	6	SENT_215	[p15l386t2573r611b2636],
6	IC	NN	O	ic	appos	3	SENT_215	[p15l637t2574r716b2629],
7	.	.	O	.	_	0	SENT_215	[p15l637t2574r716b2629],

1	Drug	NN	O	drug	nn	3	SENT_216	[p15l744t2575r886b2636],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_216	[p15l910t2571r1341b2636],
3	syndrome	NN	O	syndrome	_	0	SENT_216	[p15l1366t2571r1650b2636],
4	:	:	O	:	_	0	SENT_216	[p15l1366t2571r1650b2636],
5	DRESS	NN	O	dress	nn	8	SENT_216	[p15l1679t2574r1871b2621],
6	(	CD	NUMBER	(	num	8	SENT_216	[p15l1902t2571r2066b2636],
7	Drug	NN	O	drug	nn	8	SENT_216	[p15l1902t2571r2066b2636],
8	Reaction	NN	O	reaction	dep	3	SENT_216	[p15l113t2657r352b2706],
9	with	IN	O	with	_	0	SENT_216	[p15l376t2656r498b2706],
10	Eosinophilia	NN	PERSON	eosinophilia	nn	14	SENT_216	[p15l524t2656r868b2720],
11	and	CC	O	and	_	0	SENT_216	[p15l894t2656r994b2706],
12	Systemic	JJ	O	systemic	nn	14	SENT_216	[p15l1020t2657r1258b2721],
13	Symptoms	NNS	O	symptom	nn	14	SENT_216	[p15l1285t2656r1614b2721],
14	)	NN	O	)	prep_with	8	SENT_216	[p15l1285t2656r1614b2721],
15	.	.	O	.	_	0	SENT_216	[p15l1285t2656r1614b2721],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_217	[p15l1639t2659r1754b2706],
2	Dermatol	NNP	PERSON	Dermatol	nn	3	SENT_217	[p15l1779t2656r2033b2706],
3	Venereol	NNP	PERSON	Venereol	_	0	SENT_217	[p15l117t2741r344b2790],
4	2004	CD	DATE	2004	num	3	SENT_217	[p15l368t2745r511b2798],
5	;	:	O	;	_	0	SENT_217	[p15l368t2745r511b2798],
6	131	CD	NUMBER	131	num	8	SENT_217	[p15l542t2745r650b2790],
7	:	:	O	:	_	0	SENT_217	[p15l542t2745r650b2790],
8	293-297	CD	NUMBER	293-297	dep	3	SENT_217	[p15l678t2745r921b2790],
9	.	.	O	.	_	0	SENT_217	[p15l678t2745r921b2790],

1	9	CD	NUMBER	9	num	3	SENT_218	[p15l42t2830r70b2876],
2	Hande	NN	ORGANIZATION	hande	nn	3	SENT_218	[p15l113t2825r294b2875],
3	KR	NN	ORGANIZATION	kr	_	0	SENT_218	[p15l321t2829r420b2883],
4	,	,	O	,	_	0	SENT_218	[p15l321t2829r420b2883],
5	Noone	NNP	PERSON	Noone	nn	6	SENT_218	[p15l447t2829r632b2875],
6	RM	NN	PERSON	rm	appos	3	SENT_218	[p15l659t2829r774b2883],
7	,	,	O	,	_	0	SENT_218	[p15l659t2829r774b2883],
8	Stone	NNP	O	Stone	nn	10	SENT_218	[p15l803t2828r954b2876],
9	W	NNP	O	W	nn	10	SENT_218	[p15l978t2829r1079b2884],
10	]	NN	O	]	appos	6	SENT_218	[p15l978t2829r1079b2884],
11	.	.	O	.	_	0	SENT_218	[p15l978t2829r1079b2884],

1	Severe	JJ	O	severe	amod	2	SENT_219	[p15l1108t2828r1279b2876],
2	allopurinol	NN	O	allopurinol	_	0	SENT_219	[p15l1306t2825r1610b2890],
3	toxicity	NN	O	toxicity	dep	2	SENT_219	[p15l1635t2827r1853b2891],
4	.	.	O	.	_	0	SENT_219	[p15l1635t2827r1853b2891],

1	Description	NN	O	description	_	0	SENT_220	[p15l1882t2827r2112b2890, p15l111t2912r223b2960],
2	and	CC	O	and	_	0	SENT_220	[p15l249t2911r349b2960],
3	guidelines	NNS	O	guideline	conj_and	1	SENT_220	[p15l375t2910r648b2976],
4	for	IN	O	for	_	0	SENT_220	[p15l676t2910r754b2961],
5	prevention	NN	O	prevention	prep_for	1	SENT_220	[p15l778t2912r1075b2975],
6	in	IN	O	in	_	0	SENT_220	[p15l1102t2912r1154b2960],
7	patients	NNS	O	patient	prep_in	1	SENT_220	[p15l1179t2912r1394b2975],
8	with	IN	O	with	_	0	SENT_220	[p15l1419t2911r1540b2960],
9	renal	JJ	O	renal	amod	10	SENT_220	[p15l1567t2911r1702b2960],
10	insufﬁciency	NN	O	insufﬁciency	prep_with	7	SENT_220	[p15l1727t2910r2084b2976],
11	.	.	O	.	_	0	SENT_220	[p15l1727t2910r2084b2976],

1	Am	VBP	O	be	_	0	SENT_221	[p15l108t2997r205b3044],
2	I	PRP	O	I	nsubj	3	SENT_221	[p15l228t2998r257b3052],
3	Med	VBD	O	med	ccomp	1	SENT_221	[p15l275t2994r397b3044],
4	1984	CD	DATE	1984	dobj	3	SENT_221	[p15l427t2999r565b3051],
5	;	:	O	;	_	0	SENT_221	[p15l427t2999r565b3051],
6	76	CD	NUMBER	76	num	8	SENT_221	[p15l592t2999r670b3044],
7	:	:	O	:	_	0	SENT_221	[p15l592t2999r670b3044],
8	47-56	CD	DATE	47-56	dep	4	SENT_221	[p15l698t2999r875b3044],
9	.	.	O	.	_	0	SENT_221	[p15l698t2999r875b3044],

1	10	CD	NUMBER	10	num	3	SENT_222	[p15l14t3084r70b3129],
2	Emmerson	NNP	ORGANIZATION	Emmerson	nn	3	SENT_222	[p15l112t3083r411b3129],
3	BT	NNP	ORGANIZATION	BT	_	0	SENT_222	[p15l437t3081r530b3136],
4	,	,	O	,	_	0	SENT_222	[p15l437t3081r530b3136],
5	Hazelton	NNP	PERSON	Hazelton	nn	6	SENT_222	[p15l558t3079r806b3129],
6	RA	NN	O	ra	appos	3	SENT_222	[p15l831t3082r930b3136],
7	,	,	O	,	_	0	SENT_222	[p15l831t3082r930b3136],
8	Frazer	NNP	PERSON	Frazer	nn	9	SENT_222	[p15l958t3083r1127b3129],
9	IH	NN	O	ih	appos	6	SENT_222	[p15l1152t3083r1238b3129],
10	.	.	O	.	_	0	SENT_222	[p15l1152t3083r1238b3129],

1	Some	DT	O	some	det	3	SENT_223	[p15l1267t3082r1417b3129],
2	adverse	JJ	O	adverse	amod	3	SENT_223	[p15l1443t3079r1644b3129],
3	reactions	NNS	O	reaction	nsubjpass	8	SENT_223	[p15l1670t3081r1916b3129],
4	to	TO	O	to	_	0	SENT_223	[p15l1941t3089r1995b3129],
5	allopurinol	NN	O	allopurinol	prep_to	3	SENT_223	[p15l113t3164r417b3229],
6	may	MD	O	may	aux	8	SENT_223	[p15l443t3182r559b3230],
7	be	VB	O	be	auxpass	8	SENT_223	[p15l581t3164r643b3214],
8	mediated	VBN	O	mediate	_	0	SENT_223	[p15l669t3164r923b3214],
9	by	IN	O	by	_	0	SENT_223	[p15l946t3164r1014b3230],
10	lymphocyte	NN	O	lymphocyte	nn	11	SENT_223	[p15l1036t3164r1355b3230],
11	reactivity	NN	O	reactivity	agent	8	SENT_223	[p15l1382t3166r1635b3229],
12	to	TO	O	to	_	0	SENT_223	[p15l1658t3174r1711b3214],
13	oxypurinol	NN	O	oxypurinol	prep_to	8	SENT_223	[p15l1739t3164r2054b3230],
14	.	.	O	.	_	0	SENT_223	[p15l1739t3164r2054b3230],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_224	[p15l108t3250r337b3300],
2	Rheum	NNP	O	Rheum	_	0	SENT_224	[p15l361t3250r550b3300],
3	1988	CD	DATE	1988	num	2	SENT_224	[p15l582t3255r720b3306],
4	;	:	O	;	_	0	SENT_224	[p15l582t3255r720b3306],
5	31	CD	NUMBER	31	num	7	SENT_224	[p15l748t3255r826b3300],
6	:	:	O	:	_	0	SENT_224	[p15l748t3255r826b3300],
7	436-440	CD	NUMBER	436-440	dep	2	SENT_224	[p15l853t3254r1096b3300],
8	.	.	O	.	_	0	SENT_224	[p15l853t3254r1096b3300],

1	11	CD	NUMBER	11	num	3	SENT_225	[p15l12t3338r64b3383],
2	Dalbeth	NN	ORGANIZATION	dalbeth	nn	3	SENT_225	[p15l111t3333r327b3383],
3	N	NN	ORGANIZATION	n	_	0	SENT_225	[p15l352t3337r415b3391],
4	,	,	O	,	_	0	SENT_225	[p15l352t3337r415b3391],
5	Stamp	NNP	O	Stamp	nn	8	SENT_225	[p15l444t3336r616b3398],
6	L.	NNP	O	L.	nn	8	SENT_225	[p15l644t3337r690b3383],
7	Allopurinol	NNP	O	Allopurinol	nn	8	SENT_225	[p15l717t3333r1038b3398],
8	dosing	NN	O	dosing	appos	3	SENT_225	[p15l1064t3333r1245b3399],
9	in	IN	O	in	_	0	SENT_225	[p15l1270t3335r1323b3383],
10	renal	JJ	O	renal	amod	11	SENT_225	[p15l1350t3333r1485b3383],
11	impairment	NN	O	impairment	prep_in	8	SENT_225	[p15l1510t3335r1849b3398],
12	:	:	O	:	_	0	SENT_225	[p15l1510t3335r1849b3398],
13	walking	VBG	O	walk	dep	11	SENT_225	[p15l1876t3333r2090b3399],
14	the	DT	O	the	det	15	SENT_225	[p15l110t3417r195b3467],
15	tightrope	NN	O	tightrope	dobj	13	SENT_225	[p15l219t3417r472b3483],
16	between	IN	O	between	_	0	SENT_225	[p15l497t3417r722b3467],
17	adequate	JJ	O	adequate	amod	19	SENT_225	[p15l748t3417r992b3482],
18	urate	JJ	O	urate	amod	19	SENT_225	[p15l1018t3427r1157b3467],
19	lowering	NN	O	lowering	prep_between	15	SENT_225	[p15l1182t3417r1421b3483],
20	and	CC	O	and	_	0	SENT_225	[p15l1447t3417r1547b3467],
21	adverse	JJ	O	adverse	amod	22	SENT_225	[p15l1574t3417r1774b3467],
22	events	NNS	O	event	conj_and	19	SENT_225	[p15l1801t3427r1983b3467],
23	.	.	O	.	_	0	SENT_225	[p15l1801t3427r1983b3467],

1	Semin	NNP	O	Semin	nn	2	SENT_226	[p15l112t3502r275b3550],
2	Dial	NNP	O	Dial	_	0	SENT_226	[p15l300t3500r418b3550],
3	2007	CD	DATE	2007	num	2	SENT_226	[p15l442t3505r585b3557],
4	;	:	O	;	_	0	SENT_226	[p15l442t3505r585b3557],
5	20	CD	NUMBER	20	num	7	SENT_226	[p15l612t3505r690b3550],
6	:	:	O	:	_	0	SENT_226	[p15l612t3505r690b3550],
7	391-395	CD	NUMBER	391-395	dep	2	SENT_226	[p15l720t3505r961b3550],
8	.	.	O	.	_	0	SENT_226	[p15l720t3505r961b3550],

1	12	CD	NUMBER	12	_	0	SENT_227	[p15l12t3589r68b3633],
2	Chao	NNP	O	Chao	nn	6	SENT_227	[p15l112t3584r254b3634],
3	I	PRP	O	I	dep	6	SENT_227	[p15l281t3588r316b3642],
4	,	,	O	,	_	0	SENT_227	[p15l281t3588r316b3642],
5	Terkeltaub	NNP	O	Terkeltaub	dep	6	SENT_227	[p15l343t3584r637b3634],
6	R.	NNP	O	R.	dep	1	SENT_227	[p15l665t3588r719b3634],
7	A	NNP	O	A	nn	9	SENT_227	[p15l745t3587r790b3633],
8	critical	JJ	O	critical	amod	9	SENT_227	[p15l815t3584r1000b3634],
9	reappraisal	NN	O	reappraisal	dep	1	SENT_227	[p15l1025t3584r1324b3649],
10	of	IN	O	of	_	0	SENT_227	[p15l1350t3584r1411b3634],
11	allopurinol	NN	O	allopurinol	nn	12	SENT_227	[p15l1429t3584r1733b3649],
12	dosing	NN	O	dosing	prep_of	9	SENT_227	[p15l1760t3584r1954b3650],
13	,	,	O	,	_	0	SENT_227	[p15l1760t3584r1954b3650],
14	safety	NN	O	safety	appos	12	SENT_227	[p15l1982t3584r2149b3650],
15	,	,	O	,	_	0	SENT_227	[p15l1982t3584r2149b3650],

1	and	CC	O	and	dep	2	SENT_228	[p15l112t3669r212b3719],
2	efﬁcacy	NN	O	efﬁcacy	_	0	SENT_228	[p15l238t3669r441b3734],
3	for	IN	O	for	_	0	SENT_228	[p15l465t3669r544b3719],
4	hyperuricemia	NN	O	hyperuricemia	prep_for	2	SENT_228	[p15l568t3669r967b3734],
5	in	IN	O	in	_	0	SENT_228	[p15l993t3671r1045b3718],
6	gout	NN	O	gout	prep_in	2	SENT_228	[p15l1071t3679r1207b3734],
7	.	.	O	.	_	0	SENT_228	[p15l1071t3679r1207b3734],

1	Curr	NNP	MISC	Curr	nn	3	SENT_229	[p15l1238t3672r1364b3719],
2	Rheurnatol	NNP	MISC	Rheurnatol	nn	3	SENT_229	[p15l1386t3669r1680b3719],
3	Rep	NNP	MISC	Rep	_	0	SENT_229	[p15l1702t3673r1802b3734],
4	2009	CD	DATE	2009	num	3	SENT_229	[p15l1828t3674r1971b3726],
5	;	:	O	;	_	0	SENT_229	[p15l1828t3674r1971b3726],
6	11	CD	NUMBER	11	num	8	SENT_229	[p15l2002t3674r2076b3719],
7	:	:	O	:	_	0	SENT_229	[p15l2002t3674r2076b3719],
8	135-140	CD	NUMBER	135-140	dep	3	SENT_229	[p15l117t3757r353b3802],
9	.	.	O	.	_	0	SENT_229	[p15l117t3757r353b3802],

1	Vazquez	NNP	PERSON	Vazquez	_	0	SENT_230	[p16l109t26r590b91],
2	.	.	O	.	_	0	SENT_230	[p16l109t26r590b91],

1	—	NN	O	—	_	0	SENT_231	[p16l109t26r590b91],
2	.	.	O	.	_	0	SENT_231	[p16l109t26r590b91],

1	Mellado	NNP	PERSON	Mellado	nn	2	SENT_232	[p16l109t26r590b91],
2	I	NNP	O	I	_	0	SENT_232	[p16l618t29r653b84],
3	,	,	O	,	_	0	SENT_232	[p16l618t29r653b84],
4	Morales	NNP	O	Morales	nn	5	SENT_232	[p16l680t26r899b76],
5	EM	NNP	O	EM	appos	2	SENT_232	[p16l926t29r1037b83],
6	,	,	O	,	_	0	SENT_232	[p16l926t29r1037b83],
7	Pacheco	NNP	PERSON	Pacheco	appos	5	SENT_232	[p16l1065t26r1451b76],
8	.	.	O	.	_	0	SENT_232	[p16l1065t26r1451b76],

1	—	NN	O	—	_	0	SENT_233	[p16l1065t26r1451b76],
2	.	.	O	.	_	0	SENT_233	[p16l1065t26r1451b76],

1	Tena	NNP	PERSON	Tena	nn	2	SENT_234	[p16l1065t26r1451b76],
2	C	NNP	O	C	_	0	SENT_234	[p16l1478t28r1534b83],
3	,	,	O	,	_	0	SENT_234	[p16l1478t28r1534b83],
4	Burgos	NNP	PERSON	Burgos	appos	2	SENT_234	[p16l1561t29r1964b91],
5	.	.	O	.	_	0	SENT_234	[p16l1561t29r1964b91],

1	—	NN	O	—	_	0	SENT_235	[p16l1561t29r1964b91],
2	.	.	O	.	_	0	SENT_235	[p16l1561t29r1964b91],

1	Vargas	NNP	O	Vargas	nn	3	SENT_236	[p16l1561t29r1964b91],
2	R.	NNP	O	R.	nn	3	SENT_236	[p16l1990t29r2043b76],
3	Relation	NNP	O	Relation	nsubj	7	SENT_236	[p16l111t109r340b160],
4	between	IN	O	between	_	0	SENT_236	[p16l364t110r589b160],
5	adverse	JJ	O	adverse	amod	6	SENT_236	[p16l615t110r817b160],
6	events	NNS	O	event	prep_between	3	SENT_236	[p16l842t120r1010b160],
7	associated	VBN	O	associate	_	0	SENT_236	[p16l1037t110r1312b160],
8	with	IN	O	with	_	0	SENT_236	[p16l1336t110r1458b160],
9	allopurinol	NN	O	allopurinol	nn	12	SENT_236	[p16l1484t109r1789b174],
10	and	CC	O	and	_	0	SENT_236	[p16l1815t110r1915b160],
11	renal	JJ	O	renal	nn	12	SENT_236	[p16l1941t110r2076b160],
12	function	NN	O	function	prep_with	7	SENT_236	[p16l111t193r344b243],
13	in	IN	O	in	_	0	SENT_236	[p16l370t195r423b243],
14	patients	NNS	O	patient	prep_in	12	SENT_236	[p16l448t195r663b258],
15	with	IN	O	with	_	0	SENT_236	[p16l688t193r810b243],
16	gout	NN	O	gout	prep_with	14	SENT_236	[p16l836t204r972b259],
17	.	.	O	.	_	0	SENT_236	[p16l836t204r972b259],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_237	[p16l996t197r1112b243],
2	Rheum	NNP	PERSON	Rheum	nn	3	SENT_237	[p16l1137t194r1327b243],
3	Dis	NNP	O	Dis	_	0	SENT_237	[p16l1352t195r1441b243],
4	2001	CD	DATE	2001	num	3	SENT_237	[p16l1466t198r1609b251],
5	;	:	O	;	_	0	SENT_237	[p16l1466t198r1609b251],
6	60	CD	NUMBER	60	num	8	SENT_237	[p16l1636t198r1715b243],
7	:	:	O	:	_	0	SENT_237	[p16l1636t198r1715b243],
8	981-983	CD	NUMBER	981-983	dep	3	SENT_237	[p16l1744t198r1986b244],
9	.	.	O	.	_	0	SENT_237	[p16l1744t198r1986b244],

1	Bocquet	NNP	PERSON	Bocquet	nn	2	SENT_238	[p16l111t281r335b342],
2	H	NNP	PERSON	H	_	0	SENT_238	[p16l361t281r426b335],
3	,	,	O	,	_	0	SENT_238	[p16l361t281r426b335],
4	Bagot	NNP	PERSON	Bagot	nn	5	SENT_238	[p16l453t281r609b343],
5	M	NNP	O	M	appos	2	SENT_238	[p16l634t281r708b335],
6	,	,	O	,	_	0	SENT_238	[p16l634t281r708b335],
7	Roujeau	NNP	O	Roujeau	nn	8	SENT_238	[p16l736t279r962b343],
8	IC	NN	O	ic	appos	5	SENT_238	[p16l987t280r1066b336],
9	.	.	O	.	_	0	SENT_238	[p16l987t280r1066b336],

1	Drug	NN	O	drug	nsubj	2	SENT_239	[p16l1094t281r1236b343],
2	induced	VBD	O	induce	_	0	SENT_239	[p16l1261t277r1481b327],
3	pseudolymphoma	NN	O	pseudolymphoma	dobj	2	SENT_239	[p16l1506t277r2003b343],
4	and	CC	O	and	_	0	SENT_239	[p16l2029t277r2130b327],
5	drug	NN	O	drug	nn	10	SENT_239	[p16l112t361r239b427],
6	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_239	[p16l263t361r696b427],
7	syndrome	NN	O	syndrome	nn	10	SENT_239	[p16l720t361r992b427],
8	(	CD	NUMBER	(	num	10	SENT_239	[p16l1021t361r1271b422],
9	DRSSS	NN	O	drsss	nn	10	SENT_239	[p16l1021t361r1271b422],
10	)	NN	O	)	dobj	2	SENT_239	[p16l1021t361r1271b422],
11	.	.	O	.	_	0	SENT_239	[p16l1021t361r1271b422],

1	Semin	NNP	PERSON	Semin	nn	2	SENT_240	[p16l1300t363r1464b411],
2	Catan	NNP	PERSON	Catan	nsubj	3	SENT_240	[p16l1492t364r1655b411],
3	Med	VBD	O	med	_	0	SENT_240	[p16l1680t361r1802b411],
4	Surg	NNP	O	Surg	dobj	3	SENT_240	[p16l1827t364r1949b427],
5	1996	CD	DATE	1996	num	4	SENT_240	[p16l1977t366r2114b419],
6	;	:	O	;	_	0	SENT_240	[p16l1977t366r2114b419],
7	15	CD	NUMBER	15	num	9	SENT_240	[p16l115t450r189b494],
8	:	:	O	:	_	0	SENT_240	[p16l115t450r189b494],
9	250-257	CD	NUMBER	250-257	dep	4	SENT_240	[p16l218t450r460b494],
10	.	.	O	.	_	0	SENT_240	[p16l218t450r460b494],

1	Kardaun	NNP	PERSON	Kardaun	nn	2	SENT_241	[p16l111t530r349b580],
2	SH	NNP	O	SH	_	0	SENT_241	[p16l376t532r472b587],
3	,	,	O	,	_	0	SENT_241	[p16l376t532r472b587],
4	Sidoroff	NNP	O	Sidoroff	nn	5	SENT_241	[p16l501t529r730b580],
5	A	NNP	O	A	appos	2	SENT_241	[p16l745t533r804b587],
6	,	,	O	,	_	0	SENT_241	[p16l745t533r804b587],
7	Valeyrie	NNP	PERSON	Valeyrie	appos	5	SENT_241	[p16l830t529r1313b595],
8	.	.	O	.	_	0	SENT_241	[p16l830t529r1313b595],

1	—	NN	O	—	_	0	SENT_242	[p16l830t529r1313b595],
2	.	.	O	.	_	0	SENT_242	[p16l830t529r1313b595],

1	Allanore	NN	O	allanore	nn	2	SENT_243	[p16l830t529r1313b595],
2	L	NN	O	l	_	0	SENT_243	[p16l1339t533r1373b579],
3	et	FW	O	et	nn	4	SENT_243	[p16l1399t540r1447b579],
4	al.	FW	O	al.	dep	2	SENT_243	[p16l1469t530r1527b579],
5	.	.	O	.	_	0	SENT_243	[p16l1469t530r1527b579],

1	Variability	NN	O	variability	nsubj	17	SENT_244	[p16l1556t530r1849b595],
2	in	IN	O	in	_	0	SENT_244	[p16l1872t531r1925b579],
3	the	DT	O	the	det	5	SENT_244	[p16l1949t530r2034b580],
4	clinical	JJ	O	clinical	amod	5	SENT_244	[p16l112t613r305b663],
5	pattern	NN	O	pattern	prep_in	1	SENT_244	[p16l329t624r527b678],
6	of	IN	O	of	_	0	SENT_244	[p16l553t613r614b663],
7	cutaneous	JJ	O	cutaneous	amod	10	SENT_244	[p16l632t624r908b664],
8	side	NN	O	side	nn	10	SENT_244	[p16l936t613r1236b663],
9	—	NN	O	—	nn	10	SENT_244	[p16l936t613r1236b663],
10	effects	NNS	O	effect	prep_of	5	SENT_244	[p16l936t613r1236b663],
11	of	IN	O	of	_	0	SENT_244	[p16l1263t613r1323b663],
12	drugs	NNS	O	drug	prep_of	5	SENT_244	[p16l1341t614r1492b679],
13	with	IN	O	with	_	0	SENT_244	[p16l1516t614r1639b663],
14	systemic	JJ	O	systemic	amod	15	SENT_244	[p16l1665t615r1895b679],
15	symptoms	NNS	O	symptom	prep_with	12	SENT_244	[p16l1921t631r2087b679, p16l110t708r260b748],
16	:	:	O	:	_	0	SENT_244	[p16l1921t631r2087b679, p16l110t708r260b748],
17	does	VBZ	O	do	_	0	SENT_244	[p16l289t698r410b747],
18	a	DT	O	a	det	20	SENT_244	[p16l437t716r464b747],
19	DRESS	NN	O	dress	nn	20	SENT_244	[p16l490t700r682b748],
20	syndrome	NN	O	syndrome	nsubj	22	SENT_244	[p16l710t697r980b763],
21	really	RB	O	really	advmod	22	SENT_244	[p16l1006t698r1155b763],
22	exist	VBP	O	exist	ccomp	17	SENT_244	[p16l1179t699r1314b747],
23	.	.	O	.	_	0	SENT_244	[p16l1179t699r1314b747],

1	Br	NN	O	br	_	0	SENT_245	[p16l1341t701r1406b747],
2	I	PRP	O	I	nsubj	3	SENT_245	[p16l1425t701r1454b756],
3	Dermatol	VBP	O	dermatol	rcmod	1	SENT_245	[p16l1472t697r1728b747],
4	2007	CD	DATE	2007	dobj	3	SENT_245	[p16l1752t702r1895b755],
5	;	:	O	;	_	0	SENT_245	[p16l1752t702r1895b755],
6	156	CD	NUMBER	156	dep	1	SENT_245	[p16l1926t702r2034b747],
7	:	:	O	:	_	0	SENT_245	[p16l1926t702r2034b747],
8	609-61	CD	NUMBER	609-61	number	9	SENT_245	[p16l112t784r301b830],
9	1	CD	NUMBER	1	dep	6	SENT_245	[p16l315t785r353b829],
10	.	.	O	.	_	0	SENT_245	[p16l315t785r353b829],

1	Cacoub	JJ	O	cacoub	amod	2	SENT_246	[p16l112t864r319b914],
2	P	NN	O	p	_	0	SENT_246	[p16l345t868r396b922],
3	,	,	O	,	_	0	SENT_246	[p16l345t868r396b922],
4	Musette	NN	ORGANIZATION	musette	nn	5	SENT_246	[p16l422t868r643b914],
5	P	NN	ORGANIZATION	p	appos	2	SENT_246	[p16l668t868r719b922],
6	,	,	O	,	_	0	SENT_246	[p16l668t868r719b922],
7	Descamps	NNP	PERSON	Descamps	nn	8	SENT_246	[p16l746t868r1022b929],
8	V	NNP	O	V	appos	2	SENT_246	[p16l1045t868r1091b914],
9	et	FW	O	et	nn	10	SENT_246	[p16l1116t875r1164b914],
10	al.	FW	O	al.	dep	8	SENT_246	[p16l1185t864r1243b914],
11	.	.	O	.	_	0	SENT_246	[p16l1185t864r1243b914],

1	The	DT	O	the	det	3	SENT_247	[p16l1274t864r1378b914],
2	DRESS	NN	O	dress	nn	3	SENT_247	[p16l1403t867r1595b914],
3	syndrome	NN	O	syndrome	_	0	SENT_247	[p16l1623t864r1907b930],
4	:	:	O	:	_	0	SENT_247	[p16l1623t864r1907b930],
5	a	DT	O	a	det	7	SENT_247	[p16l1936t882r1963b914],
6	literature	NN	O	literature	nn	7	SENT_247	[p16l1987t864r2148b914, p16l110t957r220b996],
7	review	NN	O	review	dep	3	SENT_247	[p16l247t949r436b996],
8	.	.	O	.	_	0	SENT_247	[p16l247t949r436b996],

1	Am	VBP	O	be	_	0	SENT_248	[p16l460t950r558b996],
2	I	PRP	O	I	nsubj	3	SENT_248	[p16l580t951r610b1005],
3	Med	VBD	O	med	ccomp	1	SENT_248	[p16l627t947r749b996],
4	2011	CD	DATE	2011	dobj	3	SENT_248	[p16l773t952r917b1004],
5	;	:	O	;	_	0	SENT_248	[p16l773t952r917b1004],
6	124	CD	NUMBER	124	num	8	SENT_248	[p16l949t952r1056b996],
7	:	:	O	:	_	0	SENT_248	[p16l949t952r1056b996],
8	588-597	CD	NUMBER	588-597	dep	4	SENT_248	[p16l1086t952r1327b997],
9	.	.	O	.	_	0	SENT_248	[p16l1086t952r1327b997],

1	Bastuji	NNP	PERSON	Bastuji	_	0	SENT_249	[p16l111t1033r481b1096],
2	.	.	O	.	_	0	SENT_249	[p16l111t1033r481b1096],

1	—	NN	O	—	_	0	SENT_250	[p16l111t1033r481b1096],
2	.	.	O	.	_	0	SENT_250	[p16l111t1033r481b1096],

1	Garin	NNP	PERSON	Garin	nn	2	SENT_251	[p16l111t1033r481b1096],
2	S	NNP	O	S	_	0	SENT_251	[p16l507t1034r551b1088],
3	,	,	O	,	_	0	SENT_251	[p16l507t1034r551b1088],
4	Fouchard	JJ	ORGANIZATION	fouchard	amod	5	SENT_251	[p16l580t1031r841b1081],
5	N	NN	ORGANIZATION	n	appos	2	SENT_251	[p16l866t1035r929b1088],
6	,	,	O	,	_	0	SENT_251	[p16l866t1035r929b1088],
7	Bertocchi	NNP	PERSON	Bertocchi	nn	8	SENT_251	[p16l957t1031r1216b1081],
8	M	NNP	O	M	appos	2	SENT_251	[p16l1242t1035r1300b1080],
9	et	FW	O	et	nn	10	SENT_251	[p16l1328t1042r1375b1081],
10	al.	FW	O	al.	dep	8	SENT_251	[p16l1397t1031r1455b1081],
11	.	.	O	.	_	0	SENT_251	[p16l1397t1031r1455b1081],

1	SCORTEN	NNP	O	SCORTEN	_	0	SENT_252	[p16l1487t1033r1799b1081],
2	:	:	O	:	_	0	SENT_252	[p16l1487t1033r1799b1081],
3	a	DT	O	a	det	4	SENT_252	[p16l1829t1049r1856b1081],
4	severity	NN	O	severity	dep	1	SENT_252	[p16l1881t1033r2090b1097],
5	of	IN	O	of	_	0	SENT_252	[p16l112t1116r172b1166],
6	illness	NN	O	illness	nn	7	SENT_252	[p16l190t1116r353b1166],
7	score	NN	NUMBER	score	prep_of	4	SENT_252	[p16l381t1134r519b1166],
8	for	IN	O	for	_	0	SENT_252	[p16l545t1116r624b1166],
9	toxic	JJ	O	toxic	amod	11	SENT_252	[p16l648t1118r783b1166],
10	epidermal	JJ	O	epidermal	amod	11	SENT_252	[p16l809t1116r1083b1181],
11	necrolysis	NN	O	necrolysis	prep_for	7	SENT_252	[p16l1109t1116r1390b1181],
12	.	.	O	.	_	0	SENT_252	[p16l1109t1116r1390b1181],

1	I	PRP	O	I	nsubj	2	SENT_253	[p16l1414t1120r1443b1174],
2	Invest	VBP	O	invest	_	0	SENT_253	[p16l1461t1120r1622b1166],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_253	[p16l1643t1116r1898b1166],
4	2000	CD	DATE	2000	dobj	2	SENT_253	[p16l1922t1121r2065b1174],
5	;	:	O	;	_	0	SENT_253	[p16l1922t1121r2065b1174],
6	115	CD	NUMBER	115	num	8	SENT_253	[p16l115t1204r223b1249],
7	:	:	O	:	_	0	SENT_253	[p16l115t1204r223b1249],
8	149-153	CD	NUMBER	149-153	dep	4	SENT_253	[p16l257t1204r494b1249],
9	.	.	O	.	_	0	SENT_253	[p16l257t1204r494b1249],

1	Guégan	JJ	MISC	guégan	amod	2	SENT_254	[p16l112t1284r321b1349],
2	S	NN	O	s	_	0	SENT_254	[p16l347t1286r391b1341],
3	,	,	O	,	_	0	SENT_254	[p16l347t1286r391b1341],
4	Bastuji	NNP	PERSON	Bastuji	appos	2	SENT_254	[p16l419t1285r788b1349],
5	.	.	O	.	_	0	SENT_254	[p16l419t1285r788b1349],

1	—	NN	O	—	_	0	SENT_255	[p16l419t1285r788b1349],
2	.	.	O	.	_	0	SENT_255	[p16l419t1285r788b1349],

1	Garin	NNP	PERSON	Garin	nn	2	SENT_256	[p16l419t1285r788b1349],
2	S	NNP	O	S	_	0	SENT_256	[p16l815t1286r859b1341],
3	,	,	O	,	_	0	SENT_256	[p16l815t1286r859b1341],
4	Poszepczynska	NNP	LOCATION	Poszepczynska	appos	2	SENT_256	[p16l887t1284r1512b1349],
5	.	.	O	.	_	0	SENT_256	[p16l887t1284r1512b1349],

1	—	NN	O	—	_	0	SENT_257	[p16l887t1284r1512b1349],
2	.	.	O	.	_	0	SENT_257	[p16l887t1284r1512b1349],

1	Guigné	JJ	O	guigné	amod	2	SENT_258	[p16l887t1284r1512b1349],
2	E	NN	O	e	_	0	SENT_258	[p16l1539t1287r1574b1333],
3	et	FW	O	et	nn	4	SENT_258	[p16l1601t1294r1649b1334],
4	al.	FW	O	al.	dep	2	SENT_258	[p16l1670t1284r1728b1334],
5	.	.	O	.	_	0	SENT_258	[p16l1670t1284r1728b1334],

1	Performance	NNP	O	Performance	_	0	SENT_259	[p16l1760t1284r2110b1334],
2	of	IN	O	of	_	0	SENT_259	[p16l112t1367r172b1417],
3	the	DT	O	the	det	4	SENT_259	[p16l189t1368r273b1417],
4	SCORTEN	NNP	O	SCORTEN	prep_of	1	SENT_259	[p16l300t1370r599b1418],
5	during	IN	O	during	_	0	SENT_259	[p16l625t1368r808b1433],
6	the	DT	O	the	det	9	SENT_259	[p16l833t1368r917b1417],
7	ﬁrst	NN	O	ﬁrst	nn	9	SENT_259	[p16l943t1367r1049b1417],
8	ﬁve	NN	O	ﬁve	nn	9	SENT_259	[p16l1074t1367r1169b1417],
9	days	NNS	DURATION	day	prep_during	4	SENT_259	[p16l1196t1368r1313b1433],
10	of	IN	O	of	_	0	SENT_259	[p16l1341t1367r1401b1417],
11	hospitalization	NN	O	hospitalization	prep_of	9	SENT_259	[p16l1418t1367r1825b1432],
12	to	TO	O	to	aux	13	SENT_259	[p16l1850t1378r1904b1417],
13	predict	VB	O	predict	infmod	1	SENT_259	[p16l1930t1368r2124b1432],
14	the	DT	O	the	det	15	SENT_259	[p16l110t1452r194b1501],
15	prognosis	NN	O	prognosis	dobj	13	SENT_259	[p16l219t1453r485b1517],
16	of	IN	O	of	_	0	SENT_259	[p16l513t1451r573b1501],
17	epidermal	JJ	O	epidermal	amod	18	SENT_259	[p16l592t1452r865b1516],
18	necrolysis	NN	O	necrolysis	prep_of	15	SENT_259	[p16l891t1451r1173b1517],
19	.	.	O	.	_	0	SENT_259	[p16l891t1451r1173b1517],

1	I	PRP	O	I	nsubj	2	SENT_260	[p16l1197t1455r1226b1510],
2	Invest	VBP	O	invest	_	0	SENT_260	[p16l1244t1455r1405b1501],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_260	[p16l1425t1452r1681b1501],
4	2006	CD	DATE	2006	dobj	2	SENT_260	[p16l1705t1456r1848b1509],
5	;	:	O	;	_	0	SENT_260	[p16l1705t1456r1848b1509],
6	126	CD	NUMBER	126	num	8	SENT_260	[p16l1880t1456r1987b1501],
7	:	:	O	:	_	0	SENT_260	[p16l1880t1456r1987b1501],
8	272276	CD	NUMBER	272276	dep	4	SENT_260	[p16l2016t1456r2147b1501, p16l111t1538r221b1583],
9	.	.	O	.	_	0	SENT_260	[p16l2016t1456r2147b1501, p16l111t1538r221b1583],

1	Trent	NNP	O	Trent	nn	2	SENT_261	[p16l111t1619r262b1667],
2	IT	NNP	O	IT	_	0	SENT_261	[p16l287t1619r364b1675],
3	,	,	O	,	_	0	SENT_261	[p16l287t1619r364b1675],
4	Kirsner	NNP	PERSON	Kirsner	nn	5	SENT_261	[p16l392t1619r593b1667],
5	RS	NN	O	r	appos	2	SENT_261	[p16l618t1620r706b1674],
6	,	,	O	,	_	0	SENT_261	[p16l618t1620r706b1674],
7	Romanelli	NNP	PERSON	Romanelli	nn	8	SENT_261	[p16l733t1617r1014b1667],
8	P	NN	O	p	appos	2	SENT_261	[p16l1040t1621r1090b1674],
9	,	,	O	,	_	0	SENT_261	[p16l1040t1621r1090b1674],
10	Kerdel	NNP	O	Kerdel	nn	11	SENT_261	[p16l1118t1617r1297b1667],
11	FA	NNP	O	FA	appos	2	SENT_261	[p16l1322t1620r1412b1667],
12	.	.	O	.	_	0	SENT_261	[p16l1322t1620r1412b1667],

1	Use	NN	O	use	_	0	SENT_262	[p16l1440t1621r1541b1667],
2	of	IN	O	of	_	0	SENT_262	[p16l1567t1617r1627b1667],
3	SCORTEN	NNP	O	SCORTEN	prep_of	1	SENT_262	[p16l1646t1619r1945b1667],
4	to	TO	O	to	aux	6	SENT_262	[p16l1970t1627r2023b1667],
5	accurately	RB	O	accurately	advmod	6	SENT_262	[p16l112t1701r388b1767],
6	predict	VB	O	predict	infmod	1	SENT_262	[p16l410t1701r604b1766],
7	mortality	NN	O	mortality	dobj	6	SENT_262	[p16l629t1701r886b1767],
8	in	IN	O	in	_	0	SENT_262	[p16l909t1703r962b1750],
9	patients	NNS	O	patient	prep_in	7	SENT_262	[p16l987t1703r1202b1766],
10	with	IN	O	with	_	0	SENT_262	[p16l1227t1701r1349b1751],
11	toxic	JJ	O	toxic	amod	13	SENT_262	[p16l1374t1703r1509b1751],
12	epidermal	JJ	O	epidermal	amod	13	SENT_262	[p16l1535t1701r1810b1766],
13	necrolysis	NN	O	necrolysis	prep_with	6	SENT_262	[p16l1835t1701r2101b1767],
14	in	IN	O	in	_	0	SENT_262	[p16l111t1786r164b1833],
15	the	DT	O	the	det	17	SENT_262	[p16l189t1784r273b1834],
16	United	NNP	LOCATION	United	nn	17	SENT_262	[p16l299t1784r489b1834],
17	States	NNPS	LOCATION	States	prep_in	6	SENT_262	[p16l515t1787r684b1834],
18	.	.	O	.	_	0	SENT_262	[p16l515t1787r684b1834],

1	Arch	NNP	O	Arch	nn	2	SENT_263	[p16l709t1784r837b1834],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_263	[p16l861t1784r1116b1834],
3	2004	CD	DATE	2004	num	2	SENT_263	[p16l1140t1789r1283b1841],
4	;	:	O	;	_	0	SENT_263	[p16l1140t1789r1283b1841],
5	140	CD	NUMBER	140	num	7	SENT_263	[p16l1316t1789r1423b1834],
6	:	:	O	:	_	0	SENT_263	[p16l1316t1789r1423b1834],
7	890-892	CD	NUMBER	890-892	dep	2	SENT_263	[p16l1453t1789r1694b1834],
8	.	.	O	.	_	0	SENT_263	[p16l1453t1789r1694b1834],

1	International	NNP	O	International	nn	3	SENT_264	[p16l111t1869r471b1919],
2	drug	NN	O	drug	nn	3	SENT_264	[p16l497t1869r625b1934],
3	monitoring	NN	O	monitoring	_	0	SENT_264	[p16l650t1871r978b1934],
4	:	:	O	:	_	0	SENT_264	[p16l650t1871r978b1934],
5	the	DT	O	the	det	6	SENT_264	[p16l1005t1869r1090b1919],
6	role	NN	O	role	dep	3	SENT_264	[p16l1116t1869r1220b1919],
7	of	IN	O	of	_	0	SENT_264	[p16l1246t1869r1306b1919],
8	national	JJ	O	national	amod	9	SENT_264	[p16l1324t1869r1549b1919],
9	centres	NNS	O	centre	prep_of	6	SENT_264	[p16l1575t1879r1779b1919],
10	.	.	O	.	_	0	SENT_264	[p16l1575t1879r1779b1919],

1	Report	NNP	O	Report	_	0	SENT_265	[p16l1808t1873r1996b1934],
2	of	IN	O	of	_	0	SENT_265	[p16l2021t1869r2082b1919],
3	the	DT	O	the	prep_of	1	SENT_265	[p16l110t1953r194b2003],
4	WHO	WP	O	who	dep	5	SENT_265	[p16l218t1956r385b2003],
5	meeting	NN	O	meeting	rcmod	3	SENT_265	[p16l413t1955r646b2018],
6	.	.	O	.	_	0	SENT_265	[p16l413t1955r646b2018],

1	World	NNP	MISC	World	nn	5	SENT_266	[p16l679t1953r842b2003],
2	Health	NNP	MISC	Health	nn	5	SENT_266	[p16l865t1953r1046b2003],
3	Organ	NNP	MISC	Organ	nn	5	SENT_266	[p16l1075t1956r1240b2018],
4	Rep	NNP	MISC	Rep	nn	5	SENT_266	[p16l1265t1957r1365b2018],
5	Series	NNP	MISC	Series	_	0	SENT_266	[p16l1391t1955r1539b2003],
6	1972	CD	DATE	1972	num	5	SENT_266	[p16l1570t1958r1707b2010],
7	;	:	O	;	_	0	SENT_266	[p16l1570t1958r1707b2010],
8	498	CD	NUMBER	498	num	10	SENT_266	[p16l1734t1958r1847b2003],
9	:	:	O	:	_	0	SENT_266	[p16l1734t1958r1847b2003],
10	1-25	CD	NUMBER	1-25	dep	5	SENT_266	[p16l1881t1958r2019b2003],
11	.	.	O	.	_	0	SENT_266	[p16l1881t1958r2019b2003],

1	Tassaneeyakul	NNP	O	Tassaneeyakul	nn	2	SENT_267	[p16l110t2036r502b2102],
2	W	NNP	O	W	_	0	SENT_267	[p16l526t2040r604b2094],
3	,	,	O	,	_	0	SENT_267	[p16l526t2040r604b2094],
4	Iantararoungtong	NNP	ORGANIZATION	Iantararoungtong	nn	5	SENT_267	[p16l631t2040r1118b2102],
5	T	NN	ORGANIZATION	t	appos	2	SENT_267	[p16l1144t2039r1197b2094],
6	,	,	O	,	_	0	SENT_267	[p16l1144t2039r1197b2094],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_267	[p16l1226t2036r1370b2086],
8	P	NN	O	p	appos	2	SENT_267	[p16l1395t2040r1429b2086],
9	et	FW	O	et	nn	10	SENT_267	[p16l1458t2047r1505b2086],
10	al.	FW	O	al.	dep	8	SENT_267	[p16l1526t2036r1585b2086],
11	.	.	O	.	_	0	SENT_267	[p16l1526t2036r1585b2086],

1	Strong	JJ	O	strong	amod	2	SENT_268	[p16l1617t2039r1797b2102],
2	association	NN	O	association	_	0	SENT_268	[p16l1823t2038r2124b2086],
3	between	IN	O	between	_	0	SENT_268	[p16l109t2120r334b2170],
4	HLA	NN	O	hlum	prep_between	2	SENT_268	[p16l360t2122r712b2170],
5	.	.	O	.	_	0	SENT_268	[p16l360t2122r712b2170],

1	—	NN	O	—	_	0	SENT_269	[p16l360t2122r712b2170],
2	.	.	O	.	_	0	SENT_269	[p16l360t2122r712b2170],

1	B	NN	O	b	nsubj	7	SENT_270	[p16l360t2122r712b2170],
2	*	CD	NUMBER	*	number	3	SENT_270	[p16l360t2122r712b2170],
3	5801	CD	DATE	5801	dep	1	SENT_270	[p16l360t2122r712b2170],
4	and	CC	O	and	_	0	SENT_270	[p16l743t2120r843b2170],
5	allopurinol	NN	O	allopurinol	nn	6	SENT_270	[p16l870t2120r1422b2185],
6	—	NN	O	—	conj_and	1	SENT_270	[p16l870t2120r1422b2185],
7	induced	VBD	O	induce	_	0	SENT_270	[p16l870t2120r1422b2185],
8	Stevens	NNP	PERSON	Stevens	dobj	7	SENT_270	[p16l1449t2120r1904b2178],
9	—	CD	NUMBER	—	number	10	SENT_270	[p16l1449t2120r1904b2178],
10	]	CD	NUMBER	]	num	12	SENT_270	[p16l1449t2120r1904b2178],
11	ohnson	NN	O	ohnson	nn	12	SENT_270	[p16l1449t2120r1904b2178],
12	syndrome	NN	O	syndrome	dep	8	SENT_270	[p16l1931t2138r2042b2185, p16l112t2204r290b2254],
13	and	CC	O	and	_	0	SENT_270	[p16l317t2204r417b2254],
14	toxic	JJ	O	toxic	amod	16	SENT_270	[p16l442t2206r577b2254],
15	epidermal	JJ	O	epidermal	amod	16	SENT_270	[p16l603t2204r877b2269],
16	necrolysis	NN	O	necrolysis	dobj	7	SENT_270	[p16l903t2204r1169b2270],
17	in	IN	O	in	_	0	SENT_270	[p16l1197t2206r1249b2253],
18	a	DT	O	a	det	20	SENT_270	[p16l1275t2222r1303b2254],
19	Thai	NNP	LOCATION	Thai	nn	20	SENT_270	[p16l1327t2204r1451b2254],
20	population	NN	O	population	prep_in	16	SENT_270	[p16l1476t2204r1794b2269],
21	.	.	O	.	_	0	SENT_270	[p16l1476t2204r1794b2269],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_271	[p16l1821t2204r2114b2254, p16l107t2299r250b2354],
2	Genomics	NNP	O	Genomics	_	0	SENT_271	[p16l274t2291r528b2339],
3	2009	CD	DATE	2009	num	2	SENT_271	[p16l554t2293r697b2346],
4	;	:	O	;	_	0	SENT_271	[p16l554t2293r697b2346],
5	19	CD	NUMBER	19	num	7	SENT_271	[p16l729t2294r803b2339],
6	:	:	O	:	_	0	SENT_271	[p16l729t2294r803b2339],
7	704-709	CD	NUMBER	704-709	dep	2	SENT_271	[p16l833t2293r1074b2339],
8	.	.	O	.	_	0	SENT_271	[p16l833t2293r1074b2339],

1	Hung	NNP	O	Hung	nn	2	SENT_272	[p16l111t2377r268b2438],
2	SI	NNP	O	SI	_	0	SENT_272	[p16l293t2376r361b2430],
3	,	,	O	,	_	0	SENT_272	[p16l293t2376r361b2430],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_272	[p16l389t2373r573b2438],
5	WH	NNP	PERSON	WH	appos	2	SENT_272	[p16l596t2377r728b2430],
6	,	,	O	,	_	0	SENT_272	[p16l596t2377r728b2430],
7	Liou	NNP	PERSON	Liou	nn	8	SENT_272	[p16l756t2375r881b2423],
8	LB	NNP	O	LB	appos	2	SENT_272	[p16l907t2377r979b2422],
9	et	FW	O	et	nn	10	SENT_272	[p16l1007t2383r1055b2423],
10	al.	FW	O	al.	dep	8	SENT_272	[p16l1076t2373r1134b2423],
11	.	.	O	.	_	0	SENT_272	[p16l1076t2373r1134b2423],

1	HLA	NN	O	hlum	_	0	SENT_273	[p16l1165t2375r1516b2423],
2	.	.	O	.	_	0	SENT_273	[p16l1165t2375r1516b2423],

1	—	NN	O	—	_	0	SENT_274	[p16l1165t2375r1516b2423],
2	.	.	O	.	_	0	SENT_274	[p16l1165t2375r1516b2423],

1	B	NN	O	b	nsubj	14	SENT_275	[p16l1165t2375r1516b2423],
2	*	CD	NUMBER	*	number	3	SENT_275	[p16l1165t2375r1516b2423],
3	5801	CD	NUMBER	5801	num	4	SENT_275	[p16l1165t2375r1516b2423],
4	allele	NN	O	allele	npadvmod	1	SENT_275	[p16l1548t2373r1683b2423],
5	as	IN	O	as	_	0	SENT_275	[p16l1710t2391r1760b2423],
6	a	DT	O	a	det	8	SENT_275	[p16l1787t2391r1814b2423],
7	genetic	JJ	O	genetic	amod	8	SENT_275	[p16l1840t2375r2031b2438],
8	marker	NN	O	marker	prep_as	1	SENT_275	[p16l111t2457r308b2507],
9	for	IN	O	for	_	0	SENT_275	[p16l333t2457r411b2507],
10	severe	JJ	O	severe	amod	13	SENT_275	[p16l437t2474r600b2507],
11	cutaneous	JJ	O	cutaneous	amod	13	SENT_275	[p16l626t2467r902b2507],
12	adverse	JJ	O	adverse	amod	13	SENT_275	[p16l930t2457r1131b2507],
13	reactions	NNS	O	reaction	prep_for	8	SENT_275	[p16l1157t2458r1402b2507],
14	caused	VBN	O	cause	_	0	SENT_275	[p16l1430t2457r1612b2507],
15	by	IN	O	by	_	0	SENT_275	[p16l1635t2457r1703b2522],
16	allopurinol	NN	O	allopurinol	prep_by	14	SENT_275	[p16l1727t2457r2044b2522],
17	.	.	O	.	_	0	SENT_275	[p16l1727t2457r2044b2522],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_276	[p16l109t2543r229b2589],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_276	[p16l250t2540r372b2589],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_276	[p16l391t2540r531b2589],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_276	[p16l555t2541r629b2589],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_276	[p16l660t2543r707b2589],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_276	[p16l727t2542r757b2589],
7	A	NNP	O	A	_	0	SENT_276	[p16l778t2543r821b2588],
8	2005	CD	DATE	2005	num	7	SENT_276	[p16l849t2544r992b2597],
9	;	:	O	;	_	0	SENT_276	[p16l849t2544r992b2597],
10	102	CD	NUMBER	102	num	12	SENT_276	[p16l1023t2544r1131b2589],
11	:	:	O	:	_	0	SENT_276	[p16l1023t2544r1131b2589],
12	4134-4139	CD	DURATION	4134-4139	dep	7	SENT_276	[p16l1159t2544r1468b2590],
13	.	.	O	.	_	0	SENT_276	[p16l1159t2544r1468b2590],

1	Lonjou	NNP	O	Lonjou	nn	2	SENT_277	[p16l111t2625r308b2689],
2	C	NNP	O	C	_	0	SENT_277	[p16l334t2626r390b2681],
3	,	,	O	,	_	0	SENT_277	[p16l334t2626r390b2681],
4	Borot	NNP	O	Borot	nn	5	SENT_277	[p16l418t2627r573b2673],
5	N	NNP	O	N	appos	2	SENT_277	[p16l598t2627r662b2681],
6	,	,	O	,	_	0	SENT_277	[p16l598t2627r662b2681],
7	Sekula	NNP	PERSON	Sekula	nn	8	SENT_277	[p16l690t2624r866b2674],
8	P	NN	PERSON	p	appos	2	SENT_277	[p16l892t2627r926b2673],
9	et	FW	O	et	nn	10	SENT_277	[p16l953t2634r1001b2673],
10	al.	FW	O	al.	dep	8	SENT_277	[p16l1023t2623r1081b2673],
11	.	.	O	.	_	0	SENT_277	[p16l1023t2623r1081b2673],

1	A	DT	O	a	det	3	SENT_278	[p16l1110t2627r1155b2673],
2	European	JJ	MISC	european	amod	3	SENT_278	[p16l1179t2627r1444b2688],
3	study	NN	O	study	_	0	SENT_278	[p16l1471t2624r1621b2689],
4	of	IN	O	of	_	0	SENT_278	[p16l1644t2623r1704b2673],
5	HLA	NN	O	hlum	prep_of	3	SENT_278	[p16l1722t2627r1916b2673],
6	.	.	O	.	_	0	SENT_278	[p16l1722t2627r1916b2673],

1	—	NN	O	—	_	0	SENT_279	[p16l1722t2627r1916b2673],
2	.	.	O	.	_	0	SENT_279	[p16l1722t2627r1916b2673],

1	B	NN	O	b	_	0	SENT_280	[p16l1722t2627r1916b2673],
2	in	IN	O	in	_	0	SENT_280	[p16l1944t2625r1997b2673],
3	Stevens	NNP	PERSON	Stevens	prep_in	1	SENT_280	[p16l112t2708r568b2766],
4	.	.	O	.	_	0	SENT_280	[p16l112t2708r568b2766],

1	—	NN	O	—	_	0	SENT_281	[p16l112t2708r568b2766],
2	.	.	O	.	_	0	SENT_281	[p16l112t2708r568b2766],

1	Iohnson	NN	MISC	iohnson	nn	2	SENT_282	[p16l112t2708r568b2766],
2	syndrome	NN	O	syndrome	nsubj	7	SENT_282	[p16l593t2707r864b2773],
3	and	CC	O	and	_	0	SENT_282	[p16l890t2708r991b2757],
4	toxic	JJ	O	toxic	amod	6	SENT_282	[p16l1015t2709r1150b2757],
5	epidermal	JJ	O	epidermal	amod	6	SENT_282	[p16l1175t2708r1449b2772],
6	necrolysis	NN	O	necrolysis	nsubj	7	SENT_282	[p16l1474t2708r1741b2773],
7	related	VBN	O	relate	_	0	SENT_282	[p16l1767t2707r1952b2757],
8	to	TO	O	to	aux	9	SENT_282	[p16l1976t2718r2029b2757],
9	ﬁve	VB	O	ﬁve	xcomp	7	SENT_282	[p16l2056t2707r2151b2757],
10	high-risk	JJ	O	high-risk	amod	11	SENT_282	[p16l110t2791r360b2857],
11	drugs	NNS	O	drug	dobj	9	SENT_282	[p16l385t2791r549b2857],
12	.	.	O	.	_	0	SENT_282	[p16l385t2791r549b2857],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_283	[p16l576t2791r989b2857],
2	Genomics	NNP	O	Genomics	_	0	SENT_283	[p16l1013t2793r1266b2841],
3	2008	CD	DATE	2008	num	2	SENT_283	[p16l1292t2796r1435b2849],
4	;	:	O	;	_	0	SENT_283	[p16l1292t2796r1435b2849],
5	18	CD	NUMBER	18	num	7	SENT_283	[p16l1467t2796r1541b2841],
6	:	:	O	:	_	0	SENT_283	[p16l1467t2796r1541b2841],
7	99-107	CD	NUMBER	99-107	dep	2	SENT_283	[p16l1570t2796r1779b2841],
8	.	.	O	.	_	0	SENT_283	[p16l1570t2796r1779b2841],

1	Draghi	NNP	PERSON	Draghi	nn	2	SENT_284	[p16l111t2875r300b2941],
2	M	NNP	O	M	_	0	SENT_284	[p16l325t2879r399b2933],
3	,	,	O	,	_	0	SENT_284	[p16l325t2879r399b2933],
4	Yawata	NNP	ORGANIZATION	Yawata	nn	5	SENT_284	[p16l424t2879r623b2925],
5	N	NNP	ORGANIZATION	N	appos	2	SENT_284	[p16l647t2879r711b2933],
6	,	,	O	,	_	0	SENT_284	[p16l647t2879r711b2933],
7	Gleimer	NNP	O	Gleimer	nn	8	SENT_284	[p16l739t2875r958b2925],
8	M	NNP	O	M	appos	2	SENT_284	[p16l983t2879r1041b2925],
9	et	FW	O	et	nn	10	SENT_284	[p16l1069t2886r1116b2925],
10	al.	FW	O	al.	dep	8	SENT_284	[p16l1138t2875r1197b2925],
11	.	.	O	.	_	0	SENT_284	[p16l1138t2875r1197b2925],

1	Single-cell	JJ	O	single-cell	amod	2	SENT_285	[p16l1228t2875r1507b2941],
2	analysis	NN	O	analysis	_	0	SENT_285	[p16l1533t2875r1741b2941],
3	of	IN	O	of	_	0	SENT_285	[p16l1768t2875r1828b2925],
4	the	DT	O	the	det	8	SENT_285	[p16l1845t2875r1930b2925],
5	human	JJ	O	human	amod	8	SENT_285	[p16l1956t2875r2151b2925],
6	NK	NN	O	nk	nn	8	SENT_285	[p16l110t2963r205b3009],
7	cell	NN	O	cell	nn	8	SENT_285	[p16l230t2959r319b3009],
8	response	NN	O	response	prep_of	2	SENT_285	[p16l344t2976r581b3024],
9	to	TO	O	to	_	0	SENT_285	[p16l606t2969r660b3009],
10	missing	VBG	O	miss	amod	11	SENT_285	[p16l687t2961r895b3025],
11	self	NN	O	self	prep_to	8	SENT_285	[p16l921t2959r1015b3009],
12	and	CC	O	and	_	0	SENT_285	[p16l1034t2959r1134b3009],
13	its	PRP$	O	its	poss	14	SENT_285	[p16l1160t2961r1221b3009],
14	inhibition	NN	O	inhibition	prep_to	8	SENT_285	[p16l1247t2959r1522b3009],
15	by	IN	O	by	dep	19	SENT_285	[p16l1546t2959r1613b3025],
16	HLA	NN	O	hlum	nn	18	SENT_285	[p16l1636t2962r1768b3008],
17	class	NN	O	class	nn	18	SENT_285	[p16l1793t2959r1913b3009],
18	I.	NN	O	i.	pobj	15	SENT_285	[p16l1940t2963r1974b3009],
19	Blood	NN	O	blood	rcmod	14	SENT_285	[p16l2000t2959r2152b3009],
20	2005	CD	DATE	2005	num	19	SENT_285	[p16l111t3048r254b3100],
21	;	:	O	;	_	0	SENT_285	[p16l111t3048r254b3100],
22	105	CD	NUMBER	105	dep	2	SENT_285	[p16l286t3048r394b3092],
23	:	:	O	:	_	0	SENT_285	[p16l286t3048r394b3092],
24	2028-2035	CD	DATE	2028-2035	dep	22	SENT_285	[p16l422t3048r730b3093],
25	.	.	O	.	_	0	SENT_285	[p16l422t3048r730b3093],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_286	[p16l112t3128r296b3193],
2	WH	NNP	PERSON	WH	_	0	SENT_286	[p16l320t3132r451b3186],
3	,	,	O	,	_	0	SENT_286	[p16l320t3132r451b3186],
4	Hung	NNP	O	Hung	nn	5	SENT_286	[p16l479t3132r635b3193],
5	SI	NNP	O	SI	appos	2	SENT_286	[p16l661t3131r727b3178],
6	.	.	O	.	_	0	SENT_286	[p16l661t3131r727b3178],

1	Genetic	JJ	O	genetic	amod	2	SENT_287	[p16l756t3130r964b3178],
2	markers	NNS	O	marker	_	0	SENT_287	[p16l989t3128r1208b3178],
3	and	CC	O	and	_	0	SENT_287	[p16l1236t3128r1336b3178],
4	danger	NN	O	danger	nn	5	SENT_287	[p16l1362t3128r1548b3193],
5	signals	NNS	O	signal	conj_and	2	SENT_287	[p16l1574t3128r1753b3193],
6	in	IN	O	in	_	0	SENT_287	[p16l1780t3130r1833b3177],
7	StevensIohson	NN	O	stevensiohson	nn	8	SENT_287	[p16l1859t3131r2082b3178, p16l111t3212r300b3270],
8	syndrome	NN	O	syndrome	prep_in	2	SENT_287	[p16l327t3212r598b3277],
9	and	CC	O	and	_	0	SENT_287	[p16l624t3212r725b3262],
10	Toxic	JJ	O	toxic	amod	12	SENT_287	[p16l750t3214r904b3262],
11	epidermal	JJ	O	epidermal	amod	12	SENT_287	[p16l930t3212r1206b3277],
12	Necrolysis	NNP	O	Necrolysis	prep_in	2	SENT_287	[p16l1230t3212r1525b3277],
13	.	.	O	.	_	0	SENT_287	[p16l1230t3212r1525b3277],

1	Allergol	NNP	O	Allergol	nn	2	SENT_288	[p16l1549t3212r1758b3277],
2	Int	NNP	O	Int	_	0	SENT_288	[p16l1780t3216r1863b3262],
3	2010	CD	DATE	2010	num	2	SENT_288	[p16l1884t3217r2027b3269],
4	;	:	O	;	_	0	SENT_288	[p16l1884t3217r2027b3269],
5	59	CD	NUMBER	59	num	7	SENT_288	[p16l2055t3217r2133b3262],
6	:	:	O	:	_	0	SENT_288	[p16l2055t3217r2133b3262],
7	325-332	CD	NUMBER	325-332	dep	2	SENT_288	[p16l112t3300r353b3345],
8	.	.	O	.	_	0	SENT_288	[p16l112t3300r353b3345],

1	Braden	NNP	PERSON	Braden	nn	2	SENT_289	[p17l111t24r306b74],
2	GL	NNP	PERSON	GL	nsubj	15	SENT_289	[p17l332t26r427b81],
3	,	,	O	,	_	0	SENT_289	[p17l332t26r427b81],
4	Warzynski	NNP	PERSON	Warzynski	nn	6	SENT_289	[p17l453t24r744b89],
5	M	NNP	O	M	nn	6	SENT_289	[p17l770t27r867b82],
6	]	NN	O	]	appos	2	SENT_289	[p17l770t27r867b82],
7	,	,	O	,	_	0	SENT_289	[p17l770t27r867b82],
8	Golightly	NNP	PERSON	Golightly	nn	9	SENT_289	[p17l895t24r1151b89],
9	M	NNP	O	M	appos	2	SENT_289	[p17l1173t27r1247b81],
10	,	,	O	,	_	0	SENT_289	[p17l1173t27r1247b81],
11	Ballow	NNP	PERSON	Ballow	nn	14	SENT_289	[p17l1275t24r1461b74],
12	M.	NNP	O	M.	nn	14	SENT_289	[p17l1483t27r1556b74],
13	Cell	NNP	O	Cell	nn	14	SENT_289	[p17l1586t24r1972b74],
14	—	NNP	O	—	appos	2	SENT_289	[p17l1586t24r1972b74],
15	mediated	VBD	O	mediate	_	0	SENT_289	[p17l1586t24r1972b74],
16	immunity	NN	O	immunity	nsubj	20	SENT_289	[p17l111t109r387b173],
17	in	IN	O	in	_	0	SENT_289	[p17l411t109r464b157],
18	allopurinol	NN	O	allopurinol	nn	19	SENT_289	[p17l490t107r1043b172],
19	—	NN	O	—	prep_in	16	SENT_289	[p17l490t107r1043b172],
20	induced	VBD	O	induce	ccomp	15	SENT_289	[p17l490t107r1043b172],
21	hypersensitivity	NN	O	hypersensitivity	dobj	20	SENT_289	[p17l1068t108r1512b173],
22	.	.	O	.	_	0	SENT_289	[p17l1068t108r1512b173],

1	Clin	NNP	O	Clin	nn	3	SENT_290	[p17l1543t107r1653b158],
2	Immunol	NNP	O	Immunol	nn	3	SENT_290	[p17l1677t107r1927b157],
3	Immunopathol	NNP	O	Immunopathol	_	0	SENT_290	[p17l1950t111r2138b157, p17l113t192r345b257],
4	1994	CD	DATE	1994	num	3	SENT_290	[p17l375t197r513b250],
5	;	:	O	;	_	0	SENT_290	[p17l375t197r513b250],
6	70	CD	NUMBER	70	num	8	SENT_290	[p17l541t197r619b242],
7	:	:	O	:	_	0	SENT_290	[p17l541t197r619b242],
8	145-151	CD	NUMBER	145-151	dep	3	SENT_290	[p17l652t197r889b242],
9	.	.	O	.	_	0	SENT_290	[p17l652t197r889b242],

1	Halevy	NNP	PERSON	Halevy	nn	2	SENT_291	[p17l111t276r302b341],
2	S	NNP	O	S	_	0	SENT_291	[p17l326t279r370b333],
3	,	,	O	,	_	0	SENT_291	[p17l326t279r370b333],
4	Cohen	NNP	PERSON	Cohen	nn	5	SENT_291	[p17l398t276r578b326],
5	AD	NN	O	ad	appos	2	SENT_291	[p17l601t279r709b333],
6	,	,	O	,	_	0	SENT_291	[p17l601t279r709b333],
7	Livni	NNP	PERSON	Livni	nn	11	SENT_291	[p17l737t278r876b326],
8	E.	NNP	O	E.	nn	11	SENT_291	[p17l902t280r951b326],
9	The	NNP	O	The	nn	11	SENT_291	[p17l979t276r1083b326],
10	diagnostic	JJ	O	diagnostic	amod	11	SENT_291	[p17l1110t276r1389b341],
11	role	NN	O	role	appos	2	SENT_291	[p17l1415t276r1518b326],
12	of	IN	O	of	_	0	SENT_291	[p17l1544t276r1605b326],
13	the	DT	O	the	prep_of	11	SENT_291	[p17l1621t276r1706b326],
14	in	FW	O	in	nn	15	SENT_291	[p17l1733t278r1782b326],
15	vitro	FW	O	vitro	advmod	21	SENT_291	[p17l1809t278r1930b326],
16	druginduced	JJ	O	druginduced	amod	21	SENT_291	[p17l1957t276r2106b341, p17l111t360r331b410],
17	interferon	NN	O	interferon	nn	21	SENT_291	[p17l357t360r861b425],
18	—	NN	O	—	nn	21	SENT_291	[p17l357t360r861b425],
19	gamma	NN	O	gamma	nn	21	SENT_291	[p17l357t360r861b425],
20	release	NN	O	release	nn	21	SENT_291	[p17l887t360r1066b410],
21	test	NN	O	test	dep	13	SENT_291	[p17l1091t370r1186b410],
22	in	IN	O	in	_	0	SENT_291	[p17l1211t361r1264b409],
23	Stevens	NNP	O	Stevens	prep_in	21	SENT_291	[p17l1291t360r1746b418],
24	—	CD	NUMBER	—	num	23	SENT_291	[p17l1291t360r1746b418],
25	]	CD	NUMBER	]	num	27	SENT_291	[p17l1291t360r1746b418],
26	ohnson	NN	O	ohnson	nn	27	SENT_291	[p17l1291t360r1746b418],
27	syndrome	NN	O	syndrome	dep	13	SENT_291	[p17l1773t360r2057b425],
28	.	.	O	.	_	0	SENT_291	[p17l1773t360r2057b425],

1	Int	NN	O	int	_	0	SENT_292	[p17l109t446r238b500],
2	]	CD	NUMBER	]	num	1	SENT_292	[p17l109t446r238b500],
3	Dermatol	NNP	O	Dermatol	dep	1	SENT_292	[p17l257t443r512b492],
4	1999	CD	DATE	1999	num	3	SENT_292	[p17l541t447r679b500],
5	;	:	O	;	_	0	SENT_292	[p17l541t447r679b500],
6	38	CD	NUMBER	38	num	8	SENT_292	[p17l708t447r785b492],
7	:	:	O	:	_	0	SENT_292	[p17l708t447r785b492],
8	835-840	CD	NUMBER	835-840	dep	1	SENT_292	[p17l814t447r1056b492],
9	.	.	O	.	_	0	SENT_292	[p17l814t447r1056b492],

1	Britschgi	NNP	MISC	Britschgi	nn	2	SENT_293	[p17l111t527r352b592],
2	M	NNP	MISC	M	_	0	SENT_293	[p17l378t530r452b584],
3	,	,	O	,	_	0	SENT_293	[p17l378t530r452b584],
4	Pichler	NNP	PERSON	Pichler	nn	5	SENT_293	[p17l480t527r670b576],
5	WI	NNP	O	WI	appos	2	SENT_293	[p17l693t530r794b585],
6	.	.	O	.	_	0	SENT_293	[p17l693t530r794b585],

1	Acute	JJ	O	acute	nsubj	11	SENT_294	[p17l820t530r980b576],
2	generalized	VBN	O	generalize	partmod	1	SENT_294	[p17l1006t526r1313b592],
3	exanthematous	JJ	O	exanthematous	amod	4	SENT_294	[p17l1339t527r1755b577],
4	pustulosis	NN	O	pustulosis	dobj	2	SENT_294	[p17l1780t527r2069b591],
5	,	,	O	,	_	0	SENT_294	[p17l1780t527r2069b591],
6	a	DT	O	a	det	7	SENT_294	[p17l111t628r139b660],
7	clue	NN	O	clue	appos	4	SENT_294	[p17l165t611r273b661],
8	to	TO	O	to	_	0	SENT_294	[p17l298t621r351b660],
9	neutrophil	NN	O	neutrophil	nn	10	SENT_294	[p17l379t611r951b675],
10	—	NN	O	—	prep_to	7	SENT_294	[p17l379t611r951b675],
11	mediated	VBD	O	mediate	_	0	SENT_294	[p17l379t611r951b675],
12	inﬂammatory	JJ	O	inﬂammatory	amod	13	SENT_294	[p17l977t610r1357b676],
13	processes	NNS	O	process	dobj	11	SENT_294	[p17l1379t628r1632b675],
14	orchestrated	VBN	O	orchestrate	partmod	13	SENT_294	[p17l1660t611r1998b661],
15	by	IN	O	by	_	0	SENT_294	[p17l2022t610r2089b676],
16	T	NN	O	t	nn	17	SENT_294	[p17l110t696r149b744],
17	cells	NNS	O	cell	agent	14	SENT_294	[p17l176t694r302b744],
18	.	.	O	.	_	0	SENT_294	[p17l176t694r302b744],

1	Curr	NNP	O	Curr	nn	5	SENT_295	[p17l333t697r460b744],
2	Opin	NNP	O	Opin	nn	5	SENT_295	[p17l485t696r616b760],
3	Allergy	NNP	O	Allergy	nn	5	SENT_295	[p17l638t694r829b760],
4	Clin	NNP	O	Clin	nn	5	SENT_295	[p17l855t694r965b744],
5	Immunol	NNP	O	Immunol	_	0	SENT_295	[p17l989t694r1239b744],
6	2002	CD	DATE	2002	num	5	SENT_295	[p17l1264t699r1407b752],
7	;	:	O	;	_	0	SENT_295	[p17l1264t699r1407b752],
8	2	CD	NUMBER	2	num	10	SENT_295	[p17l1434t699r1479b744],
9	:	:	O	:	_	0	SENT_295	[p17l1434t699r1479b744],
10	325-331	CD	NUMBER	325-331	dep	5	SENT_295	[p17l1508t699r1749b744],
11	.	.	O	.	_	0	SENT_295	[p17l1508t699r1749b744],

1	Lockard	NNP	PERSON	Lockard	nn	3	SENT_296	[p17l111t778r334b828],
2	o	NN	O	o	nn	3	SENT_296	[p17l361t781r407b828],
3	Ir	NNP	O	Ir	_	0	SENT_296	[p17l434t782r494b837],
4	,	,	O	,	_	0	SENT_296	[p17l434t782r494b837],
5	Harmon	NNP	PERSON	Harmon	nn	6	SENT_296	[p17l522t782r756b828],
6	C	NNP	O	C	appos	3	SENT_296	[p17l783t781r839b836],
7	,	,	O	,	_	0	SENT_296	[p17l783t781r839b836],
8	Nolph	NNP	O	Nolph	nn	9	SENT_296	[p17l866t778r1040b843],
9	K	NNP	O	K	appos	3	SENT_296	[p17l1066t782r1122b836],
10	,	,	O	,	_	0	SENT_296	[p17l1066t782r1122b836],
11	Irvin	NNP	PERSON	Irvin	nn	14	SENT_296	[p17l1150t780r1283b828],
12	W.	NNP	O	W.	nn	14	SENT_296	[p17l1306t782r1384b828],
13	Allergic	JJ	O	allergic	amod	14	SENT_296	[p17l1411t778r1621b844],
14	reaction	NN	O	reaction	appos	3	SENT_296	[p17l1647t780r1869b828],
15	to	TO	O	to	_	0	SENT_296	[p17l1894t788r1947b828],
16	allopurinol	NN	O	allopurinol	prep_to	14	SENT_296	[p17l1975t778r2095b828, p17l110t862r316b927],
17	with	IN	O	with	_	0	SENT_296	[p17l339t862r462b912],
18	cross	JJ	O	cross	amod	20	SENT_296	[p17l488t864r904b927],
19	—	NN	O	—	nn	20	SENT_296	[p17l488t864r904b927],
20	reactivity	NN	O	reactivity	prep_with	16	SENT_296	[p17l488t864r904b927],
21	to	TO	O	to	_	0	SENT_296	[p17l927t872r981b912],
22	oxypurinol	NN	O	oxypurinol	prep_to	20	SENT_296	[p17l1008t862r1325b928],
23	.	.	O	.	_	0	SENT_296	[p17l1008t862r1325b928],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_297	[p17l1349t865r1465b912],
2	Intern	NNP	O	Intern	nn	3	SENT_297	[p17l1490t866r1653b912],
3	Med	NNP	O	Med	_	0	SENT_297	[p17l1678t862r1800b912],
4	1976	CD	DATE	1976	num	3	SENT_297	[p17l1829t867r1967b920],
5	;	:	O	;	_	0	SENT_297	[p17l1829t867r1967b920],
6	85	CD	NUMBER	85	num	8	SENT_297	[p17l1995t867r2073b912],
7	:	:	O	:	_	0	SENT_297	[p17l1995t867r2073b912],
8	333-335	CD	NUMBER	333-335	dep	3	SENT_297	[p17l112t951r353b995],
9	.	.	O	.	_	0	SENT_297	[p17l112t951r353b995],

1	Hamanaka	NN	PERSON	hamanaka	nn	2	SENT_298	[p17l111t1031r409b1081],
2	H	NN	PERSON	h	_	0	SENT_298	[p17l434t1035r499b1088],
3	,	,	O	,	_	0	SENT_298	[p17l434t1035r499b1088],
4	Mizutani	NNP	PERSON	Mizutani	nn	5	SENT_298	[p17l526t1033r776b1081],
5	H	NNP	PERSON	H	appos	2	SENT_298	[p17l802t1035r867b1088],
6	,	,	O	,	_	0	SENT_298	[p17l802t1035r867b1088],
7	Nouchi	NNP	O	Nouchi	nn	8	SENT_298	[p17l894t1031r1099b1081],
8	N	NNP	O	N	appos	2	SENT_298	[p17l1124t1035r1173b1081],
9	et	FW	O	et	nn	10	SENT_298	[p17l1199t1041r1247b1081],
10	al.	FW	O	al.	dep	8	SENT_298	[p17l1268t1031r1327b1081],
11	.	.	O	.	_	0	SENT_298	[p17l1268t1031r1327b1081],

1	Allopurinol	NN	O	allopurinol	nn	3	SENT_299	[p17l1355t1031r1677b1096],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_299	[p17l1701t1031r2134b1096],
3	syndrome	NN	O	syndrome	_	0	SENT_299	[p17l112t1115r396b1180],
4	:	:	O	:	_	0	SENT_299	[p17l112t1115r396b1180],
5	hypersensitivity	NN	O	hypersensitivity	dep	3	SENT_299	[p17l424t1115r858b1180],
6	to	TO	O	to	_	0	SENT_299	[p17l880t1125r934b1165],
7	oxypurinol	NN	O	oxypurinol	prep_to	5	SENT_299	[p17l961t1115r1264b1180],
8	but	CC	O	but	_	0	SENT_299	[p17l1288t1115r1381b1165],
9	not	RB	O	not	_	0	SENT_299	[p17l1407t1125r1499b1165],
10	allopurinol	NN	O	allopurinol	conj_negcc	7	SENT_299	[p17l1524t1115r1841b1180],
11	.	.	O	.	_	0	SENT_299	[p17l1524t1115r1841b1180],

1	Clin	NNP	O	Clin	nn	3	SENT_300	[p17l1873t1115r1982b1165],
2	Exp	NNP	O	Exp	nn	3	SENT_300	[p17l2008t1119r2108b1180],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_300	[p17l109t1198r364b1247],
4	1998	CD	DATE	1998	num	3	SENT_300	[p17l394t1202r532b1255],
5	;	:	O	;	_	0	SENT_300	[p17l394t1202r532b1255],
6	23	CD	NUMBER	23	num	8	SENT_300	[p17l560t1202r638b1247],
7	:	:	O	:	_	0	SENT_300	[p17l560t1202r638b1247],
8	32-34	CD	NUMBER	32-34	dep	3	SENT_300	[p17l667t1202r842b1247],
9	.	.	O	.	_	0	SENT_300	[p17l667t1202r842b1247],

1	Young	NNP	O	Young	nn	3	SENT_301	[p17l109t1285r291b1347],
2	IL	NN	O	il	nn	3	SENT_301	[p17l316t1285r373b1340],
3	Ir	NNP	O	Ir	_	0	SENT_301	[p17l398t1285r458b1340],
4	,	,	O	,	_	0	SENT_301	[p17l398t1285r458b1340],
5	Boswell	NNP	ORGANIZATION	Boswell	nn	6	SENT_301	[p17l486t1282r693b1332],
6	RB	NN	ORGANIZATION	rb	appos	3	SENT_301	[p17l719t1285r813b1339],
7	,	,	O	,	_	0	SENT_301	[p17l719t1285r813b1339],
8	Nies	NNPS	PERSON	Nies	nn	9	SENT_301	[p17l840t1283r960b1332],
9	AS	NNP	O	AS	appos	6	SENT_301	[p17l983t1284r1074b1332],
10	.	.	O	.	_	0	SENT_301	[p17l983t1284r1074b1332],

1	Severe	JJ	O	severe	amod	2	SENT_302	[p17l1103t1285r1274b1332],
2	allopurinol	NN	O	allopurinol	_	0	SENT_302	[p17l1301t1282r1605b1346],
3	hypersensitivity	NN	O	hypersensitivity	dep	2	SENT_302	[p17l1630t1282r2073b1347],
4	.	.	O	.	_	0	SENT_302	[p17l1630t1282r2073b1347],

1	Association	NNP	O	Association	_	0	SENT_303	[p17l109t1367r427b1416],
2	with	IN	O	with	_	0	SENT_303	[p17l451t1365r573b1416],
3	thiazides	NNS	O	thiazide	prep_with	1	SENT_303	[p17l598t1366r838b1416],
4	and	CC	O	and	_	0	SENT_303	[p17l865t1365r966b1416],
5	prior	JJ	O	prior	amod	7	SENT_303	[p17l990t1367r1129b1430],
6	renal	JJ	O	renal	amod	7	SENT_303	[p17l1155t1365r1290b1416],
7	compromise	NN	O	compromise	prep_with	1	SENT_303	[p17l1316t1367r1672b1430],
8	.	.	O	.	_	0	SENT_303	[p17l1316t1367r1672b1430],

1	Arch	NNP	O	Arch	nn	3	SENT_304	[p17l1697t1366r1825b1416],
2	Intern	NNP	O	Intern	nn	3	SENT_304	[p17l1849t1369r2013b1416],
3	Med	NNP	O	Med	_	0	SENT_304	[p17l108t1449r231b1498],
4	1974	CD	DATE	1974	num	3	SENT_304	[p17l260t1453r398b1506],
5	;	:	O	;	_	0	SENT_304	[p17l260t1453r398b1506],
6	134	CD	NUMBER	134	num	8	SENT_304	[p17l430t1453r537b1498],
7	:	:	O	:	_	0	SENT_304	[p17l430t1453r537b1498],
8	553-558	CD	NUMBER	553-558	dep	3	SENT_304	[p17l568t1453r808b1498],
9	.	.	O	.	_	0	SENT_304	[p17l568t1453r808b1498],

1	©	RB	O	©	dep	2	SENT_305	[p17l1623t1673r1665b1715],
2	2011	CD	DATE	2011	dep	4	SENT_305	[p17l1689t1672r1806b1715],
3	The	DT	O	the	det	4	SENT_305	[p17l1838t1671r1933b1715],
4	Authors	NNPS	O	Authors	_	0	SENT_305	[p17l1953t1671r2151b1715],

1	IEADV	NNP	O	IEADV	dep	19	SENT_306	[p17l79t1730r178b1757],
2	2012	CD	DATE	2012	num	1	SENT_306	[p17l185t1733r249b1756],
3	,	,	O	,	_	0	SENT_306	[p17l185t1733r249b1756],
4	26	CD	NUMBER	26	num	1	SENT_306	[p17l260t1733r295b1756],
5	,	,	O	,	_	0	SENT_306	[p17l260t1733r295b1756],
6	1424-1430	CD	DATE	1424-1430	num	7	SENT_306	[p17l308t1733r438b1753],
7	Journal	NNP	O	Journal	appos	1	SENT_306	[p17l558t1733r641b1753],
8	of	IN	O	of	_	0	SENT_306	[p17l652t1733r674b1753],
9	the	DT	O	the	det	11	SENT_306	[p17l682t1733r718b1753],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_306	[p17l729t1733r838b1758],
11	Academy	NN	ORGANIZATION	academy	prep_of	1	SENT_306	[p17l849t1733r958b1758],
12	of	IN	ORGANIZATION	of	_	0	SENT_306	[p17l967t1733r989b1753],
13	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	11	SENT_306	[p17l999t1733r1145b1758],
14	and	CC	O	and	_	0	SENT_306	[p17l1155t1733r1197b1753],
15	Venereology	NNP	O	Venereology	prep_of	11	SENT_306	[p17l1207t1733r1350b1758],
16	©	CD	NUMBER	©	dep	19	SENT_306	[p17l1360t1734r1379b1753],
17	2011	CD	DATE	2011	num	19	SENT_306	[p17l1390t1733r1444b1753],
18	European	JJ	ORGANIZATION	european	amod	19	SENT_306	[p17l1459t1733r1568b1758],
19	Academy	NN	ORGANIZATION	academy	_	0	SENT_306	[p17l1579t1733r1688b1758],
20	of	IN	ORGANIZATION	of	_	0	SENT_306	[p17l1698t1733r1719b1753],
21	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	19	SENT_306	[p17l1730t1733r1875b1758],
22	and	CC	O	and	_	0	SENT_306	[p17l1885t1733r1927b1753],
23	Venereology	NNP	O	Venereology	prep_of	19	SENT_306	[p17l1937t1733r2080b1758],

1	1430	CD	DATE	1430	num	2	SENT_307	[p17l82t1839r143b1861],
2	Atzori	NNP	O	Atzori	_	0	SENT_307	[p17l1889t1833r1982b1861],
3	et	FW	O	et	nn	4	SENT_307	[p17l1997t1835r2030b1861],
4	al.	FW	O	al.	dep	2	SENT_307	[p17l2041t1833r2075b1861],
5	.	.	O	.	_	0	SENT_307	[p17l2041t1833r2075b1861],

1	32	CD	NUMBER	32	_	0	SENT_308	[p17l81t1972r108b1993],
2	Garcia	NNP	PERSON	Garcia	dep	1	SENT_308	[p17l129t1970r295b1993],
3	.	.	O	.	_	0	SENT_308	[p17l129t1970r295b1993],

1	—	NN	O	—	_	0	SENT_309	[p17l129t1970r295b1993],
2	.	.	O	.	_	0	SENT_309	[p17l129t1970r295b1993],

1	Doval	NNP	O	Doval	nn	2	SENT_310	[p17l129t1970r295b1993],
2	I	NNP	O	I	_	0	SENT_310	[p17l306t1972r322b1996],
3	,	,	O	,	_	0	SENT_310	[p17l306t1972r322b1996],
4	LeCleach	NNP	O	LeCleach	nn	5	SENT_310	[p17l335t1970r447b1993],
5	L	NNP	O	L	appos	2	SENT_310	[p17l459t1972r481b1996],
6	,	,	O	,	_	0	SENT_310	[p17l459t1972r481b1996],
7	Bocquet	NNP	PERSON	Bocquet	nn	8	SENT_310	[p17l494t1972r595b2000],
8	H	NNP	O	H	appos	2	SENT_310	[p17l606t1972r629b1993],
9	et	FW	O	et	nn	10	SENT_310	[p17l641t1975r663b1993],
10	al.	FW	O	al.	dep	8	SENT_310	[p17l673t1970r699b1993],
11	.	.	O	.	_	0	SENT_310	[p17l673t1970r699b1993],

1	Toxic	JJ	O	toxic	amod	3	SENT_311	[p17l713t1971r783b1993],
2	epidermal	JJ	O	epidermal	amod	3	SENT_311	[p17l795t1970r919b2000],
3	necrolysis	NN	O	necrolysis	dep	8	SENT_311	[p17l931t1970r1052b2000],
4	and	CC	O	and	_	0	SENT_311	[p17l128t2008r174b2031],
5	Stevens	NNP	PERSON	Stevens	dep	8	SENT_311	[p17l186t2008r393b2035],
6	—	CD	NUMBER	—	dep	8	SENT_311	[p17l186t2008r393b2035],
7	]	CD	NUMBER	]	num	8	SENT_311	[p17l186t2008r393b2035],
8	ohnson	NN	O	ohnson	dep	11	SENT_311	[p17l186t2008r393b2035],
9	syndrome	NN	O	syndrome	dep	8	SENT_311	[p17l404t2008r534b2038],
10	:	:	O	:	_	0	SENT_311	[p17l404t2008r534b2038],
11	does	VBZ	O	do	_	0	SENT_311	[p17l547t2008r602b2031],
12	early	JJ	O	early	amod	13	SENT_311	[p17l614t2008r674b2038],
13	withdrawal	NN	O	withdrawal	nsubj	17	SENT_311	[p17l683t2008r823b2031],
14	of	IN	O	of	_	0	SENT_311	[p17l835t2008r862b2031],
15	causative	JJ	O	causative	amod	16	SENT_311	[p17l870t2009r982b2031],
16	drugs	NNS	O	drug	prep_of	13	SENT_311	[p17l128t2046r197b2076],
17	decrease	VBP	O	decrease	ccomp	11	SENT_311	[p17l209t2046r312b2069],
18	the	DT	O	the	det	19	SENT_311	[p17l323t2046r362b2069],
19	risk	NN	O	risk	dobj	17	SENT_311	[p17l373t2046r419b2069],
20	of	IN	O	of	_	0	SENT_311	[p17l430t2046r457b2069],
21	death	NN	O	death	prep_of	19	SENT_311	[p17l466t2046r543b2069],
22	?	.	O	?	_	0	SENT_311	[p17l466t2046r543b2069],

1	Arch	NNP	O	Arch	nn	2	SENT_312	[p17l554t2046r612b2069],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_312	[p17l623t2046r739b2069],
3	2000	CD	DATE	2000	num	2	SENT_312	[p17l750t2048r815b2072],
4	;	:	O	;	_	0	SENT_312	[p17l750t2048r815b2072],
5	136	CD	NUMBER	136	num	7	SENT_312	[p17l829t2048r878b2069],
6	:	:	O	:	_	0	SENT_312	[p17l829t2048r878b2069],
7	323327	CD	NUMBER	323327	dep	2	SENT_312	[p17l892t2048r951b2069, p17l129t2086r178b2107],
8	.	.	O	.	_	0	SENT_312	[p17l892t2048r951b2069, p17l129t2086r178b2107],

1	Schneck	NNP	PERSON	Schneck	nn	2	SENT_313	[p17l128t2122r230b2145],
2	I	NNP	O	I	_	0	SENT_313	[p17l241t2124r257b2149],
3	,	,	O	,	_	0	SENT_313	[p17l241t2124r257b2149],
4	Fagot	NNP	O	Fagot	nn	5	SENT_313	[p17l270t2124r338b2152],
5	JP	NNP	O	JP	appos	2	SENT_313	[p17l349t2124r383b2149],
6	,	,	O	,	_	0	SENT_313	[p17l349t2124r383b2149],
7	Sekula	NNP	PERSON	Sekula	nn	8	SENT_313	[p17l396t2122r476b2145],
8	P	NN	PERSON	p	appos	2	SENT_313	[p17l487t2124r503b2145],
9	et	FW	O	et	nn	10	SENT_313	[p17l515t2127r537b2145],
10	al.	FW	O	al.	dep	8	SENT_313	[p17l547t2122r573b2145],
11	.	.	O	.	_	0	SENT_313	[p17l547t2122r573b2145],

1	Effects	NNS	O	effect	dep	12	SENT_314	[p17l587t2122r668b2145],
2	of	IN	O	of	_	0	SENT_314	[p17l680t2122r707b2145],
3	treatments	NNS	O	treatment	prep_of	1	SENT_314	[p17l715t2126r848b2145],
4	on	IN	O	on	_	0	SENT_314	[p17l860t2130r891b2145],
5	the	DT	O	the	det	6	SENT_314	[p17l903t2122r941b2145],
6	mortality	NN	O	mortality	prep_on	3	SENT_314	[p17l953t2122r1046b2145, p17l128t2161r160b2190],
7	of	IN	O	of	_	0	SENT_314	[p17l171t2160r198b2183],
8	Stevens	NNP	PERSON	Stevens	prep_of	6	SENT_314	[p17l207t2160r413b2187],
9	—	CD	NUMBER	—	num	8	SENT_314	[p17l207t2160r413b2187],
10	]	CD	NUMBER	]	num	11	SENT_314	[p17l207t2160r413b2187],
11	ohnson	NN	O	ohnson	dep	12	SENT_314	[p17l207t2160r413b2187],
12	syndrome	NN	O	syndrome	dep	20	SENT_314	[p17l425t2160r548b2190],
13	and	CC	O	and	_	0	SENT_314	[p17l560t2160r606b2183],
14	toxic	JJ	O	toxic	amod	16	SENT_314	[p17l617t2161r678b2183],
15	epidermal	JJ	O	epidermal	amod	16	SENT_314	[p17l690t2160r815b2190],
16	necrolysis	NN	O	necrolysis	conj_and	12	SENT_314	[p17l826t2160r954b2190],
17	:	:	O	:	_	0	SENT_314	[p17l826t2160r954b2190],
18	a	DT	O	a	det	20	SENT_314	[p17l967t2168r980b2183],
19	retrospective	JJ	O	retrospective	amod	20	SENT_314	[p17l128t2199r287b2228],
20	study	NN	O	study	_	0	SENT_314	[p17l299t2198r367b2228],
21	on	IN	O	on	_	0	SENT_314	[p17l378t2206r409b2221],
22	patients	NNS	O	patient	prep_on	20	SENT_314	[p17l421t2199r519b2228],
23	included	VBN	O	include	partmod	20	SENT_314	[p17l531t2198r638b2221],
24	in	IN	O	in	_	0	SENT_314	[p17l650t2199r674b2221],
25	the	DT	O	the	det	28	SENT_314	[p17l686t2198r724b2221],
26	prospective	JJ	O	prospective	amod	28	SENT_314	[p17l735t2199r877b2228],
27	EuroSCAR	NN	O	euroscar	nn	28	SENT_314	[p17l889t2199r1025b2221],
28	Study	NN	O	study	prep_in	23	SENT_314	[p17l128t2236r205b2266],
29	.	.	O	.	_	0	SENT_314	[p17l128t2236r205b2266],

1	I	PRP	O	I	nsubj	4	SENT_315	[p17l216t2238r230b2263],
2	Am	VBP	O	be	cop	4	SENT_315	[p17l237t2238r281b2259],
3	Acud	NNP	O	Acud	nn	4	SENT_315	[p17l291t2236r354b2259],
4	Dermatol	NNP	O	Dermatol	_	0	SENT_315	[p17l364t2236r480b2259],
5	2008	CD	DATE	2008	dep	4	SENT_315	[p17l491t2238r556b2262],
6	;	:	O	;	_	0	SENT_315	[p17l491t2238r556b2262],
7	58	CD	NUMBER	58	num	9	SENT_315	[p17l569t2239r604b2259],
8	:	:	O	:	_	0	SENT_315	[p17l569t2239r604b2259],
9	33-40	CD	NUMBER	33-40	dep	4	SENT_315	[p17l617t2238r697b2259],
10	.	.	O	.	_	0	SENT_315	[p17l617t2238r697b2259],

1	34	CD	NUMBER	34	num	3	SENT_316	[p17l81t2276r109b2297],
2	Harr	NN	PERSON	harr	nn	3	SENT_316	[p17l128t2276r188b2297],
3	T	NN	O	t	_	0	SENT_316	[p17l199t2275r223b2300],
4	,	,	O	,	_	0	SENT_316	[p17l199t2275r223b2300],
5	French	JJ	MISC	french	amod	6	SENT_316	[p17l236t2274r321b2297],
6	LE	NNP	O	LE	appos	3	SENT_316	[p17l333t2276r371b2297],
7	.	.	O	.	_	0	SENT_316	[p17l333t2276r371b2297],

1	Toxic	JJ	O	toxic	amod	3	SENT_317	[p17l384t2275r454b2297],
2	epidermal	JJ	O	epidermal	amod	3	SENT_317	[p17l466t2274r590b2304],
3	necrolysis	NN	O	necrolysis	_	0	SENT_317	[p17l602t2274r723b2304],
4	and	CC	O	and	_	0	SENT_317	[p17l735t2274r781b2297],
5	Stevens	NNP	PERSON	Stevens	conj_and	3	SENT_317	[p17l793t2274r1000b2301],
6	—	CD	NUMBER	—	number	7	SENT_317	[p17l793t2274r1000b2301],
7	]	CD	NUMBER	]	dep	3	SENT_317	[p17l793t2274r1000b2301],
8	ohnson	NN	O	ohnson	nn	9	SENT_317	[p17l793t2274r1000b2301],
9	syndrome	NN	O	syndrome	dep	7	SENT_317	[p17l128t2312r258b2342],
10	.	.	O	.	_	0	SENT_317	[p17l128t2312r258b2342],

1	Orphanet	NNP	O	Orphanet	nn	4	SENT_318	[p17l272t2312r388b2342],
2	I	NNP	O	I	nn	4	SENT_318	[p17l396t2314r409b2339],
3	Rare	NNP	O	Rare	nn	4	SENT_318	[p17l418t2314r474b2335],
4	Dis	NNP	O	Dis	_	0	SENT_318	[p17l485t2313r525b2335],
5	2010	CD	DATE	2010	num	4	SENT_318	[p17l537t2314r602b2338],
6	;	:	O	;	_	0	SENT_318	[p17l537t2314r602b2338],
7	5	CD	NUMBER	5	num	9	SENT_318	[p17l614t2315r634b2335],
8	:	:	O	:	_	0	SENT_318	[p17l614t2315r634b2335],
9	39	CD	NUMBER	39	dep	4	SENT_318	[p17l648t2314r682b2335],
10	.	.	O	.	_	0	SENT_318	[p17l648t2314r682b2335],

1	35	CD	NUMBER	35	num	3	SENT_319	[p17l1106t1972r1134b1993],
2	Trent	JJ	PERSON	trent	amod	3	SENT_319	[p17l1153t1971r1222b1993],
3	J	NN	PERSON	j	_	0	SENT_319	[p17l1233t1972r1249b1997],
4	,	,	O	,	_	0	SENT_319	[p17l1233t1972r1249b1997],
5	Halem	NNP	O	Halem	nn	6	SENT_319	[p17l1262t1970r1344b1993],
6	M	NNP	O	M	appos	3	SENT_319	[p17l1356t1972r1390b1996],
7	,	,	O	,	_	0	SENT_319	[p17l1356t1972r1390b1996],
8	French	NNP	MISC	French	nn	9	SENT_319	[p17l1402t1970r1487b1993],
9	LE	NNP	O	LE	appos	3	SENT_319	[p17l1499t1972r1538b1996],
10	,	,	O	,	_	0	SENT_319	[p17l1499t1972r1538b1996],
11	Kerdel	NNP	O	Kerdel	nn	15	SENT_319	[p17l1551t1970r1632b1993],
12	F.	NNP	O	F.	nn	15	SENT_319	[p17l1643t1972r1664b1993],
13	Toxic	JJ	O	toxic	amod	15	SENT_319	[p17l1677t1971r1747b1993],
14	epidermal	JJ	O	epidermal	amod	15	SENT_319	[p17l1759t1970r1883b2000],
15	necrolysis	NN	O	necrolysis	appos	3	SENT_319	[p17l1895t1970r2016b2000],
16	and	CC	O	and	_	0	SENT_319	[p17l2028t1970r2074b1993],
17	intravenous	JJ	O	intravenous	amod	18	SENT_319	[p17l1154t2009r1300b2031],
18	immunoglobulinz	NN	O	immunoglobulinz	appos	3	SENT_319	[p17l1312t2008r1531b2038],
19	a	DT	O	a	det	20	SENT_319	[p17l1544t2016r1556b2031],
20	review	NN	O	review	dep	15	SENT_319	[p17l1568t2009r1654b2031],
21	.	.	O	.	_	0	SENT_319	[p17l1568t2009r1654b2031],

1	Semin	NNP	O	Semin	nn	2	SENT_320	[p17l1667t2009r1741b2031],
2	Cutan	NNP	O	Cutan	nsubj	3	SENT_320	[p17l1754t2009r1828b2031],
3	Med	VBD	O	med	_	0	SENT_320	[p17l1839t2008r1895b2031],
4	Surg	NNP	O	Surg	dobj	3	SENT_320	[p17l1906t2009r1962b2038],
5	2006	CD	DATE	2006	num	4	SENT_320	[p17l1972t2010r2036b2034],
6	;	:	O	;	_	0	SENT_320	[p17l1972t2010r2036b2034],
7	25	CD	NUMBER	25	num	9	SENT_320	[p17l1153t2048r1189b2069],
8	:	:	O	:	_	0	SENT_320	[p17l1153t2048r1189b2069],
9	91-93	CD	DATE	91-93	dep	4	SENT_320	[p17l1202t2048r1282b2069],
10	.	.	O	.	_	0	SENT_320	[p17l1202t2048r1282b2069],

1	36	CD	NUMBER	36	num	2	SENT_321	[p17l1106t2086r1134b2107],
2	Prins	NNS	ORGANIZATION	prin	_	0	SENT_321	[p17l1153t2085r1217b2107],
3	C	NN	ORGANIZATION	c	dep	2	SENT_321	[p17l1229t2085r1255b2110],
4	,	,	O	,	_	0	SENT_321	[p17l1229t2085r1255b2110],
5	Kerdel	NNP	O	Kerdel	nn	6	SENT_321	[p17l1267t2084r1348b2107],
6	FA	NNP	O	FA	appos	3	SENT_321	[p17l1360t2086r1401b2110],
7	,	,	O	,	_	0	SENT_321	[p17l1360t2086r1401b2110],
8	Padilla	NNP	O	Padilla	nn	9	SENT_321	[p17l1414t2084r1498b2107],
9	RS	NN	O	r	appos	3	SENT_321	[p17l1509t2085r1542b2107],
10	et	FW	O	et	nn	11	SENT_321	[p17l1555t2089r1576b2107],
11	al.	FW	O	al.	dep	9	SENT_321	[p17l1586t2084r1613b2107],
12	.	.	O	.	_	0	SENT_321	[p17l1586t2084r1613b2107],

1	Toxic	JJ	O	toxic	_	0	SENT_322	[p17l1626t2085r1696b2107],
2	epidermal	JJ	O	epidermal	amod	4	SENT_322	[p17l1708t2084r1833b2114],
3	necrolysisintravenous	JJ	O	necrolysisintravenous	amod	4	SENT_322	[p17l1844t2084r2075b2114, p17l1153t2130r1213b2145],
4	immunoglobulin	NN	O	immunoglobulin	dep	1	SENT_322	[p17l1225t2122r1443b2152],
5	.	.	O	.	_	0	SENT_322	[p17l1225t2122r1443b2152],

1	Treatment	NN	O	treatment	_	0	SENT_323	[p17l1456t2123r1587b2145],
2	of	IN	O	of	_	0	SENT_323	[p17l1599t2122r1626b2145],
3	toxic	JJ	O	toxic	amod	5	SENT_323	[p17l1634t2123r1695b2145],
4	epidermal	JJ	O	epidermal	amod	5	SENT_323	[p17l1707t2122r1831b2152],
5	necrolysis	NN	O	necrolysis	prep_of	1	SENT_323	[p17l1843t2122r1964b2152],
6	with	IN	O	with	_	0	SENT_323	[p17l1975t2122r2031b2145],
7	high	JJ	O	high	amod	11	SENT_323	[p17l1153t2160r1276b2190],
8	—	NN	O	—	nn	11	SENT_323	[p17l1153t2160r1276b2190],
9	dose	NN	O	dose	nn	11	SENT_323	[p17l1153t2160r1276b2190],
10	intravenous	JJ	O	intravenous	amod	11	SENT_323	[p17l1288t2161r1434b2183],
11	immunoglobulins	NNS	O	immunoglobulin	prep_with	5	SENT_323	[p17l1447t2160r1676b2190],
12	:	:	O	:	_	0	SENT_323	[p17l1447t2160r1676b2190],
13	multicenter	JJ	O	multicenter	amod	14	SENT_323	[p17l1689t2160r1834b2183],
14	retrospective	JJ	O	retrospective	amod	15	SENT_323	[p17l1845t2161r2005b2190],
15	analysis	NN	O	analysis	dep	1	SENT_323	[p17l2016t2160r2077b2183, p17l1152t2199r1196b2228],
16	of	IN	O	of	_	0	SENT_323	[p17l1208t2198r1236b2221],
17	48	CD	NUMBER	48	num	19	SENT_323	[p17l1243t2200r1271b2221],
18	consecutive	JJ	O	consecutive	amod	19	SENT_323	[p17l1284t2199r1428b2221],
19	cases	NNS	O	case	prep_of	15	SENT_323	[p17l1440t2206r1506b2221],
20	.	.	O	.	_	0	SENT_323	[p17l1440t2206r1506b2221],

1	Arch	NNP	O	Arch	nn	2	SENT_324	[p17l1518t2198r1576b2221],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_324	[p17l1587t2198r1703b2221],
3	2003	CD	DATE	2003	num	2	SENT_324	[p17l1714t2200r1779b2225],
4	;	:	O	;	_	0	SENT_324	[p17l1714t2200r1779b2225],
5	139	CD	NUMBER	139	num	7	SENT_324	[p17l1793t2200r1842b2221],
6	:	:	O	:	_	0	SENT_324	[p17l1793t2200r1842b2221],
7	26-32	CD	NUMBER	26-32	dep	2	SENT_324	[p17l1855t2200r1935b2221],
8	.	.	O	.	_	0	SENT_324	[p17l1855t2200r1935b2221],

1	37	CD	NUMBER	37	num	2	SENT_325	[p17l1106t2238r1134b2259],
2	Viard	NNP	O	Viard	_	0	SENT_325	[p17l1152t2236r1223b2259],
3	I	PRP	O	I	dep	2	SENT_325	[p17l1234t2238r1250b2262],
4	,	,	O	,	_	0	SENT_325	[p17l1234t2238r1250b2262],
5	Wehrli	NNP	PERSON	Wehrli	nn	6	SENT_325	[p17l1261t2236r1347b2259],
6	P	NN	O	p	appos	3	SENT_325	[p17l1359t2238r1382b2262],
7	,	,	O	,	_	0	SENT_325	[p17l1359t2238r1382b2262],
8	Bullani	JJ	O	bullani	amod	9	SENT_325	[p17l1394t2236r1482b2259],
9	R	NN	O	r	appos	3	SENT_325	[p17l1494t2238r1513b2259],
10	et	FW	O	et	nn	11	SENT_325	[p17l1524t2241r1545b2259],
11	al.	FW	O	al.	dep	9	SENT_325	[p17l1555t2236r1582b2259],
12	.	.	O	.	_	0	SENT_325	[p17l1555t2236r1582b2259],

1	Inhibition	NN	O	inhibition	_	0	SENT_326	[p17l1595t2236r1722b2259],
2	of	IN	O	of	_	0	SENT_326	[p17l1734t2236r1761b2259],
3	toxic	JJ	O	toxic	amod	5	SENT_326	[p17l1768t2237r1830b2259],
4	epidermal	JJ	O	epidermal	amod	5	SENT_326	[p17l1841t2236r1966b2266],
5	necrolysis	NN	O	necrolysis	prep_of	1	SENT_326	[p17l1977t2236r2078b2266, p17l1154t2275r1182b2297],
6	by	IN	O	by	_	0	SENT_326	[p17l1193t2274r1224b2304],
7	blockade	NN	O	blockade	prep_by	5	SENT_326	[p17l1234t2274r1345b2297],
8	of	IN	O	of	_	0	SENT_326	[p17l1357t2274r1384b2297],
9	CD95	NN	O	cd95	prep_of	1	SENT_326	[p17l1392t2275r1463b2297],
10	with	IN	O	with	_	0	SENT_326	[p17l1474t2274r1530b2297],
11	human	JJ	O	human	amod	13	SENT_326	[p17l1541t2274r1630b2297],
12	intravenous	JJ	O	intravenous	amod	13	SENT_326	[p17l1642t2275r1788b2297],
13	immunoglobulin	NN	O	immunoglobulin	prep_with	1	SENT_326	[p17l1801t2274r2019b2304],
14	.	.	O	.	_	0	SENT_326	[p17l1801t2274r2019b2304],

1	Science	NN	O	science	_	0	SENT_327	[p17l1154t2313r1239b2335],
2	1998	CD	DATE	1998	num	1	SENT_327	[p17l1253t2314r1315b2338],
3	;	:	O	;	_	0	SENT_327	[p17l1253t2314r1315b2338],
4	282	CD	NUMBER	282	num	6	SENT_327	[p17l1328t2314r1378b2335],
5	:	:	O	:	_	0	SENT_327	[p17l1328t2314r1378b2335],
6	490-493	CD	NUMBER	490-493	dep	1	SENT_327	[p17l1391t2314r1501b2335],
7	.	.	O	.	_	0	SENT_327	[p17l1391t2314r1501b2335],

1	©	RB	O	©	dep	2	SENT_328	[p17l1840t2418r1859b2437],
2	2011	CD	DATE	2011	dep	4	SENT_328	[p17l1870t2417r1923b2437],
3	The	DT	O	the	det	4	SENT_328	[p17l1937t2417r1980b2437],
4	Authors	NNPS	O	Authors	dep	5	SENT_328	[p17l1990t2417r2079b2437],
5	IEADV	NNP	O	IEADV	dep	20	SENT_328	[p17l79t2451r178b2478],
6	2012	CD	DATE	2012	num	5	SENT_328	[p17l185t2454r249b2477],
7	,	,	O	,	_	0	SENT_328	[p17l185t2454r249b2477],
8	26	CD	NUMBER	26	num	5	SENT_328	[p17l260t2454r295b2477],
9	,	,	O	,	_	0	SENT_328	[p17l260t2454r295b2477],
10	1424-1430	CD	DATE	1424-1430	num	11	SENT_328	[p17l309t2454r438b2474],
11	Journal	NNP	O	Journal	appos	5	SENT_328	[p17l558t2454r641b2474],
12	of	IN	O	of	_	0	SENT_328	[p17l652t2454r674b2474],
13	the	DT	O	the	det	15	SENT_328	[p17l682t2454r718b2474],
14	European	JJ	ORGANIZATION	european	amod	15	SENT_328	[p17l729t2454r838b2479],
15	Academy	NN	ORGANIZATION	academy	prep_of	5	SENT_328	[p17l848t2454r958b2479],
16	of	IN	ORGANIZATION	of	_	0	SENT_328	[p17l967t2454r989b2474],
17	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	15	SENT_328	[p17l999t2454r1145b2479],
18	and	CC	O	and	_	0	SENT_328	[p17l1154t2454r1197b2474],
19	Venereology	NNP	O	Venereology	conj_and	17	SENT_328	[p17l1207t2454r1350b2479],
20	©	CD	NUMBER	©	dep	23	SENT_328	[p17l1360t2455r1379b2474],
21	2011	CD	DATE	2011	num	23	SENT_328	[p17l1390t2454r1443b2474],
22	European	JJ	ORGANIZATION	european	amod	23	SENT_328	[p17l1459t2454r1568b2479],
23	Academy	NN	ORGANIZATION	academy	_	0	SENT_328	[p17l1578t2454r1688b2479],
24	of	IN	ORGANIZATION	of	_	0	SENT_328	[p17l1697t2454r1719b2474],
25	Dermatology	NNP	ORGANIZATION	Dermatology	prep_of	23	SENT_328	[p17l1729t2454r1875b2479],
26	and	CC	O	and	_	0	SENT_328	[p17l1884t2454r1926b2474],
27	Venereology	NNP	O	Venereology	prep_of	23	SENT_328	[p17l1936t2454r2080b2479],

